,input,Generated Text,Actual Text
0,"summarize: These true cramps, which originate from peripheral nerves, may be distinguished from other muscle pain or spasm.","These true cramps, which originate from peripheral nerves, may be distinguished from other muscle pain or spasm.","These true cramps, coming from nerves outside the brain and spinal cord, may be identifiable from other muscle pains."
1,"summarize: Medical history, physical examination, and a limited laboratory screen help to determine the various causes of muscle cramps.","medical history, physical examination, and a limited lab screen help to determine the various causes of muscle cramps.","Medical history, physical check-up, and lab screenings help determine different causes of muscle cramps."
2,summarize: Treatment options are guided both by experience and by a limited number of therapeutic trials.,Treatment options are guided both by experience and by a limited number of clinical trials.,Experience and limited medical studies guide treatment.
3,"summarize: Quinine sulfate is an effective medication, but the side-effect profile is worrisome, and other membrane-stabilizing drugs are probably just as effective.","quinoine sulfate is an effective medication, but the side-effect profile is worrisome. Other drugs that stabilize membranes are probably just as effective.","Quinine sulfate (an antimalarial drug) helps, but its side-effects are problematic. Similar drugs may be just as helpful."
4,"summarize: If a cause is identified, specific etiology-based treatments may be available.","If a cause is identified, specific causes-based treatments may be available.","If a cause is found, specific cause-based treatments may be available."
5,"summarize: In most cases, a specific cause cannot be identified, and treatments are based on symptoms.","In most cases, a specific cause cannot be identified, and treatments are based on symptoms.","In most cases, a specific cause cannot be found, and treatments are based on symptoms."
6,"summarize: Muscle cramps result in continuous, involuntary, painful, and localized contraction of an entire muscle group, individual single muscle, or select muscle fibers.","Muscle cramps result in continuous, involuntary, painful, and localized contraction of an entire muscle group, single muscle, or select muscle fibers.","Muscle cramps cause constant and unintended contraction of muscles, causing pain. They can occur for individual muscles, groups of muscles, or small parts of muscles."
7,"summarize: Despite scientists tried to understand the physiological mechanism that underlies these common phenomena, the etiology is still unclear.","Despite scientists trying to understand the physiological mechanism that underlies these common phenomena, the cause is still unclear.","Scientists have tried to explain why these cramps happen, but have not been able to."
8,"summarize: From the initial literature of 424 manuscripts, sixty-nine manuscripts were included, analyzed, compared and summarized.","59 manuscripts were included, analyzed, compared and summarized.",The search returned 424 papers. We read and analyzed 69 of them.
9,summarize: Literature analysis indicates that neuromuscular hypothesis may prevails over the initial hypothesis of the dehydration as the trigger event of muscle cramps.,a study shows that neuromuscular hypothesis may prevail over the initial hypothesis of dehydration as the trigger event of muscle cramps.,"From the latest evidence, interactions of nerves with muscles explains muscle cramps better than dehydration."
10,summarize: Current treatment options are correspondingly limited.,Current treatment options are correspondingly limited.,Current treatment is limited.
11,"summarize: Dystonia can be the manifesting neurological sign of many disorders, either in isolation (isolated dystonia) or with additional signs (combined dystonia).","Dystonia can be the manifesting neurological sign of many disorders, either in isolation (isolated dystonia) or with additional signs (combined dystonia).","Dystonia could be a sign of many underlying disorders, sometimes with other symptoms and sometimes not."
12,"summarize: The causes of, and cures for, the cramps that occur during or soon after exercise remain uncertain, although there is evidence that some cases may be associated with disturbances of water and salt balance, while others appear to involve sustained abnormal spinal reflex activity secondary to fatigue of the affected muscles.","The causes of, and cures for, the cramps that occur during or soon after exercise are uncertain. However, there is evidence that some cases may be associated with disturbances in water and salt balance, while others appear to involve sustained abnormal spinal reflex activity secondary to fatigue of the affected muscles.","The causes of and cures for exercise-related cramps remain unknown. However, some cases may be linked with disturbances of water and salt balance, while others may be from constant abnormal spinal reflex activity linked to fatigue of the affected muscles."
13,"summarize: Typically, such cramps have no obvious underlying pathology, and so are termed idiopathic.","Typically, such cramps have no obvious cause, and so are termed idiopathic.","Usually, muscle cramps have no obvious cause."
14,summarize: Magnesium supplements are marketed for the prophylaxis of cramps but the efficacy of magnesium for this purpose remains unclear.,"Magnesium supplements are marketed for the prevention of cramps, but the effectiveness of magnesium for this purpose remains unclear.","Magnesium supplements are used for preventing cramps, but their effectiveness is unclear."
15,"summarize: This is an update of a Cochrane Review first published in 2012, and performed to identify and incorporate more recent studies.","This is an update of a Cochrane Review first published in 2012, and performed to identify and incorporate more recent studies.",nan
16,"summarize: The body mass was measured at 20 min and every 10 min thereafter during DHR, and 30 min post-DHR.","The body mass was measured at 20 minutes and every 10 minutes thereafter during DHR, and 30 minutes post-DHR.","Their weights were measured 20 minutes into the exercise, then every 10 minutes, and then 30 minutes after the exercise was completed."
17,"summarize: Blood samples were taken before, immediately after and 65 min after DHR to measure serum sodium, potassium, magnesium and chroride concentrations, hematocrit (Hct), hemoglobin (Hb), and serum osmolarity.","Blood samples were taken before, immediately after and 65 minutes after DHR to measure blood sodium, potassium, magnesium and chroride concentrations, hemoglobin (Hb), and serum osmolarity.",nan
18,"summarize: Here, the gut microbiota of 57 patients with isolated dystonia and 27 age- and environment-matched healthy controls was analyzed by 16S rRNA gene amplicon sequencing.",the gut microbiota of 57 patients with dystonia and 27 healthy controls were analyzed.,"Here, the gut microbiota of 57 patients with dystonia and 27 age- and environment-matched healthy patients was analyzed by 16S DNA sequencing."
19,"summarize: The most significant changes in dystonia highlighted an increase in Clostridiales, including Blautia obeum, Dorea longicatena, and Eubacterium hallii, and a reduction in Bacteroides vulgatus and Bacteroides plebeius.","the most significant changes in dystonia highlighted an increase in Clostridiales, including Blautia obeum, Dorea longicatena, and Eubacterium hallii, and a reduction in Bacteroides vulgatus and Bacteroides plebeius.","The most different change in dystonia showed an increase in certain types of microorganisms labeled Clostridiales, including Blautia obeum, Dorea longicatena, and Eubacterium hallii, and a reduction in other microorganisms labeled Bacteroides vulgatus and Bacteroides plebeius."
20,"summarize: The gut microbiome changes provide new insight into the pathogenesis of dystonia, suggesting new potential therapeutic directions.","gut microbiome changes provide new insight into the development of dystonia, suggesting new treatments.","The gut microbiome changes provide new insight into the cause of dystonia, suggesting new potential treatment directions."
21,summarize: The pudendal somatic motor nucleus of the spinal cord is densely innervated by 5HT and NE terminals.,the spinal cord is densely innervated by 5HT and NE terminals.,The chemical messengers serotonin (5HT) and norepinephrine (NE) go to one particular part of the spinal cord.
22,summarize: The action of duloxetine in the treatment of stress urinary incontinence is associated with reuptake inhibition of serotonin and norepinephrine at the presynaptic neuron in Onuf's nucleus of the sacral spinal cord.,duloxetine is associated with reuptake inhibition of serotonin and norepinephrine at the presynaptic neuron in the sacral spinal cord.,Duloxetine works for the treatment of bladder problems by increasing the amount of the chemical messengers 5HT and NE for use in one special area of the spinal cord
23,"summarize: Numerous studies have implicated the neurotransmitters, serotonin and norepinephrine in the central neural control of the lower urinary tract function.","Numerous studies have implicated the neurotransmitters, serotonin and norepinephrine in the central neural control of the lower urinary tract function.","Chemical messengers, such as serotonin and norepinephrine, in the brain and spinal cord may control function of the bladder area."
24,summarize: The elimination half-life of duloxetine is approximately 10-12 hours and the volume of distribution is approximately 1640 L.,the half-life of duloxetine is about 10-12 hours and the volume of distribution is approximately 1640 L.,nan
25,summarize: The goal of this paper is to provide a review of the literature on intrinsic and extrinsic factors that may impact the pharmacokinetics of duloxetine with a focus on concomitant medications and their clinical implications.,the goal of this paper is to provide a review of the literature on intrinsic and external factors that may impact the drug-related effects of duloxetine with a focus on concomitant medications and their clinical implications.,The goal of this paper is to look at other studies on duloxetine to see if the drug can be used with other drugs.
26,"summarize: Pharmacodynamic study results indicate that duloxetine may enhance the effects of benzodiazepines, but not alcohol or warfarin.","duloxetine may enhance the effects of benzodiazepines, but not alcohol or warfarin.","Studies show that duloxetine may make tranquilizers like valium and xanax stronger, but does not seem to affect alcohol or the blood thinner warfarin."
27,summarize: An increase in gastric pH produced by histamine H(2)-receptor antagonists or antacids did not impact the absorption of duloxetine.,an increase in gastric pH produced by histamine H(2)-receptor antagonists or antacids did not impact the absorption of duloxetine.,Antacids and other stomach acid blockers do not affect duloxetine.
28,"summarize: Despite the widespread use of these drugs, the mechanism underlying their therapeutic action in this pain context remains partly elusive.","Despite the widespread use of these drugs, the mechanism behind their treatment in this pain context remains partly unknown.",Doctors do not yet understand how exactly these drugs treat chronic pain.
29,summarize: The present study combined data collected in male and female mice from a model of neuropathic pain and data from the clinical setting to understand how antidepressant drugs act.,the present study combined data collected in male and female mice from a model of nerve pain and data from the clinical setting to understand how antidepressant drugs work.,This study combines the results of a study done on mice and a study done on humans to try to understand how the antidepressants work on pain.
30,"summarize: The second mechanism is delayed, peripheral, and requires noradrenaline from peripheral sympathetic endings and Î22 adrenoceptors, as well as the delta opioid receptors.","the second mechanism is delayed, and requires noradrenaline from sympathetic endings and Î22 adrenoceptors, as well as the delta opioid receptors.",The other way duloxetine and amitriptyline work is by affecting the nerves in a delayed way using different chemical messengers.
31,summarize: Our study highlights a peripheral neuroimmune component of antidepressant drugs that is relevant to their delayed therapeutic action against neuropathic pain.,the study highlights a peripheral neuroimmune component of antidepressant drugs that is relevant to their delayed therapeutic action against neuropathic pain.,This study shows a delayed way that antidepressant drugs use to treat chronic pain.
32,summarize: The present study combined data collected in male and female mice from a model of neuropathic pain and data from the clinical setting to understand how antidepressant drugs act.,the present study combined data collected in male and female mice from a model of nerve pain and data from the clinical setting to understand how antidepressant drugs work.,This study examined mice with this type of pain to learn more.
33,"summarize: SIGNIFICANCE STATEMENT In addition to treating depression, antidepressant drugs are also a first-line treatment for neuropathic pain, which is pain secondary to lesion or pathology of the nervous system.","Antidepressant drugs are also a first-line treatment for nerve pain, which is pain secondary to damage or disease of the nervous system.","Antidepressant drugs, aside from treating depression, are also an important treatment for pain that comes from sensory nerve disorders."
34,"summarize: However, the mechanism by which antidepressant drugs can relieve neuropathic pain remained in part elusive.","However, the mechanism by which antidepressant drugs can relieve nerve pain remained in part unknown.","However, we still don't know why antidepressants work for this type of pain."
35,summarize: This chapter covers antidepressants that fall into the class of serotonin (5-HT) and norepinephrine (NE) reuptake inhibitors.,This chapter covers antidepressants that block the release of serotonin (5-HT) and norepinephrine (NE).,This chapter talks about the antidepressant drugs that are called serotonin (5-HT) and norepinephrine (NE) reuptake inhibitors.
36,"summarize: It is also a moderate inhibitor of CYP2D6, so that modest dose reductions and careful monitoring will be needed when prescribing duloxetine in combination with drugs that are preferentially metabolized by CYP2D6.","duloxetine is also a moderate inhibitor of CYP2D6, so that modest dose reductions and careful monitoring will be needed when prescribing duloxetine in combination with drugs that are preferentially metabolized by CYP2D6.",The way that duloxetine works means that doctors will have to watch you closely and may have to adjust your dose if you are taking certain types of other drugs.
37,summarize: All medications in the class can cause serotonin syndrome when combined with MAOIs.,All drugs in the class can cause serotonin syndrome when combined with MAOIs.,Drugs in the 5-HT and NE reuptake inhibitor class can make you very sick if taken with drugs that are in the MAOI class of antidepressants.
38,summarize: An association was also found with eight other antidepressants.,An association was also found with eight other antidepressants.,Eight other antidepressants were linked to movement disorder side effects.
39,"summarize: Conclusions: A potential harmful association was found between movement disorders and use of the antidepressants mirtazapine, vortioxetine, amoxapine, phenelzine, tryptophan, fluvoxamine, citalopram, paroxetine, duloxetine, bupropion, clomipramine, escitalopram, fluoxetine, mianserin, sertraline, venlafaxine and vilazodone.",a potential harmful link was found between movement disorders and use of antidepressants.,"This study found that movement disorder side effects were linked to the antidepressants mirtazapine, vortioxetine, amoxapine, phenelzine, tryptophan, fluvoxamine, citalopram, paroxetine, duloxetine, bupropion, clomipramine, escitalopram, fluoxetine, mianserin, sertraline, venlafaxine, and vilazodone."
40,summarize: This case report is a possible case of hypertensive urgency after the initiation of duloxetine managed with antihypertensives and resolves with the discontinuation of the duloxetine.,this case report is a possible case of hypertensive urgency after the start of duloxetine managed with antihypertensives and resolves with the stoppage of the duloxetine.,This paper reports on a case of high blood pressure caused by the drug duloxetine. It was treated with drugs that treat high blood pressure and went back to normal after the patient stopped taking duloxetine.
41,summarize: The participants filled out and completed the Beck Depression Scale.,The participants filled out and completed the Beck Depression Scale.,Patients filled our a form to measure their level of depression.
42,"summarize: Results: All conventional dry eye tests and tear meniscus parameters were significantly lesser in the depression group than in the control group (Schirmer test, 11.41  6.73 mm and 22.53  4.98 mm; TBUT, 5.29  2.92 seconds and 13.38  1.72; Corneal staining, tear meniscus area, 0.026  0.012 mm2 and 0.11  0.025 mm2; tear meniscus depth, 182.75  78.79 Î14m and 257.48  90.1 Î14m; tear meniscus height, 290.3  133.63 Î14m and 459.78  180.26 Î14m, in patients and controls, respectively).",the depression group had significantly less dry eye and tear meniscus measurements than the control group.,Those people taking antidepressant drugs had drier eyes than those that were not taking antidepressant drugs.
43,"summarize: The tear parameters of the duloxetine group were lowest among the drug groups and Schirmer test, and TBUT of the venlafaxine group was statistically significantly different from the duloxetine group (P = 0.028 and P = 0.017, respectively).","the tear parameters of the duloxetine group were lowest among the drug groups and Schirmer test, and TBUT of the venlafaxine group was statistically significantly different from the duloxetine group.",The people taking duloxetine had the driest eyes.
44,summarize: Methods: We recruited 132 patients who were using different antidepressants and 58 healthy controls.,132 patients were using different antidepressants and 58 healthy controls.,We included 132 patients using different antidepressants and 58 healthy people.
45,summarize: The participants filled out and completed the Beck Depression Scale.,The participants filled out and completed the Beck Depression Scale.,Participants filled out a questionnaire to measure depression.
46,"summarize: Atraumatic trismus can be one of the presentations of medication-induced acute dystonia, particularly by antipsychotics and less commonly antidepressants.","Atraumatic trismus can be one of the signs of medication-induced acute dystonia, particularly by antipsychotics and less commonly antidepressants.","A stiff jaw is a possible side effect of taking certain medications, such as antidepressant drugs or drugs called antipsychotics."
47,summarize: A case of an unusual emergency presentation of atraumatic trismus on initiation of duloxetine is reported.,a case of an unusual emergency presentation of atraumatic trismus on starting of duloxetine is reported.,Here is an example of someone who visited the ER with a severely stiff jaw after taking the drug duloxetine.
48,"summarize: Clinicians should be aware of this risk, especially considering the limitation of important physiological functions (such as swallowing, eating, etc) associated with this condition.","Clinicians should be aware of this risk, especially considering the limitation of important physiological functions associated with this condition.",Doctors should be aware of the risk of jaw stiffness since it could lead to very serious problems.
49,summarize: Methods: This is a re-analysis of a placebo-controlled duloxetine trial for juvenile fibromyalgia based on the main journal article and additional data published in the online supplementary material and on ClinicalTrials.gov.,this is a re-analysis of a placebo-controlled duloxetine trial for juvenile fibromyalgia based on the main journal article and additional data published in the online supplementary material and on ClinicalTrials.gov.,This study looks at data from another study where teens with chronic pain known as fibromyalgia were treated with an antidepressant called duloxetine.
50,"summarize: Results: We found that a significant portion of adolescents had treatment-emergent suicidal ideation and behaviour as well as other severe psychiatric adverse events with duloxetine, but no such events were recorded on placebo.","a large portion of adolescents had suicidal ideation and other severe mental side effects with duloxetine, but no such events were recorded on placebo.",We found that a significant portion of the adolescents on duloxetine had suicidal tendencies and other serious mental side effects. None of these problems were seen in the participants that weren't taking duloxetine.
51,"summarize: In patients with diabetic nephropathy, hyperkalemia may be caused by the syndrome of hyporeninemic hypoaldosteronism.","Hyperkalemia may be caused by hyporeninemic hypoaldosteronism, a condition in which the kidneys are not properly balanced.",Hyperkalemia can also be caused by other syndromes or conditions in patients with kidney diseases that are caused by diabetes.
52,summarize: The presence of typical electrocardiographic changes or a rapid rise in serum potassium indicates that hyperkalemia is potentially life threatening.,the presence of typical electrocardiographic changes or a rapid rise in blood potassium indicates that hyperkalemia is potentially life threatening.,Signs that hyperkalemia may be life-threatening include EKG changes that are typically seen with high potassium levels or by a rapid rise in potassium levels on a blood test.
53,summarize: Hyperkalemia is a clinically important electrolyte abnormality that occurs most commonly in patients with chronic kidney disease.,Hyperkalemia is a clinically important electrolyte abnormality that occurs most commonly in patients with chronic kidney disease.,Hyperkalemia is a condition where the potassium level in the blood is higher than normal. Potassium is a very important mineral in the body. Hyperkalemia is a important problem that happens mostly in people with long-lasting kidney disease.
54,"summarize: This review article provides an overview of the physiology and the pathophysiology of potassium metabolism and hyperkalemia, the epidemiology of hyperkalemia, and its acute and chronic management.","This review article provides an overview of the physiology and pathophysiology of potassium metabolism and hyperkalemia, the epidemiology of hyperkalemia, and its immediate and long-term management.",This research studies the way potassium is handled in the body under normal conditions and in hyperkalemia. it also studies hyperkalemia in the population and how doctors treat rapidly occurring and ongoing hyperkalemia.
55,summarize: Hyperkalemia is a clinically important electrolyte abnormality that occurs most commonly in patients with chronic kidney disease.,Hyperkalemia is a clinically important electrolyte abnormality that occurs most commonly in patients with chronic kidney disease.,Hyperkalemia (high blood potassium) is a medical issue common in patients with long-lasting kidney disease.
56,summarize: Two investigational drugs for the treatment of hyperkalemia are being evaluated in Phase III trials: sodium zirconium cyclosilicate and patiromer.,two new drugs for hyperkalemia are being evaluated in Phase III trials: sodium zirconium cyclosilicate and patiromer.,Two new drugs are being researched for the treatment of hyperkalemia in new patient studies (clinical trials). Their names are sodium zirconium cyclosilicate and patiromer.
57,summarize: The safety and efficacy of sodium zirconium cyclosilicate and patiromer were evaluated in Phase II and III trials.,The safety and effectiveness of sodium zirconium cyclosilicate and patiromer were evaluated in Phase II and III trials.,These drugs have already been studied in people for their safety and effectiveness in past clinical trials.
58,"summarize: The overall frequency of adverse effects in these clinical trials was low, with gastrointestinal adverse events being the most commonly observed.","the overall frequency of adverse effects in these clinical trials was low, with stomach side effects being the most common.",The overall number of side effects in these patient studies was low. The most common side effects seen were related to the gastrointestinal tract.
59,"summarize: While this strategy is usually successful, it also deprives patients of the recognized benefits of this class, such as their renoprotective effects.","While this strategy is usually successful, it also deprives patients of the recognized benefits of this class, such as their renoprotective effects.","While stopping these medicines usually works well to lower the potassium level, patients miss out on the known kidney protection this class of drugs can give."
60,"summarize: Hypokalemia (ie, potassium levels less than 3.5 mEq/L) occurs in fewer than 1% of healthy individuals, but is present in up to 20% of hospitalized patients, 40% of patients taking diuretics, and 17% of patients with cardiovascular conditions.","Hypokalemia (ie, potassium levels less than 3.5 mEq/L) occurs in fewer than 1% of healthy individuals, but is present in up to 20% of hospitalized patients, 40% of patients taking diuretics, and 17% of patients with heart conditions.","Hypokalemia is a condition where the potassium level in the blood is less than normal. Potassium is a very important mineral in the body. Hypokalemia rarely happens in healthy people. It happens commonly In patients in the hospital, on diuretics, or with heart and circulation conditions."
61,"summarize: Urgent management includes intravenous calcium, intravenous insulin, and inhaled beta agonists.","Urgent management includes intravenous calcium, intravenous insulin, and inhaled beta agonists.","This urgent treatment includes IV calcium, IV insulin, and medicines given by an inhalers (called beta-agonists)."
62,summarize: Hemodialysis can be used in urgent situations.,Hemodialysis can be used in urgent situations.,Kidney dialysis can be used in urgent situations
63,"summarize: Cell shift leads to transient increases in the plasma potassium concentration, whereas decreased renal excretion of potassium leads to sustained hyperkalemia.","Cell shift leads to temporary increases in the blood potassium concentration, whereas decreased kidney excretion of potassium leads to sustained hyperkalemia.","Hyperkalemia is temporary when too much comes out of the cells into the bloodstream. But, when the kidneys cannot get rid of enough potassium from the body, the hyperkalemia can last a longer time."
64,summarize: We discuss the clinical manifestations of hyperkalemia and outline an approach to its diagnosis and treatment.,the authors discuss the symptoms of hyperkalemia and outline an approach to its diagnosis and treatment.,"In this paper, we talk about how hyperkalemia can effect you. We also talk about how doctors can diagnose and treat it"
65,"summarize: Purpose of review: Hyperkalemia is a potentially fatal electrolyte disorder, more commonly present when the potassium excretion capacity is imparied.","Hyperkalemia is a potentially fatal electrolyte disorder, more commonly present when the potassium excretion capacity is imparied.",Hyperkalemia is a condition where the potassium level in the blood is higher than normal. Potassium is a very important mineral (electrolyte) in the body. Hyperkalemia is a potentially fatal electrolyte disorder. It more likely occurs when the body cannot get rid of potassium as well as it should.
66,summarize: Randomized trials have shown that the new anti-hyperkalemic agents (patiromer and zirconium cyclosilicate) are effective hyperkalemia treatment options.,Randomized trials have shown that the new anti-hyperkalemia drugs (patiromer and zirconium cyclosilicate) are effective hyperkalemia treatment options.,Patient studies have shown that the new drugs to treat hyperkalemia (patiromer and zirconium cyclosilicate) work well to treat hyperkalemia.
67,summarize: The use of anti-hyperkalemic agents may allow for a less restrictive potassium diet and lower RAASi discontinuation rates.,The use of anti-hyperkalemic agents may allow for a less restrictive potassium diet and lower RAASi discontinuation rates.,These new drugs may let doctors continue to use the RAAS blockers more often. Doctors may be able to recommend less strict potassium diets too.
68,summarize: These benefits include blood pressure reductions and reduced risks for cardiovascular disease and stroke.,These benefits include blood pressure reductions and reduced risks for heart disease and stroke.,"These benefits include lowering your blood pressure. The benefits also include lowering the risks for heart disease, blood vessel disease, and stroke."
69,summarize: These benefits include blood pressure reductions and reduced risks for cardiovascular disease and stroke.,These benefits include blood pressure reductions and reduced risks for heart disease and stroke.,These benefits include blood pressure reductions and lower risk of cardiovascular disease and stroke.
70,"summarize: This may allow them the health benefits of a high-potassium diet without the increased risk for hyperkalemia, although further studies are needed.","This may allow them the health benefits of a high-potassium diet without the increased risk for hyperkalemia, although further studies are needed.","New potassium-binding agents may allow the benefits of a high-potassium diet without risk of higher blood potassium. However, more studies are needed."
71,summarize: Real-world studies are needed for a better understanding of the prevalence of hyperkalemia outside the clinical trial setting.,Real-world studies are needed for a better understanding of the prevalence of hyperkalemia outside the clinical trial setting.,Real-world studies are needed to understand how many patients have hyperkalemia that are not under research.
72,summarize: Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences.,Hyperkalemia is an abnormality in electrolyte levels with potentially life-threatening consequences.,Hyperkalemia (high blood potassium) is an electrolyte issue with possibly life-threatening effects.
73,"summarize: New recommendations for the classification and diagnosis of diabetes mellitus include the preferred use of the terms ""type 1"" and ""type 2"" instead of ""IDDM"" and ""NIDDM"" to designate the two major types of diabetes mellitus; simplification of the diagnostic criteria for diabetes mellitus to two abnormal fasting plasma determinations; and a lower cutoff for fasting plasma glucose (126 mg per dL [7 mmol per L] or higher) to confirm the diagnosis of diabetes mellitus.","new recommendations for the classification and diagnosis of diabetes mellitus include the preferred use of the terms ""type 1"" and ""type 2"" instead of ""IDDM"" and ""NIDDM"" to designate the two major types of diabetes mellitus; simplification of the diagnostic criteria for diabetes mellitus to two abnormal fasting plasma measurements; and a lower cutoff for fasting blood sugar to confirm the diagnosis of diabetes mellitus.","New recommendations for classifying diabetes mellitus include using ""type 1"" and ""type 2"" instead of ""IDDM"" and ""NIDDM"" to identify the two major types of diabetes mellitus; simplifying the criteria for identifying diabetes mellitus to two unusual fasting blood scores; and a lower cutoff for fasting plasma glucose or blood sugar."
74,"summarize: Currently, only one half of the people who have diabetes mellitus have been diagnosed.","Currently, only one half of the people who have diabetes mellitus have been diagnosed.","Currently, only half of those with diabetes mellitus have been identified."
75,"summarize: The committee recommends against ""mixing different methods to diagnose diabetes"" because ""the tests are not completely concordant: using different tests could easily lead to confusion"".","the committee recommends against ""mixing different methods to diagnose diabetes"" because ""the tests are not completely concordant: using different tests could easily lead to confusion"".","The committee recommends not ""mixing different methods to diagnose diabetes"" because ""the tests are not completely concordant [or consistent]: using different tests could easily lead to confusion""."
76,"summarize: Fasting plasma glucose, 2-hour postglucose-load plasma glucose, and oral glucose tolerance tests are recommended for the diagnosis of diabetes only if HbA1c testing is not possible due to unavailability of the assay, patient factors that preclude its inter pretation, and during pregnancy.","Fasting blood sugar, 2-hour post-glucose-load plasma glucose, and oral glucose tolerance tests are recommended for the diagnosis of diabetes only if HbA1c testing is not possible due to lack of the assay, patient factors that prevent its inter pretation, and during pregnancy.",Fasting blood sugar tests and blood sugar tests after simple sugar intake may help identify diabetes only if testing for HbA1c is not possible.
77,"summarize: Our aim was to demonstrate that it is possible to detect the immunoreactivity against a combination of four different autoantigens by a single assay, this representing a rapid, low-cost first approach to evaluate humoral autoimmunity in diabetes.","the aim of this study was to show that it is possible to detect the immune response against a combination of four different autoantigens by a single test. This represents a quick, low-cost first approach to evaluate humoral autoimmunity in diabetes.","We aim to show a quick, low-cost approach for detecting these four self-made markers to check for antibody-related autoimmunity in diabetics."
78,summarize: Diagnostic criteria for diabetes in children have not been established with nearly the rigor as that employed in adults.,Detection criteria for diabetes in children have not been established with nearly the same rigorousness as that used in adults.,Standards of diagnosing diabetes in children have not been established with nearly the same precision as has been used in adults
79,summarize: Recently revised American Diabetes Association (ADA) criteria allowed utilization of hemoglobin A(1c) (HbA1c) â 6.5 % for diagnosis of diabetes.,Recently revised American Diabetes Association (ADA) criteria allowed use of hemoglobin A(1c) (HbA1c) â 6.5 % for diagnosis of diabetes.,Recently revised American Diabetes Association (ADA) guidelines uses the standard of â 6.5 % in the HbA1c test as a diagnosis of diabetes.
80,summarize: Studies to validate diagnostic thresholds in children appear unlikely to take place.,Studies to validate diagnostic thresholds in children appear unlikely to take place.,"Future studies, to see which glucose measuring test is best in children, are unlikely to happen."
81,"summarize: Thus, accepting the major ADA diagnostic criteria appears to be the best course of action for the pediatric community.",Accepting the major ADA diagnostic criteria appears to be the best course of action for the pediatric community.,Accepting the ADA guidelines for diagnosing diabetes in children appears to be the best option for pediatricians.
82,"summarize: Recently, it is possible to use HbA1c.","Recently, it is possible to use HbA1c.","Recently, it is possible to use HbA1c (a simple blood sugar test)."
83,summarize: The aim of this article is about the strong and weak points of these tests.,the aim of this article is about the strong and weak points of these tests.,This article's aim is about the strong and weak points of these tests.
84,summarize: Objective: The objective of this study was to compare the use of hemoglobin A1C to oral glucose tolerance testing to diagnose overt type 2 diabetes in the first trimester of pregnancy.,Objective: This study compares the use of hemoglobin A1C to oral glucose tolerance testing to diagnose type 2 diabetes in the first trimester of pregnancy.,The objective of this study was to compare the use of hemoglobin A1C (a simple blood sugar test) to oral (by-mouth) glucose sensitivity (tolerance) testing to diagnose before-birth type 2 diabetes in the first trimester of pregnancy.
85,summarize: Conclusion: The research provides beginning evidence that the hemoglobin A1C should be considered as a first-tier diagnostic test for overt type 2 diabetes in the first trimester of pregnancy.,the research provides beginning evidence that the hemoglobin A1C should be considered as a first-tier diagnostic test for type 2 diabetes in the first trimester of pregnancy.,"In conclusion, the research provides beginning evidence that the hemoglobin A1C should be considered as an important diagnostic test for before-birth type 2 diabetes in the first trimester of pregnancy."
86,summarize: MODY is caused by a single gene mutation.,MODY is caused by a single gene mutation.,MODY is caused by a single gene mutation.
87,"summarize: Using two genetic tests, NGS and MLPA, we detected both single nucleotide variants and large deletions in patients.","Using two genetic tests, NGS and MLPA, we detected both single nucleotide variants and large deletions in patients.","Using two genetic tests termed NGS and MLPA, we detected both small mutation types and large gene deletions in patients."
88,summarize: The rest of the variants were found in the NEUROD1 and HNF1A genes.,the rest of the variants were found in the NEUROD1 and HNF1A genes.,The rest of the different types were found in the NEUROD1 and HNF1A genes.
89,"summarize: With the establishment of copeptin, a stable and reliable surrogate marker for arginine vasopressin, diagnosis of the polyuria-polydipsia syndrome has been newly evaluated.","Copeptin, a stable and reliable marker for arginine vasopressin, is used to diagnose the polyuria-polydipsia syndrome.","With the creation of copeptin, a stable and reliable surrogate marker for arginine vasopressin (blood vessel constriction), diagnosis of the polyuria-polydipsia syndrome has been newly evaluated."
90,"summarize: Alternatively, arginine infusion can be used to stimulate copeptin release, opening the doors for an even shorter and safer diagnostic test.","Alternatively, arginine infusion can stimulate copeptin release, opening the doors for an even shorter and safer diagnostic test.","Alternatively, arginine infusion (adding a specific protein in) can be used to stimulate copeptin release, opening the doors for an even shorter and safer diagnostic test."
91,summarize: We used the Rauschning and Lindgren criteria for evaluation.,Statistical evaluation was done using the Rauschning and Lindgren criteria.,We used the Rauschning and Lindgren criteria tp evaluate knee joint symptoms.
92,"summarize: All of them had preoperative magnetic resonance imaging to confirm the diagnosis, identify the valvular opening, and the associated intra-articular pathology.","All of them had preoperative magnetic resonance imaging to confirm the diagnosis, identify the valve opening, and the associated intra-articular pathology.","All patients had pre-operation imaging to confirm the problem, identify the source, and the associated joint symptoms."
93,summarize: The intra-articular pathology should be first addressed by arthroscopy.,The intra-articular pathology should first be addressed by arthroscopy.,An orthopedic specialist should first use arthroscopy to examine the intra-articular tissue damage.
94,"summarize: Results: All patients had neither recurrence of popliteal cyst nor complaints of pain, swelling, or functional impairment at average 24 months follow-up after surgery.","All patients had neither recurrence of popliteal cyst nor complaints of pain, swelling, or functional impairment at average 24 months follow-up after surgery.","Results: All patients had neither recurrence of popliteal cyst nor complaints of pain, swelling, or functional impairment on follow-up examination an average of 24 months after surgery"
95,"summarize: Methods: From January 2013 to January 2017, 34 patients with symptomatic popliteal cysts were treated with our technique.","From January 2013 to January 2017, 34 patients with symptomatic popliteal cysts were treated with our technique.","From January 2013 to January 2017, 34 patients with symptomatic popliteal cysts were treated with our technique."
96,"summarize: Radiotherapy is known to be an effective treatment for osteoarthritis, with an anti-inflammatory effect.","Radiotherapy is known to be an effective treatment for osteoarthritis, with an anti-inflammatory effect.",Radiotherapy is an effective treatment for osteoarthritis because it targets inflammation
97,"summarize: Materials and methods: We performed a prospective trial, including 20 knees receiving radiotherapy for knee arthritis.","Materials and methods: We performed a prospective trial, including 20 knees receiving radiotherapy for knee arthritis.","To answer this question, we performed a prospective trial, where we examined 20 knees receiving radiotherapy for knee arthritis."
98,summarize: Whether radiotherapy is an effective treatment for Baker's cyst without associated osteoarthritis has to be further examined.,Whether radiotherapy is an effective treatment for Baker's cyst without associated osteoarthritis has to be further examined.,nan
99,"summarize: Besides osteoarthritis, also other joint pathologies of the knee can be causative for a Baker's cyst.","Besides osteoarthritis, also other joint pathologies of the knee can cause Baker's cyst.","Besides osteoarthritis, other knee joint diseases can lead to an uncomfortable fuild-filled swelling behind the knee."
100,"summarize: Radiotherapy is known to be an effective treatment for osteoarthritis, with an anti-inflammatory effect.","Radiotherapy is known to be an effective treatment for osteoarthritis, with an anti-inflammatory effect.","Radiation therapy treats osteoarthritis, with an anti-inflammatory effect."
101,summarize: Ultrasonic volumetry was performed using an ultrasound device with a high-resolution multifrequency linear probe (6-9 MHz).,Ultrasonic volumetry was performed using an ultrasound device with a high-resolution multifrequency linear probe (6-9 MHz).,nan
102,"summarize: Results: Low-dose radiotherapy improved NRS, WOMAC score and Knee Society Score significantly.","Low-dose radiotherapy improved NRS, WOMAC score and Knee Society Score.",Low-dose radiation therapy improves measurements for knee arthritis.
103,summarize: Conclusion: Radiotherapy of knee osteoarthritis is an effective treatment that decreases the volume of a Baker's cyst.,Conclusion: Radiotherapy of knee osteoarthritis is an effective treatment that decreases the volume of a Baker's cyst.,Radiation therapy of knee osteoarthritis decreases the size of a Baker's cyst.
104,summarize: Whether radiotherapy is an effective treatment for Baker's cyst without associated osteoarthritis has to be further examined.,Whether radiotherapy is an effective treatment for Baker's cyst without associated osteoarthritis has to be further examined.,Whether radiation therapy treats Baker's cyst without associated osteoarthritis is unknown.
105,"summarize: To reduce the damage to posteromedial knee capsule, we developed a direct extra-articular arthroscopic approach for excision of symptomatic popliteal cysts.","To reduce the damage to the posteromedial knee capsule, we developed a direct extra-articular arthroscopic approach for excision of symptomatic popliteal cysts.","Popliteal cysts, or Baker's cysts, are abnormal enlargements of the bursa (a protective fluid-filled sac) behind the knee. Arthroscopy (minimally-invasive surgery using fine instruments) is a treatment method for popliteal cysts. To reduce the damage to posteromedial (middle, side) knee capsule associated with this treatment, we have developed a direct arthroscopic approach from outside the knee joint (extra-articular) for removal of symptomatic popliteal cysts."
106,summarize: Twenty-one consecutive patients diagnosed of symptomatic popliteal cysts with failed initial conservative treatments were included.,Twenty-one consecutive patients diagnosed of symptomatic popliteal cysts with failed initial treatment were included.,We included twenty-one patients diagnosed with symptomatic popliteal cysts who had unsuccesful previous conservative treatments in our study.
107,"summarize: The current diagnostic methods include X-ray computed, ultrasound, and magnetic resonance.","The current diagnostic methods include X-ray computed, ultrasound, and magnetic resonance.","Orthopedic specialists can diagnose popliteal cysts using X-ray computed tomography (CT scan), ultrasound, or magnetic resonance imaging (MRI)."
108,"summarize: Among them, magnetic resonance imaging is considered the gold standard for the diagnosis of popliteal cysts.","Among them, magnetic resonance imaging is considered the gold standard for the diagnosis of popliteal cysts.",MRI is the gold standard for diagnosis of popliteal cysts
109,"summarize: In recent years, the focus of the treatment of popliteal cysts has gradually shifted from the simple removal of cysts to arthroscopic treatment of intra-articular lesions and the treatment of joint-cyst communication, and achieved a good effect.","In recent years, the focus of the treatment of popliteal cysts has gradually shifted from the simple removal of cysts to arthroscopic treatment of intra-articular lesions and joint-cyst communication.","In recent years, treatment of popliteal cysts has shifted from traditional surgical removal of the cysts to arthroscopic treatment of intra-articular lesions and the treatment of joint-cyst communication, with good results."
110,summarize: The objective of this study was to report four patients with RA (six knees) in combination with OA with a brief review of literature of previous similar published cases.,the objective of this study was to report four patients with RA (six knees) in combination with OA. The study also reviewed literature of previous similar published cases.,"In this study, we report four patients with RA in combination with OA, where we examined six knees. We also provide a brief review of literature on previous similar published cases."
111,"summarize: At the final follow-up, the Rauschning and Lindgren criteria and the Lysholm score were used for clinical evaluation.","At the final follow-up, the Rauschning and Lindgren criteria and the Lysholm score were used for clinical evaluation.","At the final follow-up, the Rauschning and Lindgren criteria, which evaluate knee joint symptoms, and the Lysholm score for knee function were used for clinical evaluation."
112,"summarize: In the OPP group, the cysts disappeared in 17 patients and reduced in size in 8 patients.","In the OPP group, the cysts disappeared in 17 patients and reduced in size in 8 patients.","In the OPP group, the cysts disappeared in 17 patients and reduced in size in 8 patients."
113,"summarize: In addition, there was no significant difference in the Lysholm score between the OPP group and the TPP group (P =.77).","In addition, there was no significant difference in the Lysholm score between the OPP group and the TPP group.",There was no significant difference in the Lysholm score between the OPP group and the TPP group.
114,"summarize: In both groups, the Rauschning-Lindgren grade at the last follow-up significantly differed from the preoperative grade (P  0.05) and the Lysholm knee score remarkably increased compared to the preoperative score (P  0.05); however, there were no differences between the two groups at the last follow-up (P > 0.05).","in both groups, the Rauschning-Lindgren grade at the last follow-up significantly differed from the preoperative grade. The Lysholm knee score remarkably increased compared to the preoperative score. However, there were no differences between the two groups at the last follow-up.","Pre-operative and post-operative knee assessment scores differed signficantly in both groups, but there were no differences between the two groups at the last follow-up."
115,summarize: Conclusion: Additional resection of cyst wall can result in a lower recurrence rate of cysts but extend the operation time and increase the incidence of perioperative complications compared with arthroscopic internal drainage of popliteal cysts alone.,Additional resection of cyst wall can result in a lower recurrence rate of cysts but extend the operation time and increase the frequency of complications after surgery compared with internal drainage of popliteal cysts alone.,Conclusion: Additional resection of cyst wall (AICR) can result in a lower recurrence rate of cysts but extend the operation time and increase the incidence of perioperative complications compared with arthroscopic internal drainage (AI) of popliteal cysts alone.
116,"summarize: Specifically, 20 of them received arthroscopic internal drainage (AI group) alone and 22 received arthroscopic internal drainage combined with cyst wall resection (AICR group) through double posteromedial portals.",20 of them received internal drainage (AI group) alone and 22 received arthroscopic internal drainage combined with cyst wall removal (AICR group) through double posteromedial portals.,"Specifically, 20 received joint or arthroscopic internal drainage (AI group alone) and 22 received internal joint drainage with cyst wall removal surgery or resection (AICR group) in two locations."
117,"summarize: In both groups, the Rauschning-Lindgren grade at the last follow-up significantly differed from the preoperative grade (P  0.05) and the Lysholm knee score remarkably increased compared to the preoperative score (P  0.05); however, there were no differences between the two groups at the last follow-up (P > 0.05).","in both groups, the Rauschning-Lindgren grade at the last follow-up significantly differed from the preoperative grade. The Lysholm knee score remarkably increased compared to the preoperative score. However, there were no differences between the two groups at the last follow-up.","In both groups, cyst scores at the last follow-up differed from the starting score. The knee scores improved compared to starting scores; however, the two groups did not differ at the last follow-up."
118,summarize: The proper treatment of hyperthyroidism depends on recognition of the signs and symptoms of the disease and determination of the etiology.,The proper treatment of hyperthyroidism depends on knowing the signs and symptoms of the disease and determining the cause.,Successfully treating an overactive thyroid depends on identifying the signs and symptoms of the disease and determining the cause.
119,"summarize: When thyroiditis is the cause, symptomatic treatment usually is sufficient because the associated hyperthyroidism is transient.","When thyroiditis is the cause, symptomatic treatment usually is enough because the associated hyperthyroidism is temporary.","When the cause is inflammation of the thyroid, treating the symptoms is enough because the overactive thyroid is short-lived."
120,"summarize: Thyroidectomy is an option when other treatments fail or are contraindicated, or when a goiter is causing compressive symptoms.","Thyroidectomy is an option when other treatments fail or are not recommended, or when a goiter is causing compressive symptoms.","Thyroid removal is an option when other treatments do not work or should not be used, or when an enlarged thyroid is causing pressure or squeezing."
121,summarize: Some new therapies are under investigation.,Several new treatments are under investigation.,New treatments are being studied.
122,summarize: Patients should be monitored for changes in thyroid function.,patients should be monitored for changes in thyroid function.,Patients should be checked for changes in thyroid function.
123,summarize: Thyroiditis is a general term that encompasses several clinical disorders characterized by inflammation of the thyroid gland.,Thyroiditis is a general term that encompasses several clinical disorders characterized by inflammation of the thyroid gland.,Thyroiditis covers multiple disorders represented by inflammation of the thyroid gland.
124,"summarize: Subacute thyroiditis is a transient thyrotoxic state characterized by anterior neck pain, suppressed thyroid-stimulating hormone, and low radioactive iodine uptake on thyroid scanning.","Subacute thyroiditis is a temporary, short-term thyroid toxic state. It is characterized by neck pain, reduced thyroid-stimulating hormone, and low thyroid uptake on thyroid scanning.","Subacute or fairly rapid thyroiditis (thyroid inflammation) is a temporary, thyroid-hormone-excess state with frontal neck pain, reduced thyroid-stimulating hormone, and low iodine sensitivity."
125,"summarize: Changes in anthropometric variables, dietary intakes, thyroid status, serum VEGF and Nesfatin-1 concentrations after 8 weeks were measured.","Changes in anthropometric variables, dietary intakes, thyroid status, blood VEGF and Nesfatin-1 concentrations after 8 weeks were measured.","We measured changes in physical body measurements, what people ate, thyroid function, blood VEGF and Nefastin-1 levels after 8 weeks."
126,summarize: Conclusions: Our data showed a potent beneficial effect of powdered Nigella sativa in improving thyroid status and anthropometric variables in patients with Hashimoto's thyroiditis.,"Using Nigella sativa, we showed a powerful beneficial effect of powdered Nigella sativa in improving thyroid status and physical measures in patients with Hashimoto's thyroiditis.",We concluded that powdered Nigella sativa improved thyroid function and physical body measurements in people with Hashimoto's thyroiditis.
127,"summarize: Moreover, Nigella sativa significantly reduced serum VEGF concentrations in these patients.",Nigella sativa significantly reduced blood VEGF levels in these patients.,Nigella sativa lowered blood VEGF levels.
128,"summarize: The use of Nigella sativa, a potent herbal medicine, continues to increase worldwide as an alternative treatment of several chronic diseases including hyperlipidemia, hypertension and type 2 diabetes mellitus (T2DM).","The use of Nigella sativa, a powerful herbal medicine, continues to increase worldwide as an alternative treatment of several long-lasting diseases including high blood sugar, high blood pressure and type 2 diabetes mellitus (T2DM).","Nigella sativa, a powerful herbal medicine, increases globally as an alternative treatment for many long-lasting diseases like high blood pressure, high blood fat, and type 2 diabetes mellitus (T2DM)."
129,summarize: None of these changes had been observed in placebo treated group.,None of these changes had been observed in the placebo group.,No changes occured in the inactive treatment group.
130,"summarize: Studies of thyroid hormone metabolism, action and pharmacokinetics have allowed evermore focused recommendations for use in clinical practice.","Studies of thyroid hormone metabolism, action and how it works have allowed ever more focused recommendations for use in clinical practice.","Better patient care has resulted from studies of thyroid hormone metabolism, how it works, and what the body does to it."
131,summarize: Conclusions: The evolution of thyroid hormone therapies has been significant over an extended period of time.,Conclusions: The evolution of thyroid hormone therapies has been significant over an extended period of time.,Thyroid hormone treatments have been developed over a long time period.
132,summarize: All of the most recent guidelines of major endocrine societies recommend levothyroxine mono-therapy for first line use in hypothyroidism.,all of the most recent guidelines of major hormonal societies recommend levothyroxine mono-therapy for first line use in low thyroid function.,Levothyroxine is widely accepted as the first treatment for an underactive thyroid.
133,"summarize: Approximately, 5%-10% of patients who normalise thyroid-stimulating hormone levels with LT4 monotherapy may have persistent symptoms that patients and clinicians may attribute to hypothyroidism.","Approximately, 5%-10% of patients who normalise thyroid-stimulating hormone levels with LT4 monotherapy may have persistent symptoms that patients and doctors may attribute to hypothyroidism.",About 5%-10% of patients who use LT4 alone to regulate thyroid-stimulating hormone levels may have ongoing symptoms that patients and doctors may think are caused by underactive thyroid.
134,summarize: A long-standing debate in the literature is whether addition of levotriiodothyronine (LT3) to LT4 will ameliorate lingering symptoms.,long-standing debate in the literature is whether adding levotriiodothyronine (LT3) to LT4 will improve lingering symptoms.,Science disagrees as to whether addition of levotriiodothyronine (LT3 - another thryoid medication) to LT4 will improve these ongoing symptoms.
135,summarize: Findings: Current clinical evidence is not sufficiently strong to support LT4/LT3 combination therapy in patients with hypothyroidism.,LT4/LT3 combination therapy is not enough strong to support LT4/LT3 combination therapy in patients with hypothyroidism.,We did not find strong proof that combining LT4 and LT3 worked to treat patients with underactive thyroids.
136,summarize: Hypothyroidism is one of the most common hormone deficiencies in adults.,Hypothyroidism is one of the most common hormone deficiencies in adults.,Underactive thyroid is one of the most common conditions caused by a lack of specific hormones in adults.
137,"summarize: However, minor alterations of thyroid function determine nonspecific manifestations.","Nevertheless, minor changes of thyroid function determine nonspecific manifestations.","However, small changes in thyroid function determine symptoms that can be caused by many conditions."
138,"summarize: Treatment guidelines of hypothyroidism recommend monotherapy with LT4 due to its efficacy, long-term experience, favorable side effect profile, ease of administration, good intestinal absorption, long serum half-life and low cost.","LT4 is the best treatment for hypothyroidism because of its effectiveness, long-term experience, favorable side effects, ease of administration, good intestinal absorption, long serum half-life and low cost.","Treatment guidelines for an underactive thyroid recommend a single drug, levothyroxine (LT4), because of how well it works, how long it has been used, few side effects, how easy it is to use, how well it is absorbed in the stomach, how long it lasts in the blood, and low cost."
139,summarize: Vitamin D deficiency has been especially demonstrated in HT patients.,Vitamin D deficiency has been especially demonstrated in HT patients.,Too little vitamin D is seen in people with Hashimoto's thyroiditis.
140,"summarize: The aim of this study was to investigate the effect of vitamin D on circulating thyroid autoantibodies and thyroid hormones profile (T4, T3, and TSH) in females with HT.",the aim of this study was to investigate the effect of vitamin D on thyroid autoantibodies and thyroid hormones profile in females with HT.,"This study aimed to determine the effect of vitamin D on thyroid autoantibodies (substances that develop when a person's immune system mistakenly attacks the thyroid) and thyroid hormone (T4, T3, and thyroid-stimulating hormone) blood levels in women."
141,summarize: No significant changes were observed in the serum levels of T3 and T4 hormones.,No significant changes were observed in the blood levels of T3 and T4 hormones.,Blood levels of T3 and T4 hormones did not change in either group.
142,"summarize: Adverse health effects have been observed at both extremes of intake, with a narrow optimum range.","adverse health effects have been observed at both extremes of intake, with a narrow optimum range.","Eating too much or too little selenium can cause health problems, with a small ideal range for consumption."
143,"summarize: Despite recommendations only extending to patients with Graves ophthalmopathy, selenium supplementation is widely used by clinicians for other thyroid phenotypes.",Selenium supplementation is widely used by doctors for other thyroid phenotypes.,"Although selenium is only recommended for people with thyroid eye disease, doctors prescribe selenium for other thyroid problems."
144,"summarize: Purpose of review: The aim of the article is to present the basics of oral levothyroxine (LT4) absorption, reasons why patients may have persistently elevated serum thyroid stimulation hormone (TSH) levels, and alternative strategies for LT4 dosing.","the aim of this article is to present the basics of oral levothyroxine (LT4) absorption, reasons why patients may have persistently elevated serum thyroid stimulation hormone (TSH) levels, and alternative strategies for LT4.","This article aims to cover the basics of how well levothyroxine (LT4 - a common thyroid medication) is absorbed when taken by mouth, reasons why people may have continuously high blood levels of thyroid stimulating hormone, and other ways to take levothyroxine."
145,"summarize: Recent findings: Although oral LT4 tablets are most commonly used for thyroid hormone replacement in patients with hypothyroidism, case studies report that liquid oral LT4, intravenous, intramuscular, and rectal administration of LT4 can successfully treat refractory hypothyroidism.","Recent findings: Although oral LT4 tablets are most commonly used for thyroid hormone replacement in patients with hypothyroidism, case studies report that liquid oral LT4, intravenous, intramuscular, and rectal administration of LT4 can successfully treat hypothyroidism.","Although LT4 tablets taken by mouth are most commonly used for thyroid hormone replacement in people with underactive thyroids, studies show that taking LT4 in liquid-form by mouth, shot to a vein or muscle, and through the rectum can work to treat poorly-controlled underactive thyroid."
146,summarize: Summary: Hypothyroidism is one of the most common endocrine disorders encountered by primary care physicians and endocrinologists.,Hypothyroidism is one of the most common hormonal disorders encountered by primary care doctors and endocrinologists.,Underactive thyroid is one of the most common hormone disorders doctors see.
147,summarize: Reliance on clinical impression to diagnose GAS tonsillopharyngitis is problematic; an overestimation of 80% to 95% by experienced clinicians typically occurs for adult patients.,Reliance on clinical impression to diagnose GAS tonsillopharyngitis is problematic; an overestimation of 80% to 95% by experienced clinicians typically occurs for adult patients.,Relying on a doctor's exam to diagnose group A strep throat and tonsil infection causes problems. Experienced doctors over-diagnose 80 to 95% of adult cases.
148,summarize: Existing data suggest that rapid GAS antigen testing as an aid to clinical diagnosis can be very useful.,Existing data suggest that rapid GAS antigen testing as an aid to clinical diagnosis can be very useful.,Studies show combining a rapid strep testing (using a throat swab to detect bacterial fragments) with a doctor exam can be helpful for diagnosis.
149,summarize: Amoxicillin/clavulanate and the extended-spectrum macrolides clarithromycin and azithromycin may also produce enhanced bacteriologic eradication in comparison to penicillin.,Amoxicillin/clavulanate and the extended-spectrum macrolides clarithromycin and azithromycin may also produce enhanced bacterial eradication in comparison to penicillin.,"A combination of amoxicillin and clavulanate, other antibiotics, and clarithromycin and azithromycin, another kind of antibiotics called macrolides that kill more types of bacteria, may also kill more bacteria than penicillin."
150,"summarize: In patients with symptoms and signs suggestive of streptococcal pharyngitis a specific diagnosis should be determined by performing a throat culture or a rapid antigen-detection test with a throat culture if the rapid antigen-detection test is negative, at least in children.","Symptoms and signs suggestive of strep throat should be determined by performing a throat culture or a rapid antigen-detection test with a throat culture if the rapid antigen-detection test is negative, at least in children.","Doctors should give patients who are believed to have strep throat a throat culture (a test using a throat swab to find, grow, and test bacteria in the throat that make you sick) or a rapid strep test (a test using a throat swab to find fragments of bacteria in the throat that make you sick) followed by a throat culture if the rapid strep test finds no strep-related bacteria, at least in children."
151,summarize: In patients with high likelihood of streptococcal infections (e.g. 3-4 Centor criteria) physicians can consider the use of rapid antigen test (RAT).,"In patients with high likelihood of streptococcal infections (e.g. 3-4 Centor criteria), doctors can consider using rapid antigen test (RAT).",Doctors might use a rapid strep test in people who are highly likely to have strep throat based on the sore throat scoring survey.
152,"summarize: Modest benefits of antibiotics, which have been observed in patients with 3-4 Centor criteria, have to be weighed against side effects, the effect of antibiotics on microbiota, increased antibacterial resistance, medicalisation and costs.","Modest benefits of antibiotics, which have been observed in patients with 3-4 Centor criteria, have to be weighed against side effects, the effect of antibiotics on microbiota, increased antibacterial resistance, medicalisation and costs.","Moderate benefits of antibiotics, seen in people with higher throat survey scores, have to be compared to side effects, effects on small organisms that live in or on the human body, the ability of bacteria to defeat the antibiotics designed to kill them, people more likely to seek medical care for future illness and costs."
153,"summarize: If antibiotics are indicated, penicillin V, twice or three times daily for 10 days is recommended.","Penicillin V, twice or three times daily for 10 days is recommended.","If using antibiotics, taking penicillin V two to three times a day for 10 days is suggested."
154,"summarize: If RAT is performed, throat culture is not necessary after a negative RAT for the diagnosis of group A streptococci.","if a test is performed, throat culture is not necessary after a negative test for group A streptococci.","If rapid antigen testing is used, testing isolated throat cells are not needed for identifying group A strep bacterial infection if no antigens are detected."
155,"summarize: To treat sore throat, either ibuprofen or paracetamol are recommended for relief of acute sore throat symptoms.","To treat sore throat, either ibuprofen or paracetamol are recommended for relief of acute sore throat symptoms.","Either ibuprofen or paracetamol, common pain relievers, can help relieve immediate sore throat symptoms."
156,summarize: Zinc gluconate is not recommended to be used in sore throat.,Zinc gluconate is not recommended to be used in sore throat.,"Zinc gluconate, a dietary supplement, is not recommeded with a sore throat."
157,"summarize: If antibiotics are indicated, penicillin V, twice or three times daily for 10 days is recommended.","Penicillin V, twice or three times daily for 10 days is recommended.","If using antibiotics, penicillin V, two or three times daily for 10 days is recommended."
158,"summarize: Several viruses and bacteria can cause acute pharyngitis; however, Streptococcus pyogenes (also known as Lancefield group A Î2-hemolytic streptococci) is the only agent that requires an etiologic diagnosis and specific treatment.","Several viruses and bacteria can cause acute pharyngitis. However, Streptococcus pyogenes (also known as Lancefield group A Î2-hemolytic streptococci) is the only agent that requires an etiologic diagnosis and specific treatment.","Many viruses and bacteria can cause short-term sore throat. However, group A strep, caused by Group A strep bacteria, is the only cause that must be identified based on signs and symptoms and treated."
159,"summarize: However, it has been underused in public health services because of its low availability and because of the 1- to 2-day delay in obtaining results.","However, it has been underused in public health services because of its low availability and 1- to 2-day delay in obtaining results.","However, it has not been used as much as it should because it is not widely available and takes 1 to 2 days to get results."
160,summarize: Another drug option is the macrolides.,Another drug option is the macrolides.,"Another drug option is macrolides, another type of antibiotics."
161,summarize: Future perspectives to prevent streptococcal pharyngitis and post-infection systemic complications include the development of an anti-Streptococcus pyogenes vaccine.,Future perspectives to prevent streptococcal pharyngitis and post-infection systemic complications include the development of an anti-Streptococcus pyogenes vaccine.,Making an anti-strep throat vaccine could be one way to prevent strep throat and post-strep throat complications throughout the body in the future.
162,"summarize: Acute pharyngitis/tonsillitis, which is characterized by inflammation of the posterior pharynx and tonsils, is a common disease.","Acute pharyngitis/tonsillitis, which is characterized by inflammation of the posterior pharynx and tonsils, is a common disease.","Immediate pharyngitis/tonsillitis, characterized by inflammation of the pharynx (an airway in the throat) and tonsils, is a common disease."
163,"summarize: S. pyogenes is of major clinical importance because it can trigger post-infection systemic complications, acute rheumatic fever, and post-streptococcal glomerulonephritis.","S. pyogenes is of major clinical importance because it can trigger post-infection systemic complications, acute rheumatic fever, and post-streptococcal glomerulonephritis.","S. pyogenes, a specific bacteria, is important since it can trigger post-infection issues, immediate rheumatic fever, and kidney disease."
164,summarize: Acute S. pyogenes pharyngitis is often a self-limiting disease.,Acute S. pyogenes pharyngitis is often a self-limiting disease.,Immediate strep throat is often a self-resolving disease.
165,"summarize: For patients with penicillin allergy, cephalosporins can be an acceptable alternative, although primary hypersensitivity to cephalosporins can occur.","Cephalosporins can be an acceptable alternative for patients with allergies to penicillin. However, high levels of cephalosporins can occur.","For patients with penicillin allergy, cephalosporins (another antibacterial) can be an alternative. Although, immediate immune responses to cephalosporins can occur."
166,summarize: The practitioner assessed the likelihood of Strep A infection based on historical and clinical findings.,the practitioner assessed the likelihood of Strep A infection based on historical and clinical findings.,The doctor determined how likely it was that people have Strep A infection based on the history of the patient and a physical exam.
167,summarize: Patients were randomised to flurbiprofen 8.75 mg or placebo lozenges under double-blind conditions and reported the three throat symptoms at baseline and at regular intervals over 24 h.,patients were randomly given flurbiprofen 8.75 mg or placebo lozenges under double-blind conditions and reported the three throat symptoms at the start and regular intervals over 24 hours.,"We gave people either flurbiprofen 8.75 mg lozenges or sugar lozenges and they reported three throat symptoms (sore throat pain, difficulty swallowing and swollen throat) at the beginning of the study and regularly over 24 h."
168,"summarize: With the growing problem of antibiotic resistance, non-antibiotic treatments should be considered.","With the growing problem of antibiotic resistance, non-antibiotic treatments should be considered.","With the growing problem of bacteria able to defeat the antibiotics designed to kill them, treatments that are not antibiotics should be considered."
169,"summarize: As demonstrated here, flurbiprofen 8.75 mg lozenges are an effective therapeutic option, providing immediate and long-lasting symptom relief in patients with and without Strep A/C infection.","flurbiprofen 8.75 mg lozenges are an effective treatment option, providing immediate and long-lasting symptom relief in patients with and without Strep A/C infection.","As shown here, flurbiprofen 8.75 mg lozenges work, giving immediate and long-lasting symptom relief in people with and without Strep A or C infection."
170,"summarize: Background: Diagnosing group A streptococcus (Strep A) throat infection by clinical examination is difficult, and misdiagnosis may lead to inappropriate antibiotic use.","Identifying group A streptococcus (Strep A) throat infection by clinical examination is difficult, and misdiagnosis may lead to inappropriate antibiotic use.",Identifying bacterial group A strep (Strep A) throat infection by examination is difficult. Misidentifying may lead to innappropriate antibacterial antibiotic use.
171,"summarize: Most patients with sore throat seek symptom relief rather than antibiotics, therefore, therapies that relieve symptoms should be recommended to patients.","Most patients with sore throat seek symptom relief rather than antibiotics, therefore, treatments that relieve symptoms should be recommended to patients.","Most with sore throat seek symptom relief rather than antibacterial antibiotics, so therapies that relieve symptoms should be promoted."
172,summarize: We report two clinical trials on the efficacy and safety of flurbiprofen 8.75 mg lozenge in patients with and without streptococcal sore throat.,two clinical trials on the efficacy and safety of flurbiprofen 8.75 mg lozenge in patients with and without strep throat.,We show two trials on the success and safety of anti-inflammatory fluriboprofen lozenges in those with and without strep throat.
173,"summarize: Methods: The studies enrolled adults with moderate-to-severe throat symptoms (sore throat pain, difficulty swallowing and swollen throat) and a diagnosis of pharyngitis.","the studies enrolled adults with moderate-to-severe throat symptoms (sore throat pain, difficulty swallowing and swollen throat) and a diagnosis of pharyngitis.","The studies enrolled adults with moderate-to-severe throat symptoms (sore throat pain, difficulty swallowing and swollen throat) and with inflammation of the pharynx (specific throat area)."
174,"summarize: Results: A total of 402 patients received study medication (n = 203 flurbiprofen, n = 199 placebo).","203 patients took flurbiprofen, 199 received placebo.",402 patients received treatment (203 with antinflammatory flurbiprofen and 199 with inactive treatment).
175,"summarize: The practitioners' assessments correctly diagnosed Strep A in 11/40 cases (sensitivity 27.5%, and specificity 79.7%).",The doctors correctly diagnosed Strep A in 11 out of 40 cases.,The practitioners correctly identified Strep A in 11/40 cases.
176,summarize: Objective: To compare azithromycin (AZT) and benzathine penicillin (BP) in the treatment of recurrent tonsillitis in children.,Objective: To compare azithromycin (AZT) and benzathine penicillin (BP) in the treatment of reoccurring tonsillitis in children.,"Our objective is to compare two antibiotics, azithromycin (AZT) and benzathine penicillin (BP), in treating reoccurring inflamed tonsils in children."
177,"summarize: Group A children received a single intramuscular BP (600,000 IU for childrenâ27kg and 1,200,000IU for â27kg) every two weeks for six months.",Group A children received a single intramuscular BP every two weeks for six months.,"Group A children got a single BP injection (600,000 international units for children weighing 27 kg or less and 1,200,000 international units for children over 27 kg) once a week for six months."
178,summarize: Results: Both groups showed marked significant reduction in recurrent tonsillitis that is comparable to results of tonsillectomy.,Both groups showed a markedly significant reduction in reoccurring tonsillitis that is similar to results of tonsillectomy.,Both groups had results similar to getting surgery to remove the tonsils.
179,summarize: Group B showed better compliance.,Group B showed better compliance.,Group B followed doctor instructions better.
180,summarize: Conclusion: AZT proved to be good alternative to BP in the management of recurrent tonsillitis with results similar to those obtained after tonsillectomy.,AZT proved to be good alternative to BP in the management of recurrent tonsillitis with results similar to those obtained after tonsillectomy.,We concluded that AZT can treat reoccurring inflamed tonsils similar to BP with results similar to getting surgery to remove the tonsils.
181,"summarize: Pathogenesis of carriage has been related to the pharynx microflora and to special properties of GAS, but several aspects are yet to be elucidated.","Pathogenesis of carriage has been linked to the pharynx microflora and to special properties of GAS, but several aspects are yet to be explained.","Whether or not GAS in the throat causes infection depends on small organisms in the throat and special qualities of GAS, but many things are not clear."
182,summarize: Surgical intervention is not indicated.,Surgical intervention is not indicated.,Surgery is not recommended.
183,"summarize: There is no clearly superior management strategy for strep throat, as significant controversy exists regarding the best methods to diagnose GABHS and under what conditions antibiotics should be prescribed.","There is no clearly superior management strategy for strep throat, as significant controversy exists regarding the best methods to diagnose GABHS and under what conditions antibiotics should be prescribed.","There is no best way to treat strep throat, as experts do not agree on the best way to diagnose group A strep throat and when antibiotics should be given."
184,"summarize: We considered the question whether the biochemical action of a neuroleptic, and specifically the ratio between DA-receptor block and NA-receptor block, might have a higher predictive value in this respect.","Specifically, the ratio between DA-receptor block and NA-receptor block might have a higher predictive value in this respect.",We looked into whether the biological and chemical changes made to the body by a drug to treat psychotic disorders might better predict how well the treatment works.
185,summarize: CLINICAL experience with tranquilizers has shown the need for prolonged therapy for chronic neurotic and psychotic disorders.,CLINICAL experience with tranquilizers has shown the need for prolonged therapy for chronic neurotic and psychotic disorders.,Use of tranquilizers on patients has shown the need for long-term treatment of long-term neurotic and pyschotic mental disorders.
186,"summarize: Since phenothiazine derivatives such as perphenazine are being employed in this manner and since there have been rare reports of jaundice and leukopenia associated with its administration, questions about a potential deleterious effect of this drug on the liver and blood have to be answered.","phenothiazine derivatives such as perphenazine are being used in this way and since there have been rare reports of jaundice and leukopenia associated with its use, questions about a potential harmful effect of this drug on the liver and blood have to be answered.","Because antipsychotic drugs like perphenazine are being used to treat long-term mental disorders and there have been rare cases of yellowing of the skin and a decrease in disease-fighting cells in the blood of people who take it, we must figure out whether this drug harms the liver and blood."
187,summarize: Background: Antipsychotic drugs are usually given orally but compliance with medication given by this route may be difficult to quantify.,"Antipsychotic drugs are usually given by mouth, but compliance with medication given by this route may be difficult to quantify.","Drugs used to treat psychotic disorders are usually given by mouth, but it is hard to measure if people take the drugs as instructed."
188,summarize: The total number of participants in the four trials with useful data is 313.,the total number of participants in the four trials with useful data is 313.,The four trials with useful results had 313 total people.
189,summarize: Until well conducted and reported randomised trials are undertaken clinicians will be in doubt as to the effects of perphenazine depots and people with schizophrenia should exercise their own judgement or ask to be randomised.,"Until well conducted and reported randomised trials are done, clinicians will be in doubt as to the effects of perphenazine depots. People with schizophrenia should exercise their own judgement or ask to be randomly assigned.",People with schizophrenia should use their own judgement until more studies are done and doctors know the effects of slow-release perphenazine shots.
190,"summarize: When compared with established newer drugs, for example, ondansetron, dexamethasone or droperidol, no significant differences were observed in the pooled analysis with limited data.","Compared with established newer drugs, such as ondansetron, dexamethasone or droperidol, no significant differences were observed.","We saw no big differences compared to newer drugs like ondansetron, dexamethasone or droperidol in studies with limited results."
191,summarize: Conclusion: there is evidence that perphenazine is effective in the prevention of PONV in children and adults without serious adverse effects compared with placebo.,there is evidence that perphenazine is effective in the prevention of PONV in children and adults without serious adverse effects compared with placebo.,Studies show that perphenazine prevents nausea and vomiting in children and adults without serious side effects compared to sham treatment.
192,"summarize: In children, perphenazine 0.07 mg kg was effective in preventing vomiting (RR, 0.31; 95% CI, 0.18-0.54), whereas in adults, a dose of about 5 mg was effective for the prevention of PONV (RR, 0.50; 95% CI, 0.37-0.67).","perphenazine 0.07 mg kg was effective in preventing vomiting, whereas in adults, a dose of about 5 mg was effective for the prevention of PONV.","In children, 0.07 mg kg of perphenzaine prevented vomiting while 5 mg prevented post-operation nausea and vomiting in adults."
193,summarize: Further studies showed that SVZ cells migrate out towards a peripheral glioblastoma.,SVZ cells migrate out towards a peripheral glioblastoma.,More studies showed cells from the part of the brain where brain cells are made move outward toward a glioblastoma.
194,"summarize: Treatment guidelines state that there is no difference in efficacy between the various first-generation antipsychotics, however, low-potency first-generation antipsychotic drugs are sometimes perceived as less efficacious than high-potency first-generation compounds by clinicians, and they also seem to differ in their side effects.","Generally, there is no difference in how well the various first-generation antipsychotics work. However, low-potency first-generation antipsychotics are sometimes perceived as less effective than high-potency first-generation drugs by clinicians, and they also seem to differ in their side effects.","Treatment recommendations say there is no difference in treatment effect among older drugs used to treat psychotic disorders. However, doctors sometimes think older drugs with lower strength used to treat psychotic disorders do not work as well as older drugs with higher strength, and they also seem to have different side effects."
195,summarize: Authors' conclusions: The results do not show a superiority in efficacy of high-potency perphenazine compared with low-potency first-generation antipsychotics.,the results do not show a superiority in effectiveness of high-potency perphenazine compared with low-potency first-generation antipsychotics.,We conclude that the results do not show that the antipsychotic perphenazine with its higher strength works better than older antipsychotics with lower strength.
196,"summarize: The number of studies as well as the quality of studies is low, with quality of evidence for the main outcomes ranging from moderate to very low, so more randomised evidence would be needed for conclusions to be made.","the number of studies as well as the quality of studies is low, with evidence for the main outcomes ranging from moderate to very low, so more randomised data would be needed for conclusions to be made.","More evidence is needed to make judgements, as the number and quality of studies is low with medium- to very low-quality results."
197,summarize: It has been used for many years and is popular in the northern European countries and Japan.,It has been used for many years and is popular in the northern European countries and Japan.,Perphenazine has been used for many years and is popular in the northern European countries and Japan.
198,"summarize: Authors' conclusions: Although perphenazine has been used in randomised trials for more than 50 years, incomplete reporting and the variety of comparators used make it impossible to draw clear conclusions.","Perphenazine has been used in randomised trials for more than 50 years. However, incomplete reporting and the variety of comparisons make it impossible to draw clear conclusions.","We conclude that although perphenazine has been used for more than 50 years, incomplete results and the variety of drugs used to compare perphenazine to make it impossible to make clear judgements."
199,"summarize: Endometrial cancer (EC) is one of the most common and fatal gynecological cancers worldwide, but there is no effective treatment for the EC patients of progesterone resistance.","Endometrial cancer (EC) is one of the most common and fatal gynecological cancers worldwide, but there is no effective treatment for the EC patients with resistance to progesterone.","Endometrial cancer (EC), cancer of the lining of the uterus, is one of the most common and deadly cancers of the female reproductive system worldwide, but there is no working treatment for EC patients who do not respond to progesterone, a hormone."
200,summarize: Annexin-V/PI double staining assay suggested that perphenazine could effectively induce ISK and KLE cell apoptosis.,perphenazine could effectively induce apoptosis in ISK and KLE cells.,Tests suggest that perphenazine could kill certain cancer-causing endometrial cells.
201,"summarize: Moreover, results of western blot assay indicated perphenazine obviously inhibited the phosphorylation of Akt.",Perphenazine obviously inhibited the phosphorylation of Akt.,nan
202,"summarize: Delightedly, PPZ also could significantly attenuate xenograft tumor growth at both 3 mg/kg and 15 mg/kg in mice without influencing the body weights.",PPZ also could significantly reduce tumor growth in mice at both 3 mg/kg and 15 mg/kg without affecting the body weights.,Perphenazine also could reduce tumor growth in mice without affecting body weight.
203,"summarize: Endometrial cancer (EC) is one of the most common and fatal gynecological cancers worldwide, but there is no effective treatment for the EC patients of progesterone resistance.","Endometrial cancer (EC) is one of the most common and fatal gynecological cancers worldwide, but there is no effective treatment for the EC patients with resistance to progesterone.","Endometrial (outer womb) cancer (EC) is a common, fatal female-related cancer worldwide, but there is no treatment for EC patients of progesterone (specific female hormone) resistance."
204,"summarize: In this text, perphenazine (PPZ), approved for psychosis therapy, was identified as a potential agent for the treatment of both progesterone sensitive and resistant endometrial cancer for the first time.","perphenazine (PPZ), approved for psychosis therapy, was identified as a potential agent for the treatment of both progesterone sensitive and resistant endometrial cancer for the first time.","In this text, perphenazine (PPZ), used for psychosis, may treat patients with both progesterone sensitive and resistant outer womb cancer."
205,"summarize: Specifically, perphenazine exhibited good cell proliferation inhibition in Ishikawa (ISK) and KLE cell lines according to the CCK-8 assay and colony formation assay.","Specifically, perphenazine showed good cell proliferation inhibition in Ishikawa (ISK) and KLE cell lines.","Perphenazine (an anti-psychotic) blocked cell growth in two, outer womb cancer cell groups."
206,"summarize: Delightedly, PPZ also could significantly attenuate xenograft tumor growth at both 3 mg/kg and 15 mg/kg in mice without influencing the body weights.",PPZ also could significantly reduce tumor growth in mice at both 3 mg/kg and 15 mg/kg without affecting the body weights.,"Delightedly, perphenazine could weaken cancer growth from a different-species organ transplant in mice at various doses without affecting body weight."
207,summarize: The current paper shows how perphenazine might reduce that contribution.,the current paper shows how perphenazine might reduce this contribution.,This paper shows how perphenazine might decrease this activity.
208,"summarize: Perphenazine is an old, generic, cheap, phenothiazine antipsychotic drug that has been in continuous clinical use worldwide since the 1950's.","Perphenazine is an old, generic, cheap, phenothiazine antipsychotic drug that has been in continuous clinical use worldwide since the 1950's.","Perphenazine is an old, generic, cheap drug used to treat psychotic disorders worldwide since the 1950s."
209,"summarize: For now (Summer, 2020) the nature of glioblastoma requires a polypharmacy approach until/unless a core feature and means to address it can be identified in the future.","For now (Summer, 2020), the nature of glioblastoma requires a multi-pharmacy approach until/unless a core feature and means to address it can be identified in the future.","As of Summer 2020, glioblastoma requires multiple drugs to treat it until and unless it is better understood and a single treatment drug is found."
210,summarize: Conclusions: Perphenazine possesses a remarkable constellation of attributes that recommend its use in GB treatment.,Perphenazine has a remarkable set of attributes that recommend its use in GB treatment.,We conclude that perphenazine has many qualities that suggest its use in treating glioblastoma.
211,"summarize: In the effort to improve treatment effectiveness in glioblastoma, this short note reviewed collected data on the pathophysiology of glioblastoma with particular reference to intersections with the pharmacology of perphenazine.","In the effort to improve treatment effectiveness in glioblastoma, this short note reviewed collected data on the pathophysiology of glioblastoma with particular reference to intersections with the pharmacology of perphenazine.","To try improving treatment in glioblastoma (a brain cancer), this work collected data on the cancer's symptoms and traits along with references to perphenazine (an anti-psychotic medication)."
212,summarize: That study identified five areas of potentially beneficial intersection.,the study identified five areas of potentially beneficial intersection.,This study found five areas of possibly beneficial treatment.
213,summarize: All these attributes argue for a trial of perphenazine's addition to current standard treatment with temozolomide and irradiation.,all these attributes suggest a trial of perphenazine's addition to current standard treatment with temozolomide and radiation.,Perphenzaine attributes argue for a trial to add it to current standard treatment with temozolomide (an anti-cancer drug) and irradiation.
214,"summarize: Clinical experience and research data over these decades have shown perphenazine to be well-tolerated in psychiatric populations, in normals, and in non-psychiatric, medically ill populations for whom perphenazine is used to reduce nausea.","perphenazine is well-tolerated in psychiatric populations, in normals, and in non-psychiatric, medically ill populations for whom perphenazine is used to reduce nausea.","Perphenzaine has been well-tolerated in psychiatric groups, in healthy groups, and in non-psychiatric but medically ill groups who use perphenazine to reduce nausea."
215,"summarize: We have found oral perphenazine 8 mg (OP8) useful as follows: (1) as a nonsedating antiemetic; (2) as a preventative measure similar to the antihistamine promethazine against ketamine-induced psychotomimetic effects; and (3) as a safe single-dose drug (only 1.3 extrapyramidal events per 10,000 patients receiving 4â8 mg oral dose, with all events easily treated).",perphenazine 8 mg (OP8) is useful as follows: (1) as a nonsedating antiemetic; (2) as a preventative measure similar to the antihistamine promethazine against ketamine-induced psychotomimetic effects; and (3) as a safe single-dose drug.,"Perphenazine 8 mg (OP8) can be taken by mouth for the following uses: (1) as a nonsedating drug to prevent nausea and vomiting; (2) like promethazine, an antihistamine (allergy drug), to prevent psychotic symptoms caused by ketamine (a pain relief drug); and (3) as a safe one-dose drug."
216,summarize: Two hundred thirty-nine foreign bodies (98.8%) were successfully managed endoscopically.,297 objects (98.8%) were successfully managed by a small tube.,"Two hundred thirty-nine objects that shouldn't be eaten (98.8%) were successfully removed by putting a long, thin tube directly into the body."
217,summarize: Meat impaction resulting in an obstructed esophagus is an urgent problem and the bolus should be removed within hours.,Meat impaction resulting in an obstructed esophagus is an urgent problem and the bolus should be removed within hours.,"Meat that gets stuck and blocks the esophagus is an urgent problem, and the blockage should be removed within hours."
218,summarize: Button batteries lodged in the esophagus represent an emergency and should be removed without delay.,Button batteries lodged in the esophagus represent an emergency and should be removed without delay.,Button batteries in the esophagus are an emergency and should be removed immediately.
219,"summarize: Once in the stomach, they will usually pass through the gastrointestinal tract without difficulty.","Once in the stomach, they will usually pass through the gastrointestinal tract without difficulty.","If button batteries make it to the stomach, they are usually passed easily."
220,summarize: Patients and methods: A total of 103 patients with history of foreign body ingestion were included in this study.,103 patients with history of foreign objects ingestion were included in this study.,We included 103 patients who ate objects that shouldn't be eaten.
221,summarize: X-ray neck and rigid oesophagoscopy was carried out in all patients for diagnosis and removal of foreign bodies.,X-ray neck and rigid oesophagoscopy was carried out in all patients for diagnosis and removal of foreign objects.,"Neck x-rays and a procedure that uses a stiff, inflexible tube with a camera were done to diagnose and remove the objects that shouldn't be eaten."
222,"summarize: Coins were the most common foreign bodies (60%), followed by meat related foreign bodies (22.5%) and dentures in 5% cases.","coins were the most common foreign objects (60%), followed by meat related objects (22.5%) and dentures in 5% cases.","Coins were swallowed most often (60%), followed by meat (22.5%) and dentures (5%)."
223,summarize: Post-cricoid region was the site of impaction of foreign bodies in 84% of the subjects.,Post-cricoid region was the site of impaction of foreign objects in 84% of the subjects.,A specific site near the bottom of the throat was the site of stuck foreign objects in 84% of patients.
224,"summarize: The most common foreign bodies are food, plastic toys, and small household items.","The most common foreign objects are food, plastic toys, and small household items.","The most common objects are food, plastic toys, and small household items."
225,"summarize: Diagnosis is often delayed because the causative event is usually unobserved, the symptoms are nonspecific, and patients often are misdiagnosed initially.","Diagnosis is often delayed because the cause of the event is usually unknown, the symptoms are nonspecific, and patients often are misdiagnosed initially.","Diagnosis is often late because the event that caused the object to get stuck wasn't seen, the symptoms are vague, and people often are diagnosed incorrectly at first."
226,summarize: Flexible or rigid endoscopy usually is required to confirm the diagnosis and to remove the foreign body.,Flexible or rigid endoscopy usually is needed to confirm the diagnosis and remove the foreign object.,Flexible or stiff tubes with cameras are usually needed to make sure the diagnosis is correct and to remove the object.
227,"summarize: Results: After a single application of 0.025% capsaicin ointment to the right external auditory canal, the endoscopic swallowing score was significantly decreased, and this effect lasted for 60 minutes.","after a single application of 0.025% capsaicin ointment to the right external auditory canal, the swallowing score was significantly decreased, and this effect lasted for 60 minutes.","After putting 0.025% capsaicin ointment to the right ear, the common swallowing test showed less difficulty swallowing. This effect lasted for one hour."
228,"summarize: Tips for success include analgesia, adequate visualization, immobilization of the patient's head, dexterity and experience level of the provider, and minimizing attempts at removal.","Tips for success include analgesia, adequate visualization, immobilization of the patient's head, dexterity and experience level of the provider, and minimizing attempts at removal.","Tips for success include painkillers, the ability to see the object, keeping the patient's head still, skill and experience of the doctor, and removing the object with the least number of tries."
229,"summarize: A description of instruments and indications for use is provided, along with circumstances where specialist referral is warranted.","A description of instruments and indications for use is provided, along with circumstances where specialist referral is warranted.","We described tools and how to use them, along with times when a specialist should see the patient."
230,"summarize: Result: The most common FBs were fish bones, which accounted for 1446 (91.98%) of 1572 FBs.","the most common FBs were fish bones, which accounted for 1446 (91.98%) of 1572 FBs.","The most common objects stuck were fish bones, which made up 1446 (91.98%) of 1572 objects."
231,"summarize: Result: The most common FBs were fish bones, which accounted for 1446 (91.98%) of 1572 FBs.","the most common FBs were fish bones, which accounted for 1446 (91.98%) of 1572 FBs.","The most common foreign substance was fish bones, seen in 91.98% of patients."
232,"summarize: Among all 1572 FBs, 1004 (63.87%) were successfully removed by video laryngoscopy without complications.","Among all 1572 FBs, 1004 (63.87%) were successfully removed by video laryngoscopy without complications.","Among all 1572 foreign substances, 1004 (63.87%) were removed by video throat treatment with a small device without issues."
233,summarize: The diagnostic rate of sharp FBs was significantly higher than that of non-sharp FBs.,Sharp FBs were much higher than non-sharp FBs.,The identification rate of sharp foreign substances was higher than that of non-sharp ones.
234,"summarize: The most common sites of throat FBs were the tongue root (42.29%), epiglottic vallecula (19.40%), tonsil (18.21%), and piriform fossa (10.65%).","the most common sites of throat FBs were the tongue root (42.29%), the epiglottic vallecula (19.40%), tonsil (18.21%), and piriform fossa (10.65%).",The most common sites of throat foreign substances were areas near the tonsil and bottom of the tongue and throat.
235,summarize: Achalasia is an esophageal motility disorder characterized by aberrant peristalsis and insufficient relaxation of the lower esophageal sphincter.,Achalasia is an esophageal motility disorder characterized by abnormal peristalsis and insufficient relaxation of the lower esophageal sphincter.,Achalasia describes a disorder in which your esophagus is unable to move food and liquids down into your stomach.
236,"summarize: Patients most commonly present with dysphagia to solids and liquids, regurgitation, and occasional chest pain with or without weight loss.","Patients most commonly present with difficulty swallowing solids and liquids, re-eating, and occasional chest pain with or without weight loss.","People often have difficulty swallowing solids and liquids, spitting up undigested or partially digested food from the stomach, and occasional chest pain with or without weight loss."
237,"summarize: In this American College of Gastroenterology guideline, we used the Grading of Recommendations Assessment, Development and Evaluation process to provide clinical guidance on how best to diagnose and treat patients with achalasia.","In this American College of Gastroenterology guideline, we used the Grading of Recommendations Assessment, Development and Evaluation process to provide clinical guidance on how best to diagnose and treat patients with achalasia.","In this guideline, we used a popular method to guide doctors on how best to diagnose and treat people with achalasia."
238,summarize: Eosinophilic esophagitis is triggered by food allergens and is increasingly prevalent; esophageal biopsies should be performed to make the diagnosis.,Eosinophilic esophagitis is caused by food allergens and is increasingly common. Eosinophilic esophagitis should be diagnosed.,"A long-term allergic condition of the esophagus is set off by food allergens and is more and more common. To diagnose this condition, a small part of the esophagus should be removed for examination."
239,"summarize: Esophageal cancer and other serious conditions have a low prevalence, and testing in low-risk patients may be deferred while a four-week trial of acid-suppressing therapy is undertaken.","Esophageal cancer and other serious conditions have a low prevalence, and testing in low-risk patients may be delayed while a four-week trial of acid-suppressing therapy is undertaken.","Cancer of the esophagus and other serious conditions are not common, and low-risk people may take acid reducers for 4 weeks before undergoing testing."
240,"summarize: Many frail older adults with progressive neurologic disease have significant but unrecognized dysphagia, which significantly increases their risk of aspiration pneumonia and malnourishment.","Many frail older adults with progressive neurologic disease have significant but unrecognized dysphagia, which significantly increases their risk of aspiration pneumonia and malnutrition.","Many weak older adults with progressive deterioration in functioning have serious but unseen difficulty swallowing, which really increases their risk of pneumonia (lung infection) caused by something entering the airway or lungs by accident and risk of lacking nutrients in the body."
241,"summarize: Infectious causes of finger pain include cellulitis, tendinitis, paronychia, felon, and infectious emboli, which generally require antibiotics with or without drainage.","Infectious causes of finger pain include cellulitis, tendinitis, paronychia, felon, and infectious emboli, which generally require antibiotics with or without drainage.","Causes of finger pain from bacteria include cellulitis (a bacterial skin infection), tendinitis (an irritation of the tendon), paronychia (a bacterial nail infection), felon (a bacterial fingertip infection), and emboli (a blood vessel blockage). These causes generally require antibacterials alomg with or without fluid drainage of the finger."
242,summarize: Objective: To identify through case study the presentation and possible pathophysiological cause of complex regional pain syndrome and its preferential response to stellate ganglion blockade.,Objective: To identify the presentation and possible cause of complex regional pain syndrome and its preferential response to stellate ganglion blockade.,"The objective of this case report (a summary of an individual patient's symptoms, diagnosis, and treatment) is to identify the sign or symptoms and causes of complex regional pain syndrome (a form of ongoing pain that affects the arm or leg) and if a pain treatment called stellate ganglion blockade (an injection of medication into nerves at the front of the neck that can relieve pain) has any effect on the pain."
243,summarize: We used a 1000 mW semiconductor laser device.,the authors used a 1000 mW laser device.,nan
244,"summarize: Each point was irradiated twice for 20 s per treatment, giving a total of three minutes for all 4 points.","Each point was irradiated twice for 20 s per treatment, giving a total of three minutes for all 4 points.","Each area was exposed two times for 20 seconds per treatment, giving a total of three minutes for all 4 points."
245,"summarize: Conclusion: We concluded that LLLT at the wavelength and parameters used in the present study was effective for chronic pain of the elbow, wrist, and fingers.","LLLT at the wavelength and parameters used in this study was effective for long-lasting pain of the elbow, wrist, and fingers.","This study found that low level laser therapy was helpful for chronic pain of the elbow, wrist, and fingers."
246,summarize: Each tender point and three points around it were irradiated with laser energy.,Each tender point and three points around it were irradiated with laser energy.,nan
247,"summarize: This article focuses on the advanced therapies that may improve pain care, including advanced treatment strategies that are available.","This article focuses on the advanced treatments that may improve pain care, including advanced treatment strategies that are available.","This article focuses on the new therapies that may improve pain care, including new treatment plans that are available."
248,"summarize: As these therapies evolve, so too will their placement within the pain care algorithm grounded by a foundation of evidence to improve patient safety and management of patients with difficult neuropathic pain.","As these therapies evolve, so too will their placement within the pain care algorithm grounded by evidence to improve patient safety and management of patients with difficult neuropathic pain.","As these therapies evolve, so too will their placement within pain care plans."
249,"summarize: As these therapies evolve, so too will their placement within the pain care algorithm grounded by a foundation of evidence to improve patient safety and management of patients with difficult neuropathic pain.","As these therapies evolve, so too will their placement within the pain care algorithm grounded by evidence to improve patient safety and management of patients with difficult neuropathic pain.","As these therapies improve, so will their use in pain care grounded by evidence to improve patient safety and monitoring of patients with complex nerve-related pain."
250,"summarize: When this happens, our hand therapist builds a relative motion splint that simulates the effect of the pencil.","When this happens, our hand therapist builds a relative motion splint that simulates the effect of the pencil.",The hand therapist will then build a relative motion splint (a piece of sturdy material to support injured bones and allow some movement) that will have the same effect of the pencil.
251,summarize: Most people can work with these splints on.,most people can work with these splints on.,Most people can work with these splints on.
252,"summarize: Guidelines published in the May 2019 issue of JOSPT make recommendations, based on best practices from the published literature, for evaluating, diagnosing, and treating carpal tunnel syndrome.","Guidelines published in the May 2019 issue of JOSPT make recommendations, based on best practices from the published literature, for evaluating, diagnosing, and treating carpal tunnel syndrome.","Guidelines from the May 2019 issue of Journal of Orthopaedic & Sports Physical Therapy, a scientific journal, make recommendations for evaluating, diagnosing, and treating carpal tunnel syndrome."
253,"summarize: Ultimately, the best care is a combination of the leading science, the clinical expertise of your health care provider, and your input as the patient.","Ultimately, the best care is a combination of the leading science, the clinical expertise of your health care provider, and your input as the patient.","Ultimately, the best care is a combination of three things: 1) the leading science, 2) the knowledge, experience, and skills of a patient's health care provider, and 3) the patient's own input."
254,"summarize: The literature review for these guidelines found that low-level laser therapy, thermal ultrasound, iontophoresis, and magnets provided no consistent benefit in treating carpal tunnel syndrome.","the literature review for these guidelines found that low-level laser therapy, thermal ultrasound, iontophoresis, and magnets provided no consistent benefit in treating carpal tunnel syndrome.","Research shows that low-level laser therapy (a laser light used at a low level applied to the skin to reduce pain and help the body heal), thermal ultrasound (a device that provides heat to tissues to increase circulation and reduce pain), iontophoresis (a procedure that uses an electrical current to deliver medicine through the skin), and magnets provided no consistent benefit in treating carpal tunnel syndrome."
255,summarize: Hyaluronic acid (HA) appears to provide substantial relief of pain and may increase functionality.,Hyaluronic acid (HA) appears to provide substantial relief of pain and may increase function.,Injections of hyaluronic acid (a natural lubricant that can relieve pain) appear to provide significant relief of pain and may increase movement.
256,"summarize: Carpal tunnel syndrome is a compressive neuropathy, and only temporarily relieved with injection therapy.","Carpal tunnel syndrome is a compressive neuropathy, and only temporarily relieved with injection therapy.",Injection therapy provides only short-term relief for carpal tunnel syndrome (pinched nerves in the wrist).
257,"summarize: In some cases, Hyaluronic acid or Botox may also be beneficial.",Hyaluronic acid or Botox may also be helpful.,"In some cases, Hyaluronic acid or Botox may also be helpful."
258,summarize: Objective: To evaluate the effectiveness of nighttime orthoses on the second or third finger of the dominant hand in controlling pain in women with symptomatic osteoarthritis (OA) in the interphalangeal joint.,Objective: To evaluate the effectiveness of nighttime orthoses on the second or third finger of the dominant hand in controlling pain in women with symptomatic osteoarthritis (OA) in the interphalangeal joint.,A nighttime orthosis is a device or brace worn at night that supports weak or damaged muscles and limits motion of the wrist. The objective of this study is to evaluate how helpful using nighttime orthoses on the second or third finger of the dominant hand is in controlling pain in women who have osteoarthritis in the hinge joint of the fingers.
259,"summarize: The improvement in pain correlated with Cochin Hand Functional Scale scores and the absence of Bouchard's nodes in the third finger, which are predictors of the best prognosis for treatment with a nighttime orthosis.","the improvement in pain was linked to Cochin Hand Functional Scale scores and the absence of nodes in the third finger, which are predictors of the best outcome for treatment with a nighttime orthosis.",The improvement in pain paralleled functionality test scores and the loss of bony lumps in the third finger. They are predictors of the best recovery for treatment with a nighttime brace.
260,summarize: Treatment of PDH deficiency rarely influences the course of the disease.,Treatment of PDH deficiency rarely influences the course of the disease.,"Pyruvate dehydrogenase deficiency or shortage is a rare disorder caused by genetic changes, and its progression can rarely be stopped by treatment."
261,"summarize: There is some evidence that dichloroacetate (which inhibits the specific PDH kinase and thereby activates any residual functioning complex) will also reduce the metabolic disturbance in some patients, but, again, this is rarely accompanied by any objective improvement in neurological performance.","There is some evidence that dichloroacetate (which blocks the specific PDH kinase and activates any remaining functioning complex) will also reduce the metabolic disturbance in some patients, but, again, this is rarely accompanied by any objective improvement in brain function.","A chemical in the body called dichloroacetate may also reduce the disturbance on metabolism in some patients, but, again, this is rarely accompanied by any improvement in mental and motor development."
262,"summarize: A more favorable outcome can be expected in the extremely rare patients with a thiamine responsive form of the disease and, for this reason, a short therapeutic trial of thiamine is worth trying in all cases.","a more favorable outcome can be expected in the extremely rare patients with a thiamine responsive form of the disease. For this reason, a short treatment trial of thiamine is worth trying in all cases.","In rare cases, a vitamin called thiamine may respond to pyruvate dehydrogenase deficiency, and so a short course of thiamine is worth trying for all cases."
263,"summarize: The transduction efficiency of scAAV2 and scAAV6 vectors was 3- to 5-fold higher than that of the other serotypes, which were subsequently used to transduce fibroblasts with wild-type PDHA1 cDNA under the control of the chicken beta-action (CBA) promoter at a vector:cell ratio of 1000.","scAAV2 and scAAV6 vectors were 3- to 5-fold higher than the other gene types, which were then used to make fibroblasts with wild-type PDHA1 cDNA under control of a chicken beta-action (CBA) promoter.","Two types of vectors, the scAAV2 and scAAv6, were found to be the most effective way to deliver the genetic material into cells."
264,summarize: Exposure for 24h to 5mM DCA increased PDH activity in non-transduced control (mean 37% increase) and PDH deficient (mean 44% increase) cells.,Exposure for 24 hours to 5mM DCA increased PDH activity in non-transduced control cells (average 37% increase) and PDH deficient cells (average 44% increase).,nan
265,"summarize: The ketogenic diet, which is high in fat and low in carbohydrates, mimics the metabolic state of starvation, forcing the body to utilize fat as its primary source of energy.","The ketogenic diet, which is high in fat and low in carbohydrates, mimics the metabolic state of starvation, forcing the body to use fat as its primary source of energy.","The ketogenic diet, which is high in fat and low in carbohydrates, forces the body to use fat as its main source of energy."
266,"summarize: Objectives: Our aime was to study the short- and long-term effects of ketogenic diet on the disease course and disease-related outcomes in patients with pyruvate dehydrogenase complex deficiency, the metabolic factors implicated in treatment outcomes, and potential safety and compliance issues.","the aim of this study was to study the short- and long-term effects of ketogenic diet on disease progression and disease-related outcomes in patients with pyruvate dehydrogenase complex deficiency, the metabolic factors involved in treatment outcomes, and potential safety and compliance issues.","A ketogenic diet is a low carb, high-fat diet that can help create fuel for the body when glucose levels are low. The aim of this study is to find the short- and long-term effects of a ketogenic diet on disease progression and disease-related outcomes (changes in health) in patients with pyruvate dehydrogenase complex deficiency, a rare disease that impacts the nervous system. The effects of a ketogenic diet on the body's chemical process to turn food into energy and potential safety issues are also studied."
267,summarize: Methods: Pediatric patients diagnosed with pyruvate dehydrogenase complex deficiency in Sweden and treated with ketogenic diet were evaluated.,Children diagnosed with pyruvate dehydrogenase complex deficiency in Sweden and treated with ketogenic diet were evaluated.,Child patients diagnosed with pyruvate dehydrogenase complex deficiency in Sweden and treated with a ketogenic diet are evaluated in this study.
268,"summarize: Study assessments at specific time points included developmental and neurocognitive testing, patient log books, and investigator and parental questionnaires.","Several study assessments at specific time points included developmental and neurocognitive testing, patient log books, and investigator and parent questionnaires.","The study includes different tests on development and brain function, recording assessments in patient log books, and a series of questions for both researchers and parents to answer."
269,"summarize: Results: Nineteen patients were assessed, the majority having prenatal disease onset.","19 patients were assessed, the majority having pre-birth disease onset.","Nineteen patients were included in the study. For most of the patients, the disease developed during pregnancy."
270,summarize: It was also safe-except in one patient who discontinued because of acute pancreatitis.,It was also safe-except in one patient who stopped taking it because of acute pancreatitis.,"It is also safe-except in one patient who had to stop because of acute pancreatitis, where the pancreas becomes swollen over a short period of time."
271,summarize: Results of neurocognitive testing are reported for 12 of 19 patients.,results of neurocognitive testing are reported for 12 out of 19 patients.,nan
272,summarize: Pyruvate dehydrogenase complex deficiency (PDCD) is a rare neurodegenerative disorder associated with abnormal mitochondrial metabolism.,Pyruvate dehydrogenase complex deficiency (PDCD) is a rare neurodegenerative disorder associated with abnormal mitochondrial metabolism.,Pyruvate dehydrogenase complex deficiency (PDCD) or shortage is a rare disorder that can impact metabolism and lead to problems in the brain and nerves.
273,summarize: His blood gas before arrest revealed lactate of 8.9 mmol/L despite normal haemodynamics.,His blood gas before arrest showed lactate of 8.9 mmol/L despite normal heart function.,nan
274,summarize: The most common cause of PDCD is a mutation in the X-linked PDHA1 gene.,the most common cause of PDCD is a mutation in the X-linked PDHA1 gene.,The most common cause of PDCD is a mutation in one of the genes called PDHA1 (a gene that encodes a building block of PCD).
275,summarize: The severity of PDCD can range from neonatal death to more delayed onset of symptoms as in our index case.,PDCD can range from neonatal death to more delayed onset of symptoms as in our index case.,The seriousness of PDCD can range from infant death to more delayed onset of symptoms as in the child case described here.
276,summarize: These molecules are used as alternative fuel for energy production in target tissues.,These molecules are used as alternative fuel for energy production in target tissues.,Ketone bodies are molecules used as alternate fuel to produce energy for tissues in the body.
277,"summarize: Î2-hydroxybutyrate has been identified as class I histone deacetylase inhibitor, thus establishing a connection between products of hepatic lipid metabolism and epigenetics.","Î2-hydroxybutyrate has been identified as class I histone deacetylase inhibitor, thus establishing a connection between products of liver lipid metabolism and epigenetics.",nan
278,"summarize: Nonetheless, clear-cut evidence of the efficacy of KD in other disorders remains to be provided in order to suggest the adoption of such diets to metabolic-related pathologies.","Nevertheless, clear-cut evidence of the efficacy of KD in other disorders remains to be provided.","Nonetheless, clear-cut evidence of the performance of ketogenic bodies in other disorders is needed in order to suggest using such diets."
279,summarize: These molecules are used as alternative fuel for energy production in target tissues.,These molecules are used as alternative fuel for energy production in target tissues.,KB are used for energy creation in certain body parts.
280,"summarize: The nuclear receptor peroxisome proliferator activated receptor Î (PPARÎ), currently recognized as one of the master regulators of ketogenesis, integrates nutritional signals to the activation of transcriptional networks regulating fatty acid Î2-oxidation and ketogenesis.",PPARÎ (PPARÎ) integrates nutritional signals to the activation of transcriptional networks regulating fatty acid oxidation and ketogenesis.,The nuclear receptor peroxisome proliferator activated receptor Î (PPARÎ) is a major regulator of the creation of KB made from fat breakdown. It combines diet signals to the start up of cellular systems monitoring fat breakdown and KB creation.
281,"summarize: Ketogenic diets (KD) are currently used to treat different forms of infantile epilepsy, also caused by genetic defects such as Glut1 and Pyruvate Dehydrogenase Deficiency Syndromes.","Ketogenic diets (KD) are currently used to treat different forms of infantile epilepsy, also caused by genetic defects such as Glut1 and Pyruvate Dehydrogenase Deficiency Syndromes.","Ketogenic diets (KD) or low-carb diets are used to treat different forms of infatile epilepsy, a disorder in babies that disturbs brain and nerve activity and causes seizures. Infantile epilepsy is also caused by flaws in gene expression."
282,"summarize: To obtain energy for all tissue, glucose has to come through glycolysis; then as pyruvate it is converted to acetyl-CoA by pyruvate dehydrogenase complex (PDC) and finally enters citric acid cycle.","To get energy for all tissue, glucose has to come through glycolysis. Then, as pyruvate, it is converted to acetyl-CoA by pyruvate dehydrogenase complex (PDC), and finally enters the citric acid cycle.","In order for energy to reach all tissues, glucose has to go through a process with several stages. One of these stages is called pyruvate dehydrogenase complex (PDC) which converts molecules and links cells to the final stage of creating energy."
283,"summarize: Promising therapy seemed to be ketogenic diet, which substitutes glucose to ketone bodies as a source of energy.","Promising therapy seemed to be ketogenic diet, which substitutes glucose to ketone bodies as a source of energy.","Promising therapy may be a low carb, high fat diet called a ketogenic diet, where the body substitutes glucose with ketone bodies (chemicals the body makes when there is not enough glucose) as a source of energy."
284,"summarize: The newest reports say that phenylbutyrate increases the level of PDC in the brain, because it reduces the level of inactive form of PDH.","phenylbutyrate increases the level of PDC in the brain, because it reduces the level of inactive form of PDH.","The newest reports say that phenylbutyrate, a type of salt in the body that helps remove ammonia and waste from the body, increases the level of pyruvate dehydrogenase complex in the brain."
285,"summarize: Hence, it is conceivable that the KD might prove useful in other metabolic disorders that present with epileptic seizures.",KD might be useful in other metabolic disorders that present with epileptic seizures.,It is possible that a ketogenic diet may be useful in other disorders of metabolism that include epileptic seizures.
286,"summarize: At the same time, however, there are notable contraindications to KD use, such as fatty acid oxidation disorders.","At the same time, however, there are notable contraindications to KD use, such as fatty acid oxidation disorders.","At the same time, there are some disorders where ketogenic diets should be avoided."
287,"summarize: In the end, the expanded knowledge base will be critical to designing metabolism-based treatments that can afford greater clinical efficacy and tolerability compared to current KD approaches, and improved long-term outcomes for patients.","the expanded knowledge base will be critical to designing metabolism-based treatments that can afford greater clinical efficacy and tolerability compared to current KD approaches, and improved long-term outcomes for patients.","Ultimately, this new knowledge will be useful to design metabolic treatments that can further help patients compared to current KD approaches, with better long-term outcomes for patients."
288,summarize: PDC deficiency can be caused by alterations in any of the genes encoding its several subunits.,PDC deficiency can be caused by changes in any of the genes encoding its several subunits.,PDC deficiency or shortage is a disorder that can be caused by changes in genes.
289,summarize: Background: The pyruvate dehydrogenase complex (PDC) catalyzes the irreversible decarboxylation of pyruvate into acetyl-CoA.,pyruvate dehydrogenase complex (PDC) catalyzes the irreversible decarboxylation of pyruvate into acetyl-CoA.,The pyruvate dehydrogenase complex (PDC) quickens the permanent conversion of pyruvate (a particle used for energy-production) into acetyl-CoA (another particle used for energy production).
290,"summarize: The latter could be the result not only of the reduction of inhalative irritants, e.g. of allergen concentration, but also by the involvement or more complex mechanisms.","the latter could be the result not only of the reduction of inhalative irritants, e.g. allergen concentration, but also by the involvement or more complex mechanisms.",Maritime climatotherapy may improve BHR by reducing the level of irritants inhaled from the air.
291,summarize: Proinflammatory mediators in combination with alterations of airway mucosa induce or amplify BHR.,Proinflammatory mediators in combination with changes in the mucus of the airways cause or increase BHR.,Proinflammatory particles with changes to throat mucus promote BHR.
292,"summarize: Upper airway viral infections, exposure to allergens in atopic subjects, chronic hyperplastic changes of the upper airways, airway irritants and analgesics are supposed to be the most likely asthma triggers in predisposed children and adults.","upper airway viral infections, exposure to allergens in atopic subjects, long-lasting hyperplastic changes of the upper airways, airway irritants and analgesics are supposed to be the most likely triggers of asthma in predisposed children and adults.","Upper airway viral infections, allergen exposure, lasting enlargement of upper airways, airway irritants and pain-relievers may be the most common triggers of asthma in susceptible people."
293,"summarize: The latter could be the result not only of the reduction of inhalative irritants, e.g. of allergen concentration, but also by the involvement or more complex mechanisms.","the latter could be the result not only of the reduction of inhalative irritants, e.g. allergen concentration, but also by the involvement or more complex mechanisms.",Improvement with coastal weather may be because of reduced inhalative irritants and more complex reasons.
294,"summarize: With the exception, perhaps, of measures for the avoidance of infrequent forms of asthma caused by very specific types of exposure (e.g., occupational or aspirin-induced asthma), no single action has been irrefutably demonstrated to decrease the risk of the development of persistent asthma in persons who do not already have the disease.","with the exception, perhaps, of measures for the avoidance of infrequent forms of asthma caused by very specific types of exposure (e.g., occupational or aspirin-induced asthma), no single action has been shown to decrease the risk of the development of persistent asthma in persons who do not already have the disease.","Except for avoiding certain factors that cause infrequent types of asthma (e.g. job or asprin-activated asthma), no single action is definitely proven to decrease the risk of developing long-term asthma in people who do not already have the disease."
295,summarize: Summary: The most promising asthma prevention strategies to date have been those that use a multi-interventional approach employing both dietary and environmental manipulations.,the most promising asthma prevention strategies to date have been those that use a multi-interventional approach using both diet and environmental manipulations.,"In summary, the most promising way to prevent asthma is to use more than one treatment that include changing environmental exposures and diet."
296,summarize: More research is needed to assess the long-term follow-up of multi-interventional trials and to evaluate novel intervention strategies in the primary or secondary prevention of asthma in childhood.,more research is needed to assess the long-term follow-up of multi-treatment trials and to evaluate new treatment strategies in the primary or secondary prevention of asthma in childhood.,We need more evidence to measure the effects of multi-treatment trials and new strategies for asthma prevention in childhood.
297,summarize: Better understanding of the complex gene-environment interactions involved in the development of asthma will provide insight into personalized interventions for asthma prevention.,Better understanding of the complex gene-environment interactions involved in the development of asthma will provide insight into personalized treatments for asthma prevention.,A better understanding of gene-environment interactions and how they are involved in the development of asthma will help create interventions and treatment programs for individuals in order to prevent asthma.
298,summarize: In this review we discuss the beneficial and pathologic contributions of neutrophils to the immune response against RSV infection.,"In this review, we discuss the beneficial and pathologic contributions of neutrophils to the immune response against RSV infection.",This review discusses how neutrophils help the immune system respond to respiratory syncytial virus (RSV) infections.
299,"summarize: However, low specificity of neutrophil antimicrobial armaments allows for collateral tissue damage.","However, low specificity of neutrophil antimicrobial armaments allows for tissue damage.",Sometimes neutrophils that are fighting infection can lead to tissue damage.
300,"summarize: It has been 15 years since the first prevention of allergy (PAT) study was published, exploring the dream of the allergist: determining whether allergen-specific immunotherapy (AIT) can alter the natural course of disease and prevent the development of asthma in children with seasonal allergic rhino-conjunctivitis.","It has been 15 years since the first prevention of allergy (PAT) study was published, exploring the dream of the allergist: determining whether allergen-specific immunotherapy (AIT) can change the natural course of disease and prevent the development of asthma in children with seasonal allergic rhino-conjunctivitis.",An early study on prevention of allergies aimed to determine if allergen-specific immunotherapy (allergy shots) can improve or prevent the development of asthma in children.
301,summarize: Two hundred five children aged 6 to 14 years with grass and/or birch pollen allergy were randomized to receive either allergen-specific injection immunotherapy with aluminum-adsorbed native allergen extract subcutaneous immunotherapy for 3 years or to an open control group.,295 children aged 6 to 14 years with allergies to grass and/or birch pollen were randomly placed in either the first group to receive allergen-specific injection immunotherapy with an aluminum-adsorbed native allergen extract subcutaneous immunotherapy for 3 years or in a second group.,"Two hundred and five children aged 6 to 14 with grass and/or birch pollen allergy were randomly selected either to receive 3 years of allergen-specific, below-skin injection immunotherapy (treatment of disease by modifying immune system activity) or to join a control group."
302,summarize: Methacholine bronchial provocation test results were significantly better in the active group.,Methacholine bronchial provocation test results were significantly better in the active group.,Lung sensitivity tests were better in the treatment group.
303,"summarize: A report published in Pediatrics outlined the effects of maternal and infant nutrition on the development of atopic disease (including asthma) in children, reflecting that multiple factors could act in concert to influence disease development.","a report published in Pediatrics outlined the effects of maternal and infant nutrition on the development of atopic disease (including asthma) in children, reflecting that multiple factors could influence disease development.","A report published in a scientific journal called Pediatrics outlined the effects of the mother's and infant's nutrition on developing atopic diseases (a genetic tendency to develop an allergy), including asthma in children."
304,summarize: A total of 136 patients with symptomatic diurnal P-AF were enrolled.,136 patients with symptoms of diurnal P-AF were enrolled.,A total of 136 patients with symptomatic daytime paroxysmal atrial fibrillation (P-AF) were included in the study.
305,"summarize: For patients with effective treatment, a long-term effect up to 24 months was evaluated.","For patients with effective treatment, a long-term effect up to 24 months was evaluated.","For patients with effective treatment, a long-term effect up to 24 months was evaluated."
306,"summarize: Patients were divided into a diurnal-specific P-AF group and a diurnal & nocturnal P-AF group, as well as into a bisoprolol single use group and a combined use group with an antiarrhythmic drug.","patients were divided into a daytime P-AF group and a daytime & nighttime P-AF group, as well as into a single use group with bisoprolol and a combined use group with an antiarrhythmic drug.",Patients were divided into a group with daily-specific P-AF and a daily and nightly P-AF group. Patients were also divided into a group with single use of bisoprlol and a combined use group with an drug that prevents an irregular heart beat.
307,summarize: The elimination rate of P-AF episodes in ECGs was higher in the diurnal P-AF group than in the diurnal & nocturnal P-AF group (P=0.042).,the elimination rate of P-AF episodes in ECGs was higher in the diurnal P-AF group than in the daytime and nocturnal P-AF group.,The elimination rate of episodes of P-AF was higher in the daily P-AF group than in the daily and nightly P-AF group.
308,"summarize: In, OSA the highest risk for sudden death is at night in comparison to general population most of who die suddenly between six and noon.","In OSA, the highest risk for sudden death is at night in comparison to the general population most of who die suddenly between six and noon.","For people with obstructive sleep apnea syndrome, the highest risk for sudden death is at night."
309,summarize: The role of pacing in OSA remains controversial.,The role of pacing in OSA remains controversial.,The role of pacing (controlling the heartbeat) in patients with OSA remains controversial.
310,"summarize: In general, pacemaker therapy is not indicated in patients with nocturnal bradyarrhythmias.","In general, pacemaker therapy is not indicated in patients with nighttime bradyarrhythmias.","In general, using a pacemaker (a small device that's placed or implanted in the chest to help control the heartbeat) is not recommended in patients with nighttime heart rate that is too slow (bradyarrhythmias)."
311,summarize: Circadian variation in atrial fibrillation (AF) frequency is explored in this paper by employing recent advances in signal processing.,Circadian variation in atrial fibrillation (AF) frequency is explored in this paper by using recent advances in signal processing.,"Circadian variation (a part of the natural, internal process that regulates the sleepâwake cycle) in atrial fibrillation (a fluttery and irregular heartbeat that can lead to blood clots or stroke) frequency is explored in this paper by using recent advances in signal processing, which monitors the heart's electrical activity."
312,"summarize: Using the autocorrelation method, circadian variation was found in 13 of 18 ambulatory ECG recordings (Holter) acquired from patients with long-standing persistent AF.","Using the autocorrelation method, circadian variation was found in 13 of 18 ambulatory ECG recordings (Holter) acquired from patients with long-standing persistent AF.",Circadian variation is found in 13 of 18 patients with long-standing and persistent (last longer than 7 days) atrial fibrillation.
313,summarize: Objective: Nighttime onset of atrial fibrillation (AF) is sometimes associated with obstructive sleep apnea accompanied by a characteristic heart rate (HR) pattern known as cyclical variation of HR.,Nighttime onset of atrial fibrillation (AF) is sometimes associated with obstructive sleep apnea (slow breathing) accompanied by a characteristic heart rate pattern known as cyclical variation of heart rate.,"Nighttime onset of atrial fibrillation (a fluttery and irregular heartbeat that can lead to blood clots or stroke) is sometimes associated with obstructive sleep apnea (where muscles in the throat relax, the airway is narrowed or closed, and breathing is momentarily cut off) along with a specific heart rate pattern called cyclical variation."
314,"summarize: Methods: The subjects consisted of 34 patients (6812 years) with paroxysmal AF, including 14 patients with daytime AF and 20 patients with nighttime AF.","The study included 34 patients (6812 years) with paroxysmal AF, including 14 patients with daytime AF and 20 patients with nighttime AF.","There are 34 patients in the study with paroxysmal AF (when the heart rate returns to normal within 7 days on its own or with treatment), including 14 patients with daytime AF and 20 patients with nighttime AF."
315,summarize: The mean power of the VLF (very low frequency) component (0.008-0.04 Hz) before the onset of AF was significantly greater in the nighttime AF episodes than in the daytime AF episodes.,the average power of the VLF component before the onset of AF was significantly greater in the nighttime AF episodes than in the daytime AF episodes.,nan
316,"summarize: The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes.","the results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (desaturation period) of less than 90%.",Heart and oxygen tests were performed in the hospital after the second cardioversion.
317,"summarize: Thus, BiPAP and medical treatments were ended.",BiPAP and medical treatments were stopped.,"Because they did not recur, the BiPAP and medical treatments were ended."
318,"summarize: Kv4.2, along with Kv4.3, contributes to the cardiac fast transient outward K+ current, Ito.","Kv4.2, along with Kv4.3, contributes to the cardiac fast transient outward potassium current, Ito.","Kv4.2 and Kv4.3 are potassium channels that release potassium from cells and contribute to the heart-related, temporary, fast, outward potassium (K+) current, Ito."
319,summarize: Coexpression of mutant and wild-type channels (recapitulating heterozygosity in affected individuals) showed results similar to the mutant channel alone.,Coexpression of mutant and wild-type channels (recapitulating heterozygosity in affected individuals) showed results similar to the mutant channel alone.,nan
320,"summarize: These effects presumably increase the repolarizing potassium current Ito, thereby abbreviating action potential duration, creating arrhythmogenic substrate for nocturnal AF.","These effects presumably increase the repolarizing potassium current Ito, thereby abbreviating action potential duration, creating arrhythmogenic substrate for nighttime AF.","These effects possibly increase the repolarizing potassium current Ito, creating arrhythmogenic substrates (factors that can produce or lead to arrhythmia) for nocturnal atrial fibrillation (an irregular and often very rapid heart rhythm occuring at night that can lead to blood clots in the heart)."
321,"summarize: The atrial-specific phenotype suggests that targeting Kv4.2 might be effective in the treatment of nocturnal paroxysmal AF, avoiding adverse ventricular effects.","the atrial-specific phenotype suggests that targeting Kv4.2 might be effective in the treatment of nighttime paroxysmal AF, avoiding adverse ventricular effects.",Targeting Kv4.2 might be effective in the treatment of nocturnal paroxysmal atrial fibrillation.
322,"summarize: Implantable cardiac monitors (ICMs) (Medtronic Reveal XT, Minneapolis, Minnesota) in the DCCV and AF ablation groups, and PPM Holters in the 'pace and ablate' group were utilized to assess cardiac rhythm beat-to-beat throughout the study period.",Implantable cardiac monitors (ICMs) were used to measure heart rhythm beat-to-beat throughout the study period.,Other devices were used to monitor heart rhythm throughout the study period.
323,summarize: AHI fell from 29.8  26.6/h to 22.2  20.4/h; P = 0.049.,AHI fell from 29.8  26.6/h to 22.2  20.4/h.,AHI fell from 29.8  26.6/h to 22.2  20.4/h.
324,"summarize: Methods: Sixty-seven patients (aged 66 to 86, 53% male) with persistent AF were randomized (1:1:1) to direct current cardioversion (DCCV) (22 patients), permanent pacemaker (PPM) + atrioventricular node ablation (AVNA) + DCCV (22 patients) or AF ablation (23 patients).","67 patients (aged 66 to 86, 53% male) with persistent AF were randomly placed in groups of either direct current cardioversion (DCCV), permanent pacemaker (PPM) + atrioventricular node ablation (AVNA) + DCCV (22 patients) or AF ablation (23 patients).","Sixty-seven patients (aged 66 to 86, 53% male) with long-lasting atrial fibrillation (irregular or rapid heart beat) were randomly grouped (1:1:1) to three standard treatments for atrial fibrillation."
325,"summarize: Twenty-five patients (15 AF ablation, 9 DCCV and 1 following DCCV post-AVNA) maintained SR at 6 months confirmed on ICMs in these patients.","25 patients (15 AF ablation, 9 DCCV and 1 following DCCV post-AVNA) maintained SR at 6 months.",Twenty-five patients (with standard treatments for irregular heart beat) maintained sinus rhythm for 6 months confirmed on implanted heart beat monitors in these patients.
326,summarize: Treatment options include positive airway pressure as well as adaptive servo-ventilation and phrenic nerve stimulation for CSA.,"Treatment options include positive airway pressure, adaptive servo-ventilation and phrenic nerve stimulation for CSA.","Treatment options include positive airway pressure (a machine used to pump air under pressure into the airway of the lungs), adaptive servo-ventilation (a device that tracks and adjusts its pressure to match the breathing pattern of a person with sleep apnea), and phrenic nerve stimulation (treatment that sends electrical stimulation to the patient's phrenic nerve to contract the diaphragm and produce breathing)."
327,"summarize: Treatment improves blood pressure, quality of life, and sleepiness, the last particularly in those at risk for cardiovascular disease.","Treatment improves blood pressure, quality of life, and sleepiness, the last particularly in those at risk for heart disease.","Treatment improves blood pressure, quality of life, and sleepiness."
328,"summarize: The normal sleep-wake cycle is characterized by diurnal variations in blood pressure, heart rate, and cardiac events.","the normal sleep-wake cycle is characterized by diurnal variations in blood pressure, heart rate, and cardiac events.","The normal sleep-wake cycle has daily changes in blood pressure, heart rate, and heart-related events."
329,"summarize: Dietary constituents with especially high anti-inflammatory and antioxidant capacity include vitamin C, vitamin E, and phytochemicals such as carotenoids and polyphenols.","Dietary constituents with especially high anti-inflammatory and antioxidant capacity include vitamin C, vitamin E, and phytochemicals such as carotenoids and polyphenols.","Foods that can help relieve inflammation and have antioxidants (vitamins, minerals, and other nutrients that protect and repair cells) have vitamin C, vitamin E, and phytochemicals (compounds found in fruits and vegetables)."
330,"summarize: Dietary fiber, fermented by the gut microbiota into short-chain fatty acids, has also been shown to produce anti-inflammatory effects.","Dietary fiber, fermented by the gut microbiota into short-chain fatty acids, has also been shown to produce anti-inflammatory effects.",Fiber in foods has also been shown to fight inflammation.
331,"summarize: According to the World Health Organization, healthy foods and hydration are vital.","According to the World Health Organization, healthy foods and hydration are vital.","According to the World Health Organization, healthy foods and drinking plenty of water are vital."
332,summarize: Zinc is necessary for maintaining the immune system.,Zinc is necessary for maintaining the immune system.,Zinc is a key mineral in the body necessary for keeping the immune system healthy.
333,"summarize: Food from plants containing vitamin A should be consumed, and 8â10 cups of water should be drunk daily.","Food from plants containing vitamin A should be eaten, and 8â10 cups of water should be drunk daily.",People should eat food from plants containing vitamin A and drink 8-10 cups of water every day.
334,"summarize: Too much caffeine, sweetened fruit juices, fruit juice concentrates, syrups, fizzy drinks, and still drinks must be avoided.","Too much caffeine, sweetened fruit juices, fruit juice concentrates, syrups, fizzy drinks, and still drinks must be avoided.","However, too much caffeine, sweetened fruit juices, fruit juice concentrates, syrups, fizzy drinks, and some still (non-carbonated) drinks must be avoided."
335,"summarize: Unsaturated fats, white meats, and fish should be consumed.","Unsaturated fats, white meats, and fish should be consumed.","Unsaturated fats (healthy fats), white meats, and fish should be eaten."
336,"summarize: Moreover, an oxidative stress imbalance has been demonstrated to occur in COVID-19 patients.","Moreover, an oxidative stress imbalance has been shown to occur in COVID-19 patients.","Also, an oxidative stress imbalance, which can lead to cell and tissue damage, has been shown to occur in COVID-19 patients."
337,summarize: N- Acetyl-L-cysteine (NAC) is a precursor of reduced glutathione (GSH).,N- Acetyl-L-cysteine (NAC) is a precursor of reduced glutathione (GSH).,"N- Acetyl-L-cysteine (NAC) is used to build antioxidants (vitamins, minerals, and other nutrients that protect and repair cells), and its presence may be followed by reduced, or charged, glutathione (GSH), a key antioxidant that protects tissues and cells."
338,"summarize: At very high doses, NAC is also used as an antidote against paracetamol intoxication.","At very high doses, NAC is also used as an antidote against paracetamol intoxication.","At very high doses, N- Acetyl-L-cysteine (NAC) is also used as a medicine against paracetamol intoxication (too much of a common oral medication called Acetaminophen used for pain and reducing fevers)."
339,"summarize: Functional foods optimize the immune system capacity to prevent and control pathogenic viral infections, while physical activity augments such protective benefits.","Functional foods improve the immune system ability to prevent and control viral infections, while physical activity increases these protective benefits.","Certain foods improve the immune system's ability to prevent and control harmful viral infections, while physical activity improves such protective benefits."
340,"summarize: Exercise enhances innate and adaptive immune systems through acute, transient, and long-term adaptations to physical activity in a dose-response relationship.","Exercise improves innate and adaptive immune systems through short-term, temporary, and long-term adaptations to physical activity.","Exercise improves general and antibody-related immune systems through immediate, temporary, and long-term changes to physical activity in a proportional relationship."
341,"summarize: In this text, aspects related to these issues are reviewed.","In this text, aspects related to these issues are reviewed.",This text reviews different issues related to vaccines and immunity.
342,summarize: Vitamin D is a key regulator of the renin-angiotensin system that is exploited by SARS-CoV-2 for entry into the host cells.,Vitamin D is a key regulator of the renin-angiotensin system that is exploited by SARS-CoV-2 for entry into the host cells.,"Vitamin D plays a key role in controlling blood pressure and fluid in the body and is used by SARS-CoV-2, the virus leading to the respiratory disease of COVID-19, for entry into cells."
343,"summarize: Several vaccines have been developed to control the COVID-19, but the potential effectiveness of the mucosal vaccine remains to be documented.","Several vaccines have been developed to control the COVID-19 virus, but the potential effectiveness of the mucosal vaccine remains unclear.","Several vaccines have been developed to control the COVID-19, but the potential effectiveness of the mucosal vaccine (vaccines given at moist, inner lining of some organs and body cavities, such as the nose, mouth, lungs, and stomach) remains to be documented."
344,"summarize: Further, we evaluated the immune response in mice via the intranasal administration of LP18:RBD.",LP18:RBD is an anti-inflammatory drug.,Researchers also evaluate the immune response in mice by the intranasal administration (a non-invasive route for drug delivery through the nose) of LP18:RBD.
345,summarize: The results showed that the LP18:RBD significantly elicited RBD-specific mucosal IgA antibodies in respiratory tract and intestinal tract.,LP18:RBD significantly elicited RBD-specific mucosal IgA antibodies in the respiratory tract and intestinal tract.,The results show that LP18:RBD significantly brought out IgA antibodies (antibodies that play a crucial role in the immune function of mucous membranes) in the organs involved in breathing and in digesting food.
346,summarize: The percentages of CD3 + CD4+ T cells in spleens of mice administrated with the LP18:RBD were also significantly increased.,the percentages of CD3 + CD4+ T cells in spleens of mice given LP18:RBD were also significantly increased.,nan
347,"summarize: As COVID-19 continues to spread rapidly worldwide and variants continue to emerge, the development and deployment of safe and effective vaccines are urgently needed.","As COVID-19 continues to spread rapidly worldwide and variants continue to emerge, the development and use of safe and effective vaccines are urgently needed.","As COVID-19, a viral breathing-related disease, continues to spread rapidly worldwide and variants continue to emerge, the development and distribution of safe and effective vaccines are urgently needed."
348,"summarize: After further challenge with live SARS-CoV-2, immunization with a two-shot low-dose regimen of TF-RBD provided adequate protection in hACE2-transduced mice.","after further challenge with live SARS-CoV-2, immunization with a two-shot low-dose regimen of TF-RBD provided adequate protection in mice that had the virus.",Immunization with two shots of a low dose vaccine of TF-RBD provided adequate protection in mice.
349,"summarize: The COVID-19 epidemic is the greatest pandemic that human kind experienced for decades, with high morbidity and mortality.","the COVID-19 epidemic is the greatest pandemic that humankind experienced for decades, with high disease and death rates.","The COVID-19 epidemic (an outbreak of the viral breathing-related disorder) is the greatest pandemic that human kind experienced for decades, with high numbers of death and illness."
350,summarize: The aim of this study is to indicate if herbs administered alone or as a complementary therapy could be used as prophylaxis or treatment of SARS-CoV-2 infection.,the aim of this study is to indicate if herbs given alone or as a complementary therapy could be used as prophylaxis or treatment of SARS-CoV-2 infection.,This study aims to find out if herbs given by themselves or as part of a combination of treatments can be used to prevent or treat SARS-CoV-2 infection (the novel coronavirus that can lead to COVID-19).
351,"summarize: Glycyrrhizin in vitro connects and changes conformation of ACE2 receptors, which are vital for SARS-CoV-2 penetration into host cells.","Glycyrrhizin in vitro connects and changes the shape of ACE2 receptors, which are vital for SARS-CoV-2 penetration into host cells.","In experiments outside of the body, liquorice connects and changes the structure of ACE2 receptors, which are proteins that allow SARS-CoV-2 to enter cells."
352,summarize: Glycyrrhiza glabra in combination with standard therapies significantly reduces the hospitalization rate and occurrence of COVID-19 symptoms.,Glycyrrhiza glabra in combination with standard treatments significantly reduces the hospitalization rate and occurrence of COVID-19 symptoms.,"Glycyrrhiza glabra, or liquorice, in combination with standard therapies significantly reduces hospitalizations and occurrence of COVID-19 symptoms."
353,"summarize: As complementary therapies lianhuaqingwen capsules and jinhua qinggan granules reduces hospitalization rates, time to symptoms recovery and improve patient psychological comfort.","lianhuaqingwen capsules and jinhua qinggan granules reduce hospitalization rates, time to symptoms recovery and improve patient psychological comfort.","Additional therapies based on a traditional Chinese medicine, lianhuaqingwen capsules and jinhua qinggan granules, reduces the number of hospitalizations and the time it takes to recover from symptoms."
354,"summarize: In view of SARS-CoV-2 other herbs are not effective, e.g. maxingshigan-yinqiaosan, or therapeutic concentration would be impossible to achieve, e.g. ephedra herb, or there is simply no proper data.","Other herbs are not effective, such as maxingshigan-yinqiaosan, or ephedra herb, or there is simply no proper data.","There are some herbs that are either not effective, would be impossible to get enough of into the body safely, or are not usefully documented to fight SARS-CoV-2."
355,"summarize: Changes in metabolism are crucial to fuel NK cell responses, and altered metabolism is linked to NK cell dysfunction in obesity and cancer.","Changes in metabolism are crucial to fuel NK cell responses, and altered metabolism is linked to NK cell dysfunction in obesity and cancer.","Changes in metabolism (the process that creates fuel for the body) are crucial to fuel NK cell responses, and changes in metabolism are linked to NK cells not working correctly in obesity and cancer."
356,"summarize: Although a role for pendrin in maintaining Na+ balance, intravascular volume, and BP is well supported, there is no in vivo evidence for the role of NDCBE in maintaining Na+ balance.","pendrin plays a role in maintaining Na+ balance, blood volume, and BP. However, there is no evidence for the role of NDCBE in maintaining Na+ balance.",There is no lab or test tube experiments that show evidence for the role of Na+-driven Cl-/2HCO3- exchanger (NDCBE) in maintaining a sodium balance.
357,"summarize: Here, we show that deletion of NDCBE in mice caused only subtle perturbations of Na+ homeostasis and provide evidence that the Na+/Cl- cotransporter (NCC) compensated for the inactivation of NDCBE.",We show that deletion of NDCBE in mice caused only subtle changes in Na+ homeostasis and provide evidence that the Na+/Cl- cotransporter (NCC) compensated for the inactivation of NDCBE.,"In this present study, researchers show that reducing Na+-driven Cl-/2HCO3- exchanger in mice causes only minor disruptions of sodium homeostasis (processes used by the body to maintain a normal sodium concentration in the fluid outside the cells). Researchers provide evidence that the Na+/Cl- cotransporter (NCC) (the carrier protein that helps reabsorb sodium and chloride ions from tube fluid into the cells) compensated for the lack of action of the Na+-driven Cl-/2HCO3- exchanger."
358,"summarize: Moreover, the downregulation of Kir4.1 increases epithelial Na channel expression in the collecting duct and urinary K excretion.","Moreover, the downregulation of Kir4.1 increases epithelial Na channel expression in the collecting duct and urinary potassium excretion.","Additionally, the decrease in function of Kir4.1 increases activity of the epithelial Na channel (the lining of the outer part of the kidney tubule) in the ducts and potassium release through urine."
359,"summarize: Recent findings: Kir4.1 is expressed in the basolateral membrane of the DCT, and plays a predominant role in contributing to the basolateral K conductance and in participating in the generation of negative membrane potential.","Kir4.1 is expressed in the basolateral membrane of the DCT, and plays a major role in contributing to the basolateral potassium conductance and in participating in the generation of negative membrane potential.",Kir4.1 is active in the outer-facing boundary of a specific region of the sub-kidney units and helps transport potassium outward and create a negative boundary charge.
360,"summarize: The genetic deletion or functional inhibition of Kir4.1 depolarizes the membrane of the DCT, inhibits ste20-proline-alanine rich kinase, and suppresses NCC activity.","Kir4.1, a protein that helps regulate cell function, depolarizes the membrane of the DCT, inhibits ste20-proline-alanine rich kinase, and suppresses NCC activity.","The gene-related deletion or silencing of Kir4.1 changes the charge of the boundary of a specific region of sub-kidney units, blocks a high-energy transporting protein, and prevents sodium-chloride channel activity."
361,"summarize: Finally, mice with low Kir4.1 activity in the DCT are hypomagnesemia and hypokalemia.","Lastly, mice with low Kir4.1 activity in the DCT are hypomagnesemia and hypokalemia.","Finally, mice with low Kir4.1 activity in a specific region of sub-kidney units have low blood magnesium and low blood potassium."
362,summarize: Summary: Recent progress in exploring the regulation and the function of Kir4.1 in the DCT strongly indicates that Kir4.1plays an important role in initiating the regulation of renal K secretion by targeting NCC and it may serves as a K sensor in the kidney.,Recent progress in exploring the regulation and the function of Kir4.1 in the DCT strongly suggests that Kir4.1 plays an important role in initiating the regulation of kidney potassium secretion by targeting NCC and may serve as a K sensor in the kidney.,Recent progress in exploring the monitoring and use of Kir4.1 in a specific region of sub-kidney units shows that Kir4.1 helps begin the monitoring of kidney-related K removal by targeting sodium-chloride channels. Kir4.1 may also be a K sensor in the kidney.
363,"summarize: Background: Potassium (K(+)) is the major intracellular cation, with 98% of the total pool being located in the cells at a concentration of 140-150 mmol/l, and only 2% in the extracellular fluid, where it ranges between 3.5 and 5 mmol/l.","Potassium (K(+) is the major intracellular cation, with 98% of the total pool being located in the cells at a concentration of 140-150 mmol/l, and only 2% in the extracellular fluid, where it ranges between 3.5 and 5 mmol/l.",There is a large amount of potassium (a mineral the body needs to function properly) in the fluid within cells.
364,"summarize: Key messages: Maintaining plasma K(+) levels in a tight range is crucial for life; thus, multiple factors are implicated in K(+) homeostasis, including kidney function.","Keeping blood potassium levels in a tight range is crucial for life. Therefore, multiple factors are involved in K(+) homeostasis, including kidney function.","Key messages in this review are that maintaining potassium levels in the blood in a tight range is very important for life. Therefore, multiple factors are connected with potassium homeostasis (the correct amount of potassium for the body to function), including kidney function."
365,summarize: Potassium secretion occurs at the distal convoluted tubule.,Potassium secretion occurs at the distal convoluted tubule.,Potassium is released at the distal convoluted tubule (a portion of the kidney nephron that functions in both absorption and secretion or release).
366,"summarize: Hypokalemia occurs when serum potassium levels under 3.6 mmol/Lâweakness, fatigue, and muscle twitching present in hypokalemia.","Hypokalemia occurs when blood potassium levels below 3.6 mmol/L are weak, fatigue, and muscle twitching present in hypokalemia.","Hypokalemia occurs when there are low potassium levels in the blood and results in weakness, fatigue, and muscle twitching."
367,summarize: Total-body potassium (K+) content and appropriate distribution of K+ across the cell membrane is vitally important for normal cellular function.,potassium (K+) content in the body and how it is distributed across the cell membrane is vitally important for normal cell function.,The total-body content of potassium (K+) and distribution of K+ across the cell membranes (the thick layer that surrounds cells) is very important for normal functioning of the body's cells.
368,summarize: We provide an up-to-date review of the regulatory aspects of normal K+ physiology as a preface to highlighting common disorders in K+ homeostasis and their treatment.,the authors provide an up-to-date review of the regulatory aspects of normal K+ physiology as a preface to highlighting common disorders in K+ homeostasis and their treatment.,Researchers review the normal regulating process of total-body potassium (K+) before highlighting common disorders in K+ homeostasis and their treatment.
369,summarize: Total-body potassium (K+) content and appropriate distribution of K+ across the cell membrane is vitally important for normal cellular function.,potassium (K+) content in the body and how it is distributed across the cell membrane is vitally important for normal cell function.,Full-body potassium (K+) content and appropriate distribution of K+ across cell boudaries is important for normal cellular function.
370,summarize: We provide an up-to-date review of the regulatory aspects of normal K+ physiology as a preface to highlighting common disorders in K+ homeostasis and their treatment.,the authors provide an up-to-date review of the regulatory aspects of normal K+ physiology as a preface to highlighting common disorders in K+ homeostasis and their treatment.,We review the current biology of K+ to introduce common disorders in K+ balance and their treatment.
371,summarize: This review of K+ homeostasis is designed as a resource for clinicians and a tool for educators who are teaching trainees to understand the pivotal factors involved in K+ balance.,This review of K+ homeostasis is designed as a resource for clinicians and a tool for educators who are teaching trainees to understand the key factors involved in K+ balance.,nan
372,summarize: Neither high- nor low-potassium diets affected the basolateral DCT's potassium conductance and membrane potential in Kcnj16-/- mice.,Neither high- nor low-potassium diets affected the basolateral DCT's potassium conductance and membrane potential in mice.,Neither a diet high nor low in potassium affected the potassium channel that is located at the base or sides of the cell or the negative charges in the cell membranes in the knockout mice.
373,"summarize: Kidney medulla-specific inhibition of class I HDACs in the rat during high-salt feeding results in hypertension, polyuria, hypokalemia, and nitric oxide deficiency.","Kidney medulla-specific inhibition of class I HDACs in the rat during high-salt feeding results in hypertension, polyuria, hypokalemia, and nitric oxide deficiency.",The slowing or stopping of class I HDACs from the kidney medulla region in rats during high-salt feedings results in diseases such as hypertension (high blood pressure) and hypokalemia (low levels of potassium in the blood).
374,"summarize: In conclusion, kidney tubular HDACs provide a link between the environment, such as consumption of high-salt diets, and regulation of homeostatic mechanisms to remain in fluid-electrolyte balance.","HDACs provide a link between the environment, such as eating high-salt diets, and regulation of homeostatic mechanisms to remain in fluid-electrolyte balance.","In conclusion, HDACs from the kidney provide a link between the environment, such as consuming high-salt diets, and regulating processes to stay in fluid-electrolyte balance."
375,"summarize: Following infusion of labeled cells, the recirculating portion of the labeled cells rapidly equilibrated with the total intravascular lymphocyte pool and the vastly larger total-body recirculating lymphocyte pool, so that by 1 hr following infusion 21.8% plus or minus 3.2% of the labeled lymphocytes were left in the circulation.","after infusion of labeled cells, the recirculating portion of the labeled cells rapidly equilibrated with the total intravascular lymphocyte pool and the vastly larger total-body recirculating lymphocyte pool. By 1 hour following infusion, 21.8% plus or minus 3.2% of the labeled lymphocytes were left in the circulation.","The recirculating or re-added part of the new lymphocyte cells returned to volunteers quickly balanced with the total lymphocyte pools and by 1 hour after the cells were put in the body, 21.8% were left in circulation."
376,"summarize: As the lymphocyte counts returned to normal following hydrocortisone, the specific activity also returned to normal.","As the lymphocyte counts returned to normal following hydrocortisone, the specific activity also returned to normal.",The lymphocyte counts (white blood cell count) returned to normal after hydrocortisone use. The specific activity also returned to normal.
377,summarize: It is thought that glucocorticosteroids impair the clearance of immune complexes by the mononuclear phagocyte system (MPS).,It is thought that glucocorticosteroids impair the clearance of immune complexes by the mononuclear phagocyte system (MPS).,It is though that glucocorticosteroids (strong medicines that fight inflammation and work with the immune system) disrupt the elimination of immune complexes (build-up in the blood that can cause infection and problems with the immune system) by the mononuclear phagocyte system (a family of cells that fight foreign substances and are part of the immune system).
378,"summarize: Fourthly, prednisolone and prednisone are interconvertible and prednisolone is given intravenously as an ester prodrug, features which created controversies about the correct interpretation of pharmacokinetic results.","Lastly, prednisolone and prednisone are interchangeable. Prednisolone is given intravenously as an ester prodrug, features which created controversy about the correct interpretation of drug results.","Fourth, prednisolone and prednisone can be exchanged for one another or converted to the other, and prednisolone is given intravenously or via injection. These features create disagreement about the correct way to understand how the body is able to handle these drugs."
379,"summarize: Finally, the total body clearances of total and (to a lesser degree) of unbound prednisolone increase with increasing concentrations of prednisolone.","Lastly, the total body clearances of total and unbound prednisolone increase with increasing levels of prednisolone.","Finally, the total amount of prednisolone that is cleared from the body and the total amount of prednisolone that has an effect on the body increase with more concentration of prednisolone."
380,"summarize: Therefore, in order to compare pharmacokinetic results between different subjects, standardised doses had to be administered.","Hence, in order to compare drug activity between different patients, standardised doses had to be given.","Therefore, in order to compare pharmacokinetic results (how the body responds to or handles a drug) between different people, the same dose has to be given to patients."
381,"summarize: The investigations performed so far have revealed that: (1) the dose-dependent pharmacokinetics partly explain the clinical observation that an alternate-day regimen with prednisone yields fewer biological effects; (2) the interconversion of prednisone into prednisolone is not a limiting factor, even in patients with severely impaired liver function; (3) hypoproteinaemia per se does not cause increased unbound concentrations of prednisolone in vivo; (4) patients with liver failure, renal failure or a renal transplant, subjects older than 65 years, women on estrogen-containing oral contraceptive steroids or subjects taking ketoconazole have increased unbound concentrations of prednisolone-whereas hyperthyroid patients, some patients with Crohn's disease, subjects taking microsomal liver enzyme-inducing agents or patients on intravenous prednisolone phthalate (instead of prednisolone phosphate) or on some brands of enteric coated prednisolone tablets have decreased concentrations of prednisolone.","the studies performed so far have shown that: (1) the dose-dependent pharmacokinetics partly explain the observation that an alternate-day regimen with prednisone yields fewer biological effects; (2) the interconversion of prednisone into prednisolone is not a limiting factor, even in patients with severely impaired liver function; (3) low levels of protein per se does not cause increased unbound concentrations of prednisolone in vivo; (4) patients with liver failure, kidney failure or a person older than 65 years","The investigations done so far reveal that: 1) using the amount of dose to understand the body's effect explains why an alternate- or every-other-day treatment with prednisone leads to fewer effects in the body; 2) it is not a limiting factor that prednisone can convert to prednisolone; 3) hypoproteinaemia (lower than normal levels of protein in the body) does not cause an increase of the amount of drug in the body that can have an effect; 4) patients with liver failure, kidney failure, or kidney transplant, as well as people with other conditions, have an increased amount of the prednisolone drugs - while"
382,summarize: The biological relevance of the altered pharmacokinetics is supported in part by altered clinical effects and altered effects on cellular immunofunctions.,the biological relevance of the altered drug-related processes is supported in part by altered clinical effects and altered effects on cellular immune function.,The importance of these changed drug reactions is supported partly by changed clinical effects and changed effects on cellular immunofunctions.
383,summarize: These effects were maximal 6 hr after drug administration and gone by 24 hr.,These effects were maximum 6 hours after the drug was given and gone by 24 hours.,"The maximum effect occurred 6 hours after the drug is provided, and effects are gone by 24 hours."
384,summarize: The pharmacokinetics of both oral prednisone and intravenous prednisolone were dose-dependent.,the pharmacokinetics of both oral prednisone and intravenous prednisolone were dose-dependent.,The pharmacokinetics (how the body handles a drug) of both oral prednisone and IV prednisolone are dose-dependent (in which the effects of a drug change when the dose of the drug is changed).
385,"summarize: Further, we tested the hypothesis of an up-regulation of Th2 immune response during successful treatment with corticosteroids to explain their beneficial effect in Graves' ophthalmopathy.","Moreover, we tested the hypothesis of an up-regulation of Th2 immune response during successful treatment with corticosteroids to explain their beneficial effect in Graves' ophthalmopathy.","Further, researchers tested the theory of an up-regulation of the Th2 immune response (where Th2 cells increase their responses to a signal from outside the cell to carry out specific functions) during successful treatment with corticosteroids."
386,"summarize: In corticosteroid-responsive patients, the balance of serum cytokines IL-4/IFNgamma, IL-4/TNFalpha, IL-10/IFNgamma and IL-10/TN Falpha increased and remained upregulated until the end of the study.","In corticosteroid-responsive patients, the balance of blood cytokines (blood molecule) increased and remained upregulated until the end of the study.","In patients that received corticosteroids and had a response from the drug, the balance of certain blood cytokines that were measured had increased and remained increased until the end of the study."
387,"summarize: Background: Renal transplant recipients were noted to appear cushingoid while on low doses of steroid as part of a triple therapy immunosuppression of cyclosporin A (CsA), prednisolone, and azathioprine.",Renal transplant recipients were noted to appear cushingoid while on low doses of steroid as part of a triple therapy against the immune system.,"People who received a renal (kidney) transplant appear cushingoid (having different symptoms, often facial puffiness and weight gain, due to too much of the hormone cortisol in the body) while on low doses of steroid as part of multiple drug treatments, including prednisolone."
388,"summarize: A significantly higher proportion of patients on triple therapy had steroid side effects compared with those on steroid and azathioprine (17/27 versus 4/15), more women than men had side effects (14/16 versus 7/22), and the AUC/mg prednisone was greater in those with side effects than without (median 377 versus 288 nmol x h/L/mg).","a significantly higher proportion of patients on triple therapy had side effects from steroids compared with those on steroid and azathioprine. More women than men had side effects, and the AUC/mg prednisone was greater in those with side effects than without.","A significantly higher proportion of patients on multiple-drug therapy had steroid side effects compared with those on steroid and azathioprine (a drug that can prevent organ rejection after a transplant). More women than men had side effects, and the area under the curve prednisone was greater in those with side effects than without."
389,summarize: The increased exposure to steroid increased the side-effect profile of steroids in the majority of patients.,the increased exposure to steroid increased the side-effect profile of steroids in the majority of patients.,The increased exposure to the steroid increased the side effects of steroids in most of the patients.
390,"summarize: Prednisolone bioavailability was measured using a limited 6-hour area under the curve (AUC), with prednisolone measured using specific HPLC assay.","Prednisolone bioavailability was measured using a limited 6-hour area under the curve (AUC), with prednisolone measured using specific HPLC assay.",nan
391,summarize: Results: The median prednisolone AUC/mg dose for all transplant recipients was significantly greater than the control group by approximately 50% (316 nmol x h/L/mg prednisolone versus 218).,the average prednisolone AUC/mg dose for all transplant recipients was significantly greater than the control group by about 50%.,The average immunosuppressive prednisolone dose measurement for all transplant receivers was higher than the baseline group by around 50%.
392,"summarize: A significantly higher proportion of patients on triple therapy had steroid side effects compared with those on steroid and azathioprine (17/27 versus 4/15), more women than men had side effects (14/16 versus 7/22), and the AUC/mg prednisone was greater in those with side effects than without (median 377 versus 288 nmol x h/L/mg).","a significantly higher proportion of patients on triple therapy had side effects from steroids compared with those on steroid and azathioprine. More women than men had side effects, and the AUC/mg prednisone was greater in those with side effects than without.",More patients on the three-part therapy had steroid side effects versus those on steroid and the immunosuppressive azathioprine drug (17/27 versus 4/15). More women than men had side effects (14/16 versus 7/22). The immunosuppressive prednisone drug score was higher in those with side effects than without.
393,"summarize: There was no substantial difference in pharmacokinetic parameters of the formulations apart from the programmed delay in release of glucocorticoid from the modified-release tablets (C(max) 97%, AUC(0-â) 101%, 90% confidence intervals within the requisite range for bioequivalence).",there was no significant difference in drug-related parameters of the formulations apart from the programmed delay in release of glucocorticoid from the modified-release tablets.,There is no great difference in pharmacokinetic measures of the doses besides the programmed delay in release of glucocorticoid from the modified-release tablets.
394,summarize: Pharmacokinetic evaluation in 9 patients with RA confirmed that modified-release prednisone tablets taken at bedtime (around 22:00 h) with or after an evening meal result in programmed release of glucocorticoid 4 to 6 hours after intake.,9 patients with RA confirmed that modified-release prednisone tablets taken at bedtime (around 22:00 h) with or after an evening meal resulted in programmed release of glucocorticoid 4 to 6 hours after intake.,Evaluating the effect of the drug in 9 patients with rheumatoid arthritis confirmed that modified-release (delayed release) prednisone tablets taken at bedtime with or after an evening meal results in programmed release of glucocorticoid 4 to 6 hours after taking the tablets.
395,"summarize: We used multiplexed techniques to query the immunome in 20 volunteers at baseline, and after intravenous hydrocortisone (HC) administered at moderate (250 mg) and low (50 mg) doses, to provide insight into how corticosteroids exert their effects.","the study used multiplexed methods to query the immune system in 20 volunteers at the start of the study, and after hydrocortisone (HC) given via veins at moderate (250 mg) and low (50 mg) doses, to provide insight into how corticosteroids exert their effects.","Researchers use multiple ways to examine the immunome in 20 volunteers at baseline (the start of the study), and again after intravenous (medication delivered through the vein) hydrocortisone (steroid medication) given at moderate and low doses."
396,"summarize: We performed comprehensive phenotyping of 120 lymphocyte subsets by high dimensional flow cytometry, and observed a decline in circulating specific B and T cell subsets, which reached their nadir 4-8 hours after administration of HC.","HC was given to 120 lymphocyte subsets, and we observed a decline in specific B and T cell subsets, which reached their lowest level 4-8 hours after treatment.",A thorough review of cell characteristics of lymphocytes subsets (parts of a type of white blood cell that is part of the immune system) saw a decline in B cell subsets that work with substances found in body fluids and in T-cell subsets that focus on specific foreign substances after receiving hydrocortisone.
397,"summarize: Whole transcriptome profiling revealed down regulation of NF-ÎoB signaling, apoptosis, and cell death signaling transcripts that preceded lymphocyte population changes, with activation of NK cell and glucocorticoid receptor signaling transcripts.","Whole transcriptome profiling revealed downregulation of NF-ÎoB signaling, cell death, and cell death signals that preceded lymphocyte population changes, with activation of NK cell and glucocorticoid receptor signaling transcripts.","Additional analysis found several results: less responsive signaling from NF-ÎoB (proteins involved in different cell functions including immunity responses), apoptosis (normal cell death), and cell death signaling that comes before changes in lymphocytes amount, with activation of signaling in natural killer cells and glucocorticoid receptors (receptors that regulates genes controlling development, metabolism, and immune response)."
398,"summarize: We also observed differential effects of the two steroid doses on lymphocyte recovery at 24âhours, with total T cells, CD4+ T cells, and B cells rebounding above baseline after the 250âmg dose and total NK cells showing no increase above baseline at 24âhours.","the two steroid doses also had different effects on lymphocyte recovery at 24 hours, with total T cells, CD4+ T cells, and B cells rebounding above baseline after the 250 mg dose and total NK cells showing no increase above baseline at 24 hours.","We also show different effects of the two steroid doses on immune cell recovery at 24 hours, with total T immune cells, specific sub-type T immune cells, and B immune cells increasing after the 250 mg dose. Also, total natural killer immune cells show no increases at 24 hours."
399,"summarize: Occasionally, however, cricothyroidotomy or tracheostomy is necessary to establish an airway.","Occasionally, however, cricothyroidotomy or tracheostomy is necessary to establish an airway.","Sometimes, however, surgery to cut a hole in the neck is needed to open the airway."
400,"summarize: Occasionally, however, cricothyroidotomy or tracheostomy is necessary to establish an airway.","Occasionally, however, cricothyroidotomy or tracheostomy is necessary to establish an airway.","Sometimes, however, airway surgery is needed to create an airway."
401,summarize: As loss of consciousness became more complete the incidence of aspiration and the amount of material inhaled increased.,"As loss of consciousness became more complete, the frequency of aspiration and the amount of material inhaled increased.","As consciousness went away, how often material entered the airways and the amount of material breathed in increased."
402,summarize: Clinically and radiologically proven aspiration occurred in 60 per cent of cases of severe head trauma.,Aspiration occurred in 60 per cent of cases of severe head trauma.,Material entering the airways happened in 60 percent of cases of severe head injury based on symptoms observed by a doctor and x-rays.
403,summarize: There was no difference in the incidence of aspiration between persons who had been intubated and those who had not been intubated prior to admission to hospital.,There was no difference in the frequency of aspiration between people who had been intubated and those who had not been intubated before admission to hospital.,Persons who had a breathing tube and those who did not before admission to the hospital did not differ in how often material entered the airways.
404,summarize: Apart from intubation and bronchial toilet artificial respiration with oxygen-enriched gas mixtures has a decisive influence on the course of the aspiration-induced pulmonary complications.,"Besides intubation and bronchial toilets, artificial respiration with oxygen-enriched gas mixtures has a decisive influence on the course of the aspiration-induced lung complications.","Aside from putting in a breathing tube and clearing mucus and secretions from the airways, substituting a person's breathing with gas mixtures with high levels of oxygen plays a big role in lung complications from material entering the airways."
405,"summarize: 180 cases of head trauma were classified according to the degree of impairment of consciousness, clinical and neurological symptoms and EEG patterns.","180 cases of head trauma were classified according to the degree of impairment of consciousness, clinical and neurological symptoms and EEG patterns.","180 cases of head trauma were classified by severity of damage to consciousness, medical and brain-related effects, and brain activity measurements."
406,summarize: Clinically and radiologically proven aspiration occurred in 60 per cent of cases of severe head trauma.,Aspiration occurred in 60 per cent of cases of severe head trauma.,Medically and x-ray proven breathing in of fluid occured in 60% of reports of severe head trauma.
407,summarize: A comparison of two groups after they had been given first aid and artificial respiration showed that the paO2 values were significantly lower in patients with radiologically proven aspiration and infiltration of the lungs than they were in those with normal chest radiograms.,a comparison of two groups after they were given first aid and artificial respiration showed that the paO2 values were significantly lower in patients with aspiration and infiltration of the lungs than in those with normal chest x-rays.,Comparing two groups after both received first aid and artificial breathing showed that oxygen was lower in patients with x-ray proven breathing in of fluids in the lungs than unaffected patients.
408,"summarize: As the latter is a very real risk in the unconscious person intubation in these cases is a ""must"".","As the latter is a very real risk in the unconscious person, breathing in these cases is a ""must"".","Breathing in fluids again is a serious risk. For unconscious patients, breathing tubes are a ""must""."
409,summarize: In none of the cases studied was death attributable to these causes.,In none of the cases studied was death attributable to these causes.,In no cases studied was death owing to these causes.
410,summarize: Apart from intubation and bronchial toilet artificial respiration with oxygen-enriched gas mixtures has a decisive influence on the course of the aspiration-induced pulmonary complications.,"Besides intubation and bronchial toilets, artificial respiration with oxygen-enriched gas mixtures has a decisive influence on the course of the aspiration-induced lung complications.","Besides adding tubes and removing lung waste, artificial breathing in of oxygen-enriched gases greatly influence breathing-related effects."
411,summarize: Study objectives: Many factors influence the rate of gastric emptying and therefore the rate of drug absorption in the orally poisoned patient.,Many factors influence the rate of gastric emptying and therefore the rate of drug absorption in the poisoned patient.,Many things determine how fast the stomach empties and therefore how fast a drug is taken in by the body in a person who swallows a toxic substance.
412,summarize: Our hypothesis was that body position would have an effect on the rate of drug absorption in an oral overdose model.,"Using an overdose model, we hypothesized that body position would have an effect on the rate of drug absorption.",We thought that body position would have an effect on how fast a drug is absorbed in a person who swallows a toxic substance.
413,"summarize: Both were significantly less than those for prone (7,432 +/- 1,809), right lateral decubitus (8,950 +/- 1,405), and sitting (8,608 +/- 1,725) positions (P less than.05 by one-way analysis of variance and follow-up paired t tests).","Both positions were significantly less than those for prone, right side decubitus, and sitting.","Absorption for the left side and back were less than for stomach, right side, and sitting positions."
414,summarize: Conclusion: Initial drug absorption as determined by two-hour AUC was lowest in the left lateral decubitus position.,the initial drug absorption was lowest in the left side of the head.,We concluded that drug absorption was lowest for the left side position.
415,summarize: Is any maneuver dangerous or deleterious?,Is any maneuver dangerous or harmful?,Is any way dangerous or harmful?
416,summarize: To date there is no consensus on any of these issues.,"to date, there is no consensus on any of these issues.","To date, there is no agreement on any of these issues."
417,"summarize: Clinically, all the maneuvers are somewhat efficacious in clearing the obstructed airway when used alone; however, each maneuver seems to be substantially more efficacious when used in combination with another maneuver.","Clinically, all the maneuvers are somewhat effective in clearing the blocked airway when used alone. However, each maneuver seems to be much more effective when used in combination with another maneuver.","All the ways work somewhat to clear the blocked airway on their own; however, each way seems to work much better when combined with another way."
418,summarize: The patient who presents with a serious head injury is often very difficult to manage.,the patient who presents with a serious head injury is often very difficult to manage.,A person with a serious head injury is often very difficult to treat.
419,summarize: The airways is of primary concern; adequate ventilation must be provided and aspiration protected against.,The airways is of primary concern; adequate ventilation must be provided and aspiration protected against.,"The airways are the most important concern; enough air movement must be provided, and material entering the airway or lungs by accident must be avoided."
420,"summarize: A bleed in the epidural space often presents with a rapid onset of signs and symptoms, as was obvious in this traumatized patient.","a bleed in the epidural space often presents with signs and symptoms, as was evident in this traumatized patient.","A bleed in the epidural space often has quick signs and symptoms, as was obvious in this injured patient."
421,"summarize: When a bleed occurs in the subdural space, the onset is usually more insidious, and an accurate history is a key to field diagnosis.","When a bleed occurs in the subdural space, the onset is usually more insidious, and an accurate history is key to diagnosis.","A bleed in the subdural space usually happens more slowly, and knowing what happened to the person is key to a diagnosis by first responders."
422,summarize: This displacement causes pressure to be exerted on the medulla of the brainstem.,This displacement causes pressure to be exerted on the medulla of the brainstem.,This movement of the brain puts pressure on the area of the brain that controls things like heartbeat and breathing (medulla).
423,"summarize: Decorticate posturing is displayed, followed by decerebrate posturing if relief is not provided.","Decorticate posturing is displayed, followed by decerebrate posturing if relief is not provided.","A person gets stiff with bent arms, clenched fists, and legs held out straight (decorticate posturing), followed by the arms and legs being held straight out, the toes being pointed downward, and the head and neck being arched backward (decerebrate posturing) if relief is not given."
424,summarize: It is important to distinguish between decorticate and decerebrate posturing.,It is important to distinguish between decorticate and decerebrate posturing.,It is important to recognize the difference between decorticate and decerebrate posturing.
425,summarize: It is important to distinguish between decorticate and decerebrate posturing.,It is important to distinguish between decorticate and decerebrate posturing.,It is important to recognize the differences between decorticate and decerebrate posturing.
426,summarize: An easy way to remember the differences is to picture the anatomy of the brain.,An easy way to remember the differences is to picture the anatomy of the brain.,An easy way to remember the differences is to picture the structure of the brain.
427,"summarize: The cerebral cortex lies above the cerebellum, so when a patient's arms flexed up toward the face, he is pointing to his ""core"" (de-cor-ticate).","the brain cortex lies above the cerebellum, so when a patient's arms flexed up toward the face, he is pointing to his ""core"" (de-cor-ticate).","One part of the brain, the cerebral cortex, lies above another part of the brain, the cerebellum, so when a patient's arms point toward the face, he is pointing to his ""core"" (de-cor-ticate)."
428,"summarize: As the arms extend downward, he is pointing to his cerebellum(de-cere-brate).","As the arms extend downward, he is pointing to his cerebellum(de-cere-brate).","As the arms go down to his side, he is pointing to his cerebellum (de-cere-brate)."
429,"summarize: With the expanding hematoma found on this patient's neck, vascular damage ws obvious and contributed to the suspicion of spinal injury.","with the expanding hematoma found on this patient's neck, damage to the heart and blood vessels is obvious and contributed to the suspicion of spinal injury.","With the growing bruise on this patient's neck, damage to blood vessels was clear and helped lead to the belief of a spinal injury."
430,summarize: Placement of an endotracheal tube and having suction equipment ready are the best tools to prevent against aspiration.,Placement of an endotracheal tube and having suction equipment ready are the best tools to prevent aspiration.,Putting in a breathing tube and having suction tools ready are the best ways to prevent material entering the airway or lungs by accident.
431,"summarize: In this case, the patient had a full neuromuscular blockade, and any seizure would not have been recognized as long as the paralytics were on board.","in this case, the patient had a full neuromuscular blockade, and any seizure would not have been recognized as long as the paralytics were on board.","In this case, the patient had a full nerve block (paralyzed skeletal muscles). Any seizure would not have been seen while the paralyzing drugs were working."
432,"summarize: This can alert them and give them the opportunity to prepare specialized equipment, such as CT scanners, mechanical ventilators, etc.","This can alert them and give them the opportunity to prepare specialized equipment, such as CT scanners, mechanical ventilators, etc.","This can warn emergency staff and give them the chance to get specialized equipment ready (e.g., CT scanners, mechanical ventilators)."
433,summarize: This patient needs to be seen in a trauma center capable of the most thorough evaluation and management.,the patient needs to be seen in a trauma center capable of the most thorough evaluation and management.,This patient needs to be seen in a trauma center able to do the most complete evaluation and treatment.
434,summarize: Evacuation by air ambulance may be the most appropriate method of transport.,Evacuation by air ambulance may be the most appropriate method of transport.,A medical helicopter may be the best way to get the patient to the hospital.
435,"summarize: Initially there is no need for any equipment, being just enough the application of manual techniques for control and disobliteration.","Initially there is no need for any equipment, being just enough the application of manual techniques for control and disobliteration.","At the beginning, there is no need for any equipment, with techniques by hand being enough for managing the airway and removing the blockage."
436,"summarize: This skill is commonly taught during basic life support (BLS) and advanced cardiac life support (ACLS) classes, but it never receives as much attention as chest compressions and rescue breaths do.","This skill is often taught during basic life support (BLS) and advanced cardiac life support classes, but it never gets as much attention as chest compressions and rescue breaths do.","This skill is commonly taught during basic life support and advanced heart life support classes, but it never gets as much attention as chest compressions and rescue breaths do."
437,summarize: The medical community of the time did not embrace the maneuver right away.,the medical community of the time did not embrace the maneuver right away.,The medical community then did not accept the maneuver right away.
438,"summarize: Furthermore, different techniques of the maneuver have been developed with conflicting effectiveness results.","Moreover, different techniques of the maneuver have been developed with conflicting effectiveness results.","Furthermore, people have come up with different ways of doing the maneuver with mixed results."
439,"summarize: This skill is commonly taught during basic life support (BLS) and advanced cardiac life support (ACLS) classes, but it never receives as much attention as chest compressions and rescue breaths do.","This skill is often taught during basic life support (BLS) and advanced cardiac life support classes, but it never gets as much attention as chest compressions and rescue breaths do.","Abdominal thrusts are usually taught during basic life support (BLS) and advanced cardiac, or heart-related, life support (ACLS) classes, but it never gets as much attention as chest squeezes and mouth-to-mouth rescue breaths do."
440,"summarize: Introduction: In acute oral poisoning, any first aid intervention that limits or delays the uptake of the ingested substance, and which can be performed by bystanders as first responders, might assist in reducing morbidity if a toxic substance has been ingested.","Introduction: In acute oral poisoning, any first aid intervention that limits or delays the uptake of the ingested substance, and which can be performed by bystanders as first responders, might help reduce illness if a toxic substance has been ingested.","In poisoning caused by swallowing a toxic substance once or many times over a short period of time, any first aid assistance that reduces or delays how much is swallowed, and which ones bystanders can do, might help in reducing illness."
441,summarize: The current recommendation by the International Federation of Red Cross/Red Crescent Societies is to place a victim in the left lateral decubitus position.,the current recommendation by the International Federation of Red Cross/Red Crescent Societies is to place a victim in the left side position.,The International Federation of Red Cross/Red Crescent Societies recommends a victim be placed on the person's left side.
442,"summarize: However, based on the evidence that the left lateral decubitus position may be effective in decreasing the absorption of several drugs, the simplicity of the intervention and the generally low perceived risk of this intervention, the recommendation of the first aid guidelines of the International Federation of Red Cross and Red Crescent Societies can remain unchanged.","However, based on the evidence that the left side position may be effective in decreasing the absorption of several drugs, the simplicity of the treatment and the generally low perceived risk of this intervention, the recommendations of the International Federation of Red Cross and Red Crescent Societies can remain unchanged.","However, based on studies that show placing a person on the person's left side may decrease absorption of many drugs, and the ease and low risk of doing so, the recommendation of the International Federation of Red Cross and Red Crescent Societies stands."
443,summarize: The extent to which given levels of caloric restriction will improve glycemic status but increase plasma ketone bodies in gestational diabetic women has received little attention.,The extent to which given levels of caloric restriction will improve glycemic status but increase blood ketone bodies in gestational diabetic women has received little attention.,How much caloric restriction (reducing the amount of calories consumed) will improve glycemic status (blood sugar levels) but increase ketone bodies (substances that the body makes if the cells don't get enough blood sugar) in gestational diabetic women (women diagnosed with diabetes for the first time during pregnancy) has received little attention.
444,summarize: Twenty-four-hour mean glucose levels remained unchanged in the control group but declined in the calorie-restricted group (6.7 mM or 121 mg/dl in week 1 vs 5.4 mM or 97.3 mg/dl in week 2) (p less than 0.01).,Twenty-four-hour average glucose levels remained unchanged in the control group but declined in the calorie-restricted group.,"The average glucose (blood sugar) levels remained unchanged in the 2,400 calorie diet group but declined in the lower calorie group that had a 1,200 calories per day diet."
445,summarize: A second study compared the impact of a 33% calorie-restricted diet or insulin to a full-calorie diet in a similar 2-week experimental design and measured hepatic glucose output and insulin sensitivity with dideuterated glucose before and during an insulin clamp.,a second study compared the impact of a 33% calorie-restricted diet or insulin to a full-calorie diet in a similar 2-week experiment. The study measured liver glucose output and insulin sensitivity with dideuterated glucose before and during an insulin clamp.,A second study compared the impact of a calorie-restricted diet reduced by 33% or insulin to a full-calorie diet in a similar 2 week experiment. The study measured liver production of sugar and insulin sensitivity with labeled glucose before and during an insulin clamp (used to maintain glucose levels).
446,"summarize: In conclusion, 50% caloric restriction improves glycemic status in obese women with gestational diabetes but is associated with an increase in ketonuria, which is of uncertain significance.","50% caloric restriction improves glycemic status in obese women with gestational diabetes but is associated with an increase in ketonuria, which is uncertain significance.","In conclusion, reducing calories by half improves blood sugar levels in obese women with gestational diabetes but is connected with an increase in high amounts of ketones in the urine, which is of uncertain significance."
447,summarize: Subjects kept dietary accounts and were followed with daily fasting and postprandial glucose assessments.,Dietary accounts were kept and patients were followed with daily fasting and post-meal blood sugar assessments.,Patients keep food diaries and are followed with assessments of daily fasting (no food) and blood sugar levels after meals.
448,summarize: Significant reductions in the postprandial glucose values were seen among subjects in the low-carbohydrate group (P .04).,significant reductions in the post-meal blood sugar values were seen among subjects in the low-carb group.,Major decreases in the after meal blood sugar numbers are seen among patients in the low-carb group.
449,summarize: Objective: To determine the effect of carbohydrate restriction on perinatal outcome in patients with diet-controlled gestational diabetes mellitus (GDM).,Objective: To determine the effect of carb restriction on perinatal outcome in patients with gestational diabetes mellitus (GDM) during pregnancy.,"The objective is to determine how carb restriction affects births in diet-controlled gestational diabetics, in which high blood sugar affects pregnant women."
450,summarize: Subjects kept dietary accounts and were followed with daily fasting and postprandial glucose assessments.,Dietary accounts were kept and patients were followed with daily fasting and post-meal blood sugar assessments.,Subjects kept diet records and were followed with daily blood sugar measurements.
451,summarize: Results: The two groups were identical in terms of demographic characteristics.,The two groups were identical in terms of demographic characteristics.,The two groups had identical socioeconomic traits.
452,"summarize: Fewer subjects in the low-carbohydrate group required the addition of insulin for glucose control (P .047; relative risk [RR] 0.14; 95% confidence interval [CI] 0.02, 1.00).",Fewer patients in the low-carb group needed insulin to control blood sugar.,Less patients in the low-carb group needed insulin for glucose control.
453,"summarize: Subjects in the low carbohydrate group also had a lower rate of cesarean deliveries for cephalopelvic disproportion and macrosomia (P .037; RR 0.15; 95% CI 0.04, 0.94).",low carb group also had a lower rate of cesarean deliveries for cephalopelvic disproportion and macrosomia.,The low-carb group also had less cesarean deliveries for large-head babies and large-body babies.
454,"summarize: One meal was administered at 7 AM (morning meal) and the other was administered at 9 PM (evening meal), each after a fast of >/=5 hours.","one meal was given at 7 AM (morning meal) and the other at 9 PM (evening meal), each after a fast of >/=5 hours.","One meal is given at 7 am (morning meal) and the second meal is given at 9 pm (evening meal), each after a fast (no food) of 5 or more hours."
455,summarize: The mechanisms underlying these differences remain to be determined but may involve diurnal influences of counterregulatory hormones.,The mechanisms underlying these differences remain to be determined but may involve changes in hormones that regulate the body's response to stress.,The process causing these differences remain to be found but may involve daily influences of hormones that increase blood sugar.
456,"summarize: In addition, women with GDM were asked to measure their postprandial glycaemia.","In addition, women with gestational diabetes mellitus were asked to measure their blood sugar levels after meals.","In addition, women with gestational diabetes were asked to measure their blood glucose after a meal."
457,summarize: The lowest levels of evening glycaemia correlated with the highest levels of ketonemia; women with GDM reported lower food and carbohydrate intakes than controls (P0.001).,the lowest levels of evening glycaemia correlated with the highest levels of ketonemia. Women with gestational diabetes reported lower food and carb intakes than controls.,The lowest levels of evening glycaemia correlated with the highest levels of ketonemia; women with gestational diabetes reported lower food and carbohydrate intakes than the comparison group.
458,summarize: Ketonemia values measured before the midday meal and prior to the evening meal were lower for control subjects than for GDM patients (P=0.002 and P=0.005).,Ketonemia values measured before the midday meal and before the evening meal were lower for control patients than for GDM patients.,Blood ketone bodies measured before the midday and evening meals were lower for standard patients than gestational diabetics.
459,"summarize: If a balance between nutrient needs and glucose control cannot be achieved, then concurrent medication therapy is needed to assist in reducing insulin resistance and supplementing insulin production to provide normoglycemia and improved pregnancy outcomes.","if a balance between nutritional needs and blood sugar control cannot be achieved, then medication therapy is needed to help reduce insulin resistance and supplementing insulin production to provide normoglycemia and improved pregnancy outcomes.","If a balance between nutrient needs and sugar control cannot be reached, then providing medication at the same time is needed to help in reducing insulin resistance (a condition that causes increased blood sugar) and increasing insulin to provide normoglycemia (normal amount of sugar in the blood) and improved pregnancy outcomes."
460,"summarize: Education, support, and follow-up are required to assist the woman to make lifestyle changes essential to successful nutrition therapy.","Education, support, and follow-up are needed to assist the woman to make lifestyle changes essential to successful nutrition therapy.","Education, support, and follow-up are required to help the woman make lifestyle changes that are key to successful nutrition therapy."
461,summarize: Women with GDM are at increased risk for type 2 diabetes; learning to manage GDM with lifestyle change provides an opportunity to affect personal risk factors and the health of the whole family.,Women with gestational diabetes mellitus are at increased risk for type 2 diabetes. Learning to manage gestational diabetes with lifestyle change provides an opportunity to affect personal risk factors and the health of the whole family.,Women with gestational diabetes mellitus are at an increased risk for type 2 diabetes (a condition where the body doesn't use insulin properly); learning to manage gestational diabetes mellitus with lifestyle changes provides an opportunity to impact personal risk factors (such as health and fitness) and the health of the whole family.
462,summarize: The patients were randomised into two groups: those on a low and those on a high carbohydrate diet (45% vs. 65% respectively of energy supply coming from carbohydrates).,the patients were randomly divided into two groups: those on a low and those on a high carb diet (45% of energy coming from carbohydrates).,The patients are randomly put into two groups: those on a low carbohydrate (carb) diet and those on a high carb diet.
463,summarize: After two weeks daily glucose profiles and compliance with the recommended diets were analysed.,After two weeks daily blood sugar profiles and compliance with the recommended diets were measured.,"After two weeks, how well women stayed on the recommend diets and daily blood sugar measures were analyzed."
464,summarize: A significant decrease in glycaemia was noticed after lunch (106 +/- 15 vs. 96 +/- 7 mg/dl) and dinner (107 +/- 12 vs. 97 +/- 7 mg/dl) (p  0.05).,a significant decrease in blood sugar was noticed after lunch and dinner.,A significant decrease in glycaemia (concentration of blood sugar) is noticed after lunch.
465,summarize: Ketonuria was not observed in either group.,Ketonuria was not observed in either group.,Ketonuria (high amounts of ketones in the urine) is not observed in either group.
466,summarize: Energy and CHO prescriptions were revised at every visit and changes were done according to weight gain and whether or not ketonuria was present.,Energy and CHO prescriptions were revised at every visit. Changes were done according to weight gain and whether or not ketonuria was present.,"Energy and carbohydrate prescriptions are revised at every visit, and changes are done according to weight gain and whether or not ketonuria (high ketones, which is a chemical made in the liver that helps break down fat, in urine) is present."
467,summarize: There is general agreement in the literature about caloric restrictions in the case of being overweight or obese.,There is general agreement in the literature about caloric restrictions in the case of being overweight or obese.,There is general agreement in studies about limiting calories in the case of being overweight or obese.
468,"summarize: Results: There were no detectable differences in blood ketones between completers in the MLC group compared with the RC group (0.1  0.0 compared with 0.1  0.0 mmol/L, n = 33, P = 0.31, respectively), even though carbohydrate and total energy intake were significantly lower in the intervention group (carbohydrate 165  7 compared with 190  9 g, P = 0.04; energy 7040  240 compared with 8230  320 kJ, P 0.01, respectively).","there were no detectable differences in blood ketones between the MLC group compared with the RC group, even though carb and total energy intake were significantly lower in the intervention group.","The results show that there are no detectable differences in blood ketones between participants in the modestly lower carb diet group when compared with women in the routine care group, even though carbs and total energy intake are much lower in the modestly low carb diet group."
469,"summarize: There were no differences in birth weight, rate of large-for-gestational-age infants, percent fat mass, or fat-free mass between groups.","There were no differences in birth weight, rate of large-for-gestational-age infants, percent fat mass, or fat-free mass between groups.","There are no differences in birth weight, rate of large-for-gestational-age infants (a newborn who weighs more than 90% of other newborns of the same gestational age at birth), percent of fat in the body, or fat-free mass (muscle mass) between the groups."
470,"summarize: There were no differences in birth weight, rate of large-for-gestational-age infants, percent fat mass, or fat-free mass between groups.","There were no differences in birth weight, rate of large-for-gestational-age infants, percent fat mass, or fat-free mass between groups.","No differences in birth weight, rate of large-for-prenatal-age infants, percent fat mass, or fat-free mass between groups existed."
471,summarize: Feeding studies with food provision may be needed to assess the benefits and risks of low-carbohydrate diets.,Feeding studies with food may be needed to assess the benefits and risks of low-carb diets.,Feeding studies providing food may have to assess the effects of low-carb diets.
472,summarize: Conclusions: The study results indicate that LCIG improves iQoL in PD in addition to the improvement of motor and non-motor symptoms.,LCIG improves quality of life in Parkinson's disease. It also improves motor and non-motor symptoms.,"In conclusion, these results suggest that levodopa-carbidopa intestinal gel improves individual quality of life in patients with Parkinson's disease in addition to the improvement of motor and non-motor symptoms."
473,"summarize: Along with this, it is also characterized by the presence of motor and non-motor symptoms, as seen in Parkinsonian patients.","Along with this, it is also characterized by the presence of motor and non-motor symptoms, as seen in Parkinsonian patients.","Additionally, it is also characterized by the presence of motor (movement) and non-motor (unrelated to movement such as pain and tiredness) symptoms, as seen in patients with Parkinson's disease."
474,"summarize: Objective: We tested the hypothesis that there are 2 distinct phenotypes of Parkinson tremor, based on interindividual differences in the response of resting tremor to dopaminergic medication.","Objective: We tested the hypothesis that there are 2 distinct phenotypes of Parkinson tremor, based on differences in the response of resting tremor to dopaminergic medication.",Researchers tested the idea that there are 2 distinct phenotypes (observable traits or characteristics) of Parkinson tremor based on differences among people in how the resting tremor (a tremor when the muscle is relaxed) responds to dopamine medication.
475,"summarize: When considering combination treatment, the estimated relative effects of selegiline, pramipexole, ropinirole, rotigotine, cabergoline, rasagiline and safinamide were 2.316 (1.819, 2.951), 2.091 (1.889, 2.317), 2.037 (1.804, 2.294), 1.912 (1.716, 2.129), 1.664 (1.113, 2.418), 1.584 (1.379, 1.820) and 1.179 (1.031, 1.352), respectively, compared with joint placebo and levodopa treatment.","Compared with joint placebo and levodopa treatment, the estimated effects of selegiline, pramipexole, ropinirole, rotigotine, cabergoline, rasagiline and safinamide were 2.316, 2.091, 2.037, 1.612, 1.584, 1.179, respectively, compared with joint placebo and levodopa treatment.",nan
476,summarize: This highlights the need of analyzing immune parameters in longitudinal studies on PD patients receiving specific therapeutic regimes.,This highlights the need of analyzing immune parameters in long-term studies on Parkinson's disease patients receiving specific treatments.,There is a need to analyze immune characteristics in long-term studies on Parkinson's disease patients who are receiving specific drugs.
477,"summarize: In this work, PD patients were included in a two-year prospective study comparing the effect of levodopa alone and a levodopa/pramipexole combo therapy on several regulatory and pro-inflammatory immune cell populations.",PD patients were included in a two-year study comparing the effect of levodopa alone and a levodopa/pramipexole combo therapy on several immune cell populations.,"In this work, patients with Parkinson's were in a two-year study comparing how levodopa (a Parkinson's medication) alone and a levodopa/pramipexole (dopamine imitator) combo affects immune cell subtypes."
478,"summarize: We demonstrated that PD patients show decreased circulating levels of several important regulatory subpopulations, as determined by flow cytometry.","PD patients show decreased levels of several important regulatory subpopulations, as determined by flow cytometry.",Patients with Parkinson's have reduced blood levels of important regulatory cell subtypes.
479,"summarize: This generated a tendency to postpone levodopa, favoring the initial use of DA agonists, which directly stimulate striatal dopaminergic receptors.",DA agonists stimulate dopamine receptors in the brain.,"This problem often leads to delaying the use of levodopa and using dopamine agonists (a medication that imitates the actions of dopamine in the body to relieve symptoms related to low levels of dopamine), which directly stimulates dopamine receptors or target sites in the brain."
480,"summarize: Expert opinion: The latest findings confirm the effectiveness of DA agonists as initial treatment or adjunctive therapy to levodopa in advanced PD, but a more conservative approach to their use is emerging, due to the complexity and repercussions of their side effects.","the latest findings confirm the effectiveness of DA agonists as first treatment or as an adjunctive therapy to levodopa in advanced Parkinson's disease, but a more conservative approach to their use is emerging due to the complexity and side effects.","The latest findings confirm the effectiveness of dopamine agonists as the first treatment and as an additional drug to use with levodopa in advanced Parkinson's disease, but a more moderate approach to their use is emerging due to their side effects."
481,"summarize: Levodopa decreased prefrontal cortex activity compared with off medication (effect size, -0.51), whereas the addition of donepezil reversed this decrease.",Levodopa decreased prefrontal cortex activity compared with off medication. The addition of donepezil reversed this decrease.,"Levodopa decreased prefrontal cortex activity (the part of the brain that controls behavior, such as decision-making) compared with off medication, whereas the addition of donepezil reversed this decrease."
482,"summarize: Cholinergic therapy, specifically donepezil 5 mg/day for 2 weeks, can alter prefrontal cortex activity when walking and improve secondary cognitive task accuracy and gait in PD.","Cholinergic therapy, specifically donepezil 5 mg/day for 2 weeks, can alter prefrontal cortex activity when walking and improve secondary cognitive task accuracy and gait in Parkinson's disease.","Cholinergic drugs, specifically donepezil for 2 weeks, can alter prefrontal cortex activity when walking and improve secondary cognitive task accuracy and gait in Parkinson's disease."
483,summarize: This effect was not modified by disease duration.,This effect was not modified by disease duration.,This effect does not change based on how long the person has the disease.
484,"summarize: Compared to the natural progression of motor disability, levodopa treatment resulted in a 31% lower annual decline in UPDRS-III scores in the OFF state (3.33 versus 2.30 points/year) with a lower model's variance explained by disease duration (67% versus 36%).","Compared to the natural progression of motor disability, levodopa treatment resulted in a 31% lower annual decline in UPDRS-III scores in the OFF state.","Compared to the natural progression of motor disability, levodopa treatment resulted in a lower annual decline in UPDRS-III scores in the OFF state with a lower number than expected, which is explained by disease duration."
485,summarize: The same applies to the yearly decline in UPDRS-III scores in the OFF state.,The same applies to the annual decline in UPDRS-III scores in the OFF state.,The same applies to the yearly decline in UPDRS-III scores in the OFF state.
486,"summarize: We aimed to describe the natural course of motor symptoms by assessing the natural OFF in consecutive Parkinson's disease patients never exposed to treatment (drug-na ve), and to investigate the effects of daily levodopa on the progression of motor disability in the OFF medication state over a 2-year period.",the study aimed to describe the natural course of motor symptoms by assessing the natural OFF in consecutive Parkinson's disease patients never exposed to treatment. We also investigated the effects of daily levodopa on the progression of motor disability in the OFF medication state over a 2-year period.,"We tried to describe the natural course of movement symptoms by measuring the OFF state when symptoms occur in patients never given treatment (drug-na ve) for Parkinson's disease. For 2 years, we also explored how daily levodopa affects the progression of movement symptoms in the OFF state after treatment wears off."
487,"summarize: At the 2-year follow-up, motor signs after overnight OFF (30.2  14.2) were still 30% milder than natural OFF (P = 0.001).","At the 2-year follow-up, motor signs after overnight OFF were still 30% milder than natural OFF.","After 2 years, movement signs after overnight withdrawal of medication was still 30% milder than movement signs with no treatment ever."
488,"summarize: The ON state UPDRS-III at the first-ever levodopa challenge was similar to the overnight OFF score at 1-year follow-up and the two conditions were correlated (r = 0.72, P  0.001).",the ON state UPDRS-III at the first-ever levodopa challenge was similar to the overnight OFF score at 1-year follow-up and the two conditions were correlated.,The no-symptom state after first-time levodopa was similar and related to the overnight typical-symptom state after 1 year.
489,"summarize: Using the equation regressed on pretreatment data, we predicted the natural OFF at 1-year and 2-year follow-up visits and estimated that the magnitude of the long-duration response to levodopa ranged between 60% and 65% of total motor benefit provided by levodopa, independently of disease duration (P = 0.13).","Using data from before treatment, we predicted the natural OFF at 1-year and 2-year follow-up visits. We estimated that the magnitude of the long-duration response to levodopa ranged between 60% and 65% of total motor benefit provided by levodopa, independently of disease duration.","We calculated that the response to levodopa involved a possible 60-65% benefit of total motor activity, regardless of disease duration."
490,"summarize: All patients were reevaluated in short- (3 months), mid- (6 months), and long-term (2.5 years) follow-up after surgery.","All patients were reevaluated in short- (3 months), mid- (6 months), and long-term (2.5 years) follow-up after surgery.","All patients are evaluated in short (3 months), mid (6 months), and long-term (2.5 years) follow-up appointments after the surgery."
491,summarize: Analysis was performed primarily in the intention-to-treat population.,analysis was performed primarily in the intention-to-treat population.,The analysis mainly focuses on the patients who were enrolled and randomly assigned to treatment.
492,summarize: Selective serotonin reuptake inhibitors (SSRIs) are a recently developed class of drugs with significantly greater antidepressant efficacy than placebo.,Selective serotonin reuptake inhibitors (SSRIs) are a recently developed class of drugs with significantly greater antidepressant effectiveness than placebo.,"Selective serotonin reuptake inhibitors (SSRIs) are a recently developed type of drugs that works better as an antidepressant than a placebo, a type of substance that looks like a real pill but is not the real medicine."
493,"summarize: Nevertheless, because of small patient numbers included in most studies that compare SSRIs with other antidepressants, no definitive statements about relative efficacy can be made.","Nevertheless, because of the small number of patients included in most studies that compare SSRIs with other antidepressants, no definitive statements can be made about their effectiveness.","Still, since the studies have small patient samples, no definite statements about the relative antidepressant success of SSRIs can be made."
494,"summarize: Importantly, differences in clinical characteristics exist between the SSRIs-differences in elimination half-life (t1/2 beta) between fluoxetine and/or its metabolite (total t1/2 beta = 330 hours) and other SSRIs (t1/2 beta range = 15 to 30 hours), for example.","Importantly, differences in clinical characteristics exist between the SSRIs-differences in elimination half-life (t1/2 beta) between fluoxetine and/or its metabolite and other SSRIs.","Importantly, SSRIs have differences like effect duration among other antidepressant medications like fluoxetine."
495,"summarize: Fluvoxamine has been associated with a high incidence of nausea (37%), although this may have resulted from high initial dosages (rather than upward dose titration protocols) used in early trials.","fluvoxamine has been associated with a high frequency of nausea (37%), although this may have resulted from high initial dosages used in early trials.","Using fluvoxamine (an antidepressant drug) may lead to nausea, but this may be due to using high starting doses rather than steadily-increasing dosages for use in early trials."
496,"summarize: Preliminary data indicate that SSRIs are effective in the treatment of panic disorder, obsessive-compulsive disorder (OCD), eating (e.g. anorexia and bulimia) and personality disorders (e.g. anger, impulsiveness) and substance abuse (e.g. alcoholism); early results with fluvoxamine in the treatment of panic disorder and OCD, and with fluoxetine in the treatment of bulimia, personality disorders and alcohol abuse, have been encouraging.","SSRIs are effective in the treatment of panic disorder, obsessive-compulsive disorder (OCD), eating (e.g. anorexia and bulimia), personality disorders (e.g. anger, impulsiveness) and substance abuse (e.g. alcoholism). Early results with fluvoxamine in the treatment of panic disorder and OCD, and with fluoxetine in the treatment of bulimia, personality disorders and alcohol abuse have been encouraging.",SSRIs like fluvoxamine and fluoxetine seem to help treat a variety of mental illnesses other than depression.
497,"summarize: SSRIs have a more favourable tolerability profile than tricyclic antidepressants and, unlike the tricyclics, are not associated with anticholinergic adverse effects, sedation, cardiotoxicity or weight gain.","SSRIs have a better tolerability profile than tricyclic antidepressants and, unlike the tricyclics, are not associated with side effects of anticholinergic drugs, sedation, cardiotoxicity or weight gain.","Patients put up with SSRIs better than other non-SSRI antidepressants and without notable side effects, sleepiness, heart damage, or weight gain."
498,"summarize: However, the incidence of nausea appears to decrease as treatment is continued.","However, the frequency of nausea appears to decrease as treatment is continued.","However, the frequency of nausea may decrease as treatment continues."
499,summarize: Nineteen (76%) experienced moderate to marked improvement in panic attacks.,19 (76%) experienced moderate to marked improvement in panic attacks.,Nineteen (76%) experienced small to major improvement in panic attacks.
500,summarize: Method: Eighteen patients who relapsed on fluoxetine 20 mg/day during long-term treatment with fluoxetine as part of a placebo-controlled study had their fluoxetine dose raised to 40 mg/day and were followed for at least 1 month (mean time = 4.7 months).,18 patients who relapsed on fluoxetine 20 mg/day during long-term treatment with fluoxetine as part of a placebo-controlled study had their fluoxetine dose raised to 40 mg/day and were followed for at least 1 month.,"In this study, 18 patients who relapsed on fluoxetine 20 mg/day during long-term treatment with fluoxetine as part of a larger study had their fluoxetine dose raised to 40 mg/day and were followed for at least 1 month."
501,summarize: Fluoxetine (FLX) has a unique pharmacokinetic profile.,fluoxetine (FLX) has a unique drug-related profile.,Fluoxetine is a type of antidepressant that is also called prozac.
502,"summarize: During the double-blind phase, blood levels for both FLX and NFLX differed across the treatment groups, yet no statistically significant difference in HAM-D scores was observed.","During the double-blind phase, blood levels for both FLX and NFLX differed across the treatment groups. However, no statistically significant difference in HAM-D scores was observed.","Blood levels for both fluoxetine and norfluoxetine differ across the three treatment groups, but there are no major differences in the scores for depression observed."
503,summarize: We prospectively evaluated the likelihood of response to increasing the fluoxetine doses in patients relapsing during a long-term efficacy study of two fluoxetine dosing regimens.,the likelihood of response to increasing the fluoxetine doses in patients relapsing during a long-term effectiveness study of two fluoxetine dosing regimens was evaluated.,Researchers evaluated the chance patients will respond to an increase in the dose of fluoxetine (a type of antidepressant also called prozac) in patients relapsing during a long-term study of two different dosing plans of fluoxetine.
504,summarize: Response was defined as a 50% reduction in the modified HAMD17 score since time of relapse and a CGI-severity score  or =2.,HAMD17 score was reduced by 50% since time of relapse and a CGI-severity score.,Researchers used scoring tools that measure depression severity and seeing how much the depression scores are reduced since the time of the last relapse.
505,"summarize: Results: Overall, patients relapsing during the continuation treatment responded to an increased dose (57% of the 40-mg-daily group and 72% of the enteric-coated 90-mg-twice-weekly group).","overall, patients relapsing during the continuation treatment responded to an increased dose (57% of the 40-mg-daily group and 72% of the enteric-coated 90-mg-two times-weekly group).","Overall, patients relapsing during the continuation treatment phase responded to an increased dose (57% of the 40-mg-daily group and 72% of the 90-mg-twice-weekly group)."
506,summarize: Conclusions: The patients relapsing after initially responding to fluoxetine can benefit from an increase in fluoxetine dose.,the patients relapsing after initially responding to fluoxetine can benefit from an increase in fluoxetine dose.,"In conclusion, patients who relapsed after first responding to fluoxetine can benefit from an increase in the dose amount of fluoxetine."
507,summarize: A total of 47 (35.6%) out of 132 patients did not complete the 28-week continuation phase.,47 out of 132 patients did not complete the 28-week continuation phase.,A total of 47 out of 132 patients did not complete the 28 weeks phase of the study.
508,"summarize: In this sample of outpatients in continuation phase treatment for major depressive disorder, the combination of cognitive therapy and fluoxetine 40 mg failed to yield any significant benefit in symptoms or relapse rates over fluoxetine 40 mg alone during 28 weeks of follow-up.","In this sample of outpatients in continuation phase treatment for major depressive disorder, the combination of cognitive therapy and fluoxetine 40 mg failed to yield any significant benefit in symptoms or relapse rates over fluoxetine 40 mg alone during 28 weeks of follow-up.","In this sample of patients being treated for major depressive disorder, the combination of cognitive therapy and fluoxetine at 40 mg failed to lead to any significant benefit in symptoms or in relapse rates over fluoxetine 40 mg alone during the 28 week follow-up period."
509,summarize: Change in residual symptoms or wellbeing as measured by Hamilton Depression Scale score or Symptom Questionnaire self-report also did not differ between groups.,Change in symptoms or wellbeing as measured by the Hamilton Depression Scale score or Symptom Questionnaire also did not differ between groups.,Change in depressive symptoms did not differ between groups.
510,"summarize: Pediatric generalized anxiety disorder (GAD) is characterized by excessive and uncontrollable worry about a variety of events and is accompanied by physical symptoms such as headaches, tension, restlessness, gastrointestinal distress, and heart palpitations.","Pediatric generalized anxiety disorder (GAD) is characterized by excessive and uncontrollable worry about a variety of events and is accompanied by physical symptoms such as headaches, tension, restlessness, stomach distress, and heart palpitations.","In children, generalized anxiety disorder (GAD) includes having more than normal and uncontrollable worry about different events and is also includes physical symptoms such as headaches, tension, restlessness, digestive problems, and a racing heartbeat."
511,"summarize: With pharmacotherapy, systematic tracking of treatment-emergent adverse events such as headaches, stomach aches, behavioral activation, worsening symptoms, and emerging suicidal thoughts is important.","With pharmacotherapy, systematic tracking of treatment-emergent side effects such as headaches, stomach aches, behavioral activation, worsening symptoms, and emerging suicidal thoughts is important.","When using medications for treatment, it is important to monitor and track negative side effects that occur such as headaches, stomach aches, behavioral activation, worsening symptoms, and emerging suicidal thoughts."
512,"summarize: Dosing can be adjusted as often as weekly with the goal of achieving a high-quality response, while minimizing side effects.","Dosing can be adjusted as often as weekly with the goal of achieving a high-quality response, while minimizing side effects.","Dosing can be changed as often as weekly with the goal of achieving a high-quality response, while minimizing side effects."
513,"summarize: It is recommended to continue medication for approximately 1 year following remission in symptoms, and when discontinuing medication to choose a stress-free time of the year.","It is recommended to continue medication for about 1 year following remission in symptoms, and when discontinuing medication to choose a stress-free time of the year.","It is recommended to continue medication for about 1 year after remission in symptoms, and to choose a stress-free time of the year when stopping medication."
514,"summarize: If symptoms return, medication re-initiation should be considered seriously.","If symptoms return, re-starting the medication should be considered seriously.","If symptoms return, restarting the medication should be considered seriously."
515,summarize: We have aimed to summarise the currently available best evidence to inform this clinical question.,the current best evidence to inform this clinical question is summarized.,We have aimed to summarize the best available evidence to inform this clinical question.
516,"summarize: For SSRIs (99 treatment groups), the dose-efficacy curve showed a gradual increase up to doses between 20 mg and 40 mg fluoxetine equivalents, and a flat to decreasing trend through the higher licensed doses up to 80 mg fluoxetine equivalents.","SSRIs showed a gradual increase up to doses between 20 mg and 40 mg fluoxetine equivalents, and a flat to decreasing trend through the higher licensed doses up to 80 mg fluoxetine equivalents.","For SSRIs or selective serotonin reuptake inhibitors (a type of antidepressant that can increase the amount of serotonin, a mood stabilizer), the dose-efficacy curve (relationship between an effect of a drug and the amount of drug given) showed a gradual increase up to doses between 20mg and 40mg fluoxetine (a type of SSRI also called prozac), and a flat to decreasing trend through the higher doses up to 80 mg fluoxetine equivalents."
517,summarize: Conclusions: Fluoxetine may be used as an effective drug in the treatment of misophonia.,Fluoxetine may be used as an effective drug in the treatment of misophonia.,"In conclusion, fluoxetine may be used as an effective drug in the treatment of misophonia."
518,"summarize: Hiatus hernia refers to conditions in which elements of the abdominal cavity, most commonly the stomach, herniate through the oesophageal hiatus into the mediastinum.","Hiatus hernia refers to conditions in which parts of the abdominal cavity, most commonly the stomach, herniate through the oesophageal hiatus into the mediastinum.",Hiatus hernia refers to when the upper part of the stomach pushes up through the diaphragm into the chest.
519,"summarize: Sliding hiatus hernia is readily diagnosed by barium swallow radiography, endoscopy, or manometry when greater than 2 cm in axial span.","Sliding hiatus hernia is easily diagnosed by barium swallow radiography, endoscopy, or manometry when greater than 2 cm in axial span.","Sliding hiatus hernia is easily diagnosed by a swallowing test during x-ray, a flexible tube with a light and camera attached, or an esophagus test when more than 2 cm along an axis."
520,summarize: Knowledge of symptoms and signs is vital to diagnosis and treatment of these rare type of hernias.,Knowledge of symptoms and signs is vital to diagnosis and treatment of this rare type of hernias.,Knowledge of symptoms and signs is important to diagnose and treat these rare hernias.
521,"summarize: Hiatal hernias may become symptomatic or, less frequently, can incarcerate or become a volvulus leading to organ ischemia.","Hiatal hernias may become symptoms or, less frequently, can incarcerate or become a volvulus leading to organ ischemia.","Hiatal hernias may cause symptoms or, less often, can become trapped or twisted, cutting off blood flow to organs."
522,summarize: Results: Asymptomatic hiatal and paraesophageal hernias become symptomatic and necessitate repair at a rate of 1% per year.,Asymptomatic hiatal and paraesophageal hernias become symptomatic and require repair at a rate of 1% per year.,We found that hiatal hernias without symptoms develop symptoms and need repair at a rate of 1% per year.
523,summarize: Watchful waiting is appropriate for asymptomatic hernias.,Watchful waiting is appropriate for hernias without symptoms.,Watching without treatment unless symptoms appear or change is suggested for people with hernias with no symptoms.
524,"summarize: Key operative steps include the following: reduction and excision of hernia sac, 3 cm of intraabdominal esophageal length, crural closure with mesh reinforcement, and an anti-reflux procedure.","Surgical steps include the reduction and excision of hernia sac, 3 cm of length in the esophagus, closure with mesh reinforcement, and an anti-reflux procedure.",Surgery has key steps.
525,summarize: Methods: A literature review of contemporary and latest studies with highest quality of evidence was completed.,Methods: A literature review of current and latest studies with highest quality of evidence was completed.,nan
526,"summarize: Key operative steps include the following: reduction and excision of hernia sac, 3 cm of intraabdominal esophageal length, crural closure with mesh reinforcement, and an anti-reflux procedure.","Surgical steps include the reduction and excision of hernia sac, 3 cm of length in the esophagus, closure with mesh reinforcement, and an anti-reflux procedure.","Key surgery steps include: cutting out the bulging sac, 3 cm of the lower esophagus, closing the site with mesh, and an anti-acid reflux operation."
527,"summarize: It is usually performed as an elective procedure in local, spinal or general anasthesia.","It is usually performed as an elective procedure in local, spinal or general anasthesia.",Surgery of the lower-ab organ bulge is usually performed with anasthesia.
528,summarize: This evidence based review describes the -epidemiology and etiology of inguinal hernia together with the most common surgical procedures; focusing on recent innovations.,this evidence based review describes the causes and causes of inguinal hernias along with the most common surgical procedures. This review focuses on recent innovations.,The article reviews the spread and causes of inguinal hernia along with common surgical treatments.
529,"summarize: Based on this systematic review, ultrasound may be the preferred imaging modality when physical examination is inconclusive, given that local expertise in performing US examination for hernia disease is adequate.","based on this systematic review, ultrasound may be the preferred imaging method when physical examination is inconclusive, given that local expertise in performing US examination for hernia disease is adequate.","Based on this review, ultrasound may be the best option when physical exam is uncertain, given that ultrasound is done acceptably at the local level."
530,summarize: Magnetic resonance imaging has higher sensitivity and specificity than ultrasonography and is useful for diagnosing occult hernias if clinical suspicion is high despite negative ultrasound findings.,Magnetic resonance imaging (MRI) has higher accuracy and specificity than ultrasonography. It is useful for diagnosing occult hernias if suspicion is high despite negative ultrasound findings.,MRI has higher accuracy for detection and no detection than ultrasound and is useful for diagnosing hidden hernias if a doctor thinks it is hernia even if an ultrasound does not show one.
531,summarize: Surgery is the appropriate treatment of complicated LH that is an extremely rare condition with approximately 50 cases reported in the literature over the past 300 years.,Surgery is the best treatment of complicated LH that is an extremely rare condition with about 50 cases reported in the literature over the past 300 years.,"Surgery is the best treatment for inflamed LH, a very rare condition with about 50 cases reported in scientific papers over the past 300 years."
532,summarize: Acute traumatic abdominal wall hernia (TAWH) is a rare type of hernia that occurs after a low or high velocity impact of the abdominal wall against a blunt object with few cases reported.,Acute traumatic abdominal wall hernia (TAWH) is a rare type of hernia that occurs after a low or high velocity impact of the abdominal wall against a blunt object with few cases reported.,Acute traumatic abdominal wall hernia (TAWH) is a rare type of hernia that happens when the stomach wall hits a smooth object at low or high speed with few cases reported.
533,summarize: Perforations of the hollow viscera commonly follow abdominal trauma and likely require surgery for hemorrhage and sepsis source control.,Perforations of the hollow viscera commonly follow abdominal trauma and likely require surgery for hemorrhage and sepsis source control.,Tears in the stomach wall that allow stomach contents to spill out often result from stomach injury and likely require surgery for bleeding and controlling the source of the body's extreme response to the spillage.
534,"summarize: On examination, he had guarding in the right hypochondrium with a positive Murphy's sign.","On examination, he had guarding in the right hypochondrium with a positive Murphy's sign.",He had tensing of the muscles in the right upper stomach with a physical exam test showing pain.
535,summarize: Segmental resection of the gangrenous ileum was done with a double-barrel stoma.,Segmental resection of the gangrenous ileum was done with a double-barrel stoma.,The dead portion of the last part of the small intestine was removed with a temporary opening in the abdominal wall made during surgery.
536,summarize: We report a rare presentation of incarcerated incisional Richter's hernia of the cecum in a 39-year-old female.,the authors report a rare presentation of Richter's hernia of the cecum in a 39-year-old female.,We report a rare case of Richter's hernia trapped at the area of a healing surgical scar at the first part of the small intestine in a 39-year-old female.
537,"summarize: Although management of renal tumors of low malignant potential is the primary focus of longitudinal care, pulmonary manifestations including cyst formation and spontaneous pneumothorax are among the most common manifestations in BHD.","Although management of kidney tumors with low malignant potential is the main focus of long-term care, pulmonary manifestations including cyst formation and spontaneous breathing are among the most common symptoms in Birt-Hogg-Dub.","While managing low-risk kidney tumors is primary for long-term care, lung issues like cyst formation and random lung collapsions are common in BHD."
538,summarize: The risk of lung collapse (pneumothorax) in BHD patients is 50-fold higher than in the general population.,the risk of lung collapse (pneumothorax) in BHD patients is 50-fold higher than in the general population.,"The risk of lung collapse, which is when air leaks into the space between the lung and chest wall, in Birt-Hogg-Dube patients is 50 times higher than in the general population."
539,"summarize: In addition, the pathologic features of human BHD cysts have been recently comprehensively characterized.","In addition, the pathologic features of human BHD cysts have been recently characterized.","Also, how human Birt-Hogg-Dube cysts are formed and how they progress has been recently described."
540,summarize: This hypothesis ties together many of the new data from cellular and mouse models of BHD and from the human pathologic studies.,Cette hypothese ties together many of the new data from cell and mouse models of BHD and from human disease studies.,This idea ties together many of the new data from cell and mouse studies of Birt-Hogg-Dube and from the human studies of the disease.
541,summarize: Critical questions remain.,Critical questions remain.,Critical questions remain.
542,"summarize: Germline mutations in the novel tumor suppressor gene FLCN are responsible for the autosomal dominant inherited disorder Birt-Hogg-Dub (BHD) syndrome that predisposes to fibrofolliculomas, lung cysts and spontaneous pneumothorax, and an increased risk for developing kidney tumors.","mutations in the new tumor suppressor gene FLCN are responsible for the autosomal dominant inherited disorder Birt-Hogg-Dub (BHD) syndrome that predisposes to fibrofolliculomas, lung cysts and spontaneous breathing, and an increased risk for developing kidney tumors.","Changes in the gene called FLCN, which is a gene that suppresses tumor growth, are responsible for the inherited disorder Birt-Hogg-Dub syndrome. This syndrome makes people likely to get non-cancerous tumors in hair follicles around the face, neck and chest (fibrofolliculomas), cysts (sacs of air) in the lungs, sudden collapse of the lung, and an increased risk for developing tumors in the kidneys."
543,"summarize: FLCN forms a complex with folliculin interacting proteins 1 and 2 (FNIP1, FNIP2) and with 5' AMP-activated protein kinase (AMPK).","FLCN forms a complex with folliculin interacting proteins 1 and 2 (FNIP1, FNIP2) and with 5' AMP-activated protein kinase (AMPK).","FLCN binds with folliculin proteins 1 and 2 (FNIP1, FNIP2) and with a protein kinase that is a critical molecule for energy sensing."
544,summarize: Objective: Birt-Hogg-Dub (BHD) syndrome is an autosomal dominant inherited syndrome involving multiple organs.,Birt-Hogg-Dub (BHD) syndrome is an inherited disorder that involves multiple organs.,Birt-Hogg-Dub syndrome is a genetically inherited syndrome involving multiple organs.
545,summarize: Birt-Hogg-Dub (BHD) syndrome is an autosomal dominant disorder caused by germline loss-of-function mutations in Folliculin gene (FLCN).,Birt-Hogg-Dub (BHD) syndrome is a disorder caused by genetic mutations in the Folliculin gene (FLCN).,"Birt-Hogg-Dub syndrome is an genetic disorder caused by a loss-of-function mutations in the Folliculin gene (FLCN), a gene that stops or slows tumor growth."
546,"summarize: Therefore, FLCN-deficient cells are predicted to have reduced mTORC1 and Wnt activity and enhanced TFE3 activity.",FLCN-deficient cells are predicted to have reduced mTORC1 and Wnt activity and enhanced TFE3 activity.,"Therefore, FLCN cells that are damaged are thought to have reduced activity in other proteins and increase activity in others that may lead to the development of kidney tumors."
547,"summarize: Folliculin also has functions in autophagy, mitochondrial biogenesis, cell-cell adhesion, 5' AMP activated protein kinase activity, and other pathways.","Folliculin also has functions in autophagy, mitochondrial biogenesis, cell-cell adhesion, 5' AMP activated protein kinase activity, and other pathways.","Folliculin also has other functions including cleaning out damaged cells, helping cells connect with other cells, and working with enzymes that activate the proteins that regular cell energy and fuel."
548,summarize: The specific contributions of these pathways to the lung manifestations of BHD are largely unknown.,The specific contributions of these pathways to the lung manifestations of BHD are largely unknown.,How these functions contribute to the lung problems of Birt-Hogg-Dub are largely unknown.
549,"summarize: The pulmonary cysts may lead to pneumothorax, and in cases of primary, spontaneous pneumothorax the syndrome should be excluded.","pulmonary cysts may lead to pneumothorax, and in cases of primary, spontaneous, breathing-related lung collapse, the syndrome should be excluded.","The pulmonary cysts may lead to a collapsed lung when air leaks into the space between the lung and chest wall. In cases of the major, sudden collapsed lung, Birt-Hogg-Dub should be excluded."
550,summarize: Screening and family assessment enable discovery of renal cancer at an early stage.,Screening and family assessment enable detection of kidney cancer at an early stage.,Screening and learning about the health history of family members help doctors discover kidney cancer at an early stage.
551,summarize: The syndrome is underdiagnosed and little known.,The syndrome is underdiagnosed and little known.,Birt-Hogg-Dub is often missed or not recognized as a diagnosis.
552,"summarize: Birt-Hogg-Dub syndrome (BHD) is a rare inherited autosomal dominant disorder caused by germline mutations in the tumour suppressor gene FLCN, encoding the protein folliculin.","Birt-Hogg-Dub syndrome (BHD) is a rare disorder caused by genetic mutations in the tumor suppressor gene FLCN, which encodes the protein folliculin.","Birt-Hogg-Dub syndrome is a rare inherited genetic disorder caused by changes in the gene FLCN that makes a protein called folliculin, which helps suppress tumor growth."
553,summarize: BHD has no sex predilection and tends to manifest in the third or fourth decade of life.,BHD has no sexual preference and tends to manifest in the third or fourth decade of life.,Birt-Hogg-Dub has no preference between male and female and often appears when people are in their 30s or 40s.
554,summarize: Multiple bilateral pulmonary cysts are found on chest computed tomography in >80% of patients and more than half experience one or more episodes of pneumothorax.,Multiple pulmonary cysts are found on chest computed tomography (CT) in >80% of patients and more than half experience one or more episodes of breathing difficulty.,Multiple cysts on both lungs are identified using x-rays in more than 80% of patients. More than half experience one or more collapsed lung events which is when air leaks into the space between the lung and chest wall.
555,"summarize: Unlike other cystic lung diseases such as lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis, BHD does not lead to progressive loss of lung function and chronic respiratory insufficiency.","Unlike other cystic lung diseases such as lymphangioleiomyomatosis and lung Langerhans cell histiocytosis, BHD does not lead to progressive loss of lung function and long-lasting respiratory insufficiency.","Unlike other cystic lung diseases, Birt-Hogg-Dub does not lead to loss of lung function over time or to ongoing breathing problems."
556,"summarize: Renal tumours affect about 30% of patients during their lifetime, and can be multiple and recurrent.","Renal tumors affect about 30% of patients during their lifetime, and can be multiple and reoccurring.","Kidney tumors affect about 30% of patients during their lifetime. There can be multiple number of tumors, and they can be recurring."
557,"summarize: The diagnosis of BHD is based on a combination of genetic, clinical and/or skin histopathological criteria.","The diagnosis of BHD is based on a combination of genetic, clinical and/or skin histopathological criteria.",The diagnosis of Birt-Hogg-Dub is based on a combination of genetic and medical characteristics and/or studying skin and skin cells with a microscope.
558,"summarize: Management mainly consists of early pleurodesis in the case of pneumothorax, periodic renal imaging for tumour detection, and diagnostic work-up in search of BHD in relatives of the index patient.","Management mainly consists of early pleurodesis in the case of pneumothorax, periodic kidney imaging for tumor detection, and diagnostic work-up in search of BHD in relatives of the index patient.","For a collapsed lung, care mostly involves doing a procedure called pleurodesis early that involves sticking the lung to the chest wall to reduce space in the lungs and chest wall. Scanning the kidneys for tumors using x-rays and finding out if relatives have Birt-Hogg-Dub are also ways to manage the disorder."
559,"summarize: A family history of pneumothorax is an important clue, which suggests the diagnosis of BHD.","A family history of breathing problems is an important clue, which suggests the diagnosis of BHD.",A family history of collapsing lungs may help identify BHD.
560,"summarize: Unlike other cystic lung diseases such as lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis, BHD does not lead to progressive loss of lung function and chronic respiratory insufficiency.","Unlike other cystic lung diseases such as lymphangioleiomyomatosis and lung Langerhans cell histiocytosis, BHD does not lead to progressive loss of lung function and long-lasting respiratory insufficiency.","Unlike other lung diseases with lung cysts or swellings, BHD does not lead to loss of lung function overtime and long-lasting breathing deficits."
561,"summarize: The diagnosis of BHD is based on a combination of genetic, clinical and/or skin histopathological criteria.","The diagnosis of BHD is based on a combination of genetic, clinical and/or skin histopathological criteria.","Identifying BHD involves genetic, medical, and/or skin-related criteria."
562,summarize: Examples of putative founding populations for PKU in both Europe and Asia will be presented.,Examples of putative founding populations for PKU in both Europe and Asia will be presented.,We will show populations thought to be where PKU first developed in both Europe and Asia.
563,"summarize: Its metabolic phenotype is accountable to multifactorial origins both in nurture, where the normal nutritional experience introduces L-phenylalanine, and in nature, where mutations (>500 alleles) occur in the phenylalanine hydroxylase gene (PAH) on chromosome 12q23.2 encoding the L-phenylalanine hydroxylase enzyme (EC 1.14.16.1).","L-phenylalanine is responsible for its metabolic phenotype due to many factors. These include nurture, where the normal nutritional experience introduces L-phenylalanine, and nature, where mutations occur in the phenylalanine hydroxylase gene (PAH), which encodes the L-phenylalanine hydroxylase enzyme (EC 1.14.16.1).","The metabolic characteristics of PKU occur due to nurture, in which a normal diet includes the molecule L-phenylalanine, and nature, where DNA mutations influence the gene that creates the L-phenylalanine breakdown enzyme."
564,"summarize: The PAH enzyme converts phenylalanine to tyrosine in the presence of molecular oxygen and catalytic amounts of tetrahydrobiopterin (BH4), its nonprotein cofactor.","PAH enzyme converts phenylalanine to tyrosine in the presence of oxygen and catalytic amounts of tetrahydrobiopterin (BH4), its nonprotein cofactor.","The phenylalanine breakdown enzyme converts PKU into another molecule, tyrosine, using oxygen and non-protein helpers."
565,"summarize: Phenylketonuria (PKU), a Mendelian autosomal recessive phenotype (OMIM 261600), is an inborn error of metabolism that can result in impaired postnatal cognitive development.","Phenylketonuria (PKU), a disorder in which the body cannot properly process food, is an abnormal metabolism that can result in impaired postnatal cognitive development.","Phenylketonuria (PKU), an inheritable disorder, is an inborn (i.e, existing from birth) error of metabolism that can lead to impaired cognitive development."
566,summarize: This knowledge is now being applied in the development of patient-specific therapies.,This knowledge is now being used in the development of patient-specific therapies.,Patient-specific therapies are being developed for diseases like PKU.
567,"summarize: A spectrum of over 850 variants, gives rise to a continuum of hyperphenylalaninemia from very mild, requiring no intervention, to severe classical PKU, requiring urgent intervention.","A spectrum of over 850 variants, gives rise to a continuum of hyperphenylalaninemia from very mild, requiring no intervention, to severe classical PKU, requiring urgent intervention.","A range of over 850 genetic alterations causes elevated phenylalanine blood levels from very mild with no treatment to severe PKU, which needs immediate treatment."
568,"summarize: If left untreated, the main clinical feature is intellectual disability.","If left untreated, the main clinical feature is intellectual disability.",PKU can cause intellectual disability if not treated.
569,summarize: Gene therapy and enzyme replacement or substitution therapy have yielded more promising data in the recent years.,Gene therapy and enzyme replacement or substitution therapy have yielded more promising data in the recent years.,Transferring genetic material into a patient's cell and replacing or substituting a substance that is lacking in the PKU patient's body have been successful in recent years.
570,"summarize: If left untreated, the main clinical feature is intellectual disability.","If left untreated, the main clinical feature is intellectual disability.","If left untreated, phenylketonuria may lead to intellectual disability."
571,summarize: Advances in dietary therapy such as the use of large neutral amino acids (LNAA) and glycomacropeptides (GMP; found within the whey fraction of bovine milk) have been explored.,Advances in dietary therapy such as the use of large neutral amino acids (LNAA) and glycomacropeptides (GMP; found within the whey fraction of bovine milk) have been explored.,Changes like using new amino acids and protein units have been explored.
572,summarize: In this review the current and possible future treatments for PKU are discussed.,The current and possible future treatments for PKU are discussed.,This article reviews current and possible treatments for PKU.
573,summarize: PKU management differs widely across Europe and therefore these guidelines have been developed aiming to optimize and standardize PKU care.,PKU management differs widely across Europe and therefore these guidelines have been developed aiming to optimize and standardize PKU care.,The European guidelines on PKU were made to improve and reduce the variation or differences in care because PKU treatment differs a lot across Europe.
574,"summarize: Mutations in an enzyme, such as PAH, are recessive since one functioning enzyme with the wild-type allele is sufficient.","Mutations in an enzyme, such as PAH, are recessive since one functioning enzyme with the wild-type allele is sufficient.","Changes to DNA of a protein, such as PAH, are made in both copies of the gene that is altered, because one working copy of the gene allows the protein to function."
575,summarize: In this article we summarize the gene therapeutic attempts of correcting a mouse model for PKU and discuss the future implications for human gene therapy.,"In this article, we summarize the gene therapy attempts of correcting a mouse model for PKU and discuss the future implications for human gene therapy.","In this paper, we summarize future impacts for transferring genetic material into a patient's cells."
576,"summarize: Most genotypes (73%) were compound heterozygous, 27% were homozygous, and 55% of 3,659 different genotypes occurred in only a single individual.","most genotypes (73%) were compound heterozygous, 27% were homozygous, and 55% of 3,659 different genotypes occurred in only one individual.","Most genetic makeups (73%) were compound heterozygous (both forms of the gene have different mutations), 27% were homozygous (both forms of the gene have the same mutation), and 55% of 3,659 different genetic makeups happened in only one person."
577,"summarize: Early diagnosis is based on newborn screening, and if treatment is started early and continued, intelligence is within normal limits with, on average, some suboptimal neurocognitive function.","early diagnosis is based on newborn screening, and if treatment is started early and continued, intelligence is within normal limits with, on average, some suboptimal neurocognitive function.","Early diagnosis is based on checks for conditions that affect newborns, and if treatment is started early and continued, intelligence is usually normal with some decreased mental function."
578,"summarize: Dietary restriction of phenylalanine has been the mainstay of treatment for over 60 years and has been highly successful, although outcomes are still suboptimal and patients can find the treatment difficult to adhere to.","Dietary restriction of phenylalanine has been the mainstay of treatment for over 60 years and has been highly successful, although results are still suboptimal and patients can find the treatment difficult to follow.","Low-phenylalanine diets have been the go-to treatment for over 60 years and have worked, although results could be better and patients have trouble following the diets."
579,summarize: Its mechanism of action remains to be elucidated.,Seizures mechanism of action remains unclear.,How it works is not yet fully understood.
580,"summarize: In several studies, a 'lagtime' of 1 to 2 weeks to the onset of anxiolytic effect has been noted; hence motivation of patient compliance may be necessary.","'lagtime' of 1 to 2 weeks to the start of anxiolytic effect has been noted. Therefore, motivation of patient compliance may be needed.","In many studies, it takes 1 to 2 weeks for anxiety relief after starting buspirone, so doctors may need to encourage patients to keep taking buspirone."
581,summarize: Sedation occurs much less often after buspirone than after the benzodiazepines; other side effects are minor and infrequent.,Sedation occurs much less often after buspirone than after the benzodiazepines. Other side effects are minor and infrequent.,"Sedation happens much less often with buspirone than benzodiazepines, and other side effects are mild and uncommon."
582,summarize: Patients were on a benzodiazepine before the study and were stabilized on 3 to 5 mg/day lorazepam for 5 weeks (weeks 0 to 5).,patients were on a benzodiazepine before the study and were stabilized on 3 to 5 mg/day of lorazepam for 5 weeks (weeks 0 to 5).,"Patients were taking a benzodiazepine before the study and were stabilized on 3 to 5 mg/day lorazepam for 5 weeks (weeks 0-5), both anxiety-reducing drugs."
583,"summarize: During weeks 12 to 13, patients received single-blind placebo.","During weeks 12 to 13, patients received single-blind placebo.","During weeks 12 to 13, all patients took sugar pills."
584,summarize: Side effects were assessed through the Dosage Treatment Emergent Symptoms at the same times.,Side effects were assessed through the Dosage Treatment Emergent Symptoms at the same times.,"At the same times, we measured side effects using another questionnaire."
585,"summarize: The benzodiazepine-withdrawal syndrome was evaluated through a 27-symptom checklist (Clinical-Rated Benzodiazepine Withdrawal Symptom Schedule) at weeks 0, 5, 6, 7, 11, and 13.","Benzodiazepine-withdrawal syndrome was evaluated through a 27-symptom checklist at weeks 0, 5, 6, 7, 11, and 13.","At the beginning of the study and weeks 5, 6, 7, 11, and 13, we measured withdrawal symptoms using a common checklist."
586,"summarize: For the respiratory studies, one group of monkeys inhaled either air or 5% CO2 mixed in air according to a fixed alternating schedule; respiratory frequency and minute volume were monitored.","During the respiratory studies, one group of monkeys inhaled either air or 5% CO2 mixed in air according to a fixed alternating schedule; breathing frequency and minute volume were monitored.","For the breathing-related studies, one group of monkeys breathed air or 5% CO2 mixed in air; breaths per minute and amount of gas breathed were measured."
587,summarize: 4. This study confirmed that buspirone was as effective as lorazepam at D56 in monitored outpatients with generalized anxiety disorder.,4. This study confirmed that buspirone was as effective as lorazepam at D56 in monitored outpatients with generalized anxiety disorder.,This study showed that buspirone worked as well as lorazepam 56 days into the study in patients with generalized anxiety disorder.
588,"summarize: These included the Hamilton anxiety scale, the visual analogue scale, the CHESS 84 (a check list for the evaluation of somatic symptoms) and the Lader tranquilizer withdrawal scale (translated in french).","Among these tests were the Hamilton anxiety scale, the visual analogue scale, the CHESS 84 (a check list for the evaluation of somatic symptoms) and the Lader tranquilizer withdrawal scale.",nan
589,summarize: No withdrawal phenomena was observed for both drugs using HAM-A lorazepam D63 :12.59 +/- 2.26 D70: 12.0 +/- 1.75 (p = ns) buspirone D63 :10.05 +/- 1.28 D70: 10.32 +/- 1.82 (p = ns) and the same significant difference using Lader scale: lorazepam D63 :4.44 +/- 0.89 D70: 6.96 +/- 1.28 (p  or = 0.05) buspirone D63 :2.95 +/- 0.66 D70: 4.15 +/- 0.92 (p  or = 0.05),no withdrawal phenomena were observed for both drugs.,No withdrawal effects were seen with either drug.
590,summarize: The dosages were increased progressively during the first week of treatment.,The dosages were increased progressively during the first week of treatment.,The amount taken was increased gradually during the first week of treatment.
591,summarize: All the drugs were equally effective after three weeks of treatment.,All the drugs were equally effective after three weeks of treatment.,All the drugs worked equally well after three weeks of treatment.
592,"summarize: Method: After a benzodiazepine stabilization period taking either diazepam, lorazepam, or alprazolam, patients were treated for 4 weeks with imipramine, buspirone, or placebo under double-blind conditions while benzodiazepine intake was kept stable (treatment phase).","Benzodiazepine stabilization period after taking either diazepam, lorazepam, or alprazolam, patients were treated for 4 weeks with imipramine, buspirone, or placebo while benzodiazepine intake was kept stable (treatment phase).","After a period to stabilize benzodiazepine levels taking either diazepam, lorazepam, or alprazolam, patients took imipramine, buspirone, or sugar pills for 4 weeks while the amount of benzodiazepines taken were kept the same (treatment phase)."
593,summarize: Benzodiazepine-free status was assessed 3 and 12 months posttaper.,Benzodiazepine-free status was assessed 3 and 12 months after surgery.,We measured how many patients no longer had benzodiazepine in their blood 3 and 12 months after the last sugar pill.
594,"summarize: Method: After a benzodiazepine stabilization period taking either diazepam, lorazepam, or alprazolam, patients were treated for 4 weeks with imipramine, buspirone, or placebo under double-blind conditions while benzodiazepine intake was kept stable (treatment phase).","Benzodiazepine stabilization period after taking either diazepam, lorazepam, or alprazolam, patients were treated for 4 weeks with imipramine, buspirone, or placebo while benzodiazepine intake was kept stable (treatment phase).","After using either diazepam, lorazepam, or alprazolam (anxiety-reducing benzodiazepines) for a period of time, patients used imipramine, busprione, or an inactive placebo for 4 weeks while benzodiazepine usage was stable."
595,"summarize: Patients then entered a 4-6 week benzodiazepine taper and a 5-week posttaper phase with imipramine, buspirone, and placebo treatment being continued until 3 weeks into the posttaper phase, at which time all patients were switched to placebo for 2 weeks.","4-6 weeks of benzodiazepine was gradually reduced and patients continued with imipramine, buspirone, and placebo treatment until 3 weeks into the posttaper phase, at which time all patients were switched to no medication for 2 weeks.","For 4-6 weeks, patients lessened benzodiazepine use. Then, for 5 weeks, patients kept using imipramine, busiprone, and inactive treatment until 3 weeks in this 5-week phase, at which all patients switched to inactive treatment for 2 weeks."
596,"summarize: The imipramine effect remained highly significant even after the analysis adjusted for three other independent predictors of taper success: benzodiazepine dose, level of anxious symptoms at baseline, and duration of benzodiazepine therapy.","imipramine effect remained highly significant even after the analysis adjusted for three other independent predictors of taper success: benzodiazepine dose, level of anxious symptoms at start, and duration of benzodiazepine therapy.","The imipramine effect was still high even after accounting for benzodiazepine dose, baseline level of anxious symptoms, and duration of benzodiazepine treatment."
597,"summarize: Daily benzodiazepine dose, severity of baseline symptoms of anxiety and depression, and duration of benzodiazepine use were additional significant predictors of successful taper outcome.","Daily benzodiazepine dose, severity of initial symptoms of anxiety and depression, and duration of benzodiazepine use were additional predictors of successful taper.","Daily benzodiazepine dose, severity of starting symptoms of anxiety and depression, and length of benzodiazepine use help predict successful reduction of drug use."
598,"summarize: Methodological issues are stressed, particularly drug plasma concentrations, dose-response relationships and time-course of effects (fluoxetine/buspirone), and unsolved questions are addressed (yohimbine/caffeine, hydroxizyne/alcohol).","Several issues are stressed, including blood concentrations, dose-response relationships and time-course of effects (fluoxetine/buspirone), and unsolved questions (yohimbine/caffeine, hydroxizyne/alcohol).","We focus on methods, especially drug blood levels, response as a function of dosage, and varying activity of the drug over time (fluoxetine/buspirone) and talk about unsolved questions."
599,"summarize: Among GAD-related medications (including benzodiazepines, tricyclic antidepressants [TCAs], selective serotonin reuptake inhibitors, venlafaxine, hydroxyzine, buspirone, pregabalin, and trifluoperazine), long-acting benzodiazepines, selected short-acting benzodiazepines at relatively high dosages, selected TCAs, and hydroxyzine were designated ""potentially inappropriate"" for use in patients aged > or = 65 years, based on published criteria.","Benzodiazepines, tricyclic antidepressants [TCAs], selective serotonin reuptake inhibitors (SERS inhibitors), venlafaxine, hydroxyzine, buspirone, pregabalin, and trifluoperazine are considered ""potentially inappropriate"" for use in patients aged > or = 65 years.","Among drugs to treat GAD (including benzodiazepines, tricyclic antidepressants [TCAs], SSRIs, venlafaxine, hydroxyzine, buspirone, pregabalin, and trifluoperazine), long-acting benzodiazepines, some short-acting benzodiazepines at relatively high doses, some TCAs, and hydroxyzine were categorized ""potentially inappropriate"" for people 65-years-old and above."
600,summarize: Further research is needed to ascertain whether there are specific subgoups of elderly patients with GAD for whom the benefits of these medications outweigh their risks.,further research is needed to determine if there are specific subgroups of elderly patients with GAD for whom the benefits of these drugs outweigh their risks.,More research is needed to understand whether certain groups of elderly patients with GAD exist with whom the benefits outweigh the risks of these drugs.
601,summarize: Her initial vital signs were remarkable for tachycardia (120 bpm).,Her first vital signs were remarkable for tachycardia (120 bpm).,She had a high heart rate (120 beats per minute).
602,summarize: She was transferred to a receiving hospital.,She was transferred to a receiving hospital.,She was transferred to another hospital.
603,summarize: Her bupropion concentration was 92 ng/mL (reference 50-100 ng/mL).,Her bupropion concentration was 92 ng/mL (reference 50-100 ng/mL).,nan
604,summarize: Importance: The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of people worldwide.,The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of people worldwide.,"The COVID-19 pandemic is threatening billions of people worldwide. COVID-19 is a viral, breathing-related disease."
605,summarize: Objective: To evaluate the effect of early tocilizumab administration vs standard therapy in preventing clinical worsening in patients hospitalized with COVID-19 pneumonia.,Objective: To evaluate the effect of early tocilizumab administration vs standard therapy in preventing clinical worsening in patients hospitalized with COVID-19 pneumonia.,"The objective of this study is to evaluate the effect of giving tocilizumab early, compared to the standard treatment, to prevent a hospitalized COVID-19 patient with pneumonia from getting worse."
606,"summarize: Interventions: Patients in the experimental arm received intravenous tocilizumab within 8 hours from randomization (8 mg/kg up to a maximum of 800 mg), followed by a second dose after 12 hours.","patients in the experimental arm received tocilizumab within 8 hours from randomization, followed by a second dose after 12 hours.",Patients in the experimental group receive tocilizumab through an IV (medicine is delivered in a vein in the arm) within 8 hours of being randomly placed in the group. A second dose is given after 12 hours.
607,summarize: Patients in the control arm received supportive care following the protocols of each clinical center until clinical worsening and then could receive tocilizumab as a rescue therapy.,patients in the control arm received supportive care following the procedures of each clinical center until symptoms worsening and then could receive tocilizumab as a rescue therapy.,"Patients in the comparison group receive support care based on hospital standards until the patient's condition worsens, and then they receive tocilizumab."
608,"summarize: The median (interquartile range) age was 60.0 (53.0-72.0) years, and the majority of patients were male (77 of 126, 61.1%).","the average age was 60.0 years, and the majority of patients were male.","The average age is 60 years, and most patients (61.1%) are male."
609,summarize: The trial was prematurely interrupted after an interim analysis for futility.,the trial was prematurely interrupted after an interim analysis for futility.,The trial was stopped early after an analysis showed that the experimental group is not likely to show any added benefit than the comparison group.
610,"summarize: With this review paper, we aim to demonstrate the inhibitory effect of mavrilimumab on cytokine storms in patients with COVID-19 by reviewing published clinical trials and emphasize the importance of extensive future trials.","Using this review paper, we aim to demonstrate the inhibitory effect of mavrilimumab on cytokine storms in patients with COVID-19 by reviewing published clinical trials and emphasize the importance of extensive future studies.","This paper reviews data from published studies to show how mavrilimumab can block cytokine storms in patients with COVID-19, and to highlight the importance of future studies."
611,summarize: Background: Monoclonal antibody therapy (MAT) is recommended in mild to moderate Coronavirus disease 2019 (COVID-19) patients who are at risk of progressing to severe disease.,Monoclonal antibody therapy (MAT) is recommended in mild to moderate Coronavirus disease 2019 (COVID-19) patients who are at risk of progressing to severe disease.,"Monoclonal antibodies are medicines recommended in mild to moderate COVID-19 patients who are at risk of progressing to a severe stage of the disease. Monoclonal antibodies are medicines that may block the virus that causes COVID-19 (a breathing-related disease) from attaching to human cells, making it more difficult for the virus to reproduce."
612,"summarize: Due to limited data on its outcomes and the logistic challenges in administering the drug, MAT has not been widely used in the United States (US) despite of emergency use authorization (EUA) approval by the Food and Drug Administration (FDA).",MAT has not been widely used in the United States (US) despite emergency use authorization by the Food and Drug Administration (FDA).,"Monoclonal antibodies are not widely used in the United States because there is little data on the impact of these drugs, and it is difficult to give these drugs to patients."
613,"summarize: A majority of patients (76%) in the study group reported symptomatic improvement, the day after infusion.","A majority of patients (76%) in the study group reported symptom improvement, the day after injection.",A majority of patients (76%) reported improvement in their symptoms the day after receiving the medicine.
614,summarize: Conclusion: Two-m Ab therapy can drive the selection of resistant SARS-CoV-2 variants in immunocompromised patients.,Two-m Ab therapy can drive the selection of resistant SARS-CoV-2 variants in immunocompromised patients.,"In conclusion, two monoclonal antibody drugs can drive the targeting of coronavirus variants in patients with weak immune systems."
615,"summarize: The fourth patient harbored a variant with a Q493K spike mutation 7 days post-treatment, and the fifth patient had a variant with a E484K spike mutation on day 21.","the fourth patient had a variant with a mutation 7 days after treatment, and the fifth patient had a variant with a mutation on day 21.","The fourth patient had a variant with a mutation 7 days after treatment, along with a fifth patient on day 21."
616,summarize: Conclusion: Two-m Ab therapy can drive the selection of resistant SARS-CoV-2 variants in immunocompromised patients.,Two-m Ab therapy can drive the selection of resistant SARS-CoV-2 variants in immunocompromised patients.,Two-mAb treatment can lead to resistant SARS-CoV-2 variants in patients with an impaired immune system.
617,summarize: Treatment generally requires the administration of high doses of these mAbs with limited efficacy in preventing disease complications or mortality among hospitalized COVID-19 patients 5.,Covid-19 is a viral respiratory disease that causes COVID-19 in patients who are hospitalized.,Treatment usually requires high doses of these monoclonal antibodies with limited ability in preventing complications or death among patients hospitalized with COVID-19.
618,summarize: Here we report the development and evaluation of Fc-optimized anti-SARS-CoV-2 mAbs with superior potency to prevent or treat COVID-19 disease.,the authors report the development and evaluation of anti-SARS-CoV-2 mAbs with superior potency to prevent or treat COVID-19 disease.,This study reports on the development and evaluation of monoclonal antibodies enhanced with the Fc (the part of the antibody that helps interactions with other cells) to prevent or treat COVID-19.
619,"summarize: We tested therapeutic equine polyclonal antibodies (pAbs) that are being assessed in clinical trials in Costa Rica against five globally circulating variants of concern: alpha, beta, epsilon, gamma and delta, using plaque reduction neutralization assays.","equine polyclonal antibodies (pAbs) are being evaluated in clinical trials in Costa Rica against five globally circulating variants of concern: alpha, beta, epsilon, gamma and delta.","We tested horse-derived polyclonal antibodies (pAbs), a mixture of antibodies that bind to the same foreign organism. These pAbs are being measured in Costa Rica against five alarming, global variants: alpha, beta, epsilon, gamma, and delta."
620,"summarize: We show that equine pAbs efficiently neutralize the variants of concern, with inhibitory concentrations in the range of 0.146-1.078 Î14g/mL, which correspond to extremely low concentrations when compared to pAbs doses used in clinical trials.","equine pAbs efficiently neutralize the variants of concern, with inhibitory concentrations in the range of 0.146-1.078 Î14g/mL, which correspond to extremely low doses when compared to pAbs doses used in clinical trials.",Horse-derived pAbs efficiently treat the concerning variants with much lower dosages than those used in clinical trials.
621,"summarize: Over 80 mAbs have been shown to block the interaction between the SARS-CoV-2 S1 glycoprotein and its cellular receptor, thus neutralizing virus infectivity in vitro.","Over 80 mAbs have been shown to block the interaction between the SARS-CoV-2 S1 glycoprotein and its cell receptor, thus neutralizing virus infection in vitro.","Over 80 monoclonal antibody medicines have been shown to block the interaction between the coronavirus glycoprotein (a molecule that has a carbohydrate and a protein) and its cell receptor that can send signals, resulting in making the virus ineffective. The coronavirus causes COVID-1, a viral breathing-related disorder, and monoclonal antibodies are medicines that may block the virus that causes COVID-19 from attaching to human cells."
622,"summarize: The neutralization mechanisms of mAbs against SARS-CoV-2 in vivo are not fully understood, but optimal protection correlates with Fc effector functions.","mAbs are not fully understood, but the best protection is linked to Fc effector functions.","The process used by monoclonal antibodies to make the virus ineffective in humans and animals is not fully understood, but the best protection is associated with the Fc effector functions, which are the part of the antibody that interacts with other cells."
623,"summarize: The primary outcome was Covid 19 related hospitalisation of â 24 hours or death from any cause by day 29, and this occurred in 2.1% subjects in the bamlanivimab/etesevimab group, compared to 7.0% in the placebo group.","the primary outcome was Covid 19 related hospitalisation of â 24 hours or death from any cause by day 29. This occurred in 2.1% patients in the bamlanivimab/etesevimab group, compared to 7.0% in the placebo group.","The main result researchers look for is COVID-19 related hospital stays that lasted at least 24 hours or death. This result occurred in 2.1% of patients in the bamlanivimab/etesevimab group, compared to 7.0% in the placebo group."
624,"summarize: Thus, the benefits of bamlanivimab/etesevimab in the phase 3 of the BLAZE-1 may be solely due to etesevimab, and this needs to be tested.","Hence, the benefits of bamlanivimab/etesevimab in the phase 3 of the BLAZE-1 may only be due to etesevimab, and this needs to be tested.","Therefore, the benefits of the bamlanivimab/etesevimab in phase 3 of the BLAZE-1 trial may be solely due to the etesevimab medicine, and this needs to be tested."
625,summarize: Objective: To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19).,"Objective: To evaluate the effectiveness and safety of antiviral antibody therapies and blood products for the treatment of new coronavirus disease 2019 (covid-19), a viral respiratory disease.",The objective of this paper is to evaluate the performance and safety of antiviral antibody therapies that help the body fight off or prevent a virus and blood products used to treat COVID-19.
626,summarize: No other intervention had any meaningful effect on any outcome in patients with non-severe covid-19.,No other treatment had any meaningful effect on any outcome in patients with non-severe covid-19.,No other treatment intervention is found to have any meaningful effect on any outcome in patients with non-severe COVID-19.
627,"summarize: Study selection: Trials randomising people with suspected, probable, or confirmed covid-19 to antiviral antibody therapies, blood products, or standard care or placebo.",Covid-19 is a viral infection that can spread through the body's immune system.,"People with suspected, probable, or confirmed covid-19 were randomized to antiviral antibody therapies, substances from blood, or standard care or an inactive placebo."
628,"summarize: Results: As of 21 July 2021, we identified 47 trials evaluating convalescent plasma (21 trials), intravenous immunoglobulin (IVIg) (5 trials), umbilical cord mesenchymal stem cells (5 trials), bamlanivimab (4 trials), casirivimab-imdevimab (4 trials), bamlanivimab-etesevimab (2 trials), control plasma (2 trials), peripheral blood non-haematopoietic enriched stem cells (2 trials), sotrovimab (1 trial), anti-SARS-CoV-2 IVIg (1 trial), therapeutic plasma exchange (1 trial), XAV-19 polyclonal antibody (1 trial), CT-P59 monoclonal antibody (1 trial) and INM005 polyclonal antibody (1 trial) for the treatment of covid-19.","47 trials evaluated convalescent plasma (21 trials), intravenous immunoglobulin (IVIg) (5 trials), umbilical cord stem cells (5 trials), bamlanivimab (4 trials), casirivimab-imdevimab (4 trials), bamlanivimab-etesevimab (2 trials), control plasma (2 trials), peripheral blood non-haematopoietic enriched stem cells (2 trials), sotrovimab (1 trial), anti-SARS-CoV-2 IVIg (1 trial), therapeutic plasma exchange (1 trial), CT-P59 monoclonal antibody (1 trial), and INM005 poly","As of 21 July 2021, we identified 47 trials evaluating a variety of substances from blood and antiviral antibody treatments for treating covid-19."
629,"summarize: No intervention, including antiviral antibodies, had an important impact on any outcome in patients with severe or critical covid-19, except casirivimab-imdevimab, which may reduce mortality in patients who are seronegative.","No treatment, including antiviral antibodies, had an important impact on any outcome in patients with severe or critical covid-19, except casirivimab-imdevimab, which may reduce death in patients who are not positive for the virus.","No treatment, including antiviral antibodies, had an important effect on any outcome in patients with severe covid-19, except the antibodies casirivimab-imdevimab. These antibodies may reduce risk of death in those who do not make the antibodies naturally."
630,"summarize: There is limited support for many of its key epidemiologic features, including the incubation period for clinical disease (coronavirus disease 2019 [COVID-19]), which has important implications for surveillance and control activities.","There is limited support for many of its key epidemiologic features, including the incubation period for clinical disease (coronavirus disease 2019 [COVID-19], which has important implications for surveillance and control activities.","Little is known about how COVID-19 impacts human health, including how long the disease's incubation period (the time between initial exposure and the first signs of illness) lasts. Knowing the incubation period of the disease is important for preventing further spread."
631,"summarize: Setting: News reports and press releases from 50 provinces, regions, and countries outside Wuhan, Hubei province, China.","News reports and press releases from 50 provinces, regions, and countries outside Wuhan, Hubei province, China.",The information was gathered from news reports and press releases from over 50 locations outside of Wuhan city within the Hubei province of China.
632,"summarize: The median incubation period was estimated to be 5.1 days (95% CI, 4.5 to 5.8 days), and 97.5% of those who develop symptoms will do so within 11.5 days (CI, 8.2 to 15.6 days) of infection.","the average incubation period is estimated to be 5.1 days, and 97.5% of those who develop symptoms will do so within 11.5 days of infection.","The average incubation period was estimated to be 5.1 days. Overall, the majority of people will develop symptoms within 11.5 days after time of infection."
633,"summarize: Limitation: Publicly reported cases may overrepresent severe cases, the incubation period for which may differ from that of mild cases.","Limitation: Publicly reported cases may overrepresent severe cases, the incubation period for which may differ from that of mild cases.","Because only cases from new outlets and press releases were evaluated, the estimations may be based on more severe COVID-19 cases. Mild cases, which may go unreported, may have a different incubation period."
634,"summarize: Considering the significance of this ongoing global public health emergency, it is necessary to carry out large studies to better understand the issue of potential SARSâ CoVâ2 recurrence in COVIDâ19 patients.","Considering the importance of this ongoing global public health emergency, it is necessary to carry out large studies to better understand the issue of possible SARS-CoV-2 recurrence in COVID-19 patients.","Due to the large scale impact the COVID-19 pandemic is having on the world, it is important to conduct research to better understand how previous COVID-19 patients can become ill with the virus more than once."
635,"summarize: Results: Over 6 weeks, 230 HCP had 528 tests performed.","Over 6 weeks, 230 HCP had 528 tests performed.","Over six weeks, 230 health care personnel had 528 tests performed."
636,"summarize: Of the area under the curve (AUC) spanning symptom onset to 30 days, 96.9% lay within the first 7 days, and 99.7% within 10 days.","96.9% lay within the first 7 days, and 99.7% within 10 days.",The majority of the participants had peak viral load within the first 7 to 10 days.
637,summarize: The vast majority of the viral load-time AUC lies within 10 days of symptom onset.,the vast majority of the viral load-time AUC lies within 10 days of symptom onset.,The largest amount of viral load was on average within 10 days of symptom onset.
638,summarize: Serial interval distribution could be automatically estimated from our data.,Statistical interval distribution could be automatically estimated from our data.,The time between the date of infection and the time a person is capable of spreading COVID-19 to others could be predicted.
639,"summarize: The median incubation period was estimated to be 2.87 days (95% CI, 2.33-3.50 days), and the median serial interval to be 3.56 days (95% CI, 2.72-4.44 days).","the average incubation period was estimated to be 2.87 days, and the average serial interval to be 3.56 days.",The average time between COVID-19 entering a person's body (time of exposure) and the onset of symptoms was 2.87 days.
640,"summarize: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), has spread globally in a few short months.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), has spread globally in a few short months.","Severe acute respiratory syndrome coronavirus 2, also known as SARS-CoV-2, is the cause of coronavirus disease 2019 or COVID-19 (a viral lung infection). Within a short period of time, SARS-CoV-2 has spread around the world."
641,"summarize: Although several experimental studies have cultured live virus from aerosols and surfaces hours after inoculation, the real-world studies that detect viral RNA in the environment report very low levels, and few have isolated viable virus.","Several experimental studies have cultured live virus from aerosols and surfaces hours after inoculation, but the real-world studies that detect viral RNA in the environment report very low levels, and few have isolated viable virus.","Several laboratory studies have been able to grow live COVID-19 viruses from the air and surfaces, even several hours after the virus was placed there. However, real-world studies that detect COVID-19 genetic material in the environment report very low levels. Few have been able to grow the virus from these samples."
642,summarize: The longest interval associated with replication-competent virus thus far is 20 days from symptom onset.,the longest interval associated with replication-competent virus thus far is 20 days from symptom onset.,The longest documented duration between symptom onset and viral spread is 20 days.
643,"summarize: Many patients, however, have persistently positive RT-PCR tests for weeks to months following clinical recovery, and multiple studies now indicate that these generally do not reflect replication-competent virus.","Many patients, however, have persistently positive RT-PCR tests for weeks to months following clinical recovery. Multiple studies now show that these tests generally do not reflect replication-competent virus.",Many patients still have test results detecting the disease for weeks to months after recovery. Studies note that these results generally do not reflect contagious viruses.
644,"summarize: This review summarizes evidence-to-date on the duration of infectivity of SARS-CoV-2, and how this has informed evolving public health recommendations on when it is safe to discontinue isolation precautions.","This review summarizes evidence-to-date on the duration of infectivity of SARS-CoV-2, and how this has informed public health recommendations on when it is safe to stop isolation precautions.","This review summarizes current evidence on the duration of infectivity of SARS-CoV-2, and how this affects new public health recommendation for releasing people in isolation."
645,summarize: Conclusion: COVID-19 patients with mild-to-moderate illness are highly unlikely to be infectious beyond 10 days of symptoms.,COVID-19 patients with mild-to-moderate illness are highly unlikely to be infected beyond 10 days of symptoms.,The authors concluded that COVID-19 patients with mild to moderate symptoms are unlikely to spread the virus to others beyond 10 days of symptoms.
646,"summarize: Recruits who did not volunteer for the study underwent qPCR testing only on day 14, at the end of the quarantine period.","recruits who did not volunteer for the study underwent qPCR testing only on day 14, at the end of the quarantine period.",Marine recruits who did not want to participate in the study only received one COVID-19 test on day 14 (the final day of supervised quarantine).
647,"summarize: Most recruits who tested positive were asymptomatic, and no infections were detected through daily symptom monitoring.","most recruits who tested positive had no symptoms, and no infections were detected through daily symptom monitoring.",Most recruits who tested positive showed no signs of illness. No infections were detected through daily symptom monitoring.
648,summarize: No SARS-CoV-2 infections were identified through clinical qPCR testing performed as a result of daily symptom monitoring.,No SARS-CoV-2 infections were identified through clinical qPCR testing performed as a result of daily symptom monitoring.,No SARS-CoV-2 infections were detected by clinical testing performed for daily symptom checks.
649,"summarize: Most recruits who tested positive were asymptomatic, and no infections were detected through daily symptom monitoring.","most recruits who tested positive had no symptoms, and no infections were detected through daily symptom monitoring.",Most recruits with positive tests had no symptoms. No infections were detected from daily symptom checks.
650,"summarize: On April 10, the patient was transferred to the Fever Clinic for further treatment due to close contact to one confirmed COVID-19 patient in the same room.","On April 10, the patient was transferred to the Fever Clinic for further treatment due to close contact with one confirmed COVID-19 patient in the same room.","On April 10th, the man was transferred to the Fever Clinic within the hospital for additional treatment as he had experienced close contact with a confirmed COVID-19 patient."
651,"summarize: During the period from April 10 to May 6, nucleic acid and antibodies to SARS-CoV-2 were tested 7 and 4 times, respectively, all of which were negative.","During the period from April 10 to May 6, nucleic acid and antibodies to SARS-CoV-2 were tested 7 and 4 times, respectively, all of which were negative.","From April 10th to May 6th, the man was tested for COVID-19 several times. All tests returned negative, detecting no COVID-19."
652,summarize: Conclusion: This case highlights the importance of the SARS-CoV-2 incubation period.,Conclusion: This case highlights the importance of the SARS-CoV-2 incubation period.,This example shows the importance of the COVID-19 incubation period.
653,"summarize: BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein.","BNT162b2 is a lipid-based, nucleoside-modified RNA vaccine that encodes a SARS-CoV-2 full-length spike protein.",The BNT162b2 vaccine works by increasing proteins that help the immune system.
654,"summarize: The safety profile of BNT162b2 was characterized by short-term, mild-to-moderate pain at the injection site, fatigue, and headache.","The safety profile of BNT162b2 was characterized by short-term, mild-to-moderate pain at the injection site, fatigue, and headache.","The safety of the BNT162b2 vaccine is described as having short-term, mild-to-moderate pain on the arm where the shot was given, tiredness, and a headache."
655,summarize: Conclusions: A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older.,A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older.,"In conclusion, receiving two doses of the BNT162b2 vaccine provided 95% protection against Covid-19 in people 16 years or older."
656,summarize: Safety over a median of 2 months was similar to that of other viral vaccines.,safety over a median of 2 months was similar to that of other viral vaccines.,Safety over an average of 2 months is similar to those of other vaccines.
657,"summarize: Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group (56.5 per 1000 person-years; 95% confidence interval [CI], 48.7 to 65.3) and in 11 participants in the mRNA-1273 group (3.3 per 1000 person-years; 95% CI, 1.7 to 6.0); vaccine efficacy was 94.1% (95% CI, 89.3 to 96.8%; P0.001).",Symptomatic Covid-19 illness was confirmed in 185 participants in the placebo group and in 11 participants in the mRNA-1273 vaccine group. The effectiveness of the vaccine was 94.1%.,"185 participants in the inactive placebo group showed symptoms of Covid-19., while11 participants in the vaccine group showed symptoms of Covid-19."
658,"summarize: Efficacy was similar across key secondary analyses, including assessment 14 days after the first dose, analyses that included participants who had evidence of SARS-CoV-2 infection at baseline, and analyses in participants 65 years of age or older.","Efficacy was similar across key secondary analyses, including assessment 14 days after the first dose, analyses that included participants who had evidence of SARS-CoV-2 infection at the start, and analyses in participants 65 years of age or older.","Effectiveness was similar for key secondary analyses like analysis 14 days after the first dose, analysis with participants who had evidence of SARS-CoV-2 infection at the start, and analysis in participants 65 years or older."
659,"summarize: Among these, 175 case reports were identified for further review as possible cases of severe allergic reaction, including anaphylaxis.","Among these, 175 case reports were identified for further review as possible cases of severe allergic reaction, including anaphylaxis.","Among the unfortunate events, 175 individual patient reports were picked for further review as possible cases of severe allergic reaction, including life-threatening reactions."
660,summarize: Seven case reports were still under investigation.,7 case reports were still under investigation.,Seven individual patient reports were still under investigation.
661,"summarize: As of January 20, 2021, a total of 24,135,690 cases of coronavirus disease 2019 (COVID-19) and 400,306 associated deaths had been reported in the United States (https://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days).","a total of 24,135,690 cases of coronavirus disease 2019 (COVID-19) and 400,306 associated deaths had been reported in the United States.","As of January 20, 2021, a total of 24,135,690 cases of Covid-19 (a viral, respiratory disease) and 400,306 associated deaths have been reported in the United States."
662,"summarize: Among these case reports, 10 cases were determined to be anaphylaxis (a rate of 2.5 anaphylaxis cases per million Moderna COVID-19 vaccine doses administered), including nine in persons with a documented history of allergies or allergic reactions, five of whom had a previous history of anaphylaxis.","Among these case reports, 10 cases were determined to be anaphylaxis (a rate of 2.5 anaphylaxis cases per million Moderna COVID-19 vaccine doses given), including nine in persons with a documented history of allergies or allergic reactions, five of whom had anaphylaxis before.","Among these case reports, 10 cases are determined to be anaphylaxis, including 9 in people with a history of allergies or allergic reactions, 5 of whom had a previous history of anaphylaxis."
663,"summarize: Results: Based on the currently available literature, both vaccines are beneficial to provide immunity against SARS-CoV-2 infection.","Results: Based on the currently available literature, both vaccines are beneficial to provide immunity against SARS-CoV-2 infection.","Based on available information, both vaccines are beneficial in providing immunity (resistance) against the coronavirus infection."
664,"summarize: However, Moderna Vaccine has been recommended to people 18 years of age and older, with a dose of 50 Î14g (0.5 mL) at a cost of $32-37.","Moderna Vaccine is recommended to people 18 years of age and older, with a dose of 50 Î14g (0.5 mL) at a cost of $32-37.","However, the Moderna vaccine is recommended to people 18 years of age and older."
665,"summarize: However, some associated allergic symptoms have been reported for both vaccines.","However, some associated allergic symptoms have been reported for both vaccines.","However, some allergic reactions have been reported for both vaccines."
666,"summarize: The COVID-19 vaccines can cause mild adverse effects after the first or second doses, including pain, redness or swelling at the site of vaccine shot, fever, fatigue, headache, muscle pain, nausea, vomiting, itching, chills, and joint pain, and can also rarely cause anaphylactic shock.","the COVID-19 vaccines can cause mild side effects after the first or second doses, including pain, redness or swelling at the site of the vaccine shot, fever, fatigue, headache, muscle pain, nausea, vomiting, itching, chills, and joint pain. They can also rarely cause anaphylactic shock.","The Covid-19 vaccines can cause mild side effects after the first and second shot, including pain, redness or swelling at the site of the vaccine shot, fever, fatigue, headache, muscle pain, nausea, vomiting, itching, chills, and joint pain. Rarely, it can cause anaphylactic shock which is a severe allergic reaction that begins very quickly and can be life-threatening."
667,"summarize: In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for Pfizer-BioNTech and Moderna COVID-19 vaccines, and in February 2021, FDA issued an EUA for the Janssen (Johnson & Johnson) COVID-19 vaccine.","In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for Pfizer-BioNTech and Moderna Covid-19 vaccines. In February 2021, FDA issued an EUA for the Janssen (Johnson & Johnson) Covid-19 vaccine.","In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (when unapproved medicines may be used) for Pfizer-BioNTech and Moderna Covid-19 vaccines (vaccines for the viral, respiratory disease). In February 2021, the FDA issued an emergency authorization for the Janssen (Johnson & Johnson) Covid-19 vaccine."
668,summarize: ACIP has met three times to review the data associated with these reports of serious adverse events and has comprehensively assessed the benefits and risks associated with receipt of these vaccines.,ACIP has met three times to review the data associated with these reports of serious adverse events and has evaluated the benefits and risks associated with receiving these vaccines.,"Data associated with these reports of serious side effects, in addition to the benefits and risks associated with vaccination, have been reviewed by the Advisory Committee on Immunization Practices (ACIP)."
669,"summarize: During the most recent meeting in July 2021, ACIP determined that, overall, the benefits of COVID-19 vaccination in preventing COVID-19 morbidity and mortality outweigh the risks for these rare serious adverse events in adults aged â18 years; this balance of benefits and risks varied by age and sex.","During the most recent meeting in July 2021, ACIP determined that, overall, the benefits of COVID-19 vaccination in preventing COVID-19 morbidity and death outweigh the risks for these rare serious adverse events in adults aged 18 years. This balance of benefits and risks varied by age and sex.","During the most recent meeting in July 2021, ACIP determined that, overall, the benefits of Covid-19 vaccination in preventing Covid-19 illness and death outweigh the risks for these rare serious side effects in adults aged 18 years or older. This balance of benefits and risks was different by age and sex."
670,summarize: ACIP continues to recommend COVID-19 vaccination in all persons aged â12 years.,ACIP continues to recommend COVID-19 vaccination in all persons aged 12 years and older.,ACIP continues to recommend Covid-19 vaccination in all people aged 12 years and older.
671,summarize: CDC and FDA continue to closely monitor reports of serious adverse events and will present any additional data to ACIP for consideration.,CDC and FDA continue to closely monitor reports of serious adverse events and will present any additional data to the ACIP for consideration.,CDC and FDA continue to closely monitor reports of serious side effects and will present any additional data to ACIP for review.
672,"summarize: The incidence of myocarditis in the week following a second dose of the vaccine was 5.07/100,000 people vaccinated.","the frequency of myocarditis in the week following a second dose of the vaccine was 5.07/100,000 people vaccinated.","The number of myocarditis in the week following a second dose of the vaccine is 5.07 out of 100,000 people vaccinated."
673,summarize: Clinicians should be aware of the possibility of myocarditis following Pfizer-BioNTech vaccination.,Clinicians should be aware of the possibility of myocarditis following Pfizer-BioNTech vaccination.,Medical providers should be aware of the possibility of myocarditis following Pfizer vaccination.
674,summarize: We surveyed all hospitalized military personnel in the Isareli Defense Forces during the period of the COVID-19 vaccination operation (12/28/2021-3/7/2021) for diagnosed myocarditis.,the study surveyed all hospitalized military personnel in the Isareli Defense Forces during the period of the COVID-19 vaccination operation (12/28/2021-3/7/2021) for diagnosed myocarditis.,We checked all hospitalized military people in the Isareli Defense Forces during the COVID-19 vaccination operation (12/28/2021-3/7/2021) for diagnosed myocarditis.
675,summarize: True incidence rates should be further investigated.,True incidence rates should be further investigated.,True frequency rates should be further investigated.
676,"summarize: The coronavirus disease 2019 (COVID-19) pandemic is a global crisis, with devastating health, business and social impacts.","the coronavirus disease 2019 (COVID-19) pandemic is a global crisis, with devastating health, business and social impacts.","The Covid-19 (a breathing-related, viral disease) pandemic is a global crisis, with devastating health, business and social impacts."
677,summarize: Current vaccines have shown efficacy with low risk of adverse effects.,Current vaccines have shown effectiveness with low risk of side effects.,"Current vaccines are shown to be effective with a low risk of unexpected serious side effects, also called adverse effects."
678,"summarize: However, COVID-19 vaccines have been related to a relatively small number of cases of heart inflammation, anaphylaxis (allergic reactions), and blood clots formation.","COVID-19 vaccines have been linked to a relatively small number of cases of heart inflammation, anaphylaxis (allergic reactions), and blood clots formation.","However, Covid-19 vaccines are related to a relatively small number of cases of heart inflammation that can cause damage to the heart muscle via redness and swelling from an infection, anaphylaxis (severe allergic reactions that may be life-threatening), and blood clot formation."
679,"summarize: Furthermore, It has been proposed that some new variants (e.g., Lambda and Delta) are proficient in escaping from the antiviral immunity elicited by vaccination.","It has been suggested that some new variants (e.g., Lambda and Delta) are capable of escaping from the antiviral immunity elicited by vaccination.","Also, it is proposed that some new variants (e.g., Lambda and Delta) are able to escape the immune response from vaccinations."
680,"summarize: Since the widespread implementation of vaccination campaigns, reports of ocular adverse effects after COVID-19 vaccinations have emerged.","Since the widespread use of vaccination campaigns, reports of eye-related side effects after COVID-19 vaccinations have emerged.","Since the start of major efforts to promote vaccination, reports of ocular adverse effects, which are side effects that impact the eyes or the face near the eyes, after Covid-19 vaccinations have emerged."
681,"summarize: Hence, we hypothesize that the human body's immune response to COVID-19 vaccinations may be involved in the pathogenesis of the ocular adverse effects post-COVID-19 vaccination.","Hence, we hypothesize that the human body's immune response to COVID-19 vaccinations may be involved in the development of the eye-related side effects post-COVID-19 vaccination.",Researchers have a theory that the body's immune response to Covid-19 vaccinations may be involved in the development of the ocular adverse effects that occur after receiving the Covid-19 vaccine.
682,summarize: Importance: Thrombosis with thrombocytopenia syndrome (TTS) has been reported after vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford-AstraZeneca) and Ad26.COV2.S (Janssen/Johnson & Johnson).,Thrombosis with thrombocytopenia syndrome (TTS) has been reported after vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 and Ad26.COV2.S (Janssen/Johnson & Johnson).,"Thrombosis with thrombocytopenia syndrome (TTS) is a rare condition of blood clots in the veins and arteries and low blood platelet counts. TTS has been reported in some people after they receive the AstraZeneca and Janssen/Johnson & Johnson vaccines. These vaccines provide immunity or resistance to the coronavirus, which causes COVID-19 (a viral, respiratory disease)."
683,"summarize: Design, setting, and participants: This cohort study used data from an international registry of consecutive patients with CVST within 28 days of SARS-CoV-2 vaccination included between March 29 and June 18, 2021, from 81 hospitals in 19 countries.","this study used data from an international registry of consecutive patients with CVST within 28 days of SARS-CoV-2 vaccination. The data were collected from 81 hospitals in 19 countries between March 29 and June 18, 2021.",This study uses data from patients who have CVST within 28 days of vaccination in March-June 2021. Data came from 81 hospitals in 19 countries.
684,"summarize: Clinical characteristics and mortality rate were described for adults with (1) CVST in the setting of SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia, (2) CVST after SARS-CoV-2 vaccination not fulling criteria for TTS, and (3) CVST unrelated to SARS-CoV-2 vaccination.","Symptoms and death rate were described for adults with (1) CVST in the setting of SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia, (2) CVST after SARS-CoV-2 vaccination not fulling criteria for TTS, and (3) CVST unrelated to SARS-CoV-2 vaccination.","Clinical traits and death are described for adults with (1) CVST in the case of coronavirus vaccine-induced immune thrombotic thrombocytopenia, (2) CVST after coronavirus vaccination not meeting all parts for TTS, and (3) CVST unrelated to the coronavirus vaccination."
685,"summarize: Results: Of 116 patients with postvaccination CVST, 78 (67.2%) had TTS, of whom 76 had been vaccinated with ChAdOx1 nCov-19; 38 (32.8%) had no indication of TTS.","Of 116 patients with postvaccination CVST, 78 (67.2%) had TTS, of whom 76 had been vaccinated with ChAdOx1 nCov-19; 38 (32.8%) had no indication of TTS.","Of the 116 patients with CVST after being vaccinated, 78 (67.2%) have TTS. Of those, 76 people had been vaccinated with AstraZeneca and 38 (32.8%) have no indication of TTS."
686,"summarize: In the current COVID-19 pandemic, the majority of the patients experienced serious pneumonia resulting from inflammation (Acute respiratory distress syndrome/ARDS).","In the current pandemic of COVID-19, the majority of patients had serious pneumonia resulting from inflammation (Acute respiratory distress syndrome/ARDS).","The majority of patients of COVID-19 (a viral, breathing-related or respiratory disease) have suffered from a condition known as acute respiratory distress syndrome (ARDS) that results from inflammation. It is similar to pneumonia (lung infection)."
687,"summarize: Senescent cells, which arise due to damage-associated signals, are apoptosis-resistant and can express a pro-inflammatory, tissue-destructive senescence-associated secretory phenotype (SASP).","Senescent cells, which arise due to damage-associated signals, are resistant to apoptosis and can express a pro-inflammatory, tissue-destructive senescence-associated secretory phenotype.","Senescent cells are cells that are no longer able to divide but are still active. Senescent cells become active when damage-associated signals are triggered. These cells are resistant to cell death. They can also release tissue damaging, senescence-associated secretory phenotype (SASP). This means these cells release high levels of inflammatory (infection-fighting) cells."
688,"summarize: Here, we show that SARS-CoV-2 induces senescence in human non-senescent cells and exacerbates the SASP in human senescent cells through Toll-like receptor-3 (TLR-3).",SARS-CoV-2 induces senescence in human non-senescent cells and exacerbates the SASP in human senescent cells through Toll-like receptor-3 (TLR-3).,"In this study, the authors demonstrate that COVID-19 causes cells to become senescent and overactive SASP in human senescent cells through a specific immune system receptor known as Toll-like receptor-3 (TLR-3). Immune receptors are structures that bind to the surface of a cell and causes a response."
689,"summarize: Notably, genetically or pharmacologically inhibiting TLR-3 prevented senescence induction and SASP amplification by SARS-CoV-2 or Spike pseudotyped virus.","Notably, genetically or pharmacologically inhibiting TLR-3 prevented senescence induction and SASP amplification by SARS-CoV-2 or Spike pseudotyped virus.",The blocking of TLR-3 prevented senescence causation and SASP amplification from occurring following COVID-19 or Spike pseudo-typed virus (a virus manipulated to not replicate).
690,"summarize: While an artificial TLR-3 agonist alone was not sufficient to induce senescence, it amplified the SASP in senescent human cells.","TLR-3 agonist alone was not enough to induce senescence, but it amplified the SASP in senescent human cells.","An artificial TLR-3 agonist, a substance that induces a specific response similar to the original, was not strong enough to induce or cause senescence. However, it did amplify SASP in senescent human cells."
691,"summarize: Moreover, by screening a natural microbial compound library containing 154 natural compounds, simvastatin was identified as a potent inhibitor of NP-induced endothelial activation.",simvastatin was identified as a potent inhibitor of NP-induced endothelial activation.,"Secondly, the authors identified a prescription medication, known as Simvastatin, that can reduce the identified endothelial activation."
692,summarize: These findings are well consistent with the results from clinical investigations showing broad endotheliitis and organ injury in severe COVID-19 patients.,These findings are well consistent with the results from clinical studies showing broad endotheliitis and organ injury in severe COVID-19 patients.,These scientific findings match with results from clinical research (research within patients). Clinical research has shown broad endothelial cell inflammation and organ injury within COVID-19 patients.
693,"summarize: IMPORTANCE Coronavirus disease 2019 (COVID-19), caused by the betacoronavirus SARS-CoV-2, is a worldwide challenge for health-care systems.","COVID-19, caused by the betacoronavirus SARS-CoV-2, is a worldwide challenge for health-care systems.","COVID-19, caused by a coronavirus, is a worldwide challenge for health-care."
694,"summarize: In this study, we screened the SARS-CoV-2 viral proteins that potently activate human endothelial cells and found that nucleocapsid protein (NP) significantly activated human endothelial cells through TLR2/NF-ÎoB and MAPK signaling pathways.","In this study, we screened the SARS-CoV-2 viral proteins that potently activate human endothelial cells and found that nucleocapsid protein (NP) significantly activated human endothelial cells through TLR2/NF-ÎoB and MAPK signaling pathways.","In this study, we tested COVID-19 virus proteins that activate these blood-vessel lining cells and found that viral proteins activate these cells through phosphate-related pathways."
695,"summarize: The precise immune response profile is likely, therefore, to determine and predict patient outcomes and also represents a target for intervention.",The precise immune response profile is likely to determine and predict patient outcomes and also represents a target for treatment.,"Each person's unique immune response will likely determine and predict how a patient will react to infection. Therefore, each person's immune system represents a target for intervention to prevent harmful side effects."
696,summarize: Manipulating T cell responses by targeting the PI3K/Akt/mTOR pathway could provide the means to control the immune response in COVID-19 patients.,Manipulating T cell responses by targeting the PI3K/Akt/mTOR pathway could provide the means to control the immune response in COVID-19 patients.,"Manipulating T cell responses could provide the means to control the immune response in patients with COVID-19 (a viral, breathing-related disorder)."
697,"summarize: Additionally, immune dysregulation can be addressed by enhancing immune suppressor functions by targeting downstream mTOR, an important intracellular modulator of cellular metabolism.","Moreover, immune dysregulation can be addressed by enhancing immune suppressor functions by targeting downstream mTOR, an important intracellular modulator of cellular metabolism.","Additionally, immune dysregulation or errors can be addressed by enhancing immune suppressor functions by targeting molecules that control cell metabolism."
698,summarize: Some COVID-19 patients suffer complications from anti-viral immune responses which can lead to both a dangerous cytokine storm and development of blood-borne factors that render severe thrombotic events more likely.,Some COVID-19 patients have complications from immune responses to the virus. This can lead to a dangerous cytokine storm and development of blood-borne factors that make severe thrombotic events more likely.,Some patients of COVID-19 (a respiratory viral illness) suffer issues from anti-viral immune responses. These can lead to a dangerous inflammatory molecule overproduction and blood-borne substances that increase blood clotting risk.
699,"summarize: The precise immune response profile is likely, therefore, to determine and predict patient outcomes and also represents a target for intervention.",The precise immune response profile is likely to determine and predict patient outcomes and also represents a target for treatment.,The exact immune response type may determine and predict patient outcomes. It may also be a target for treatment.
700,summarize: Anti-viral T cell exhaustion in the early stages is associated with disease progression.,Anti-viral T cell exhaustion in the early stages is associated with disease progression.,Elimination of specific anti-viral immune cells called T cells in the early stages is linked with disease progression.
701,summarize: The ultimate goal is to identify targets that can quickly control the immune response in COVID-19 patients to improve patient outcome.,"Ultimately, the goal is to identify targets that can quickly control the immune response in COVID-19 patients to improve patient outcome.",The end goal is to identify targets that can quickly control the immune response in COVID-19 patients to improve patient outcome.
702,summarize: Targeting different levels of the PI3K/Akt/mTOR signalling pathway could potentially achieve this during each stage of the disease.,Targeting different levels of the PI3K/Akt/mTOR signaling pathway could possibly achieve this during each stage of the disease.,Targeting different parts of a specific cellular pathway could achieve this immune response control at each stage of the disease.
703,summarize: The acute and long-term effects of SARS-CoV-2 on the nervous system pose major public health challenges.,the short- and long-term effects of SARS-CoV-2 on the nervous system pose major public health challenges.,The immediate and long-term effects of SARS-CoV-2 on the nervous system present major public health challenges.
704,"summarize: The possible mechanisms of SARS-CoV-2 injury to the central nervous system include: 1) direct injury of nerve cells, 2) activation of the immune system and inflammatory cytokines caused by systemic infection, 3) a high affinity of the SARS-CoV-2 spike glycoprotein for the angiotensin-converting enzyme ACE2, 4) cerebrovascular disease caused by hypoxia and coagulation dysfunction, and 5) a systemic inflammatory response that promotes cognitive impairment and neurodegenerative diseases.","the possible mechanisms of SARS-CoV-2 injury to the central nervous system include: 1) direct injury of nerve cells, 2) activation of the immune system and inflammatory cytokines caused by infection, 3) a high affinity of the SARS-CoV-2 spike glycoprotein for the angiotensin-converting enzyme ACE2, 4) cerebrovascular disease caused by hypoxia and coagulation dysfunction, and 5) a systemic inflammatory response that promotes cognitive impairment and neurodegenerative diseases.","Some ways SARS-CoV-2 may injure the brain and spinal cord are: 1) directly harming nerve cells, 2) activating the immune system and inflammatory molecules from full-body infection, 3) binding of the virus to a specific molecule, 4) damaged blood flow in the brain due to reduced oxygen and blood clotting, and 5) full-body inflammation leading to cognitive damage and harmful nervous system diseases."
705,"summarize: In order to elucidate its functions, interaction partners of the SARS-CoV-2 N protein in human cells were identified via affinity purification and mass spectrometry.","In order to elucidate its functions, interactions of the SARS-CoV-2 N protein in human cells were identified.","In order to better understand how the virus protein works, proteins within human cells that interact with the COVID-19 protein were identified."
706,"summarize: This study comprehensively profiled the viral-host interactome of the SARS-CoV-2 N protein in human cells, and the findings provide the basis for further studies on the pathogenesis and antiviral strategies for this emerging infection.",this study detailed the viral-host interactionome of the SARS-CoV-2 N protein in human cells. The findings provide the basis for further studies on the development and antiviral strategies for this emerging infection.,This study thoroughly characterized how the viral protein and the host (or human) protein interact when a person is infected. These findings can provide a foundation for future studies on the development and treatment options for COVID-19.
707,summarize: Drugs acting against ssRNA(+) viral replication for cardiac cells can be effective.,drugs acting against ssRNA(+) viral replication for heart cells can be effective.,Drugs that prevent the creation of RNA for viral replication could be helpful.
708,"summarize: (5) Programmed cell death: SARS-CoV-2 inhibits programmed cell death in early stages and induces apoptosis, necroptosis, and pyroptosis in later stages.","(5) Programmed cell death: SARS-CoV-2 inhibits programmed cell death in early stages and causes apoptosis, necroptosis, and pyroptosis in later stages.","Fifth, COVID-19 prevents cells from dying in the early stages of infection but induces cell death later, once it has replicated and moved to other cells."
709,summarize: The main points are: (1) Viral entry: SARS-CoV-2 uses specific receptors and proteases for docking and priming in cardiac cells.,The main points are: (1) Viral entry: SARS-CoV-2 uses specific receptors and proteases for docking and priming in cardiac cells.,The main points are: (1) Viral entry: SARS-CoV-2 uses specific cell parts to attach to heart cells.
710,"summarize: Thus, different receptors or protease inhibitors might be effective in SARS-CoV-2-infected cardiac cells.","Hence, different receptors or protease inhibitors might be effective in SARS-CoV-2-infected cardiac cells.","Thus, different blockers of specific cell parts may help with SARS-CoV-2-infected heart cells."
711,summarize: (2) Viral replication: SARS-CoV-2 uses RNA-dependent RNA polymerase for replication.,(2) Viral replication: SARS-CoV-2 uses RNA-dependent RNA polymerase for replication.,(2) Viral replication: SARS-CoV-2 uses a specific molecule for replication.
712,summarize: (3) Autophagy and double-membrane vesicles: SARS-CoV-2 manipulates autophagy to inhibit viral clearance and promote SARS-CoV-2 replication by creating double-membrane vesicles as replication sites.,(3) Autophagy and double-membrane vesicles: SARS-CoV-2 manipulates autophagy to inhibit viral clearance and promote replication by creating double-membrane vesicles as replication sites.,(3) Cell degradation and transport molecules: SARS-COV-2 alters cell degradation to block virus removal and promote virus replication by making transport molecules as replication sites.
713,summarize: (4) Immune response: Host immune response is manipulated to evade host cell attacks against SARS-CoV-2 and increased inflammation by dysregulating immune cells.,(4) Immune response: Host immune response is manipulated to evade host cell attacks against SARS-CoV-2 and increased inflammation by dysregulating immune cells.,(4) Immune response: Patient immune response is altered to evade paitent cell attacks against SARS-CoV-2 and increased inflammation by impairing immune cells.
714,summarize: The coronavirus disease 2019 (COVID-19) pandemic has raised concerns about the detrimental effects of antibodies.,The coronavirus disease 2019 (COVID-19) pandemic has raised concerns about the harmful effects of antibodies.,"The pandemic of COVID-19 (a viral, breathing-related disease) has raised concerns about the harmful effects antibodies can have. Antibodies are proteins used by the immune system to identify and neutralize viruses."
715,"summarize: Although ADE of infection was observed in monocyte-derived macrophages infected with SARS-CoV-2, including its variants, proinflammatory cytokine/chemokine expression was not upregulated in macrophages.","ADE of infection was observed in monocyte-derived macrophages infected with SARS-CoV-2, including its variants. However, proinflammatory cytokine/chemokine expression was not upregulated in macrophages.","Although ADE of infection was found in macrophages (a white blood cell) infected with COVID-19, and its variants, proteins that increase inflammation were not upregulated or increased."
716,"summarize: Here, using convalescent-phase plasma from COVID-19 patients, we found that two types of FcÎ3Rs, FcÎ3RIIA and FcÎ3RIIIA, mediate ADE of SARS-CoV-2 infection.","We found that two types of FcÎ3Rs, FcÎ3RIIA and FcÎ3RIIIA, mediate ADE of SARS-CoV-2 infection.","In this study, using plasma or blood from COVID-19 patients, we found that two types of FcÎ3 receptors mediate ADE of COVID-19 infection."
717,summarize: Antibody-dependent enhancement (ADE) of infection is one of the biggest concerns in terms of not only the antibody reaction to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon reinfection with the virus but also the reaction to COVID-19 vaccines.,ADE is one of the biggest concerns in terms of not only the antibody reaction to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon returning with the virus but also the reaction to COVID-19 vaccines.,"Antibody-dependent enhancement (ADE) of infection is a big concern because of the antibody reaction to severe acute respiratory syndrome coronavirus (SARS-CoV-2), which causes COVID-19, upon reinfection and the reaction to COVID-19 vaccines."
718,"summarize: In this study, we evaluated ADE of infection by using COVID-19 convalescent-phase plasma and BHK cells expressing human FcÎ3 receptors (FcÎ3Rs).","In this study, we evaluated ADE of infection by using COVID-19 convalescent-phase plasma and BHK cells expressing human FcÎ3 receptors (FcÎ3Rs).",nan
719,"summarize: Conclusively, our results suggest that genomic RNA absorption to host miRNAs may be a vital approach by which SARS-CoV-2 disturbs the host immune system and infects host cells.","Ultimately, our results suggest that genomic RNA absorption to host miRNAs may be a vital approach by which SARS-CoV-2 disturbs the host immune system and infects host cells.",These results suggest that the absorption of viral RNA to host miRNAs may be a way that COVID-19 disturbs the host immune system and infects host cells.
720,summarize: The role nutrition plays in supporting the immune system is well-established.,The role nutrition plays in supporting the immune system is well-established.,The role nutrition plays in supporting the immune or infection-fighting system is well-documented.
721,"summarize: Against this background the following conclusions are made: (1) supplementation with the above micronutrients and omega-3 fatty acids is a safe, effective, and low-cost strategy to help support optimal immune function; (2) supplementation above the Recommended Dietary Allowance (RDA), but within recommended upper safety limits, for specific nutrients such as vitamins C and D is warranted; and (3) public health officials are encouraged to include nutritional strategies in their recommendations to improve public health.","Against this background, the following conclusions are made: (1) supplementation with the above micronutrients and omega-3 fatty acids is a safe, effective, and low-cost strategy to help support optimal immune function; (2) supplementation above the Recommended Dietary Allowance (RDA), but within recommended safety limits, for specific nutrients such as vitamins C and D is warranted; and (3) public health officials are encouraged to include nutritional strategies in their recommendations to improve public health.","Based on this available information, the following conclusions are made: 1) using supplements to add vitamins, minerals, and omega-3 fatty acids is a safe, effective, and inexpensive way to help support immune system functions; 2) supplements above the recommended amount, but still within safety limits, for certain nutrients may be allowed; and 3) public health officials are encouraged to include nutrition plans in their recommendations to improve public health."
722,"summarize: Results: There were a few studies providing direct evidence on associations between zinc, selenium, and vitamin D, and COVID-19.","There were a few studies providing direct evidence on links between zinc, selenium, and vitamin D, and COVID-19.","There are a few studies that show direct evidence on associations between zinc, selenium, and vitamin D, and Covid-19."
723,summarize: Conclusion: We recommended initiation of adequate supplementation in high-risk areas and/or soon after the time of suspected infection with SARS-CoV-2.,Conclusion: We recommend starting adequate supplementation in high-risk areas and/or soon after the time of suspected infection with SARS-CoV-2.,Researchers of this paper recommend giving supplements to high-risk areas and/or soon after suspected infection with coronavirus.
724,summarize: This review focused on the use of plant based foods for enhancing the immunity of all aged groups against COVID-19.,This review focused on the use of plant based foods for enhancing the immunity of all aged groups against COVID-19.,"This review focuses on the use of plant based foods for increasing the immunity of all age groups against Covid-19 (a viral, breathing-related illness)."
725,"summarize: By the use of plenty of water, minerals like magnesium and Zinc, micronutrients, herbs, food rich in vitamins C, D & E and better life style one can promote the health and can overcome this infection.","Using lots of water, minerals like magnesium and zinc, micronutrients, herbs, food rich in vitamins C, D & E and better life style one can promote the health and can overcome this infection.","Drinking plenty of water, consuming minerals like magnesium and Zinc, vitamins, herbs, food with a lot of vitamins C, D & E, and a healthy life style can promote health and can fight this infection."
726,"summarize: In this report, an update on the evidence of the contribution of nutritional factors as immune-enhancing aspects, factors that could reduce their bioavailability, and the role of the optimal status of these nutrients within the COVID-19 pandemic context was carried out.","In this report, an update on the evidence of the contribution of nutritional factors as immune-enhancing aspects, factors that could reduce their bioavailability, and the role of the optimal status of these nutrients within the COVID-19 pandemic context was carried out.","In this report is an update on the evidence of 1) how nutrition impacts the immune system, 2) what things might reduce how long nutrients stay in the body, and 3) the role of the healthy balance of these nutrients during the Covid-19 pandemic."
727,"summarize: Second, a compilation from published sources and an analysis of nutritional data from 10 European countries was performed, and the relationship between country nutritional status and epidemiological COVID-19 data (available in the Worldometers database) was evaluated following an ecological study design.","Second, a compilation from published sources and an analysis of nutrition data from 10 European countries was performed. The relationship between country nutritional status and epidemiological COVID-19 data (available in the Worldometers database) was evaluated following an ecological study design.","Second, nutrition data from 10 European countries are compiled and analyzed, and the relationship between country nutrition and Covid-19 data is evaluated."
728,"summarize: Results from the review approach show the importance of maintaining a correct nutritional status of these 10 nutrients analyzed for the health of the immune system, highlighting the importance of Vitamin D and iron in the context of COVID-19.","the results show the importance of maintaining a correct nutritional status of these 10 nutrients for the health of the immune system, highlighting the importance of Vitamin D and iron in the context of COVID-19.",Results from the review show the importance of keeping a correct nutritional balance of these 10 nutrients for the health of the immune system and highlights the importance of Vitamin D and iron in the context of Covid-19.
729,"summarize: Viral infections are a leading cause of morbidity and mortality worldwide, and the importance of public health practices including handwashing and vaccinations in reducing their spread is well established.","Viral infections are a leading cause of illness and death worldwide, and the importance of public health practices including handwashing and vaccinations in reducing their spread is well established.","Virus infections are a leading cause of illness and death across the world, and the importance of practices such as handwashing and vaccination in reducing the spread of viruses is well known."
730,"summarize: The main aim of this manuscript is to discuss of the potential role of micronutrients supplementation in supporting immunity, particularly against respiratory virus infections.","The main aim of this paper is to discuss the potential role of micronutrients supplementation in supporting immunity, particularly against respiratory virus infections.","The aim of this paper is to discuss how adding vitamins and minerals (also called micronutrients) to the body might support immunity, especially immunity against viruses that impact the lungs."
731,summarize: Supplementation should be in addition to a healthy diet and fall within recommended upper safety limits set by scientific expert bodies.,Supplementation should be in addition to a healthy diet and fall within recommended safety limits set by scientific experts.,Supplements should be an addition to healthy diets and should be taken at the safe amounts recommended by experts.
732,"summarize: Therefore, implementing an optimal nutrition, with micronutrients and omega-3 fatty acids supplementation, might be a cost-effective, underestimated strategy to help reduce the burden of infectious diseases worldwide, including coronavirus disease 2019 (COVID-19).","Implementing an optimal nutrition, with micronutrients and omega-3 fatty acids supplementation, might be a cost-effective, underestimated strategy to help reduce the burden of infectious diseases worldwide, including coronavirus disease 2019 (COVID-19).","Developing a good nutrition plan, with micronutrients and omega-3 fatty acids supplements, might be a cost-effective way to help reduce the effects of infectious diseases around the world, including Covid-19 (a viral, respiratory disease)."
733,"summarize: Viral infections are a leading cause of morbidity and mortality worldwide, and the importance of public health practices including handwashing and vaccinations in reducing their spread is well established.","Viral infections are a leading cause of illness and death worldwide, and the importance of public health practices including handwashing and vaccinations in reducing their spread is well established.",Viral infections are a leading cause of illness and death worldwide. The importance of public health practices like handwashing and vaccinations in reducing their spread is well supported.
734,"summarize: Several vitamins and trace elements play an important role in supporting the cells of the immune system, thus increasing the resistance to infections.","Several vitamins and trace elements play an important role in supporting the cells of the immune system, thus increasing the resistance to infections.","Many vitamins and trace elements or minerals help support immune cells, thus increasing resistance to infections."
735,"summarize: The main aim of this manuscript is to discuss of the potential role of micronutrients supplementation in supporting immunity, particularly against respiratory virus infections.","The main aim of this paper is to discuss the potential role of micronutrients supplementation in supporting immunity, particularly against respiratory virus infections.","This manuscript discusses the possible role of micronutrients supplementation to support immunity, especially against breathing-related virus infections."
736,summarize: These can be received from either nutrition rich food sources or from vitamin supplements.,These can come from nutrient-rich foods or vitamin supplements.,These can be received from either foods that have a lot of healthy nutrients or from vitamin supplements.
737,"summarize: Furthermore, these macromolecules might have roles to play in boosting the immune response, in the healing process and the recovery time.","Moreover, these macromolecules might have roles to play in boosting the immune response, in the healing process and the recovery time.","Also, these tiny molecules might have roles to play in boosting the immune response as well as the healing process and recovery time."
738,summarize: L. plantarum MPL16 induced these beneficial effects more efficiently than the CRL1506 strain.,L. plantarum MPL16 induced these beneficial effects more efficiently than the CRL1506 strain.,The lactobacilli MPL16 bacteria started these beneficial effects more efficiently than the CRL1506.
739,summarize: Further mechanistic studies and in vivo experiments in animal models of SARS-CoV-2 infection are necessary to identify specific strains of beneficial immunobiotic lactobacilli like L. plantarum MPL16 or CRL1506 for the prevention or treatment of the COVID-19.,Detailed studies and experiments in animal models of SARS-CoV-2 infection are needed to identify specific strains of beneficial immunebiotic lactobacilli like L. plantarum MPL16 or CRL1506 for the prevention or treatment of the COVID-19 infection.,Further studies and experiments with animals with the coronavirus are necessary to identify specific types of lactobacilli from plants for the prevention or treatment of Covid-19.
740,"summarize: Unfortunately, as in the case of drugs, studies in humans have not confirmed any specific food components to be effective in the case of COVID-19.","Unfortunately, as in the case of drugs, studies in humans have not confirmed any specific food components to be effective in the case of COVID-19.","Unfortunately, studies in humans have not confirmed any specific foods to be effective in the case of Covid-19."
741,"summarize: Many products consumed by people and used in traditional medicine have been shown to contain substances with anti-inflammatory, antibacterial, and antiviral properties, e.g., vitamin C in the fruit or juice of raspberries or elderberries, hesperidin in St. Johnâs wort, kaempferol and methylglyoxal in honey, allicin in garlic and onion, gingerols in ginger, curcumin in turmeric, and piperine in black pepper.","many products consumed by people and used in traditional medicine have been shown to contain substances with anti-inflammatory, antibacterial, and antiviral properties.","Many products consumed by people and used in traditional medicine are shown to contain substances with properties described as anti-inflammatories that can relieve pain or swelling, antibacterial to prevent the spread of bacteria, and antiviral to fight viruses. Examples include vitamin C from fruits and substances in honey, garlic, onions, ginger, turmeric, and black pepper."
742,"summarize: Unfortunately, as in the case of drugs, studies in humans have not confirmed any specific food components to be effective in the case of COVID-19.","Unfortunately, as in the case of drugs, studies in humans have not confirmed any specific food components to be effective in the case of COVID-19.","Unfortunately, as with drugs, human studies have not confirmed specific foods to be effective with COVID-19."
743,"summarize: Numerous clinical studies have shown that nutraceuticals can beneficially stimulate the immune response in patients with various diseases, such as cancer or AIDS, and in healthy people at risk of viral infections.","Numerous clinical studies have shown that nutraceuticals can help stimulate the immune response in patients with various diseases, such as cancer or AIDS, and in healthy people at risk of viral infections.","Many studies show that certain foods used as medicine can beneficially activate the immune response in patients with many diseases, like cancer or AIDS (a disease from an immunodeficiency virus), and healthy people at risk of viral infections."
744,"summarize: Many products consumed by people and used in traditional medicine have been shown to contain substances with anti-inflammatory, antibacterial, and antiviral properties, e.g., vitamin C in the fruit or juice of raspberries or elderberries, hesperidin in St. Johnâs wort, kaempferol and methylglyoxal in honey, allicin in garlic and onion, gingerols in ginger, curcumin in turmeric, and piperine in black pepper.","many products consumed by people and used in traditional medicine have been shown to contain substances with anti-inflammatory, antibacterial, and antiviral properties.","Many products consumed by people and used in traditional medicine have substances with anti-inflammatory, antibacterial, and antiviral properties like vitamins and other plant chemicals."
745,"summarize: SARS-CoV-2 infection is associated with diverse clinical manifestations, immune dysfunction, and gut microbiota alterations.","SARS-CoV-2 infection is associated with various symptoms, immune dysfunction, and gut microbiota changes.","Coronavirus infection (a viral, respiratory disease) is associated with different types of symptoms, as well as damage to the immune system and changes in gut microbiota, which are important microorganisms in the digestive system that process food and help the body use nutrients."
746,"summarize: In the COVID-19 pandemic, besides the development of pharmacological therapies, a healthy balanced diet, rich with food-derived antioxidants, may be a useful strategy.","In the COVID-19 pandemic, besides developing drugs, a healthy balanced diet, rich with food-derived antioxidants, may be a useful strategy.","In the Covid-19 pandemic, besides developing medicines and vaccines, a healthy diet with antioxidants (vitamins, minerals, and other nutrients that protect and repair cells) may be a useful option."
747,"summarize: Our review suggests the need for timely, parallel testing of different samples, including, for example, fecal specimens, from COVID-19 patients before and after they are discharged from hospitals.","Using different samples from COVID-19 patients before and after they are released from hospitals suggests the need for timely, parallel testing of different samples.","The review suggests the need for testing different samples at the same time, including, for example, fecal (poop) samples, from Covid-19 patients before and after they are sent home from hospitals."
748,"summarize: For Coronavirus Disease 2019 (COVID-19), the relationship between nasopharyngeal (NP) swab positivity, the development of antibodies against COVID-19, and clinical history are unclear.","Coronavirus Disease 2019 (COVID-19), the relationship between nasopharyngeal (NP) swab positivity, the development of antibodies against COVID-19, and clinical history is unclear.","For Covid-19 (a viral, respiratory illness), the relationship between a positive (or virus-detected) nasal swab where a sample is taken from the back of the nose and throat, the development of antibodies (proteins in the body) that fight Covid-19, and the clinical history is unclear."
749,"summarize: Conclusions: SARS-CoV-2 nucleic acid is detectable long after the resolution of symptoms in a significant percentage of previously diagnosed individuals, which is important to consider when interpreting PCR swab results.","SARS-CoV-2 nucleic acid is detectable long after symptoms resolve in a large percentage of previously diagnosed individuals, which is important to consider when interpreting PCR results.","In conclusion, traces of genetic material from coronavirus can be found long after symptoms end in a significant percentage of people who have been diagnosed, which is important to remember when reading swab test results."
750,summarize: Background: Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) collection began in two Brazilian hospitals for treatment of severe/critical patients.,Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) collection began in two Brazilian hospitals for treatment of severe/critical patients.,"Collection of blood plasma from people who have recovered from the viral, respiratory illness Covid-19, also called convalescent plasma, began in two hospitals in Brazil for treatment of severe patients."
751,"summarize: Methods and materials: Mild/moderate COVID-19 convalescents were selected as CCP donors after reverse transcription polymerase chain reaction (RT-PCR) confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and absence of symptoms for â14 days plus (a) age (18-60 years), body weight greater than 55 kg; (b) immunohematological studies; (c) no infectious markers of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human T-lymphotropic virus-1/2, Chagas and syphilis infection; (d) no HLA antibodies (multiparous); (e) second RT-PCR (nasopharyngeal swab and/or blood) negativity; (f) virus neutralization test (cytopathic effect-based virus neutralization test neutralizing antibody) and anti-nucleocapsid protein SARS-CoV-2 IgM, IgG, and IgA enzyme-linked immunosorbent assays.","COVID-19 convalescents were selected as CCP donors after detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and absence of symptoms for â14 days plus age (18-60 years), body weight greater than 55 kg, and blood tests. There are no infectious markers of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human T-lymphotropic virus-1/2, Chagas and syphilis infection.",People recovering from mild or moderate Covid-19 infection are selected as donors for blood plasma if they have had no symptoms for at least 14 days. Additional tests are done for other infections such as hepatitis and HIV and for antibodies (or infection-fighting proteins) for Covid-19.
752,summarize: Correlation between IgG signal/cutoff of 5.0 or greater and neutralizing antibody of 160 or greater was 82.4%.,IgG signal/cutoff of 5.0 or greater and neutralizing antibody of 160 or greater was 82.4%.,nan
753,summarize: Many studies have shown that re-positive tests for SARS-CoV-2 by RT-PCR in recovered COVID-19 patients are very common.,Many studies have shown that re-positive tests for SARS-CoV-2 by RT-PCR in recovered COVID-19 patients are very common.,"Many studies have shown that testing positive again for (or having) coronavirus in recovered Covid-19 patients (patients recovered from the serious viral, lung infection of Covid-19) is very common."
754,summarize: Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody tests beyond 35 days after the clinical onset of COVID-19 is insufficient.,COVID-19 is a viral breathing-related disease.,There is not enough information on how well tests for coronavirus (which causes Covid-19 - a breathing-related illness) can correctly diagnose a positive case (which signals presence of the virus) beyond 35 days after the start of Covid-19.
755,summarize: We aimed to describe positivity rate of SARS-CoV-2 assays employing three different measurement principles over a prolonged period.,"Using three different measurement methods over a long period, we measured the positiveness rate of SARS-CoV-2 assays.","This study aims to describe the percentage of positive coronavirus tests out of all tests, also called positivity rate, using three different measurements over a long period of time."
756,summarize: Heat maps were constructed to graphically illustrate operational test characteristics.,Heat maps were created to graphically illustrate test characteristics.,Maps are created to show how the different tests operate.
757,"summarize: During a follow-up period of more than 9 weeks, chemiluminescence assays and one ELISA IgG test showed stable positivity rates after the third week.","During a follow-up period of more than 9 weeks, chemiluminescence assays and one ELISA IgG test showed stable positivity rates after the third week.","During a follow-up period of more than 9 weeks, a type of ECLIA and one ELISA antibody test showed stable positivity rates after the third week."
758,"summarize: When interpreting results from SARS-CoV-2 tests, the pretest probability, time of blood draw, and assay characteristics must be carefully considered.","When interpreting results from SARS-CoV-2 tests, the pretest probability, time of blood draw, and assay characteristics must be carefully considered.","When reading results from coronavirus tests, the estimate of the chance of having the disease before confirming with a test, the time that blood is drawn, and test characteristics must be considered."
759,summarize: Methods: We used generalised additive mixed models to analyse publicly available data from patients who received multiple RT-PCR tests and were identified as SARS-CoV-2 positive at least once.,Methods: We used generalised additive mixed models to analyze publicly available data from patients who received multiple RT-PCR tests and were identified as SARS-CoV-2 positive at least once.,Publicly available data from patients who received several RT-PCR tests and identified as positive for coronavirus are analyzed.
760,summarize: Conclusion: NP samples are more sensitive than OP samples.,NP samples are more sensitive than OP samples.,"In conclusion, the samples from the back of the nose called nasopharyngeal are more sensitive than the samples taken in the middle of the throat."
761,"summarize: Results: The probability of a positive test decreased with time since symptom onset, with oropharyngeal (OP) samples less likely to yield a positive result than nasopharyngeal (NP) samples.","the probability of a positive test decreased with time since symptoms started, with oropharyngeal (OP) samples less likely to yield a positive result than nasopharyngeal (NP) samples.","The chance of detecting the target decreased with time since symptoms. Also, oropharyngeal (OP) or mouth samples are less likely to detect the target than nasopharyngeal (NP) or nasal samples."
762,"summarize: Currently, PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in fecal sample is not routinely performed.","Currently, PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a viral breathing-related disease, in fecal sample is not routinely performed.","Currently, testing of for coronavirus using a fecal or poop sample is not usually done."
763,"summarize: Conclusions: Based on the experience from the 2003 SARS epidemic, we recommend that fecal RNA testing of SARS-CoV-2 should be incorporated into the discharge criteria to minimize the risk of transmission from the gastrointestinal tract.","Conclusions: Based on the experience from the 2003 SARS epidemic, we recommend that fecal RNA testing of SARS-CoV-2 should be included in the discharge criteria to minimize the risk of transmission from the stomach.","In conclusion, based on the experience from previous epidemics of lung infections, researchers recommend that testing fecal samples for coronavirus should be included into the standard for sending people home to decrease the risk of transmission (or spread) from the digestive system."
764,"summarize: Currently, PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in fecal sample is not routinely performed.","Currently, PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a viral breathing-related disease, in fecal sample is not routinely performed.","Currently, testing of severe acute respiratory syndrome cornoavirus 2 (SARS-CoV-2), which causes COVID-19, in poop samples in not regularly performed."
765,"summarize: Conclusions: Based on the experience from the 2003 SARS epidemic, we recommend that fecal RNA testing of SARS-CoV-2 should be incorporated into the discharge criteria to minimize the risk of transmission from the gastrointestinal tract.","Conclusions: Based on the experience from the 2003 SARS epidemic, we recommend that fecal RNA testing of SARS-CoV-2 should be included in the discharge criteria to minimize the risk of transmission from the stomach.","Based on the 2003 SARS virus epidemic, we recommend that poop testing for SARS-CoV-2 should be added to the hospital release criteria to minimize risk of spread from the digestive tract."
766,"summarize: However, the association of viral load and severity of the disease is not yet resolved.",The link between viral load and severity of the disease is not yet resolved.,"However, the association of the amount of virus and the severity of the disease is not yet understood."
767,summarize: Nasopharyngeal samples from 458 patients were tested by RT-PCR for SARS-CoV-2 diagnosis.,nasopharyngeal samples from 458 patients were tested for SARS-CoV-2 diagnosis.,Samples from the back of the nose from 458 patients are tested by RT-PCR for coronavirus.
768,"summarize: Cases between 10 and 49 years old mostly showed low and moderate viral load during the first 2 days postinfection (range, 0.03 to 17.24; -1.50 to 1.24).",Those between 10 and 49 years old mostly showed low and moderate viral load during the first 2 days after infection.,Cases between 10 and 49 years old mostly showed low and moderate viral load during the first 2 days after infection.
769,summarize: Viral load by real-time RT-PCR has been suggested as a biomarker of the SARS-CoV-2 infection.,Viral load by real-time RT-PCR has been suggested as a biomarker of the SARS-CoV-2 infection.,Viral amount by real-time RT-PCR may be a signal of the SARS-CoV-2 infection.
770,summarize: Nasopharyngeal samples from 458 patients were tested by RT-PCR for SARS-CoV-2 diagnosis.,nasopharyngeal samples from 458 patients were tested for SARS-CoV-2 diagnosis.,Nasal samples from 458 patients were tested by RT-PCR for SARS-CoV-2.
771,summarize: Relative quantitation was made by the comparative threshold cycle (ÎÎCt ) formula between ORF1ab viral and RNase P housekeeping genes.,ÎÎCt is a measure of viral activity.,nan
772,"summarize: Hypertension (18.2%), neurological diseases (15.1%), and asthma and hypothyroidism (12.1%) were most frequent comorbidities.","Hypertension (18.2%), neurological diseases (15.1%), and asthma and hypothyroidism (12.1%) were most frequent comorbidities.","High blood pressure (18.2%), brain-related diseases (15.1%), and asthma and reduced thyroid function, which affects metabolism, (12.1%) were the most frequent associated conditions."
773,summarize: Children under 10 years old have a high viral load (313.84; 2.50) in the first 2 days postinfection with a sharp decline thereafter.,children under 10 years old have a high viral load in the first 2 days after infection with a sharp decline thereafter.,Children under 10 years have a high virus amount in the first 2 days after infection with a sharp decline after.
774,summarize: SARS-CoV-2 IgM/IgG antibodies were detected via serum chemiluminescence assay.,SARS-CoV-2 IgM/IgG antibodies were detected via a blood chemiluminescence test.,nan
775,"summarize: The IgG and IgM response rates were 19/37 (51.4%) and 23/37 (62.6%) among the 29 confirmed patients and 8 asymptomatic carriers, respectively, within 66 days from symptom or detection onset.","IgG and IgM response rates were 19/37 (51.4%) and 23/37 (62.6%) among the 29 confirmed patients and 8 carriers without symptoms, respectively, within 66 days from symptom or detection onset.",Antibodies to fight the viruses responded in 51.4% of confirmed patients and 62.6% among asymptomatic people within 66 days from symptom starting.
776,summarize: Shorter viral habitation time (1-8 days) was observed in the oropharyngeal site and intestinal tract of asymptomatic carriers.,shorter viral habitation time (1-8 days) was observed in the oropharyngeal site and intestinal tract of carriers without symptoms.,Shorter virus lifetime (1-8 days) was seen in the throat near the mount and digestive tract of carriers without symptoms.
777,"summarize: Thus, independent validations using an unbiased sample selection are required for meaningful serology data interpretation.","Hence, independent validations using an unbiased sample selection are required for meaningful serology data interpretation.","Therefore, confirming the performance of the test using an unbiased sample is required in order to understand and describe the antibody data."
778,"summarize: High specificity was found in all evaluated assays, but the sensitivity was variable depending on the time PSO, severity of disease, detection method and targeted antigen.","high specificity was found in all tested assays, but the sensitivity was variable depending on the time PSO, severity of disease, detection method and targeted antigen.","The ability to correctly have a negative (or no virus) test among negative people is found in all evaluated blood tests, but the ability to correctly diagnose a true positive varies depending on the time after the start of symptoms and the type of test."
779,"summarize: This article addresses the prevalence, risk factors, and prevention of TD; assessment strategies including diagnostic criteria and rating scales; and evidence for TD treatments, including 2 newly approved medications: deutetrabenazine and valbenazine.","This article addresses the prevalence, risk factors, and prevention of TD; assessment strategies including diagnostic criteria and rating scales; and evidence for TD treatments, including 2 newly approved drugs: deutetrabenazine and valbenazine.","This article looks at the total number of TD cases at a given time, risk factors, and prevention of TD; ways to measure TD including signs and symptoms and questionnaires; and TD treatments, including 2 newly approved drugs: deutetrabenazine and valbenazine."
780,"summarize: Tardive dyskinesia (TD) is a disorder characterized by involuntary movements, typically of the orofacial muscles and also of the extremities and other muscle groups.","Tardive dyskinesia (TD) is characterized by involuntary movements, typically of the facial muscles and also of the legs and other muscle groups.","Tardive dyskinesia (TD) is a disorder of involuntary movements, typlically of the lower face muscles, limbs, and other muscle groups."
781,"summarize: The condition is associated with exposure to dopamine receptor blocking agents, including antipsychotics.","the condition is associated with exposure to dopamine receptor blocking agents, including antipsychotics.","The condition is linked to exposure with blocking agents, like antipsychotics used to treat mental illnesses, of the chemical messenger dopamine."
782,"summarize: While evidence suggests that patients being treated with second-generation antipsychotics have less risk for developing TD than those treated with first-generation antipsychotics, the decreased risk is not as great as was originally expected.","TD is less likely for patients taking second-generation antipsychotics than those taking first-generation antipsychotics. However, the decreased risk is not as great as originally thought.","While patients treated with one class of antipsychotics may have less risk for developing TD than those treated with another class, the decreased risk is not as big as expected."
783,"summarize: Materials and methods: We conducted a literature search in PubMed, Cochrane Database, and ClinicalTrials.gov, screening for systematic reviews, meta-analyses or double-blind, randomized, placebo-controlled trials (DBRPCTs) reporting efficacy or safety data of VMAT-2 inhibitors (tetrabenazine, deutetrabenazine, and valbenazine) in patients with TD.","the study included a search for studies reporting the effectiveness or safety of VMAT-2 inhibitors (tetrabenazine, deutetrabenazine, and valbenazine) in patients with TD.","We searched for published scientific studies, including studies that summarized other studies, used statistics to combine results from other studies, or randomly assigned participants to groups receiving TD treatment or sugar pills that looked at how well treatments worked and safety of VMAT-2 inhibitors (tetrabenazine, deutetrabenazine, and valbenazine) in patients with TD."
784,"summarize: No head-to-head comparison among VMAT-2 inhibitors and no high-quality, meta-analyzable data are available for tetrabenazine in patients with TD.",tetrabenazine in patients with TD is not compared to other VMAT-2 inhibitors and no high-quality data are available.,No direct comparison between the VMAT-2 inhibitors and no high-quality data are available for tetrabenazine in patients with TD.
785,"summarize: Furthermore, they potentially contribute to further stigmatization of the affected patients.","Moreover, they could potentially contribute to further stigmatization of the affected patients.","Furthermore, TDs possibly cause patients to be viewed more negatively by society."
786,"summarize: Therefore, knowledge about risk factors and prevention of TDs is crucial.","Hence, knowledge about risk factors and prevention of TDs is crucial.","Therefore, knowing about TD risk factors and prevention is very important."
787,summarize: This review summarizes the current evidence of treatment options of TDs and seeks to formulate clinical recommendations for the prevention and management of TDs.,This review summarizes the current evidence of treatment options of TDs and seeks to formulate clinical recommendations for the prevention and management of TDs.,We summarize the current data on TD treatment options and try to come up with recommendations for doctors to prevent and treat TDs.
788,"summarize: Historically many pharmacological therapies have been studied in TD, finding varying degrees of treatment success.","Historically, many drugs have been studied in TD, finding varying degrees of treatment success.",Many drugs made to treat TD have been studied with different levels of success.
789,"summarize: Most recently, the VMAT2 inhibitors valbenazine and deutetrabenazine were rigorously studied in TD in large, phase III clinical trials, and were shown to be beneficial in this population.","valbenazine and deutetrabenazine, two drugs that block the VMAT2 pathway, were studied in TD in large, phase III clinical trials. They were shown to be beneficial in this population.","Most recently, the vesicular monoamine transporter type 2 (VMAT2) inhibitors, drugs that reduce dopamine (a chemical messenger released when your brain is expecting a reward), valbenazine and deutetrabenazine, were studied in TD in large human trials, and were shown to work in this group."
790,"summarize: Yet, for many patients with serious mental illness, the discontinuation of antipsychotics is not possible due to disease relapse.","Yet, for many patients with serious mental illness, stopping antipsychotics is not possible due to disease relapse.",Stopping antipsychotics is not possible for many patients with serious mental illness due to the disease returning.
791,summarize: These medications have not been approved for use in Canada.,These drugs have not been approved for use in Canada.,Canada has not approved these drugs for use.
792,"summarize: Purpose of review: Tardive dyskinesia (TD) is caused by exposure to medications with dopamine antagonism, mainly antipsychotics.","Tardive dyskinesia (TD) is caused by exposure to drugs with dopamine antagonism, mainly antipsychotics.","Taking medications, mainly antipsychotics, that reduce activity of dopamine (a chemical messenger released when your brain is expecting a reward) causes tardive dyskinesia (TD) - a movement disorder."
793,"summarize: Instead, changing prescription practices and increased off-label prescription of DRBAs have placed more patients than ever at risk of this potentially dangerous and disabling condition.","Instead, changing prescription practices and increased off-label prescription of DRBAs have placed more patients than ever at risk of this potentially dangerous and disabling condition.","Instead, changes in how antipsychotics are prescribed and antipsychotics prescribed for unapproved use have increased the patients at risk of TD."
794,summarize: Tardive dyskinesia (TD) is an iatrogenic condition that encompasses a wide phenomenological spectrum of movement disorders caused by exposure to dopamine receptor blocking agents (DRBAs).,"Tardive dyskinesia (TD) is an iatrogenic condition that encompasses a wide spectrum of movement disorders caused by exposure to dopamine receptor blocking agents (DRBAs), drugs that block the release of dopamine.",Tardive dyskinesia (TD) is a condition that includes a wide range of uncontrollable movement disorders caused by taking antipsychotics.
795,summarize: Dopamine-depleting vesicular monoamine transporter type 2 inhibitors are considered the treatment of choice of TD.,Dopamine-depleting vesicular monoamine transporter type 2 inhibitors are considered the treatment of choice for TD.,"Vesicular monoamine transporter type 2 (VMAT2) inhibitors, drugs that reduce dopamine (a chemical messenger released when your brain is expecting a reward), are the best treatment for TD."
796,summarize: A meta-analysis was conducted utilizing a fixed-effects model.,"Using a fixed-effects model, the study was analyzed.",We used statistical methods to combine the results of multiple studies.
797,"summarize: Results: Vitamin E was associated with significantly greater reduction in TD symptoms compared to placebo (standardized mean difference [SMD] = 0.31  0.08; 95% CI, 0.16 to 0.46; z = 4.1; P .001).",Vitamin E was associated with significantly greater reduction in TD symptoms compared to placebo.,Results favored vitamin E over sugar pills in TD symptom reduction.
798,summarize: Shorter duration of treatment and lower dose of vitamin E were significantly associated with greater measured treatment benefit.,Shorter duration of treatment and lower dose of vitamin E were significantly associated with greater measured treatment benefit.,Taking vitamin E for a shorter amount of time and at a lower dose was associated with greater TD symptom reduction.
799,"summarize: While prevention is the best strategy, it is not always possible.","While prevention is the best strategy, it is not always possible.","While prevention is the best approach, it is not always possible."
800,summarize: Objectives: Elevated plasma homocysteine has been implicated as a risk factor for hypertension.,Elevated blood homocysteine (a protein found in the blood) is a risk factor for high blood pressure.,"Increase plasma, or blood, homocysteine has been identified as a risk factor for hypertension (high blood pressure). Homocysteine is a chemical your body produces to help make proteins."
801,"summarize: However, baseline systolic blood pressure (SBP) and SBP response did not significantly associate with MTHFR C677T polymorphism.","Nevertheless, baseline systolic blood pressure (SBP) and SBP response did not significantly correlate with MTHFR C677T polymorphism.","However, baseline systolic blood pressure (when the heart is contracting) was not significantly associated with the unique genetic variation."
802,"summarize: C677T polymorphism in methylenetetrahydrofolate reductase gene (MTHFR) is a major determinant of hyperhomocysteinemia, which results in endothelial dysfunction.","C677T polymorphism in methylenetetrahydrofolate reductase gene (MTHFR) is a major determinant of hyperhomocysteinemia, which results in endothelial dysfunction.","A specific mutation in DNA (C677T) encoding methylenetetrahydrofolate reductase (MTHFR), a protein that transforms homocysteine, greatly influences hyperhomocysteinemia, or high blood levels of homocysteine. This condition results in damage to cells that line the heart and blood vessels."
803,"summarize: The co-existence of genetic polymorphisms in drug metabolizing enzymes, targets, receptors, and transporters may influence the drug efficacy.","The presence of genetic variations in the drug metabolizing enzymes, targets, receptors, and transporters may influence the drug effectiveness.","The co-existence of varied DNA for drug-digesting enzymes, targets, target sites, and transporters may affect drug effect."
804,summarize: The aim of present study was to investigate the effect of antihypertensive therapy (AHT) on Hcy levels in essential hypertensive subjects.,The aim of this study was to investigate the effect of antihypertensive therapy (AHT) on Hcy levels in essential hypertensive patients.,The goal of this study was to investigate the effect of antihypertensive therapy (AHT) on Hcy levels in essential hypertensive subjects. Essential hypertensive patients have high blood pressure that is not the result of a medical condition.
805,"summarize: In conclusion, these results show that riboflavin supplementation targeted at hypertensive individuals with the MTHFR 677TT genotype can decrease BP more effectively than treatment with current antihypertensive drugs only and indicate the potential for a personalized approach to the management of hypertension in this genetically at-risk group.",riboflavin supplementation targeted at hypertensive individuals with the MTHFR 677TT genotype can decrease BP more effectively than treatment with current antihypertensive drugs only. These results indicate the potential for a personalized approach to the management of high blood pressure in this genetically at-risk group.,"The study concluded riboflavin supplementation within hypertensive individuals with the MTHFR 677TT genotype decreases BP more efficiently than current antihypertensive drugs only. Furthermore, this study indicates the potential for a personalized, or individualized, approach to the way high blood pressure is managed in this genetically at-risk group."
806,"summarize: The present review will explore the evidence which supports a role for this polymorphism as a risk factor for a number of adverse health outcomes, and the potential modulating roles for B-vitamins in alleviating disease risk.","the present review will explore the evidence which supports a role for this genetic variation as a risk factor for a number of adverse health outcomes, and the potential modulating roles for B-vitamins in alleviating disease risk.","The study aimed to explore the evidence available that supports this genetic variation increasing the risk for several adverse or bad health outcomes. Additionally, the study aimed to explore the evidence of how B-vitamins can help alleviate or lessen disease risk."
807,"summarize: Furthermore, elevated blood pressure was found to be highly responsive to riboflavin intervention specifically in individuals with the MTHFR 677TT genotype.","Moreover, elevated blood pressure was found to be highly responsive to riboflavin treatment specifically in individuals with the MTHFR 677TT genotype.","Furthermore, high blood pressure was found to be highly responsive to or affected by riboflavin intervention or treatment specifically in individuals with the MTHFR 677TT genotype."
808,"summarize: Previous research has shown that 5-methyltetrahydrofolate, the product of the reaction catalysed by MTHFR, appears to be a positive allosteric modulator of endothelial nitric oxide synthase (eNOS) and may thus increase the production of nitric oxide, a potent vasodilator.","Earlier research has shown that 5-methyltetrahydrofolate, the product of the reaction catalysed by MTHFR, appears to be a positive allosteric modulator of endothelial nitric oxide synthase (eNOS) and may thus increase the production of nitric oxide, a potent vasodilator.","Previous research has shown that the product produced by the biological reaction caused by MTHFR is a positive modulator (increases activity) of a specific enzyme. The enzyme is known as endothelial nitric oxide synthase (eNOS), which helps fight blood vessel disease. The product of MTHFR, known as 5-methyltetrahydrofolate, may increase the production of nitric oxide, a potent vasodilator. Vasodilators widen blood vessels, which decreases blood pressure."
809,"summarize: Any deviation from this pattern, which can only be identified using ambulatory blood pressure monitoring (ABPM), has been associated with increased cardiovascular disease (CVD) risk.","Any deviation from this pattern, which can only be identified using ambulatory blood pressure monitoring (ABPM), has been associated with increased risk of cardiovascular disease (CVD).","Any change in this pattern, which can only be identified using ambulatory blood pressure monitoring (ABPM), has been associated with increased cardiovascular (or heart-related) disease (CVD) risk."
810,summarize: Participants were randomized to receive treatment with either a combination of enalapril and folic acid or enalapril.,participants were randomly assigned to receive either a combination of enalapril and folic acid or enalapril.,Participants were randomized to receive treatment with either a combination of enalapril (common blood pressure medication) and folic acid or enalapril.
811,"summarize: Results: During the follow-up, change in folate was significantly and independently correlated with change in ba-PWV in study patients (Î2 = -1.31, P  0.001).","During the follow-up, change in folate was significantly and independently correlated with change in ba-PWV in study patients.","During the follow-up, change in folate (vitamin in the body) was significantly and independently linked with change in PWV in patients."
812,"summarize: Conclusion: In a subgroup of Chinese hypertensive patients who had received 5-year antihypertensive therapy, increases in folate status were associated with higher reductions in PWV, and individuals with the CC genotype showed greatest PWV response to folic acid supplementation.","In a subgroup of Chinese hypertensive patients who had received 5-year antihypertensive therapy, increases in folate status were linked with higher reductions in PWV. Individuals with the CC genotype showed greatest PWV response to folic acid supplementation.","The study concluded that within the analyzed subgroup of Chinese hypertensive patients who had received a 5-year antihypertensive therapy, increase in folate status were correlated or linked with decreased PWV. Additionally, individuals with CC genotype showed greatest PWV response to folic acid treatment."
813,"summarize: Over a median of 4.5 years, among those not receiving folic acid, participants with baseline serum B12 or serum folate above the median had a significantly lower risk of first ischemic stroke (hazard ratio [HR], 0.74; 95% confidence interval [CI], 0.57-0.96), especially in those with MTHFR 677 CC genotype (wild-type) (HR, 0.49; 95% CI, 0.31-0.78).","Over a median of 4.5 years, among those not receiving folic acid, participants with baseline blood B12 or serum folate above the average had a significantly lower risk of first ischemic stroke, especially in those with MTHFR 677 CC genotype (wild-type).","Over an average of 4.5 years, participants not receiving folic acid with baseline (starting) serum or blood B12 or serum folate above the median (average) had a significantly lower risk of first ischemic stroke. This decreased risk was found especially in those with MTHFR 677 CC genotype (wild-type or normal)."
814,"summarize: Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B12 below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in MTHFR 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55).","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with folate and B12 below the average, especially in MTHFR 677 CC carriers.","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B12 below the median, particularly in patients with CC genotype."
815,"summarize: However, TT homozygotes responded better with both folate and B12 levels above the median (HR, 0.28; 95% CI, 0.10-0.75).",TT homozygotes responded better with folate and B12 levels above the average.,"However, participants with TT genotype responded better with both folate and B12 levels above the median of participants."
816,summarize: Participants were followed up every 3 months.,Participants were followed up every 3 months.,Participants were checked every 3 months.
817,"summarize: However, TT homozygotes responded better with both folate and B12 levels above the median (HR, 0.28; 95% CI, 0.10-0.75).",TT homozygotes responded better with folate and B12 levels above the average.,"However, those with certain MTHFR genotypes responded with both folate and B12 levels above the average."
818,summarize: This study analyzed the relationship between C677T MTHFR polymorphism and the therapeutic effect of lowering HCY in stroke patients with HHCY.,this study analyzed the relationship between C677T MTHFR polymorphism and the therapeutic effect of lowering HCY in stroke patients with HHCY.,"This study analyzed the relationship between C677T MTHFR variation and the therapeutic, beneficial effect (response after a treatment) of lowering HCY in stroke patients with HHCY."
819,"summarize: Most of them responded well to treatment (103 cases, 63.5%), but 59 (36.4%) patients were in the poor efficacy group.","63.5% responded well to treatment, but 59 (36.4%) patients were in the poor efficacy group.","Most of them responded well to treatment, but 59 patients were in the poor efficacy or poor effect group."
820,"summarize: In the codominant model the TT genotype was associated with poor outcome (OR = 0.862, 95%CI: 0.767, 0.970, P = 0.017) and this was also the case in the recessive model (OR = 0.585, 95%CI: 0.462, 0.741, P  0.001) but there was no association between CT and TT in the dominant model.","the TT genotype was associated with poor outcome in the model. This was also the case in the model that is not used, but there was no association between CT and TT in the model.",The TT genotype was associated with poor outcomes.
821,summarize: Participants were recruited from the Republic of Ireland and Northern Ireland (UK) in 2008-2012 using standardised methods.,Participants were recruited from the Republic of Ireland and Northern Ireland (UK) in 2008-2012 using standardised methods.,Participants were recruited from the Republic of Ireland and Northern Ireland (UK) in 2008-2012 using standard methods.
822,"summarize: Background: Genome-wide and clinical studies have linked the 677CâT polymorphism in the gene encoding methylenetetrahydrofolate reductase (MTHFR) with hypertension, whilst limited evidence shows that intervention with riboflavin (i.e. the MTHFR co-factor) can lower blood pressure (BP) in hypertensive patients with the variant MTHFR 677TT genotype.","Background: Genome-wide and clinical studies have linked the 677CâT gene mutation in the gene encoding methylenetetrahydrofolate reductase (MTHFR) with hypertension, while limited evidence shows that treatment with riboflavin (the MTHFR co-factor) can lower blood pressure (BP) in hypertensive patients with the variant MTHFR 677TT gene.","Genetic and clinical studies have linked variation in a specific DNA sequence for methylenetetrahydrofolate reductase (MTHFR), a certain protein, with high blood pressure. Some evidence shows that treatment with riboflavin (a molecule that attaches to MTHFR) can lower blood pressure (BP) in patients with high blood pressure and an altered DNA sequence for MTHFR called 677TT."
823,summarize: Participants were recruited from the Republic of Ireland and Northern Ireland (UK) in 2008-2012 using standardised methods.,Participants were recruited from the Republic of Ireland and Northern Ireland (UK) in 2008-2012 using standardised methods.,Patients were recruited from the Republic of Ireland and Northern Ireland in 2008-2012.
824,"summarize: Because the clearance of gabapentin is dependent on renal function, the pharmacokinetics of gabapentin were investigated in anuric subjects maintained on hemodialysis.","Because the clearance of gabapentin is dependent on kidney function, the pharmacokinetics of gabapentin were investigated in anuric patients maintained on dialysis.","Because the clearance of gabapentin depends on the kidneys, how the body processes gabapentin is investigated in patients who do not make enough urine and who are on dialysis, a process of cleaning the blood of a person whose kidneys are not working normally."
825,summarize: Gabapentin elimination half-life during hemodialysis was approximately 4 hours.,Gabapentin elimination half-life during hemodialysis was about 4 hours.,The time for half of gabapentin to clear during hemodialysis was around 4 hours.
826,summarize: Systemic plasma gabapentin concentrations increased approximately 30% during the first 2 hours after hemodialysis as a result of drug redistribution in the body.,gabapentin concentrations in the blood increased about 30% during the first 2 hours after dialysis as a result of drug being redistributed in the body.,Blood gabapentin levels increased around 30% during the first 2 hours after hemodialysis due to drug redistribution in the body.
827,"summarize: At steady state, it has a half-life of 6-8 h, and is eliminated unchanged by renal route with a plasma clearance proportional to the creatinine clearance.","at steady state, it has a half-life of 6-8 hours, and is eliminated unchanged by kidneys with a blood clearance proportional to the creatinine clearance.","When the amount of the drug in the body is the same amount that is being cleared, the time it takes for the concentration of the gabapentin in the plasma or body to be reduced by half is 6-8 hours and is eliminated through the kidneys."
828,summarize: It is devoid of significant drug-drug interactions when administered with the established AEDs or with oral contraceptives.,It does not have significant drug-drug interactions when given with the established AEDs or with oral contraceptives.,Gabapentin does not have any major interactions with other drugs when given with other standard drugs that treat seizures or with oral (by mouth) birth control.
829,"summarize: Gabapentin used as an add-on AED significantly reduced the frequency of partial seizures and secondarily generalized tonic-clonic seizures in three large double-blind, placebo-controlled, parallel-group clinical trails.",Gabapentin used as an add-on AED significantly reduced the frequency of partial seizures and secondarily generalized tonic-clonic seizures in three large clinical trials.,"In 3 clinical studies, gabapentin used as an add-on anti-seizure drug to assist the main treatment reduces the frequency of partial seizures (impacting half the brain) and seizures (impacting both halves of the brain)."
830,"summarize: Gabapentin used as an add-on AED significantly reduced the frequency of partial seizures and secondarily generalized tonic-clonic seizures in three large double-blind, placebo-controlled, parallel-group clinical trails.",Gabapentin used as an add-on AED significantly reduced the frequency of partial seizures and secondarily generalized tonic-clonic seizures in three large clinical trials.,Gabapentin used as an add-on AED greatly reduces the amount of partial seizures and partial seizures developing into standard serizures in three clinical trials.
831,summarize: Excretion intact in the urine affords dose adjustment on the basis of creatinine clearance.,Excretion intact in the urine affords dose adjustment on the basis of creatinine clearance.,Doses can be adjusted based on the amount of the drug found in the urine.
832,"summarize: The only pharmacokinetic parameter that was significantly different between genders was Cmax, which was approximately 25% higher for women than for men (p = 0.016), consistent with gender differences in body size.","the only pharmacokinetic parameter that was significantly different between genders was Cmax, which was about 25% higher for women than for men, consistent with gender differences in body size.","The only measure that is very different between genders is the highest (peak) gabapentin amount, which is approximately 25% higher for women than for men, consistent with gender differences in body size."
833,summarize: Reduction of GBP dosage may be required in elderly patients with reduced renal function.,Reduction of GBP dosage may be required in elderly patients with reduced kidney function.,Giving a lesser dose of gabapentin may be required in elderly patients who have weaker kidney functions.
834,summarize: Purpose: The pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures was studied.,the pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures was studied.,"How the pediatric or child patients with uncontrolled seizures are able to handle gabapentin (a nerve-related pain medication) and the processes of absorbing, distributing, using, and removing it is studied."
835,summarize: Pharmacokinetic parameters for gabapentin were determined by non-compartment methods using multivariate regression analysis.,pharmacokinetic parameters for gabapentin were determined using non-compartment methods.,"Absorption, distribution, use, and removal of gabapentin in the body is analyzed."
836,"summarize: However, there are no data in elderly nursing home (NH) patients to evaluate gabapentin absorption and elimination.","However, there are no data in elderly nursing home (NH) patients to evaluate gabapentin absorption and elimination.","However, there are no data in elderly nursing home patients to evaluate how the body absorbs and removes gabapentin."
837,"summarize: After adjusting for the effect of GFR, GBP CL was not affected by age, sex, body weight, or comorbidity scores.","GBP CL was not affected by age, sex, body weight, or other factors.","After accounting for the rate that measures how well the kidneys are working, GBP clearance is not affected by age, sex, body weight, or other illnesses and their medications."
838,summarize: Prediction-corrected visual predictive check (pc-VPC) suggests adequate fixed- and random-effects models that successfully simulated the mean trend and variability in gabapentin concentration-time profiles.,Prediction-corrected visual predictive check (pc-VPC) suggests adequate models that successfully simulated the average trend and variability in gabapentin concentration-time profiles.,Additional calculations are done on the entire group to evaluate the performance of the drug and identify other individual factors that may impact the effect.
839,summarize: Pharmacokinetic data of gabapentin (GBP) in community-dwelling elderly patients show a significant effect of advanced age on GBP pharmacokinetics due to altered renal function.,pharmacokinetic data of gabapentin (GBP) in community-dwelling elderly patients show a significant effect of advanced age on GBP pharmacokinetics due to altered kidney function.,Drug activity data of gabapentin (GBP) in community-dwelling elderly patients show a great effect of advanced age on GVP drug activity due to altered kidney function.
840,"summarize: After adjusting for the effect of GFR, GBP CL was not affected by age, sex, body weight, or comorbidity scores.","GBP CL was not affected by age, sex, body weight, or other factors.","After adjusting for kidney filtration, GBP clearance was not affected by age, sex, body weight, or associated diseases."
841,"summarize: No significant effects of body size measures, age, and sex were detected on volume of distribution.","No significant effects of body size measures, age, and sex were detected on volume of distribution.","No effects of body size, age, and sex were detected on amount of distribution."
842,"summarize: In this analysis, the parameters of the hyperbolic nonlinearity appear to be similar between elderly and younger adults.",the results of this analysis appear to be similar between elderly and younger adults.,"In this analysis, certain measures seem similar between elderly and young adults."
843,summarize: We find that continuous PD provides significant clearance of gabapentin.,PD provides significant clearance of gabapentin.,Researchers find that continuous peritoneal dialysis provides significant clearance of gabapentin.
844,summarize: Population pharmacokinetics (PKs) of gabapentin was estimated using a nonlinear mixed-effects model (NONMEM).,"Using a nonlinear mixed-effects model (NONMEM), we estimated how gabapentin affects the body.",How the body handles and uses gabapentin is measured.
845,"summarize: The absorption rate constant was estimated at 0.860 h-1, and the lag time was predicted at 0.311 h.","the absorption rate constant was estimated at 0.860 h-1, and the lag time was predicted at 0.311 h.",How quickly the medication enters the body remains steady.
846,"summarize: However, ABCB1 1236C > T and 3435C > T genotypes showed no significant effect on gabapentin PK parameters.","However, the ABCB1 genotypes showed no significant effect on gabapentin PK parameters.","However, genes showed no significant effect on gabapentin drug activity parameters."
847,"summarize: Our objective was to evaluate the potential drug-drug interaction between GBP and cetirizine (CTZ), an inhibitor of transporters for organic cations.","Specifically, we evaluated the possible drug-drug interaction between GBP and cetirizine (CTZ), an inhibitor of transporters for organic cations.",The objective of this study is to evaluate how gabapentin may interact with another medicine called cetirizine (CTZ) that is used to temporarily relieve allergies.
848,"summarize: The interaction of GBP and CTZ with transporters for organic cations was studied in human embryonic kidney (HEK) cells expressing the organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and OCTN1.","The interaction of GBP and CTZ with transporters for organic cations was studied in human embryonic kidney (HEK) cells that expressed the organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and OCTN1.",The interaction of gabapentin and cetirizine is analyzed.
849,"summarize: In treatment B, the lower plasma concentrations of GBP resulted in reduced pain attenuation.","In treatment B, the lower blood levels of GBP resulted in reduced pain attenuation.","In treatment B, the lower concentrations of gabapentin or GBP in the blood results in reduced pain."
850,summarize: GBP renal clearance was similar between treatments.,GBP clearance was similar between treatments.,GBP clearance from the kidneys is similar between treatments A and B.
851,"summarize: GBP has low apparent affinity for OCT2 (concentration of an inhibitor where the response [or binding] is reduced by half [IC50 ] 237 mol/L) and a high apparent affinity for hMATE1 (IC50 1.1 nmol/L), hMATE2-K (IC50 39 nmol/L), and hOCTN1 (IC50 2.1 nmol/L) in HEK cells.","GBP has low apparent affinity for OCT2 and a high apparent affinity for hMATE1, hMATE2-K, and hOCTN1 in HEK cells.",GBP appears to bind less to some receptors or kidney target sites such as OCT2 and attach more towards others such as hMATE1 in certain human kidney cells.
852,summarize: All participants were treated with a single oral dose GBP.,All participants were treated with a single oral dose of GBP.,All participants are treated with a single dose of gabapentin by mouth.
853,summarize: Data were analysed with a population approach using the stochastic approximation expectation maximization algorithm.,the data were analysed using a population approach.,Data are analyzed using computer models.
854,summarize: Our objective was to evaluate the role of diabetes and glycaemic control on GBP population pharmacokinetics.,"Specifically, the aim of this study was to evaluate the role of diabetes and blood sugar control on GBP.",We evaluate the role of diabetes and blood sugar control on drug activity in the GBP population.
855,summarize: All participants were treated with a single oral dose GBP.,All participants were treated with a single oral dose of GBP.,All participants swallowed a single dose of GBP.
856,"summarize: Results: GBP drug disposition was described by a 1-compartment model with lag-time, first-order absorption and linear elimination.","GBP drug disposition was described by a 1-compartment model with lag-time, first-order absorption and linear elimination.",nan
857,"summarize: No significant association was observed with hyperglycaemia, glycated haemoglobin, diabetes diagnosis, age, sex, weight, body mass index, SLC22A2 or SLC22 A4 genotypes.","No significant association was observed with hyperglycaemia, glycated hemoglobin (a protein that helps regulate blood sugar), diabetes diagnosis, age, sex, weight, body mass index, SLC22A2 or SLC22 A4 genotypes.","No link was seen with high blood sugar, blood sugar levels, diabetes diagnosis, age, sex, weight, body mass index, or certain DNA sequences."
858,summarize: The distribution and excretion processes of GBP were not affected by hyperglycaemia or diabetes.,The distribution and excretion processes of GBP were not affected by high blood sugar or diabetes.,The distribution and removal processes of GBP were not affected by high blood sugar or diabetes.
859,summarize: Method: Retrospective observational study in pre-dialysis patients who began treatment with PEG-EPO between May 2008 and February 2009.,Methods: Retrospective observational study in pre-dialysis patients who began treatment with PEG-EPO between May 2008 and February 2009.,This study uses data from pre-dialysis patients who started treatment with Methoxy polyethylene glycol-epoetin beta (PEG-EPO) between May 2008 and February 2009.
860,"summarize: Hb values were higher than 12g/l (P.0001) after 12 months of treatment in 25% of patients; of these, 45% had values above 13g/l.","Hb values were higher than 12g/l after 12 months of treatment in 25% of patients; of these, 45% had values above 13g/l.","Hemoglobin levels are higher than 12 grams/liter after 12 months of treatment in 25% of patients. Among these patients, 45% have levels above 13 grams/liter."
861,"summarize: The prevalence of PEW in early to moderate CKD is â20-25% and increases as CKD progresses, in part because of activation of proinflammatory cytokines combined with superimposed hypercatabolic states and declines in appetite.","the prevalence of PEW in early to moderate chronic kidney disease is â20-25% and increases as chronic kidney disease progresses, in part because of proinflammatory cytokines (the body's natural defense system that fight inflammation) combined with increased muscle activity and declines in appetite.","Protein-energy wasting often increases as chronic kidney disease gets worse, in part because of more inflammation (redness and swelling from fighting an infection) combined with too much breakdown of proteins and loss of appetite."
862,"summarize: Worsening uremia also renders CKD patients vulnerable to potentially deleterious effects of uncontrolled diets, including higher phosphorus and potassium burden.","Worsening uremia also renders CKD patients vulnerable to potentially harmful effects of uncontrolled diets, including higher phosphorus and potassium burden.","Worsening uremia, which is when there is too much waste in the blood, may make uncontrolled diets have a negative impact on chronic disease patients."
863,"summarize: Given such complex pathways, nutritional interventions in CKD, when applied in concert with nonnutritional therapeutic approaches, encompass an array of strategies (such as dietary restrictions and supplementations) aimed at optimizing both patients' biochemical variables and their clinical outcomes.","Given such complex pathways, nutritional interventions in chronic kidney disease, when applied together with other treatments, include an array of strategies (such as dietary restrictions and supplements) aimed at optimizing both patients' biochemical variables and their clinical outcomes.","Nutritional interventions (changing diet and diet behavior to reach a health goal) in chronic kidney disease, when combined with other therapies unrelated to nutrition, create a number of strategies aimed at improving the internal systems of the body in the patient and the patient's health outcomes."
864,summarize: In clinical practice the most common tests for CKD include GFR estimated from the serum creatinine concentration (eGFR) and albuminuria from the urinary albumin-to-creatinine ratio.,the most common tests for CKD include GFR estimated from serum creatinine concentration (eGFR) and albuminuria (an abnormal amount of protein in urine) from urinary albumin-to-creatinine ratio.,The most common tests for chronic kidney disease include the glomerular filtration rate that is estimated from the amount of creatinine (a waste product from the normal wear and tear on muscles) in the blood and too much albumin (a blood protein) in the urine which is called albuminuria.
865,"summarize: Management of CKD includes reducing the patient's risk of CKD progression and risk of associated complications, such as acute kidney injury and cardiovascular disease, anemia, and metabolic acidosis, as well as mineral and bone disorder.","Management of chronic kidney disease includes reducing the patient's risk of developing chronic kidney disease and risk of associated complications, such as acute kidney injury and heart disease, anemia, and acidosis, as well as mineral and bone disorder.","Managing chronic kidney disease includes reducing the patient's risk of the disease getting worse and risk of related complications, such as acute or immediate kidney injury or heart disease."
866,"summarize: The ultimate goal of CKD management is to prevent disease progression, minimize complications, and promote quality of life.","CKD management is to prevent disease progression, minimize complications, and promote quality of life.","The main goal of managing chronic kidney disease is to prevent the disease from getting worse, to minimize complications, and to promote quality of life."
867,summarize: Assessment of eGFR and albuminuria should be performed for persons with diabetes and/or hypertension but is not recommended for the general population.,eGFR and albuminuria should be measured for people with diabetes and/or high blood pressure but is not recommended for the general population.,Measuring eGFR and albumin levels should be done in persons with diabetes and/or high blood pressure but not for the general population.
868,"summarize: Management of CKD includes reducing the patient's risk of CKD progression and risk of associated complications, such as acute kidney injury and cardiovascular disease, anemia, and metabolic acidosis, as well as mineral and bone disorder.","Management of chronic kidney disease includes reducing the patient's risk of developing chronic kidney disease and risk of associated complications, such as acute kidney injury and heart disease, anemia, and acidosis, as well as mineral and bone disorder.","Managing CKD includes lowering the patient's risk of CKD worsening and risk of associated issues, like immediate kidney injury, heart disease, low blood level, high acid level, and mineral and bone disorder."
869,summarize: People who have kidney disease have prioritised dietary modifications as an important treatment uncertainty.,People with kidney disease have prioritized dietary changes as an important treatment uncertainty.,People who have kidney disease have prioritized changes in their diet as uncertain treatment.
870,summarize: Participants were followed up for a median of 12 months (range 1 to 46.8 months).,participants were followed up for a median of 12 months.,"Participants are followed up for about 12 months, but the time ranges between 1 to 46.8 months."
871,summarize: Adverse events were generally not reported.,Adverse events were generally not reported.,Adverse (unexpected and negative) events are generally not reported.
872,"summarize: Dietary interventions were associated with a higher estimated glomerular filtration rate (eGFR) (5 studies, 219 people: SMD 1.08; 95% CI 0.26 to 1.97; I2 = 88%) and serum albumin levels (6 studies, 541 people: MD 0.16 g/dL, 95% CI 0.07 to 0.24; I2 = 26%).",Dietary interventions were associated with a higher kidney filtration rate and serum albumin levels.,"Dietary interventions are associated with a higher estimated glomerular filtration rate (eGFR), a blood test that measures removal of creatinine levels which are waste products from digestion and muscle breakdown. They are also linked to higher albumin (liver proteins that keep fluid in the bloodstream) levels in the blood."
873,"summarize: Authors' conclusions: Dietary interventions have uncertain effects on mortality, cardiovascular events and ESKD among people with CKD as these outcomes were rarely measured or reported.","Dietary interventions have uncertain effects on death, heart events and ESKD among people with chronic kidney disease as these outcomes were rarely measured or reported.","In conclusion, dietary interventions have uncertain effects on death, heart events, and end-stage kidney disease among people with chronic kidney disease because these effects are rarely measured or described."
874,summarize: Background: Dietary changes are routinely recommended in people with chronic kidney disease (CKD) on the basis of randomised evidence in the general population and non-randomised studies in CKD that suggest certain healthy eating patterns may prevent cardiovascular events and lower mortality.,Dietary changes are routinely recommended in people with chronic kidney disease (CKD) on the basis of randomised evidence in the general population and non-randomised studies in CKD that suggest certain healthy eating patterns may prevent cardiovascular events and lower death.,Diet changes are usually recommended in people with long-lasting or chronic kidney disease (CKD) since studies suggest certain healthy eating patterns may prevent heart-related events and lower deaths.
875,"summarize: In absolute terms, dietary interventions may prevent one person in every 3000 treated for one year avoiding ESKD, although the certainty in this effect was very low.","dietary interventions may prevent one person in every 3000 treated for one year avoiding ESKD, although the certainty in this effect was very low.","In established results, diet treatments may prevent kidney failure in one in every 3000 people, although the certainty of this effect was very low."
876,summarize: Adverse events were generally not reported.,Adverse events were generally not reported.,Side effects were generally not reported.
877,"summarize: Dietary interventions lowered systolic blood pressure (3 studies, 167 people: MD -9.26 mm Hg, 95% CI -13.48 to -5.04; I2 = 80%) and diastolic blood pressure (2 studies, 95 people: MD -8.95, 95% CI -10.69 to -7.21; I2 = 0%) compared to a control diet.",Dietary interventions lowered systolic blood pressure and diastolic blood pressure compared to a control diet.,Diet treatments lowered systolic and diastolic blood pressure compared to a control or regular diet.
878,"summarize: Dietary interventions may increase health-related quality of life, eGFR, and serum albumin, and lower blood pressure and serum cholesterol levels.","Dietary interventions may increase health-related quality of life, eGFR, and serum albumin, and lower blood pressure and serum cholesterol levels.","Diet treatment may increased health-related quality of life, kidney filtration rate, and blood albumin. Diet treatment may lower blood pressure and blood cholesterol levels."
879,"summarize: Appropriate screening, diagnosis, and management by primary care clinicians are necessary to prevent adverse CKD-associated outcomes, including cardiovascular disease, end-stage kidney disease, and death.","Appropriate screening, diagnosis, and management by primary care clinicians are necessary to prevent adverse CKD-associated outcomes, including heart disease, kidney disease, and death.","Appropriate screening, diagnosis, and care by primary care (family) doctors are necessary to prevent negative outcomes associated with CKD, including heart disease, end-stage kidney disease, and death."
880,"summarize: Conclusions and relevance: Diagnosis, staging, and appropriate referral of CKD by primary care clinicians are important in reducing the burden of CKD worldwide.","Diagnosis, staging, and appropriate referral of chronic kidney disease by primary care clinicians are important in reducing the burden of chronic kidney disease worldwide.","Diagnosis, determining the stage, and appropriate referral of chronic kidney disease by primary care doctors are important in reducing the negative impact of chronic kidney disease worldwide."
881,"summarize: Whereas skeletal health in this population has conventionally been associated with bone and mineral disorders, sarcopenia has been observed to impact skeletal muscle health in CKD.","skeletal health in this population has traditionally been associated with bone and mineral disorders. However, sarcopenia has been observed to impact skeletal muscle health in chronic kidney disease.",Sarcopenia is a disorder that results in loss of muscle mass and function and is found to impact overall skeletal muscle health in chronic kidney disease.
882,"summarize: It was created by the German College of General Practitioners and Family Physicians (Deutsche Gesellschaft f14r Allgemeinmedizin und Familienmedizin, DEGAM) and consented with the German Societies of Nephrology and Internal Medicine (DGfN, DGIM) and patient representation.","German College of General Practitioners and Family Physicians (Deutsche Gesellschaft f14r Allgemeinmedizin und Familienmedizin, DEGAM) created the study. It was approved by the German Society of Nephrology and Internal Medicine (DGfN, DGIM) and patient representation.",It is created by the German College of General Practitioners and Family Physicians and agreed with by the German Societies of Nephrology and Internal Medicine and patient representation.
883,"summarize: Results: Upon the initial diagnosis of CKD (glomerular filtration rate [GFR] 60 mL/ min), the patient's blood pressure and urinary albumin-to-creatinine ratio (ACR) should be measured, and the urine should be examined for hematuria.","Upon the first diagnosis of CKD, the patient's blood pressure and urinary albumin-to-creatinine ratio (ACR) should be measured. The urine should be examined for hematuria.","At the first diagnosis of chronic kidney disease, the patient's blood pressure, as well as a urine sample that may indicate a kidney complication from high proteins, should be measured. The urine should also be checked for the presence of blood."
884,"summarize: Enthusiasm on prescription of vitamin D receptor activators (VDRA) in non-dialysis renal patients, has been mitigated by the risk of low bone turnover and positive calcium-phosphate balance.","Enthusiasm on prescription of vitamin D receptor activators (VDRA) in non-dialysis renal patients, has been mitigated by the risk of low bone turnover and positive calcium-phosphate balance.","Enthusiasm on prescription of vitamin D treatments in non-dialysis kidney patients is lessened by the risk of low bone turnover (when the bone tissue is reabsorbed and replaced by a new bone), and positive calcium-phosphate balance that makes sure systems in the body work well."
885,"summarize: Areas covered: The review discusses available data on safety and efficacy of nutritional vitamin D, VDRA and nutritional therapy in replenishing 25(OH)D deficiency and counteracting SHPT in non-dialysis CKD patients.","The review discusses available data on safety and effectiveness of nutritional vitamin D, VDRA and nutritional therapy in replenishing vitamin D deficiency and counteracting SHPT in non-dialysis CKD patients.","Other areas covered in this review are the data available on safety and effectiveness (success) of vitamin D, vitamin D prescriptions, and nutritional therapy in restoring vitamin D to normal levels (via diet) and acting against secondary hyperparathyroidism."
886,"summarize: Although untreated SHPT may degenerate into tertiary hyperparathyroidism with detrimental consequences in advanced CKD, best treatments for counteracting SHPT from stage 3 CKD are still debated.","Untreated SHPT may develop into tertiary hyperparathyroidism (hyperparathyroidism) with harmful consequences in advanced chronic kidney disease. However, the best treatments for counteracting SHPT from stage 3 chronic kidney disease are still debated.","While untreated SHPT may worsen to uncontrolled, excess parathyroid hormone production with harmful effects in advanced CKD, best treatments for preventing this worsening are unknown."
887,summarize: VDRA should be restricted to uncontrolled SHPT by first-line therapy.,VDRA should be limited to uncontrolled SHPT by first-line therapy.,VDRA should be limited to uncontrolled SHPT by first-choice therapy.
888,"summarize: Interestingly, eating in company was associated with a lower frequency of depression ( 2 5â 975, P = 0â 015).","Interestingly, eating in company was associated with a lower frequency of depression.","Interestingly, eating with others is associated with a lower frequency of depression."
889,"summarize: To conclude, Mediterranean dietary habits were favourably associated with cardiometabolic markers and management of some comorbidities in this group of people with non-dialysis dependent CKD.",Mediterranean dietary habits were favourably associated with heart health and management of some diseases in this group of people with non-dialysis dependent kidney disease.,"In conclusion, Mediterranean dietary habits are positively linked with heart-related measures and care of other health problems in this group of people with non-dialysis chronic kidney disease."
890,summarize: Osteoporosis risk index scores were compared to bone density T-scores.,osteoporosis risk index scores were compared to bone density T-scores.,We compared risk scores to bone density tests.
891,"summarize: A simple algorithm based on age, weight, history of previous low impact fracture, early menopause, and corticosteroid therapy was developed.","A simple algorithm based on age, weight, history of previous low impact fractures, early menopause, and corticosteroid therapy was developed.","We came up with a simple calculation based on age, weight, history of previous falls from a standing height or lower, early menopause, and use of a certain kind of steroid."
892,"summarize: Validation of this five-item osteoporosis prescreening risk assessment (OPERA) index showed that the tool, at the recommended threshold (or cutoff value) of two, had a sensitivity that ranged from 88.1 [95% confidence interval (CI) for the mean: 86.2-91.9%] at the femoral neck to 90% (95% CI for the mean: 86.1-93.1%) at the lumbar spine area.",OPERA is a risk assessment tool for osteoporosis. The tool has sensitivity from 88.1 at the femur neck to 90% at the lumbar spine area.,Testing of this five-item osteoporosis prescreening risk assessment (OPERA) shows high accuracy for osteoporosis detection.
893,"summarize: The positive predictive value (PPV) ranged from 29 at the femoral neck to 39.2% at the lumbar spine, while the corresponding negative predictive values (NPVs) reached 96.5 and 96.2%, respectively.","the positive predictive value (PPV) ranged from 29 at the femoral neck to 39.2% at the lumbar spine, while the corresponding negative predictive values reached 96.5 and 96.2%, respectively.","The accuracy for results detecting osteoporosis ranged from 29 at the femoral neck to 39.2% at the lumbar spine, while the corresponding accuracy for results not detecting osteoporosis reached 96.5 and 96.2%, respectively."
894,summarize: We evaluated the prevalence and geographic variation of short-interval (repeated in under 2 years) dual-energy X-ray absorptiometry tests (DXAs) among Medicare beneficiaries.,the prevalence and geographic variation of short-interval (repeated in under 2 years) dual-energy X-ray absorptiometry tests (DXAs) among Medicare beneficiaries.,We rated the number and variation (or differences) across the country of dual-energy x-ray absorptiometry tests (DXAs - useful tests for measuring bone density) repeated in under 2 years (short-interval) in people on Medicare during a specific period.
895,summarize: Short-interval DXA use fluctuated substantially with payment changes; other DXAs did not.,Short-interval DXA use fluctuated substantially with payment changes; other DXAs did not.,Short-interval DXA use changed a lot based on payment; other DXAs did not.
896,"summarize: Short-interval DXAs, which represented 10.1 % of all DXAs, cost Medicare approximately US$16 million in 2011.","Short-interval DXAs, which represented 10.1 % of all DXAs, cost Medicare approximately US$16 million in 2011.","In 2011, Medicare spent about $16 million USD on short-interval DXAs, which made up 10.1% of all DXAs."
897,summarize: Conclusions: One out of ten DXAs was administered in a time frame shorter than recommended and at a substantial cost to Medicare.,one out of ten DXAs was given in a time frame shorter than recommended and at a substantial cost to Medicare.,"We conclude that one out of 10 DXAs was done sooner than recommended, costing Medicare considerably."
898,"summarize: The index value was derived by age and body weight of the participants according to weighted odds of each risk factor and the selected cutoff value was set at ""-1"".","the index value was derived by age and body weight of the participants according to weighted odds of each risk factor. The selected cutoff value was set at ""-1"".",nan
899,"summarize: Although guidelines are lacking for rescreening women who have normal bone mineral density on initial screening, intervals of at least four years appear safe.","Although guidelines are lacking for rescreening women who have normal bone mineral density on initial screening, intervals of at least four years seem safe.","Although there are not guidelines for rechecking women who have initial normal bone mineral density, four years between checks looks safe."
900,"summarize: First-line treatment to prevent fractures consists of fall prevention, smoking cessation, moderation of alcohol intake, and bisphosphonate therapy.","First-line treatment to prevent fractures consists of fall prevention, smoking cessation, moderate drinking of alcohol, and bisphosphonate therapy.","The best treatment to prevent breaks includes preventing falls, stopping smoking, reducing alcohol consumption, and a group of drugs that help prevent or slow down bone thinning."
901,summarize: Clinicians should consider discontinuing bisphosphonate therapy after five years in women without a personal history of vertebral fractures.,patients should consider stopping bisphosphonate therapy after five years in women without a personal history of vertebral fractures.,Doctors should think about stopping a group of drugs that help prevent or slow down bone thinning after five years in women without a history of spine breaks.
902,summarize: Most osteoporotic and nonosteoporotic men had â1 laboratory abnormality.,â1 laboratory abnormality was found in most men with osteoporosis and nonosteoporosis.,Most men with and without osteoporosis had one or more abnormal lab measurement.
903,summarize: The benefit of routine laboratory testing in older osteoporotic men may be low.,The benefit of routine laboratory testing in older men with osteoporosis may be low.,Routine lab testing in older men with osteoporosis may not be helpful.
904,"summarize: Introduction: To evaluate the utility of recommended laboratory testing to identify secondary causes in older men with osteoporosis, we examined prevalence of laboratory abnormalities in older men with and without osteoporosis.","To evaluate the utility of recommended laboratory testing to identify secondary causes in older men with osteoporosis, we examined prevalence of laboratory abnormalities in older men with and without osteoporosis.",We aim to rate how useful recommended lab testing is to find underlying causes of osteoporosis in older men by looking at the number of older men with lab abnormalities with and without osteoporosis during a specific period.
905,"summarize: Using cross-sectional analyses, we calculated prevalence ratios (PRs) and 95 % confidence intervals (CI) for the association of any and specific laboratory abnormalities with osteoporosis and the number of men with osteoporosis needed to test to identify one additional laboratory abnormality compared to testing men without osteoporosis.","Using cross-sectional analyses, we calculated the association of any and specific laboratory abnormalities with osteoporosis and the number of men with osteoporosis needed to test to identify one additional lab abnormality compared to testing men without osteoporosis.",We checked for links of any lab abnormalities with osteoporosis and the number of men with osteoporosis needed to test to find one more lab abnormality compared to testing men without osteoporosis.
906,summarize: The timing of occurrence of treatment-level (according to 2014 National Osteoporosis Foundation guidelines) or screening-level (according to 2011 US Preventive Services Task Force guidelines) fracture risk scores has not been estimated in postmenopausal women.,the timing of occurrence of treatment-level (according to 2014 National Osteoporosis Foundation guidelines) or screening-level (according to 2011 US Preventive Services Task Force guidelines) fracture risk scores has not been estimated in postmenopausal women.,The timing of treatment-level or screening-level fracture risk scores based on guidelines has not been estimated in women who have gone through menopause (a point in time 12 months after the last period).
907,summarize: Background: Clinical practice guidelines recommend use of fracture risk scores for screening and pharmacologic treatment decisions.,Practicing guidelines recommend using fracture risk scores for screening and drug treatment decisions.,Healtchare guidelines recommend using fracture risk scores for screening and drug treatment decisions.
908,summarize: The timing of occurrence of treatment-level (according to 2014 National Osteoporosis Foundation guidelines) or screening-level (according to 2011 US Preventive Services Task Force guidelines) fracture risk scores has not been estimated in postmenopausal women.,the timing of occurrence of treatment-level (according to 2014 National Osteoporosis Foundation guidelines) or screening-level (according to 2011 US Preventive Services Task Force guidelines) fracture risk scores has not been estimated in postmenopausal women.,The timing of occurence of treatment-level (according to 2014 guidelines by an expert goup) or screening-level (according to 2011 guidelines by national experts) fracture risk scores has not been estimated in postmenopausal women who finished their last menstrual cycle.
909,"summarize: In 6096 women who had FRAX scores calculated with bone mineral density, the estimated unadjusted time to treatment-level FRAX ranged from 7.6 years (95% confidence interval [CI], 6.6-8.7) for those aged 65 to 69, to 5.1 years (95% CI, 3.5-7.5) for those aged 75 to 79 at baseline.","In 6096 women who had FRAX scores calculated with bone mineral density, the estimated time to treatment-level FRAX ranged from 7.6 years for those aged 65 to 69, to 5.1 years for those aged 75 to 79 at the start.","In 6096 women who had fracture risk scores calculated with bone hardness, the estimated unadjusted time to treatment-level fracture risk ranged from 7.6 years for those aged 65 to 69, to 5.1 years, for those aged 75 to 79 at the start."
910,summarize: Background: Existing guidelines for repeat screening and treatment monitoring intervals regarding the use of dual-energy x-ray absorptiometry (DXA) scans are conflicting or lacking.,Background: Existing guidelines for repeat screening and treatment monitoring intervals regarding the use of dual-energy x-ray absorptiometry (DXA) scans are conflicting or lacking.,"Current guidelines disagree or do not exist for how long to wait between checks and treatment check-ins involving the use of dual-energy x-ray absorptiometry (DXA) scans, a technique used by doctors to measure a patient's risk of osteoporosis (a condition in which bones become weak and brittle)."
911,"summarize: Main measures: Two- and five-year cumulative incidence and hazard rations (HR) of repeat DXA by initial screening result (classified into three groups: low or high risk of progression to osteoporosis, or osteoporosis) and whether women were prescribed osteoporosis drugs after initial DXA.","Main measures: Two- and five-year cumulative frequency and risk of repeat DXA by initial screening results (classified into three groups: low or high risk of progression to osteoporosis, or osteoporosis) and whether women were prescribed osteoporosis drugs after initial DXA.","Main test scores included two- and five-year amounts and risks of repeat DXA by initial test results (classified into three groups: low or high risk of worsening to osteoporosis, or osteoporosis) and whether women were given osteoporosis drugs after the first DXA."
912,"summarize: Relative to women with low-risk initial DXA, high-risk initial DXA significantly predicted repeat screening for untreated women [adjusted HR 1.67 (95% CI 1.40-2.00)] but not within the treated group [HR 1.09 (95% CI 0.91-1.30)].","Compared to women with low-risk initial DXA, high-risk initial DXA significantly predicted repeat screening for untreated women but not within the treated group.","Compared to women with low-risk initial DXA, high-risk initial DXA significantly led to repeat screening for untreated women but not within the treated group."
913,"summarize: Osteoporotic fractures, particularly hip fractures, are associated with limitations in ambulation, chronic pain and disability, loss of independence, and decreased quality of life, and 21% to 30% of patients who experience a hip fracture die within 1 year.","Osteoporotic fractures, especially hip fractures, are associated with limitations in ambulation, long-lasting pain and disability, loss of independence, and decreased quality of life. 21% to 30% of patients who experience a hip fracture die within 1 year.","Broken bones from osteoporosis, especially hip breaks, are related to a limited ability to walk, long-term pain and disability, loss of independence, and reduced quality of life. 21% to 30% of people who break a hip die within 1 year."
914,summarize: Objective: To update the 2011 US Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis.,Objective: To update the 2011 US Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis.,We aim to update a 2011 expert panel suggestion on checking for osteoporosis.
915,"summarize: (B recommendation) The USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in postmenopausal women younger than 65 years at increased risk of osteoporosis, as determined by a formal clinical risk assessment tool.",(B recommendation) The USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporosis in postmenopausal women younger than 65 years at increased risk of osteoporosis.,"The expert panel suggests checking for osteoporosis with bone measurement testing to prevent bone breaks from osteoporosis in women younger than 65 years who have gone through menopause who have a greater risk of osteoporosis, as decided by a tool used by doctors to measure risk."
916,"summarize: The prevalence of renal stones has increased from 3.8% in 1970 to 8.8% in 2010 in the United States, with annual healthcare costs of USD 3.8 billion.","the prevalence of kidney stones has increased from 3.8% in 1970 to 8.8% in 2010 in the United States, with annual healthcare costs of 3.8 billion dollars.","The number of kidney stones has increased from 3.8% in 1970 to 8.8% in 2010 in the United States, and yearly healthcare costs are at $3.8 billion."
917,summarize: There are many treatment modalities available for managing renal stones.,There are many treatment options available for managing kidney stones.,There are many treatment methods available for managing kidney stones.
918,summarize: They range from completely non-invasive outpatient procedures to invasive procedures requiring hospital admission and increased risks of complications.,They range from completely non-invasive outpatient procedures to invasive procedures that require hospital admission and increased risks of complications.,These options range from non-invasive (non-surgical) outpatient procedures that do not require hospital stays to invasive (surgical) procedures requiring staying in the hospital and an increased risk of complications.
919,"summarize: Extracorporeal shockwave lithotripsy (ESWL) is a truly non-invasive procedure as opposed to other surgical treatments used, such as retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PCNL).","Extracorporeal shockwave lithotripsy (ESWL) is a truly non-invasive procedure as opposed to other surgical treatments, such as retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PCNL).","Extracorporeal shockwave lithotripsy (ESWL) is a truly non-invasive procedure as opposed to other surgical treatments used, such as retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PCNL) that require an incision into the skin."
920,"summarize: The efficacy of ESWL lies in its ability to pulverize calculi in vivo into smaller segments, which are them expelled spontaneously by the boy.","ESWL works because it can break down calculi in vivo into smaller segments, which are removed spontaneously by the boy.","ESWL is effective because it can crush stones inside the body into smaller parts, which are then released from the body when going to the bathroom."
921,summarize: Shockwaves are generated and are then focused on a point within the body.,Shockwaves are generated and then focused on a point within the body.,Shockwaves are generated and focused on a point within the body.
922,summarize: The shockwaves propagate through the body with minimal dissipation of energy (and therefore damage) due to minimal difference in density of the soft tissues.,shockwaves spread through the body with minimal dissipation of energy (and therefore damage) due to small differences in density of the soft tissues.,The shockwaves go through the body with little damage to surrounding tissues.
923,"summarize: At the stone fluid interface, a relatively significant difference in density, combined with a large concentration of multiple shockwaves in a small area, produces a significant dissipation of energy.","at the stone fluid interface, a relatively significant difference in density, combined with a large concentration of multiple shockwaves in a small area, produces a significant dissipation of energy.","When the stone changes, there is a big difference in the density of the stone which may produce a larger reach of energy due to a lot of shockwaves in a small area of the body."
924,summarize: Repetition of this process leads to the pulverization of the stone into small fragments that the body then can pass painlessly and spontaneously.,Repetition of this process leads to the pulverization of the stone into small fragments that the body then can pass painlessly and spontaneously.,Repeating this process leads to the pulverizing of the stone into small fragments that the body can then pass through the body with no pain.
925,"summarize: The mainstay treatment balances between shockwave lithotripsy (SWL) and ureteroscopy (URS), with the latter usually recommended for larger stones.","The mainstay treatment balances between shockwave lithotripsy (SWL) and ureteroscopy (URS), with the latter usually recommended for larger stones.","Main treatments include using shockwaves or a flexible telescope to help remove kidney stones, with the latter usually recommended for larger stones."
926,summarize: Dissemination of technologies and demonstration of their efficacy and safety will eventually result in new recommendations among international guidelines and evolution of new gold standards.,Dissemination of technologies and demonstration of their effectiveness and safety will eventually result in new recommendations among international guidelines and new gold standards.,Spreading these technologies and demonstrating their success and safety will lead to new recommendations for international guidelines and new standard treatments.
927,summarize: We aimed to evaluate if lasers perform as equal as non-laser devices in patients with kidney stones candidate to PCNL.,"Specifically, the aim of this study is to evaluate if lasers perform as well as non-laser devices in patients with kidney stones who are candidates for PCNL.",This study aims to evaluate if lasers perform as well as non-laser devices in patients with kidney stones.
928,"summarize: The need for stent positioning due to urine extravasation was higher risk in the laser group but the difference did not reach significance (RR:0.49, 95% CI:0.17-1.41 p=0.19).",the need for stent positioning due to urine extravasation was higher risk in the laser group but the difference did not reach significance.,"There is a higher need in the laser group for a thin tube called a stent to be placed in the body to help drain urine, but it is not a major difference between the two groups on needing a stent."
929,summarize: The aim of our study is to compare the efficacy and safety of M-PCNL and RIRS in kidney stone treatment over 50 years old patients.,The aim of this study is to compare the effectiveness and safety of M-PCNL and RIRS in kidney stone treatment over 50 years old patients.,The aim of this study is to compare the effectiveness and safety of M-PCNL and RIRS in kidney stone treatment in patients over 50 years old.
930,"summarize: A total of 125 patients, 65 of whom had RIRS, and 60 of whom had M-PCNL, were included in the study.","125 patients, 65 of whom had RIRS, and 60 of whom had M-PCNL, were included in the study.","A total of 125 patients, 65 who had RIRS, and 60 who had M-PCNL, are included in the study."
931,"summarize: The data between the two groups had similar characteristics in terms of age, gender, BMI, HU, stone size, operation side, stone location, ESWL history, operation time, postoperative transfusion rate, postoperative Clavien complications (p > 0.05).","the data between the two groups had similar characteristics in terms of age, gender, BMI, HU, stone size, operation side, stone location, ESWL history, operation time, transfusion rate, postoperative complications.","The data between the RIRS and M-PCNL groups have similar characteristics in age, gender, BMI, HU, stone size, operation side, stone location, ESWL history, operation time, transfusion rates needed after the procedure, and complications after the procedure."
932,"summarize: When the ASA categories were evaluated, the mean ASA scores, ASA I, and ASA II data had similar characteristics in both groups (p > 0.05).","ASA scores, ASA I, and ASA II data were similar in both groups.","When the ASA categories are evaluated to determine the risk of surgery before the procedure, the average ASA scores, ASA I, and ASA II data had similar characteristics in both groups."
933,"summarize: When the ASA 3 scores were evaluated, the number of ASA III patients in the RIRS group was statistically significantly higher (p  0.05).","ASA 3 scores were evaluated, the number of ASA III patients in the RIRS group was statistically significantly higher.","When the ASA 3 scores are evaluated, the number of ASA III patients in the RIRS group is statistically significantly (the result is unlikely to be random or by chance) higher."
934,summarize: Background: This study aimed to assess the efficacy and safety of minimally invasive percutaneous nephrolithotomy (MPCNL) versus standard percutaneous nephrolithotomy in patients with renal and upper ureteric stones.,this study aimed to assess the effectiveness and safety of minimally invasive percutaneous nephrolithotomy (MPCNL) versus standard percutaneous nephrolithotomy (MPCNL) in patients with kidney and upper ureteric stones.,"This study aims to assess the effectiveness and safety of minimally invasive percutaneous nephrolithotomy (MPCNL), when a doctor makes a small incision in the patient and uses a scope to remove kidney stones versus the standard percutaneous nephrolithotomy that uses a larger instrument to remove stones."
935,"summarize: Besides, the vacuum suction effect in MPCNL played a more important role.","Besides, the vacuum suction effect in MPCNL played a more important role.","Additionally, the vacuum suction effect in MPCNL played a more important role."
936,"summarize: After positioning in either the supine or prone position, a cystoscopy is performed to place an open-ended catheter, occlusion balloon, or Accordian device into the collecting system.","after positioning in either the supine or prone position, a cystoscopy is performed to place an open-ended catheter, occlusion balloon, or Accordian device into the collecting system.","When lying either flat on the back (supine position) or on the stomach and face down (prone position), a hollow tube with a lens is inserted into the urethra tube that goes to bladder to allow another device such as a catheter (a clean tube that goes into the bladder) into the collecting system which is the series of tubes and ducts of the kidney."
937,"summarize: Once access is obtained, a small 0.5 cm skin incision is made and the percutaneous tract is dilated over a wire.","Once access is obtained, a small 0.5 cm skin incision is made and the percutaneous tract is dilated over a wire.","Once access is obtained, a small incision (cut) on the skin is made, and the tract through the skin is increased in size."
938,summarize: A 16.5F metallic or self-dilating suctioning access sheath is positioned with fluoroscopic guidance.,16.5F metallic or self-dilating suctioning access sheath is placed with fluoroscopic guidance.,A device called a suctioning access sheath is positioned to act like a vacuum and absorb fragments.
939,summarize: Guidelines for postoperative care and troubleshooting techniques for mini-PCNL are reviewed along with the surgical steps in the accompanying video (Supplementary Video S1).,guidelines for care after surgery and troubleshooting techniques for mini-PCNL are reviewed along with the surgical steps in the accompanying video.,Guidelines for care after the procedure and for troubleshooting techniques for mini-PCNL are reviewed along with the surgical steps in an available video.
940,"summarize: Details of technique, operative time, outcomes, need for further treatments, complications, and patients' satisfaction were evaluated.","Details of technique, operative time, outcomes, need for further treatments, complications, and patients' satisfaction were evaluated.","Details of the technique, how long the procedure takes, results, need for additional treatments, complications, and patients' satisfaction are evaluated."
941,"summarize: Although SA is usually adopted in unfit patients for GA, it may be considered as a viable alternative in fit patients.","Although sham ablation is usually used in unfit patients for GA, it may be considered as a viable alternative in fit patients.","Although spinal anesthesia is usually used in unfit patients for general anesthesia, it may be considered as a good alternative in fit patients."
942,"summarize: Introduction: We determine the effect of patient characteristics (age, sex, and body mass index BMI) and stone characteristics (density, location, and size) by non-contrast computed tomography of the kidneys, ureters, and bladder (CT-KUB) in predicting the success of extracorporeal shock wave lithotripsy (ESWL) in the treatment of kidney and ureteric stones.","Using non-contrast computed tomography of the kidneys, ureters, and bladder (CT-KUB) in predicting the success of extracorporeal shock wave lithotripsy (ESWL) in the treatment of kidney and ureteric stones.","Extracorporeal shock wave lithotripsy (ESWL) is a procedure to break up stones in the body by using shock waves and an X-ray to target the stones. Researchers search for the effects of patient characteristics (age, sex, and body mass index or BMI) and stone characteristics (density, location, and size) on how successful ESWL procedure is on stones in the kidneys, ureters (tubes that carry urine from the kidney to the urinary bladder), and bladder."
943,summarize: ESWL was successful if post-treatment residual renal stone fragments were â3 mm and for ureteric stones should be totally cleared.,ESWL was successful if residual kidney stone fragments after treatment were less than 3mm in diameter and for urinary stones should be completely cleared.,ESWL is considered to be successful if the size of remaining kidney stone fragments after the procedure are â3 mm and if ureteric stones are totally cleared.
944,summarize: Conclusions: This study shows that determination of stone density and stone size on CT KUB pre ESWL can help to predict the outcome of ESWL.,Conclusions: This study shows that determination of stone density and stone size on CT KUB before ESWL can help predict the outcome of ESWL.,"In conclusion, this study shows that finding out the density and size of stones using a scanned x-ray image before extracorporeal shock wave lithotripsy (ESWL) can help predict the outcome of ESWL."
945,summarize: The analysis made it possible to identify factors promoting the development of infectious and inflammatory complications.,The analysis made it possible to identify factors promoting the development of infectious and inflammatory complications.,The analysis makes it possible to find things that lead to the development of infectious or inflammatory complications.
946,summarize: The introduction of technologically advanced methods of lithotripsy into medical practice changes the nature of postoperative complications.,The introduction of technologically advanced methods of lithotripsy into medical practice changes the nature of complications after surgery.,New advanced technology for breaking up stones in the kidney and the tube to the bladder changes the nature of issues after operation.
947,"summarize: Among them, the main complications are inflammatory infections.","Among them, the main complications are infections caused by inflammation.","Among them, the main issues are inflammatory infections."
948,summarize: The method of controlled stone fragmentation by a diode laser with a hot-spot effect was tested on postoperative samples of 26 renal calculi.,the method of controlled stone fragmentation by a diode laser with a hot-spot effect was tested on samples of 26 kidney calculi.,The method of controlled breaking up of stones with a special laser with a hot-spot was tested on 26 kidney stone samples collected after surgery.
949,"summarize: Results: In the percutaneous nephrolithotripsy group, postoperative infectious and inflammatory complications occurred in 34.1% of cases, in the percutaneous nephrolithoextraction group - in 24.6%, in the contact ureterolithotripsy group - in 7.8%, in the ureterolithoextraction group - in 2.5%.","In the percutaneous nephrolithotripsy group, post-operation infections and inflammatory complications occurred in 34.1% of cases, in the percutaneous nephrolithoextraction group (a group that uses a needle to remove stones), in 24.6%, in the contact ureterolithotripsy group (a group that uses a laser to remove stones), in 7.8%, in the ureterolithoextraction group (a group that uses a catheter to remove stones) in 2.5%.","In the group that had a small cut to remove kidney stones, infections and inflammatory issues after surgery occured in 34.1% of cases. In the group that had a cut and small tube to remove stones, infections and issues occured in 24.6%. In the group that had a small cut to remove stones in the urine, infections and issues occured in 7.8%. In the group that had a cut and tube to remove stones, infections and issues occured in 2.5%."
950,"summarize: Conclusion: The method of laser-induced controlled coarse fragmentation of stones with a hot-spot effect, developed and tested in clinical practice, is promising for the prevention of infectious and inflammatory complications in patients with potentially infected stones since their fine fragmentation and, consequently, spread of stone-associated toxins and microflora within the urinary system is avoided.","the method of laser-induced controlled fragmentation of stones with a hot-spot effect, developed and tested in clinical practice, is promising for the prevention of infectious and inflammatory complications in patients with potentially infected stones since their fine fragmentation and, consequently, spread of stone-associated toxins and microflora within the urinary system is avoided.","The method of using a laser with a hot-spot to break up stones, developed and tested in clinical practice, may prevent infectious and inflammatory effects in patients with possibly infected stones since their previous stone fragmentation. This method may also prevent spread of stone-associated toxins and bacteria in the urinary system."
951,"summarize: Three of 6 target cognitive measures (Digit Symbol, Stroop, Controlled Oral Word Association) revealed significant test-retest differences between the pregabalin and placebo groups, all showing negative effects with pregabalin (p  0.05).","3 of 6 cognitive measures (Digit Symbol, Stroop, Controlled Oral Word Association) showed significant test-retest differences between the pregabalin and placebo groups, all showing negative effects with pregabalin.","Three of 6 cognitive measures revealed significant test-retest differences between the pregabalin and placebo groups, all showing negative effects with pregabalin."
952,summarize: Class of Evidence: This study provides Class I evidence that pregabalin 300 mg BID negatively impacts cognition on some tasks in healthy volunteers.,Pregabalin 300 mg BID negatively impacts cognition on some tasks in healthy volunteers.,This study provides evidence that pregabalin 300 mg negatively impacts cognition on some tasks in healthy volunteers.
953,summarize: The aim of the present study was to investigate the changes in several core cognitive functions after successful treatment of long-term BDZ use and dependence with PGB.,The aim of this study was to investigate the changes in several core cognitive functions after successful treatment of long-term BDZ use and dependence with PGB.,The goal of the study was investigate the changes in cognitive function after successful treatment of long-term BDZ use and dependence with PGB.
954,"summarize: Despite their significant improvement, patients' scores on most tests remained still at the lower percentiles of CANTAB normative scores.","Despite their significant improvement, patients' scores on most tests remained at the lower percentiles of CANTAB normative scores.","Despite their significant improvement, patients' scores on most tests were low when compared to control scores."
955,"summarize: A bedside electroencephalogram was performed to rule out nonconvulsive status epilepticus, which showed continuous triphasic waves (TWs) with slow background activity.","a bedside electroencephalogram was performed to rule out nonconvulsive status epilepticus, which showed continuous triphasic waves (TWs) with slow background activity.","A bedside test for brain activity was performed to rule out nonconvulsive status epilepticus, or a prolonged seizure. The test showed continuous triphasic waves (TWs), which is abnormal body activity, with slow background activity."
956,summarize: We present a rare case of PBG-induced TWs thereby highlighting the extent of the etiologic spectrum of TWs and discussing the literature related to this association.,the authors present a rare case of PBG-induced TWs. This study highlights the extent of the cause and discusses the literature related to this association.,"This study presents a rare case of PBG-induced TWs. This paper highlighting the extent of the etiologic spectrum of TWs, or how TWs promote disease. Additionally, the paper discusses the literature related to this association (or link)."
957,summarize: Conclusion: Gastroretentive gabapentin demonstrated reduced driving impairment and lower scores on key neurotoxicity measures.,Gastroretentive gabapentin showed reduced driving impairment and lower scores on key neurotoxicity measures.,The study concluded gastroretentive gabapentin reduced driving impairment and showed lower scores on key neurotoxicity (abnormal nervous system function) measures.
958,summarize: Placebo rates for cognitive side effects ranged from 0 to 10.6% while those for fatigue ranged from 2.5 to 37.7%.,Placebo rates for cognitive side effects ranged from 0 to 10.6% while those for fatigue ranged from 2.5 to 37.7%.,Placebo (harmless pills) rates for cognitive side effects ranged from 0 to 10.6% while those for fatigue ranged from 2.5 to 37.7%.
959,"summarize: A randomized, parallel group, placebo-controlled investigation in 80 donor nephrectomy patients was previously performed that evaluated the analgesic, opioid-sparing, and antihyperalgesic effects of pregabalin.","nephrectomy patients were previously treated with pregabalin. The study evaluated the painkilling, opioid-sparing, and antihyperalgesic effects of pregabalin.","A study in 80 patients that had one or both of their kidneys removed was previously conducted to evaluate the opioid-sparing, analgesic, and antihyperalgesic (reduction of pain sensitivity) effects of pregabalin."
960,summarize: This article describes a secondary exploratory analysis that tested the hypothesis that pregabalin would impair cognitive function compared to placebo.,this article describes a secondary study that tested the hypothesis that pregabalin would impair cognitive function compared to placebo.,This paper describes a secondary investigation that tested if pregabalin would impair cognitive function when compared to a control (no treatment) group.
961,summarize: Alpha tocopherol treatment significantly attenuated the deleterious effects induced by pregabalin.,Alpha tocopherol treatment significantly reduced the harmful effects induced by pregabalin.,Alpha tocopherol treatment significantly reduced the harmful effects induced by pregabalin.
962,"summarize: Herpes zoster is an acute, painful, herpes skin disease caused by varicella-zoster virus, which may cause viral meningitis.","Herpes zoster is an acute, painful, herpes skin disease caused by varicella-zoster virus, which may cause viral meningitis.","Herpes zoster (shingles) is an immediate, painful, skin disease involved with reactivating the chickenpox virus. It may cause viral meningitis (inflamation of the brain and spine)."
963,"summarize: We describe a 68-year-old female patient with herpes zoster, and she was treated with pregabalin.","68-year-old female patient with herpes zoster, and she was treated with pregabalin.",We describe a 68-year-old female with herpes zoster and treated with pregabalin.
964,"summarize: In this case, the etiology of stuttering and frequent blepharospasm may be related to pregabalin.","In this case, the cause of stuttering and frequent blepharospasm may be related to pregabalin.","In this case, the cause of stuttering and eye twitching may be linked to pregabalin."
965,summarize: Clinicians should be alert to the rare symptoms associated with the use of pregabalin.,doctors should be alert to the rare symptoms associated with the use of pregabalin.,Clinicians should be alert to the rare symptoms linked with pregabalin use.
966,summarize: Central nervous system adverse effects are commonly reported with pregabalin (PGB).,negative effects on the nervous system are often reported with pregabalin (PGB).,"Central nervous system (brain and spinal cord) adverse effects (side effects) are commonly reported with pregabalin (PGB), a drug commonly given for nerve pain."
967,summarize: The time from PGB withdrawal to recovery was  1 week at 77%.,the time from PGB withdrawal to recovery was  1 week at 77%.,The time from PGB withdrawal to recovery was less than 1 week for a majority of cases.
968,summarize: The best management for all MDs is probably PGB withdrawal.,The best treatment for all MDs is probably PGB withdrawal.,The best management for all MDs is probably PGB withdrawal.
969,"summarize: However, their occurrence could significantly affect the quality of life of PGB users.","However, their presence could significantly affect the quality of life of PGB users.","Still, their occurence could affect the quality of life of PGB users."
970,summarize: The best management for all MDs is probably PGB withdrawal.,The best treatment for all MDs is probably PGB withdrawal.,The best treatment for all MDs is likely PGB drug use stoppage.
971,summarize: This study included eighty adult male albino rats which were divided into three groups.,This study included eighty adult male albino rats which were divided into three groups.,This study included eighty adult male albino rats which were divided into three groups.
972,"summarize: Further, the dependent dose was given daily for another 2 months.",The dependent dose was given daily for another 2 months.,"Further, the dependent dose was given daily for another 2 months."
973,summarize: The specimens were taken from the frontal cortex for histologic and immunohistochemical staining as well as morphometric analysis.,the specimens were taken from the frontal cortex for histologic and immunohistochemical staining as well as morphometric analysis.,"Samples were taken from the frontal cortex, a section of the brain, for further analysis."
974,summarize: The PGB- induced neurotoxic effects persisted after withdrawal.,PGB- induced neurotoxic effects continued after withdrawal.,The PGB- induced neurotoxic effects continued after withdrawal.
975,"summarize: Furthermore, it is recommended to quantify the behavioral changes related to PGB dependence as well as withdrawal in future studies.","Moreover, it is recommended to quantify the behavior changes related to PGB dependence and withdrawal in future studies.","Furthermore, it is recommended to measure the behavioral changes related to PGB dependence and withdrawal in future studies."
976,"summarize: Additional factors associated with pressure ulcer development include cerebrovascular accident, impaired nutritional intake, urinary or fecal incontinence, hypoalbuminemia, and previous fracture.","Additional factors associated with pressure ulcer development include brain injury, impaired nutrition, urinary or fecal incontinence, low levels of albumin (a protein that helps regulate blood sugar), and previous fractures.","Additional reasons pressure ulcers develop include cerebrovascular accident (damage to the brain and its blood vessels) or impaired nutritional intake (poor diet). Additionally, reasons include urinary or fecal incontinence (lack of control on bladder or bowels), hypoalbuminemia (low blood albumin - a protein in the blood), and previous fracture."
977,"summarize: If the ulcer is full thickness (stage III and IV), it is secondary to pressure or shearing forces.","If the ulcer is full thickness (stage III and IV), it is secondary to pressure or shearing forces.","If the ulcer is full thickness (stage III and IV), it is secondary to (caused by) pressure or shearing forces."
978,"summarize: Antibiotic therapy is indicated only upon evidence of infection (cellulitis, osteomyelitis, leukocytosis, bandemia, or fever).","Antibiotic therapy is indicated only upon evidence of infection (cellulitis, osteomyelitis, leukocytosis, bandemia, or fever).",Taking antibiotics (which fight bacteria) is used if there is evidence of infection.
979,"summarize: These products may improve healing rates but also offer improved comfort to the patient, reduced dressing time and improved cosmesis.","These products may improve healing rates but also offer improved comfort to the patient, reduced dressing time and improved cosmesis.","These products may improve healing rates. They may also offer improved comfort to the patient, reduced dressing time, and improved wound appearance."
980,"summarize: However, healing is unlikely to be achieved unless the factors that contribute to ulcer formation are addressed.","However, healing is unlikely to be achieved unless the factors that contribute to ulcer formation are addressed.","However, healing is unlikely to occur unless the reasons the ulcer was formed are addressed."
981,"summarize: Principles of management include the elimination or reduction of pressure and other contributing factors, treatment of infection, appropriate wound management, involvement and education of the patient and caregivers, and maintenance of healed tissue.","Principles of management include the elimination or reduction of pressure and other contributing factors, treatment of infection, appropriate wound management, involvement and education of the patient and caregivers, and maintenance of healed tissue.","There are several principles of ulcer management or healing. These principles include: eliminating or reducing pressure and other contributing factors, treating infection, appropriate wound management, involvement and education of the patient and caregivers, and maintenance of healed tissue."
982,summarize: Use of assessment tools that quantify the primary risk factors for the development of pressure ulcers is helpful in predicting and preventing compromise of tissue.,Use of assessment tools that quantify the primary risk factors for the development of pressure ulcers is helpful in predicting and preventing tissue damage.,Use of assessment (measurement) tools that identify the main reasons pressure ulcers are caused is helpful to predict and prevent injuries to the skin.
983,"summarize: Guidelines for prevention include identifying patients at risk, reducing the effect of pressure, friction, shear forces, and assessing co-morbidities such as nutritional status.","Guidelines for prevention include identifying patients at risk, reducing the effect of pressure, friction, shear forces, and assessing co-morbidities such as nutritional status.","Advice on how to prevent getting pressure ulcers include identifying patients at risk, reducing pressure, friction, shear forces, and assessing (measuring) compounding factors such as nutritional status."
984,"summarize: Mechanical, enzymatic, and autolytic debridement methods are nonurgent treatments.","mechanical, enzymatic, and autolytic debridement methods are non-urgent treatments.","Mechanical (surgery), enzymatic (chemical agents), and autolytic debridement (body's natural defense system) methods are nonurgent treatments."
985,summarize: Bacterial load can be managed with cleansing.,bacteria load can be managed with cleaning.,"Bacterial load, or the amount of bacteria within the body, can be managed with cleansing."
986,"summarize: Predisposing factors are classified as intrinsic (e.g., limited mobility, poor nutrition, comorbidities, aging skin) or extrinsic (e.g., pressure, friction, shear, moisture).","Predisposing factors are classified as intrinsic (e.g., limited mobility, poor nutrition, comorbidities, aging skin) or extrinsic (e.g., pressure, friction, shear, moisture).","Risk factors can be intrinsic (e.g., limited movement, poor diet, other diseases, aging skin) or extrinsic (e.g, pressure, friction, strain, moisure)."
987,summarize: Urgent sharp debridement should be performed if advancing cellulitis or sepsis occurs.,Urgent sharp debridement should be performed if advancing cellulitis or sepsis occurs.,Urgent debridement should be done if bacterial skin infections develop.
988,"summarize: Wound cleansing, preferably with normal saline and appropriate dressings, is a mainstay of treatment for clean ulcers and after debridement.","Wound cleansing, preferably with normal saline and appropriate dressings, is a mainstay of treatment for clean ulcers and after debridement.","Wound cleaning, preferably with salt water and appropriate bandages, are common treatment for clean bedsores and after removing damaged body tissue."
989,summarize: Topical antibiotics should be considered if there is no improvement in healing after 14 days.,Topical antibiotics should be considered if there is no improvement in healing after 14 days.,Antibiotics applied skin-level should be considered if there is no healing after 14 days.
990,"summarize: Comprehensive evidence is required to facilitate decision making, regarding the benefits and harms of using anabolic steroids.","Detailed evidence is needed to help decision making, regarding the benefits and harms of using anabolic steroids.",Thorough evidence is required to encourage decision making in regards to the benefits and harms of using anabolic steroids.
991,"summarize: Main results: The review contains only one trial with a total of 212 participants, all with spinal cord injury and open pressure ulcers classed as stage III and IV.","the main results are only one study with a total of 212 participants, all with spinal cord injury and open pressure ulcers classed as stage III and IV.","The review contains a medical trial of 212 participants, all with spinal cord injury and open pressure ulcers classed as stage III and IV."
992,"summarize: There was very low-certainty evidence on the relative effect of oxandrolone on complete ulcer healing at the end of a 24-week treatment period (risk ratio RR) 0.81, 95% confidence interval (CI) 0.52 to 1.26) (downgraded twice for imprecision due to an extremely wide 95% CI, which spanned both benefit and harm, and once for indirectness, as the participants were mostly male spinal cord injury patients).",oxandrolone had very low-certainty evidence on the relative effect of oxandrolone on complete ulcer healing at the end of a 24-week treatment period.,There was very low-certainty evidence on the relative effect of oxandrolone on complete ulcer healing at the end of a 24-week treatment period.
993,"summarize: Thus, the treatment with oxandrolone may increase the risk of non-serious adverse events reported in participants.","Hence, the treatment with oxandrolone may increase the risk of non-serious side effects reported in participants.",Treatment with oxandrolone may increase the risk of non-serious negative side events reported in participants.
994,"summarize: There was very low-certainty evidence on the risk of serious adverse events reported in participants treated with oxandrolone compared with placebo (RR 0.54, 95% CI 0.25 to 1.17) (downgraded twice for imprecision due to an extremely wide 95% CI, which spanned both benefit and harm, and once for indirectness, as the participants were mostly male spinal cord injury patients).",oxandrolone was used to treat spinal cord injury. The risk of serious side effects was low in participants treated with oxandrolone compared with placebo.,There was very low-certainty evidence on the risk of serious adverse events reported in participants treated with oxandrolone compared with placebo.
995,"summarize: Secondary outcomes such as pain, length of hospital stay, change in wound size or wound surface area, incidence of different type of infection, cost of treatment and quality of life were not reported in the included trial.","secondary outcomes such as pain, length of hospital stay, change in wound size or surface area, frequency of different type of infection, cost of treatment and quality of life were not reported in the included trial.","Secondary outcomes were not reported in the included trial. Secondary outcomes include pain, length of hospital stay, change in wound size or wound surface area, incidence of different type of infection, cost of treatment, and quality of life."
996,summarize: Overall the evidence in this study was of very low quality (downgraded for imprecision and indirectness).,overall the evidence in this study was of very low quality (downgraded for imprecision and indirectness).,Overall the evidence in this study was of very low quality. This is due to lack of precision (low confidence in results) and indirectness (only males were evaluated) in data.
997,"summarize: Background: Pressure ulcers, also known as pressure injuries and bed sores, are localised areas of injury to the skin or underlying tissues, or both.","Pressure ulcers, also known as pressure injuries and bed sores, are localised areas of injury to the skin or underlying tissues, or both.","Pressure ulcers, also known as pressure injuries and bed sores, are localized areas of injury to the skin or underlying tissues, or both."
998,"summarize: Dressings made from a variety of materials, including foam, are used to treat pressure ulcers.","Dressings made from a variety of materials, including foam, are used to treat pressure ulcers.","Dressings made from a variety of materials, including foam, are used to treat pressure ulcers."
999,summarize: We had very little confidence in the estimate of effect of included studies.,the estimates of effect of included studies were not reliable.,The authors had very little confidence in the estimate of effect of included studies.
1000,summarize: We present data for four comparisons.,The authors present data for four comparisons.,The authors present data for four comparisons.
1001,"summarize: It was uncertain whether foam dressings affected the probability of healing in comparison to hydrocolloid dressings over a short follow-up period in three trials (RR 0.85, 95% CI 0.54 to 1.34), very low-certainty evidence, downgraded for very serious study limitations and serious imprecision.","the probability of healing was uncertain whether foam dressings affected the probability of healing compared to hydrocolloid dressings over a short follow-up period in three trials. It was unclear whether foam dressings affected the probability of healing in comparison to hydrocolloid dressings over a short time period. There was low certainty of evidence, downgraded for serious study limitations and imprecision.",It was unclear whether foam dressing affected healing in comparison to hydrocolloid dressings over a short follow-up period in three trials. It is unclear as there was low certainty of evidence with serious study limitations and imprecision.
1002,"summarize: One trial (34 participants), compared foam and hydrogel dressings over an eight-week (short-term) follow-up.","one trial (34 participants), compared foam and hydrogel dressings over an eight-week (short-term) follow-up.",One trial with 34 participants compared foam and hydrogel dressings over an eight-week (short-term) follow-up.
1003,summarize: We assessed the certainty of the evidence in the included trials as low to very low.,the certainty of the evidence in the included trials was low to very low.,The authors determined the certainty of the evidence in the included trials as low to very low.
1004,summarize: Wound pressure injuries have been given various names over the last several years.,Wound pressure injuries have been given various names over the last several years.,Wound pressure injuries (skin sores) have been given various names over the last several years.
1005,summarize: This can be from a bony area on the body coming into contact with an external surface which leads to pressure injury.,This can be from a bony area on the body coming into contact with an external surface which leads to pressure injury.,Pressure injuries can come from a bony area on the body coming into contact with an external surface.
1006,summarize: These wounds represent the destruction of normal structure and function of the skin and soft tissue through a variety of mechanisms and etiologies.,These wounds represent the destruction of normal structure and function of the skin and soft tissue through a variety of mechanisms and causes.,"Pressure injuries represent the breakdown of normal structure and function of the skin and soft tissue. Soft tissue includes muscles, fat, blood vessels, nerves, tendons, and tissues surrounding bones and joints. Pressure injuries are formed through several different mechanisms and causes."
1007,"summarize: In pressure ulcers, the external pressure exceeds capillary closing pressure.","In pressure ulcers, the external pressure exceeds capillary closing pressure.","In pressure ulcers, the outside pressure is greater than blood vessel closing pressure."
1008,summarize: The wound healing property of the loaded hydrocolloid films was explored in a rat model and in a clinical trial (sacrum pressure ulcer).,the wound healing property of the loaded hydrocolloid films was explored in a rat model and in a clinical trial (sacrum pressure ulcer).,The wound healing property of the hydrocolloid films was explored in a rat model. The wound healing property was also explored in a human clinical trial looking at lower back pressure ulcers (skin sores).
1009,summarize: Results: The films showed an adequate water-uptake capacity between 100-160%.,The films showed an adequate water-uptake capacity between 100-160%.,The films showed an adequate water-uptake capacity between 100-160%.
1010,summarize: The incorporation of the bioactive extracts in the polysaccharide films inhibited the topical edematous response by about 50%.,The incorporation of the bioactive extracts in the polysaccharide films inhibited the skin-level edematous response by about 50%.,Adding plant extracts into the films blocked the skin swelling by around 50%.
1011,"summarize: In this time of mandatory personal protective equipment requirements in healthcare facilities, protection and assessment of skin in the vulnerable postauricular area are needed.","In this time of mandatory personal protective equipment requirements in healthcare facilities, protection and assessment of skin in the vulnerable postauricular area are needed.",Right now is a time of mandatory personal protective equipment requirements in healthcare facilities. Continual wear of personal protective equipment requires care for and assessment (evaluation) of the skin of the ear.
1012,summarize: Treating Mask-Related Pressure Injury: Begin by removing the offending device.,Mask-Related Pressure Injury: Start by removing the offending device.,"When treating a mask-related pressure injury, you first begin by removing the mask."
1013,"summarize: The case of a patient with chronic PI who has been treated with APRP is presented, achieving resolution of the lesion.","the case of a patient with chronic PI who has been treated with APRP is presented, achieving resolution of the lesion.","The case of a patient with chronic PI who has been treated with APRP is presented, achieving resolution (healing) of the lesion (wound)."
1014,"summarize: However, clinical feature of PPA based on AÎ2 positivity remains unclear.","Nevertheless, clinical features of PPA based on AÎ2 positivity remains unclear.","However, diagnosis of PPA based on AÎ2 positivity (presence) remains unclear."
1015,"summarize: Further, we observed that more than 90%(13/14) of the patients with A+ PPA had tau deposition.",13/14) of the patients with A+ PPA had tau deposition.,"Also, over 90% (13/14) patients with A+ PPA had tau, a brain protein associated with Alzheimer's disease."
1016,summarize: Recent advancements in metabolomics research have led to improved capabilities to explore human metabolic profiles in breath.,Recent advances in metabolomics research have led to improved abilities to explore human metabolic profiles in breath.,Recent advancements in metabolomics research have led to better opportunities to explore human metabolic profiles in depth. Metabolomics is the study of metabolites within the body. Metabolites are small substances involved in cell metabolism or energy-production.
1017,"summarize: Despite some notable challenges in sampling and analysis, exhaled breath represents a desirable medium for metabolomics applications, foremost due to its non-invasive, convenient and practically limitless availability.","Despite some notable challenges in sampling and analysis, exhaled breath is a desirable medium for metabolomics applications, foremost due to its non-invasive, convenient and practically unlimited availability.","Despite some test challenges, exhaled breath represents a good sample for metabolomics applications. Breath is ideal as it is non-invasive, convenient, and nearly limitless in availability."
1018,summarize: This review outlines the concept of breath analysis in the context of these unique tests and their applications.,this review outlines the concept of breath analysis in the context of these unique tests and their applications.,This paper reviews the concept of breath analysis used for these unique tests and their applications.
1019,summarize: The paper concludes with a brief insight into prospective tests and an outlook of the future direction of breath research.,the paper concludes with a brief insight into prospective tests and an outlook of the future direction of breath research.,The paper concludes with a brief insight into prospective (future) tests and an outlook of the future direction of breath research.
1020,"summarize: Despite some notable challenges in sampling and analysis, exhaled breath represents a desirable medium for metabolomics applications, foremost due to its non-invasive, convenient and practically limitless availability.","Despite some notable challenges in sampling and analysis, exhaled breath is a desirable medium for metabolomics applications, foremost due to its non-invasive, convenient and practically unlimited availability.","Despite some methodological challenges, exhaled breath is a desirable tool for metabolomics due to its non-surgery, convenient, and limitless availability."
1021,summarize: The paper concludes with a brief insight into prospective tests and an outlook of the future direction of breath research.,the paper concludes with a brief insight into prospective tests and an outlook of the future direction of breath research.,The paper ends with a short look into future tests and direction of breath research.
1022,summarize: Elevated expression of Î2-amyloid (AÎ21-42) and tau are considered risk-factors for Alzheimer's disease in healthy older adults.,Elevated expression of Î2-amyloid (AÎ21-42) and tau are considered risk-factors for Alzheimer's disease in healthy older adults.,"Increased amounts of Î2-amyloid (AÎ21-42) and tau, biological proteins, are considered risk factors for Alzheimer's disease in healthy, older adults."
1023,"summarize: Biomarkers are classified into several categories depending on whether they address personal or predictive susceptibility, diagnosis, prognosis, disease activity, or response to treatment in different clinical courses of MS.","Biomarkers are classified into several categories depending on whether they address personal or predictive susceptibility, diagnosis, prognosis, disease activity, or response to treatment in different clinical courses of MS.","Biomarkers are classified into several categories. These categories depend on whether the biomarkers address personal or predictive susceptibility (or risk), diagnosis, disease forecast (or progression), disease activity, or response to treatment in different clinical courses of MS."
1024,"summarize: Despite the development of chemical, radiological, and immunotherapies, many patients do not benefit from these therapies, as recurrence is common.","Despite the development of chemical, radiological, and immunotherapies, many patients do not benefit from these therapies, as recurrence is common.","Despite the development of several therapy types, many patients do not benefit from these therapies. Recurrence, or the return of lung cancer, is common."
1025,summarize: Validation of scRNA-seq differentially expressed genes (DEGs) through quantitative real time-polymerase chain reaction (qRT-PCR) found a positive correlation in fold-change values between C-X-C motif chemokine ligand 1 (CXCL1) and 2 (CXCL2) compared with bulk-cell level in 34 primary lung adenocarcinomas (LUADs) from Stage I patients.,scRNA-seq differentially expressed genes (DEGs) were found to have a positive correlation between C-X-C motif chemokine ligand 1 (CXCL1) and 2 (CXCL2) compared with bulk-cell level in 34 primary lung adenocarcinomas (LUADs) from Stage I patients.,"The analysis found a positive correlation (link) between a gene and a chemokine, both with roles in a pro-inflammatory or infection-fighting response, in human lung cancer cells taken from cancer patients. Chemokines are signaling proteins that attract white blood cells to infection sites."
1026,summarize: This literature review focuses on the role of disease biomarkers in the management of patients with diabetic retinopathy (DR) investigating in detail the problem of retinal neurodegeneration in such patients.,"this review focuses on the role of disease biomarkers in the management of patients with diabetic retinopathy (DR), a type of retinal neurodegeneration, in such patients.","This review article focuses on the role of biological disease markers in treating patients with diabetic retinopathy (DR), or eye diseases from diabetes. The article also investigates how nerve cells in the eye die in these patients."
1027,summarize: They are associated with incompetence of valves in the deep leg veins and venous hypertension.,They are associated with incompetence of valves in the deep leg veins and venous hypertension.,They are associated with incompetence of valves in the deep leg veins and venous hypertension (high blood pressure in veins).
1028,summarize: They are associated with incompetence of valves in the deep leg veins and venous hypertension.,They are associated with incompetence of valves in the deep leg veins and venous hypertension.,Venous leg ulcers are linked to high blood pressure in impaired leg veins.
1029,"summarize: The main approaches in the management of venous leg ulcers have been to reduce the 'back pressure' in the veins by surgical removal of any varicose veins, postural drainage (elevation of the legs when the patient is lying or seated), and use of compression therapy with bandages, hosiery or intermittent pneumatic compression.","the main approaches in the management of venous leg ulcers have been to reduce the 'back pressure' in the veins by surgical removal of any varicose veins, postural drainage (elevation of the legs when the patient is lying or sitting), and use of compression therapy with bandages, hosiery or intermittent pneumatic compression.","Main treatments of venous leg ulcers have been to reduce pressure in veins by surgical removal of enlarged veins, drainage using gravity, and compression from bandages, legwear, or inflatable leg sleeves."
1030,"summarize: In this article, we review the efficacy and discuss correct use of compression therapy.","In this article, we review the effectiveness and discuss correct use of compression therapy.","In this article, we review the effectiveness and correct use of compression therapy."
1031,"summarize: Prevention and treatment of venous ulcers is aimed at reducing the pressure either by removing / repairing the veins, or by applying compression bandages / stockings to reduce the pressure in the veins.","Prevention and treatment of venous ulcers is aimed at reducing the pressure either by removing/repairing the veins, or by applying compression bandages / stockings to reduce the pressure in the veins.",Prevention and treatment of venous ulcers is aimed at reducing the pressure. This is achieved by removing or repairing the veins. It can also be achieved by applying compression material to reduce vein pressure.
1032,summarize: One trial (300 patients) compared high (UK Class 3) compression hosiery with moderate (UK Class 2) compression hosiery.,one trial (300 patients) compared high (UK Class 3) compression hosiery with moderate (UK Class 2) compression hosiery.,One trial (300 patients) compared high compression hosiery with moderate compression hosiery.
1033,summarize: Compliance rates were significantly higher with medium compression than with high compression hosiery.,Compliance rates were significantly higher with medium compression than with high compression hosiery.,"Compliance rates, or the amount of people who used compression consistently, were higher with medium compression than with high compression hosiery."
1034,summarize: Both trials reported that not wearing compression hosiery was strongly associated with ulcer recurrence and this is circumstantial evidence that compression reduces ulcer recurrence.,Both trials reported that not wearing compression hosiery was strongly associated with ulcer recurrence. This is circumstantial evidence that compression reduces ulcer recurrence.,Both trials reported that not wearing compression hosiery was strongly associated with ulcer recurrence. This is circumstantial evidence that compression reduces ulcer recurrence.
1035,summarize: No trials were found which evaluated compression bandages for preventing ulcer recurrence.,No studies were found that evaluated compression bandages for preventing ulcer recurrence.,No studies that evaluated compression bandages for preventing ulcer recurrence were found.
1036,summarize: Recurrence rates may be lower in high compression hosiery than in medium compression hosiery and therefore patients should be offered the strongest compression with which they can comply.,Recurrence rates may be lower in high compression hosiery than in medium compression hosiery and therefore patients should be offered the strongest compression with which they can comply.,"Third, recurrence rates may be lower if patients wear high compression hosiery over medium compression hosiery. Because of this, patients should be offered the strongest compression they can tolerate."
1037,summarize: The following article deals with this topic.,The following article deals with this topic.,The following article deals with this topic.
1038,summarize: A new option for compression therapy of crural ulcers is presented and the possibility for checking the effectiveness of the compression stockings during outpatient,A new option for compression therapy of crural ulcers is presented and the possibility to check the effectiveness of compression stockings during outpatient care.,This paper presents a new option for compression therapy of crural (leg) ulcers. This paper also checks the effectiveness of the compression stockings during outpatient treatment.
1039,"summarize: Background: A too high resting pressure of compression devices is poorly tolerated and may cause skin defects, especially in patients with concomitant arterial occlusive disease.","too high resting pressure of compression devices is poorly tolerated and may cause skin defects, especially in patients with concomitant arterial occlusive disease.","A too high resting pressure of compression devices, or when the device is just lying on the skin, is poorly tolerated and may cause skin defects. This is especially common in patients with concomitant arterial occlusive disease, blockage of an artery."
1040,"summarize: Measurements were repeated after application of knee-high medical compression stockings and of inelastic bandages applied with a pressure of 20, 40 and 60 mmHg in the supine position.","Measurements were repeated after applying knee-high medical compression stockings and inelastic bandages applied with a pressure of 20, 40 and 60 mmHg in the supine position.",Measurements were taken after application of knee-high medical compression stockings and of inelastic bandages applied while lying down.
1041,summarize: Results: EF was significantly reduced compared with healthy controls.,EF was significantly reduced compared with healthy controls.,Results showed EF was significantly reduced compared with healthy controls.
1042,summarize: A significant improvement in venous pumping function was achieved with inelastic bandages even at a resting pressure of 20 mmHg.,Using inelastic bandages even at resting pressure was achieved.,Inelastic bandages even with a pressure of 20 mmHg improved blood vessel pumping.
1043,"summarize: Compression can be achieved by multiple different modalities, such as inelastic bandages; multilayered wraps; short, medium, and long stretch bandages; graduated compression stockings; and pneumatic compression devices.","Compression can be achieved by multiple different ways, such as inelastic bandages; multilayered wraps; short, medium, and long stretch bandages; graduated compression stockings; and pneumatic compression devices.","Compression can be achieved by multiple different methods. These methods include inelastic bandages; multilayered wraps; short, medium, and long stretch bandages; graduated (pressure-varying) compression stockings; and pneumatic (inflatable) compression devices."
1044,"summarize: Results: LDF values under the bandages increased by 33% (95% confidence interval [CI], 17-48; P .01), 28% (95% CI, 12-45; P .05), and 10% (95% CI, -7 to 28), respectively, under the three pressure ranges applied.","LDF values under the bandages increased by 33%, 28%, and 10%, respectively, under the three pressure ranges applied.",LDF values under the bandages increased at all three pressure ranges.
1045,"summarize: At toe level, a significant decrease in flux of -20% (95% CI, -48 to 9; P .05) was seen when bandage pressure >41 mm Hg.","at toe level, a significant decrease in flux of -20% was seen when bandage pressure >41 mm Hg.","At toe level, a significant decrease in flux (blood buildup) was seen when bandage pressure was >41 mm Hg."
1046,"summarize: Methods: Interface pressure and stiffness of compression devices, alone or in combination can be measured in vivo.","pressure and stiffness of compression devices, alone or in combination, can be measured in vivo.","The levels of pressure and stiffness of the compression devices, alone or in combination with other materials, can be measured on living organisms."
1047,summarize: Oedema reduction can be measured by limb volumetry.,Oedema reduction can be measured by measuring limb volume.,"Oedema (swelling) reduction can be measured by limb volumetry, a method of suspending a limb in water to determine the amount of water displaced."
1048,"summarize: In the upright position, an interface pressure of more than 50 mmHg is needed for intermittent occlusion of incompetent veins and for a reduction of ambulatory venous hypertension during walking.","In the upright position, an interface pressure of more than 50 mmHg is needed for intermittent occlusion of incompetent veins and for a reduction of ambulatory venous hypertension during walking.","In the upright position, specific pressure (>50 mmHg) is needed for intermittent (irregular) closing of abnormal veins and for pressure reduction during walking."
1049,summarize: These materials have to be placed correctly.,These materials have to be placed correctly.,These materials have to be placed correctly.
1050,summarize: Inelastic systems should be applied with high initial pressure because the pressure will loose at some time after walking.,Inelastic systems should be applied with high initial pressure because the pressure will loose at some time after walking.,Inelastic systems should be applied with high initial pressure. This is because the pressure will decrease after walking.
1051,"summarize: Even after one week of wearing, inelastic bandages keep higher resting and working pressure during walking than elastic bandages.","Even after one week of wearing, inelastic bandages keep higher resting and working pressure during walking than elastic bands.","Even after one week of wearing, inelastic bandages keep higher optimal pressure during walking than elastic bandages."
1052,summarize: Objectives: This study was conducted to determine hemodynamic and clinical tolerance under short-stretch compression therapy in elderly patients suffering from mixed-etiology leg ulcers.,Objects: This study was conducted to determine hemodynamic and clinical tolerance under short-stretch compression therapy in elderly patients suffering from leg ulcers.,The aim of this study was to determine how short-stretch compression therapy affected blood flow and clinical tolerance (how much a patient could take). The study was conducted in elderly patients suffering from leg ulcers (sores) caused by various reasons.
1053,"summarize: Ankle-brachial pressure, great toe laser Doppler flowmetry (LDF) and transcutaneous oxygen pressure (TcPO2) on dorsum of the foot were measured at baseline and after its removal at 24hours.","Ankle-brachial pressure, great toe laser Doppler flowmetry (LDF), and transcutaneous oxygen pressure (TcPO2) on the dorsum of the foot were measured at baseline and after its removal at 24 hours.","Several health measures were taken before the bandages were applied and after 24 hours. These measures include: ankle-brachial pressure, great toe laser Doppler flowmetry (LDF), and transcutaneous oxygen pressure (TcPO2) on top of the foot. LDF measures blood flow. TcPO2 measures oxygen in the skin."
1054,"summarize: Toe pressure index and TcPO2 values did not significantly change under compression therapy (P=0.51 and P=0.09, respectively) whereas CP decreased significantly during 24hours.",Toe pressure index and TcPO2 values did not significantly change under compression therapy whereas CP decreased significantly during 24 hours.,Toe pressure index and TcPO2 values did not significantly change under compression therapy. CP decreased significantly during 24 hours.
1055,summarize: Great toe LDF was also measured at 10minutes after bandage application.,Great toe LDF was also measured at 10 minutes after bandage application.,Big toe blood flow was measured 10 minutes after applying the bandage.
1056,summarize: No increase in pain and no ischemic skin damage occurred under compression therapy.,No increase in pain and no ischemic skin damage occurred under compression therapy.,No increase in pain or blood-flow-related skin damage occured with compression.
1057,"summarize: In the study, an overview of the current knowledge related to the benefits and risk of using MC in the supportive treatment of leg oedema in CHF patients is presented.",MC is used to treat leg oedema in CHF patients.,This study is an overview of evidence related to the benefits and risk of using MC in the treatment of leg oedema in CHF patients.
1058,"summarize: In studies performed on CHF populations, manual lymphatic drainage, MC stocking, multilayer bandaged, as well as intermittent pneumatic compression or electric calf stimulations were used.","In studies performed on CHF populations, manual lymphatic drainage, MC stocking, multilayer bandaged, as well as intermittent pneumatic compression or electric calf stimulations were used.","In studies of CHF populations, several treatment options were used. These options include manual lymphatic drainage, MC stocking, multilayer bandaged, and electric calf stimulations."
1059,summarize: The use of the intermittent pneumatic compression in CHF patients significantly increases the right auricular pressure and mean pulmonary artery pressures as well as decreases systemic vascular resistance in most patients without the clinical worsening.,The use of the intermittent pneumatic compression in CHF patients significantly increases the right auricular pressure and average pulmonary artery pressures. It also decreases systemic vascular resistance in most patients without the symptoms worsening.,"Intermittent pneumatic compression is a treatment that uses a device that squeezes fluids from an infected area. The treatment in CHF patients significantly increased pressure in the lungs and heart. The treatment decreased systemic vascular resistance, or the resistance that must be overcome to push blood through veins, in most patients without the disease worsening."
1060,"summarize: The transient and rapid increase in the human atrial natriuretic peptide, after an application of the MC stocking in New York Heart Association (NYHA) class II patients was observed without clinical exacerbation.","the short-term and rapid increase in the human atrial natriuretic peptide, after an application of the MC stocking in New York Heart Association (NYHA) class II patients was observed without symptoms.","Human atrial natriuretic peptide, a substance in the body that reduces fluid volume, increased in patients without clinical exacerbation or pain."
1061,summarize: An application of the multilayer bandages in NYHA classes III and IV patients lead a significant increase in the right arterial pressure and lead to transient deterioration of the right and the left ventricular functions.,An application of the multilayer bandages in NYHA classes III and IV patients leads to a significant increase in the right arterial pressure and lead to temporary deterioration of the right and left ventricular functions.,Use of multilayer bandages in patients significantly increased the right arterial (section of the heart) pressure. Use of multilayer bandages also lead to deterioration of heart chamber function.
1062,"summarize: Autosomal dominant polycystic kidney disease is an important cause of end-stage renal disease, for which there is no proven therapy.","Autosomal dominant polycystic kidney disease is an important cause of end-stage renal disease, for which there is no proven treatment.","Autosomal dominant polycystic kidney disease is an inherited disease that causes many cysts (growths) usually in the kidneys, and is an important cause of end-stage kidney disease, for which there is no proven therapy."
1063,"summarize: We now show that inactivation of Pkd1 in mice before postnatal day 13 results in severely cystic kidneys within 3 weeks, whereas inactivation at day 14 and later results in cysts only after 5 months.","Inactivation of Pkd1 in mice before birth day 13 results in severely cystic kidneys within 3 weeks, whereas inactivation at day 14 and later results in cysts only after 5 months.","When the Pkd1 gene is not active in mice within 13 days after birth, this results in many cysts in the kidneys within 3 weeks. However, inactivation (turning off) of Pkd1 at day 14 or later results in cysts only after 5 months."
1064,summarize: These results have important implications for clinical understanding of the disease and therapeutic approaches.,These results have important implications for clinical understanding of the disease and treatment approaches.,These results influence clinical understanding of the disease and treatment options.
1065,"summarize: However, it is presumed that formation of renal cysts and their conversion to ccRCC involve additional genetic changes at other loci.",It is assumed that formation of kidney cysts and their conversion to ccRCC involve additional genetic changes at other loci.,"However, it is believed that formation of kidney cysts and their change to the ccRCC kidney cancer involve additional genetic changes at other locations."
1066,"summarize: Strikingly, combined conditional inactivation of Vhlh and the Pten tumour suppressor gene, which normally antagonises PI3K signalling, in the mouse kidney, elicits cyst formation after short latency, whereas inactivation of either tumour suppressor gene alone failed to produce such a phenotype.","Interestingly, combined conditional inactivation of Vhlh and the Pten tumour suppressor gene, which normally blocks PI3K signaling, in the mouse kidney causes cyst formation after short time. Inactivation of either tumour suppressor gene alone failed to produce such a physical effect.","When two genes called Vhlh and Pten that keep cells from growing too fast are turned off, this brings about cyst formation in the kidneys of mice after a short delay. However, inactivation of only one of these genes fails to produce this same effect."
1067,"summarize: Interestingly, cells lining these cysts frequently lack a primary cilium, a microtubule-based cellular antenna important for suppression of uncontrolled kidney epithelial cell proliferation and cyst formation.","Interestingly, cells lining these cysts often lack a primary cilium, a cell antenna important for stopping uncontrolled kidney cell proliferation and cyst formation.","Interestingly, cells lining these cysts frequently lack primary cilium, that acts like a cell antenna and is important for stopping or slowing kidney epithelial cells from multiplying and for stopping cyst formation."
1068,"summarize: Anti-miR-17 treatment recapitulated the gene expression pattern observed after miR-1792 genetic deletion and was associated with upregulation of mitochondrial metabolism, suppression of the mTOR pathway, and inhibition of cyst-associated inflammation.","Anti-miR-17 treatment recapitulated the gene expression pattern observed after miR-1792 gene deletion and was associated with upregulation of mitochondrial metabolism, suppression of the mTOR pathway, and inhibition of cyst-associated inflammation.","The anti-miR-17 treatment is associated with extending the lifespan of energy from certain cells, stopping or slowing cell growth often found in tumors, and stopping or slowing inflammation (redness and swelling from fighting an infection) associated with cysts."
1069,summarize: Suspicion of a cystic kidney disease should prompt consultation of a pediatric nephrologist.,Suspicion of a cystic kidney disease should prompt consultation with a pediatric kidney specialist.,Suspicion of a cystic kidney disease should lead to consulting a kidney specialist of children.
1070,summarize: Complex renal cysts require further investigation.,Complex kidney cysts require further investigation.,Complex kidney cysts require more investigation.
1071,summarize: This consensus-based guideline was developed by all relevant German pediatric medical societies.,this consensus-based guideline was developed by all relevant German pediatric medical societies.,All relevant German child-care medical groups created the agreed-upon guideline.
1072,summarize: Prenatal management must be tailored to very different degrees of disease severity.,Pregnancy management must be tailored to very different degrees of disease severity.,Pre-birth management should be personalized to different degress of disease severity.
1073,"summarize: Children with unilateral multicystic dysplastic kidney do not require routine further imaging or nephrectomy, but long-term nephrology follow-up (as do children with uni- or bilateral kidney hypo-/dysplasia with cysts).","Children with unilateral multicystic dysplastic kidney do not need routine further imaging or nephrectomy, but long-term nephrology follow-up (as do children with uni- or bilateral kidney hypo-/dysplasia with cysts).","Children with a single, enlarged, nonfunctional kidney with cysts do not need regular imaging or kidney removal, but long-term kidney-related follow-ups (as do children with single or multiple kidney abnormalities with cysts)."
1074,summarize: The factors promoting cyst formation and tumor growth in TSC are incompletely understood.,The factors promoting cyst formation and tumor growth in TSC are incompletely understood.,The factors promoting cyst formation and tumor growth in TSC are not completely understood.
1075,summarize: DNA damage and alterations in DNA damage response (DDR) signaling could be one of the molecular mechanisms mediating focal kidney cyst formation in autosomal dominant polycystic kidney disease (ADPKD).,DNA damage and changes in DNA damage response (DDR) signaling could be one of the molecular mechanisms mediating focal kidney cyst formation in autosomal dominant polycystic kidney disease (ADPKD).,"Damage to DNA and changes to the body's response to DNA damage, called DNA damage response or DDR, could be one of the processes involved in the development of kidney cysts (growths) in the inherited disease called autosomal dominant polycystic kidney disease (ADPKD)."
1076,"summarize: In the human ADPKD transcriptome, the number of up-regulated DDR-related genes was increased by 16.6-fold compared with that in normal kidney, and by 2.5-fold in cystic compared with that in minimally cystic tissue (P  0.0001).","the number of up-regulated DDR-related genes was increased by 16.6-fold compared with that in normal kidney, and by 2.5-fold in cystic compared with that in minimally cystic tissue.","In the part of the human ADPKD genes that transfer information to molecules, the DNA damage response (DDR) genes increased 16 times compared with that in a normal kidney. DDR also more than doubled in tissues with cysts compared to DDR in tissues with few cysts."
1077,"summarize: Here, we show that Quinomycin A decreased cell proliferation and cyst growth of human ADPKD cyst epithelial cells cultured within a 3D collagen gel.",the authors show that quinomycin A decreased cell proliferation and cyst growth of human ADPKD cyst epithelial cells cultured within a 3D collagen gel.,"Here, we show that Quinomycin A decreased cell and cyst growth of human, diseased cyst cells created in an isolated environment."
1078,"summarize: We also observed that TWEAK and Fn14 were overexpressed in mouse ADPKD kidney cysts, and TWEAK was significantly high in urine and cystic fluid from patients with ADPKD.","TWEAK and Fn14 were overexpressed in mouse ADPKD kidney cysts, and TWEAK was significantly high in urine and cystic fluid from patients with ADPKD.","Researchers also found that too many TWEAK and Fn14 gene-derived molecules are in made in mouse ADPKD kidney cysts, and TWEAK is very high in the urine and cystic fluid from patients with ADPKD."
1079,"summarize: Anti-TWEAK antibodies significantly slowed the progression of ADPKD, preserved renal function, and improved survival.","Anti-TWEAK antibodies significantly slowed the progression of ADPKD, preserved kidney function, and improved survival.","Anti-TWEAK antibodies (a protein used by the immune system to identify and neutralize foreign objects such as harmful bacteria and viruses) significantly slowed the progression of ADPKD, protected kidney function, and improved survival."
1080,"summarize: Furthermore, the anti-TWEAK cystogenesis reduction is related to decreased cell proliferation-related MAPK signaling, decreased NF-ÎoB pathway activation, a slight reduction of fibrosis and apoptosis, and an indirect decrease in macrophage recruitment.","Moreover, the anti-TWEAK cystogenesis reduction is related to decreased cell proliferation-related MAPK signaling, decreased NF-ÎoB pathway activation, a slight reduction of fibrosis and apoptosis, and an indirect decrease in macrophage recruitment.","Additionally, the reduction of cyst formation is related to decreased cell growth and a decrease in macrophage recruitment."
1081,"summarize: Downregulation or overexpression of PKD1 or PKD2 in mouse models results in renal cyst formation, suggesting that the quantity of PC1 and PC2 needs to be maintained within a tight functional window to prevent cystogenesis.","Downregulation or overexpression of PKD1 or PKD2 in mouse models results in kidney cyst formation, suggesting that the amount of PC1 and PC2 needs to be maintained within a tight functional window to prevent cysts.","In experiments with mice, when the PKD1 or PKD2 genes are less sensitive to other cells or make too many proteins, it may lead to cysts forming in the kidneys. This suggests that the number of PC1 and PC2 proteins needs to be stable within a brief time period to prevent the formation of cysts."
1082,"summarize: However, our data also suggest that more effective protein folding contributes to the augmented levels of PC2.","Nevertheless, our data also suggest that more effective protein folding contributes to the increased levels of PC2.","However, this data also suggests that more effective protein folding, which is when a protein changes from a long chain to a functional shape, contributes to more levels of PC2 proteins."
1083,summarize: Inhibition of HDAC6 decreased PC2 suggesting that HDAC6 and GRP94 work together to regulate PC2 levels.,"Inhibition of HDAC6 decreased PC2, suggesting that HDAC6 and GRP94 work together to regulate PC2 levels.","Slowing or stopping HDAC6 decreases PC2 proteins, suggesting that HDAC6 and GRP94 work together to regulate PC2 levels."
1084,summarize: Taken together our data uncovered a novel HDAC6-GRP94-related axis that likely participates in maintaining elevated PC2 levels in Pkd1 mutant cells.,"Taken together, our data uncovered a new HDAC6-GRP94-related axis that likely participates in maintaining elevated PC2 levels in Pkd1 mutant cells.","Together, these data uncover a new HDAC6-GRP94-related point that likely participates in maintaining higher PC2 levels in Pkd1 mutant cells."
1085,summarize: This case is about a young woman who presented with left flank pain and urinary tract infection who was later diagnosed as having left renal hydatid cyst.,this case is about a young woman who had pain on the left side and infection in the urinary tract. She was later diagnosed with a left kidney hydatid cyst.,This case is about a young woman who presented with left back pain and urinary tract infection (UTI - bladder infection) who was later diagnosed as having left kidney hydatid cyst.
1086,"summarize: The most common organs involved are liver and lungs although the heart, brain, bone, central nervous system, and kidney may also be involved.","liver and lungs are the most common organs involved. However, the heart, brain, bone, central nervous system, and kidney may also be involved.","Most common organs affected are the liver and lungs although the heart, brain, bone, spinal cord, and kidney may also be involved."
1087,"summarize: With timely management using combination therapy, this condition is curable and the patient can live a healthy life with normal kidney function.","With timely management using combination therapy, this condition is curable and the patient can live a healthy life with normal kidney function.","With proper use of multiple treatments, Hyadtid disease is curable and the patient can live a healthy life with normal kidney function."
1088,summarize: The possibility for either opposite or synergistic effects on gene regulation must be considered at this point.,the possibility for either opposite or synergistic effects on gene regulation must be considered at this point.,The possibility for either opposite or cooperative effects on regulating genes must be considered at this point.
1089,summarize: Histones are known for their ability to bind to and regulate expression of DNA.,Histones are known for their ability to bind to and regulate DNA expression.,Histones proteins are known for their ability to attach to and regulate how instructions and information from DNA are used to build proteins or other molecules.
1090,summarize: Histones are known for their ability to bind to and regulate expression of DNA.,Histones are known for their ability to bind to and regulate DNA expression.,Histones are proteins that bind to and influence DNA expression.
1091,"summarize: In this Review, we discuss the regulation of non-acetyl histone acylation by enzymatic and metabolic mechanisms, the acylation'reader' proteins that mediate the effects of different acylations and their physiological functions, which include signal-dependent gene activation, spermatogenesis, tissue injury and metabolic stress.","In this review, we discuss the regulation of non-acetyl histone acylation by enzymatic and metabolic mechanisms. We also discuss the acylation'reader' proteins that mediate the effects of different acylations and their physiological functions, including signal-dependent gene activation, spermatogenesis, tissue injury and metabolic stress.","In this review, researchers discuss how some histones are regulated in the body and how some acylation proteins bring about the effects of other acylations and their functions."
1092,"summarize: Results: Using different phylogenetic approaches, we show that MV histone domains encode obligate H2B-H2A and H4-H3 dimers of possible proto-eukaryotic origin.",MV histone domains encode obligate H2B-H2A and H4-H3 dimers of possible proto-eukaryotic origin.,"Using different approaches, researchers show that Marseilleviridae histone provide genetic information to H2B-H2A and H4-H3 structures."
1093,summarize: MV core histone moieties form sister clades to each of the four eukaryotic clades of canonical and variant core histones.,MV core histones form sister clades to each of the four eukaryotic clades of canonical and variant core histones.,Marseilleviridae core histones form similar copies to each of the four eukaryotic histone groups.
1094,summarize: This is a relevant finding given that DNA topo II influences histone deposition and chromatin compaction and is the second most abundant nuclear protein after histones.,DNA topo II influences histone deposition and chromatin compaction. It is the second most abundant nuclear protein after histones.,This is a relevant finding given that DNA unwinding enzymes influences histone structure and the folding of DNA and is the second most abundant nuclear protein after histones.
1095,summarize: We thus suggest MV histone doublet genes and their DNA topo II gene possibly were acquired from an organism with a chromatinized replisome that diverged prior to the origin of eukaryotic core histone variants for H2/H2A.Z and H3/cen H3.,MV histone doublet genes and their DNA topo II gene may have been acquired from an organism with a different type of histone that diverged prior to the origin of eukaryotic core histone variants for H2/H2A.Z and H3/cen H3.,It is suggested that Marseilleviridae histone genes and their DNA genes are possibly taken from an organism that can replicate DNA that diverged before the beginning of eukaryotic core histone types for H2/H2A.Z and H3/cen H3.
1096,"summarize: These interactions prove to be essential for the higher levels of chromatin organization like chromatin loops, transcription factories and chromosome territories.","These interactions prove to be essential for the higher levels of chromatin organization like chromatin loops, transcription factories and chromosome territories.",These interactions prove to be very important for the higher levels of chromatin organization.
1097,summarize: The abolished interaction between the linker histone and Arp4p leads the mutant yeast cells to premature ageing phenotypes.,The abolished interaction between the linker histone and Arp4p leads the mutant yeast cells to premature ageing.,The interaction that stopped between the linker histone and Arp4p leads the changed yeast cells to start aging early.
1098,summarize: We validate cell sorting directly into H2SO4 for immediate histone extraction to decrease time and number of steps after FACS to analyze histone PTMs.,"Using H2SO4 to extract histones, we decrease time and number of steps after FACS to analyze histone PTMs.",Researchers tested and confirmed the method to sort cells to decrease time and number of steps after FACS to analyze histone changes.
1099,summarize: The results show a streamlined approach for quantifying global changes in histone PTMs in cell types separated by FACS that is poised for clinical deployment.,the results show a streamlined approach for quantifying global changes in histone PTMs in cell types separated by FACS that is poised for clinical use.,The results show a streamlined approach for identifying changes in histone PTMs in cell types separated by FACS.
1100,"summarize: Recurrent mutations targeting histone genes have been described in pediatric brain tumors, chondroblastoma, giant cell tumor of bone and other tumor types.","Recurrent mutations targeting histone genes have been described in pediatric brain tumors, chondroblastoma, giant cell tumor of bone and other tumor types.","Recurring mutations (changes) that target histone genes are described in brain tumors in children, in a rare type of noncancerous bone tumor that begins in cartilage chondroblastoma (noncancerous bone tumors in cartilage), and in giant tumors of bones and other types of tumors."
1101,summarize: Oncohistones are often dominant-negative and occur at higher frequencies in tumors affecting children and adolescents.,Oncohistones are often dominant-negative and occur at higher frequency in tumors affecting children and adolescents.,Oncohistones (the mutant histones that can cause tumors) often occur more in tumors affecting children and adolescents.
1102,"summarize: However, further studies are necessary to fully elucidate the mechanism of action of oncohistones, as well as to evaluate their possible application to cancer classification, prognosis and to the identification of new therapies.","Nevertheless, further studies are needed to fully understand the mechanism of action of oncohistones. Further studies are also needed to evaluate their possible application to cancer classification, prognosis and new treatments.","However, further studies are necessary to fully describe the process of histone proteins that may cause cancer (oncohistones), as well as to evaluate how they might influence cancer classification, the course of the disease, and the identification of new treatments."
1103,"summarize: Initially, histones were only known as DNA packaging proteins but later, it was discovered that they act extracellularly as powerful antimicrobial agents and also as potentially self-detrimental agents.","Initially, histones were only known as DNA packaging proteins but later, it was discovered that they act extracellularly as powerful antimicrobial agents and potentially self-destructive agents.","At first, histones were only known as DNA packaging proteins, but later it was discovered that they act outside of cells as a powerful antimicrobial, an agent that can kill microorganisms or stop their growth. They may also be self-destructive agents."
1104,"summarize: Indeed, histones were found to be the most abundant proteins within neutrophil extracellular traps what ultimately highlighted their microbicidal function.","Histones were found to be the most abundant proteins within neutrophil extracellular traps, which ultimately highlighted their microbicidal function.","Histones were found to be the most abundant proteins within neutrophil extracellular traps (net like structures that protect against infection) and highlighted their microbicidal function that kills microorganisms such as fungi, bacteria, and viruses."
1105,summarize: H3.3 is a subtype of H3 histone and can be encoded either by the H3F3A or H3F3B genes independently.,H3.3 is a subtype of H3 histone and can be encoded either by the H3F3A or H3F3B genes independently.,H3.3 is a subtype of H3 histone and can be encoded (given instructions on how to structure it) either by the H3F3A or H3F3B genes independently.
1106,"summarize: The first cardiac implantable electronic device (CIED), the electronic pacemaker, maintains cardiac contraction during bradycardia.","the first heart implantable electronic device (CIED), the electronic pacemaker, maintains cardiac contraction during bradycardia.","The first cardiac implantable electronic device (CIED), the electronic pacemaker, maintains the pumping of blood in and out of the heart when heart beats are unusually slow."
1107,"summarize: Despite >50 years of pacing and 40 years of ICD therapy, the lead remains the weakest link between the device and the patient.","Despite >50 years of pacing and 40 years of ICD therapy, the lead remains the weakest link between the device and the patient.","Despite >50 years of pacing and 40 years of ICD therapy, the lead or contact point remains the weakest link between the device and patient."
1108,"summarize: When a device patient undergoes any procedure (with or without anesthesia), special precautions have to be observed including a focused history/physical examination, interrogation of pacemaker before and after the procedure, emergency drugs/temporary pacing and defibrillation, reprogramming of pacemaker and disabling certain pacemaker functions if required, monitoring of electrolyte and metabolic disturbance and avoiding certain drugs and equipments that can interfere with pacemaker function.","Whenever a device patient undergoes any procedure (with or without anesthesia), special precautions have to be observed. These include a focused history/physical examination, interrogation of pacemaker before and after the procedure, emergency drugs/temporary pacing and defibrillation, reprogramming of pacemaker and disabling certain pacemaker functions if required, monitoring electrolyte and metabolic disturbance and avoiding certain drugs and equipments that can interfere with pacemaker function.","When a patient who has a device undergoes any procedure (with or without anesthesia), special precautions have to be taken including a history of the patient's health and a physical exam, checking the pacemaker before and after the procedure to make sure its working, emergency drugs/temporary pacing and defibrillation, reprogramming of the pacemaker, and disabling certain pacemaker functions if required. Monitoring of problems with electrolytes and the metabolism and avoiding certain drugs and equipments that can interfere with pacemaker function are also reviewed."
1109,"summarize: If unanticipated device interactions are found, consider discontinuation of the procedure until the source of interference can be eliminated or managed and all corrective measures should be taken to ensure proper pacemaker function should be done.","If unanticipated device interactions are found, consider stopping the procedure until the source of interference can be eliminated or managed and all corrective measures should be taken to ensure proper pacemaker function.","If unexpected interactions between the pacemaker and other devices are found, consider stopping the procedure until the source of interference can be eliminated or managed. All other measures should be taken to ensure proper pacemaker function."
1110,summarize: There have been significant advances in pacing and implantable defibrillator technology over the past decade.,There have been significant advances in pacing and implantable defibrillator technology over the past decade.,"Over the past decade, there have been major advances in the development of pacemakers and the implantable defibrillator, a device that monitors your heart rate and delivers a strong electrical shock to restore the heartbeat to normal."
1111,"summarize: The relationships between ventricular activation sequence and cardiac mechanical performance are now better appreciated, and will become more completely understood.","The relationships between ventricular activation sequence and cardiac mechanical performance are now better understood, and will become more fully understood.",The relationship between when the lower chambers of the heart are activated and how the heart pumps are now better understood.
1112,"summarize: The advent of pacing leads with multiple electrodes for placement in the coronary venous system is a notable advance, that in contrast to traditional bipolar leads, provides multiple LV pacing configurations from which to select the optimal site for LV pacing without compromising lead stability.","the advent of pacing leads with multiple electrodes for placement in the coronary venous system is a notable advance, that provides multiple LV pacing configurations from which to select the best site for LV pacing without compromising lead stability.",The development of pacing devices with multiple placements in the heart system is an important advance and provided multiple left ventricle pacing arrangements to select from to find the best site.
1113,"summarize: It ultimately led to the development of totally implantable pacemaker by Chardack, Gage, and Greatbatch.","It eventually led to the development of totally implantable pacemaker by Chardack, Gage, and Greatbatch.","It ultimately led to the development of the totally implantable (permanently under the skin) pacemaker by Chardack, Gage, and Greatbatch."
1114,"summarize: There are 3 types of artificial pacemakers: Implantable pulse generators with endocardial or myocardial electrodes; External, miniaturized, patient portable, battery-powered, pulse generators with exteriorized electrodes for temporary transvenous endocardial or transthoracic myocardial pacing; Console battery or AC-powered cardioverters or monitors with high-current external transcutaneous or low-current endocardial or myocardial circuits for temporary pacing in asynchronous or demand modes, with manual or triggered initiation of pacing.","3 types of artificial pacemakers exist: implantable pulse generators with electrodes in the heart; external, miniaturized, patient-portable, battery-powered, pulse generators with electrodes for temporary transvenous or transthoracic myocardial pacing; console battery or AC-powered cardioverters or monitors with high-current external transcutaneous or low-current endocardial or myocardial circuits for temporary pacing.","There are 3 types of artificial pacemakers: Implantable pulse generators; External, miniaturized, patient portable, battery-powered, pulse generators to temporarily control heart rates; Console battery or AC-powered devices or monitors with high-current external pads placed on top of the skin, or low-current inside the body for temporary pacing in uncoordinated contracting of the heart or at infrequent times."
1115,"summarize: In 1952, Zoll described an effective means of supporting the patients with intrinsic cardiac pacemaker activity and/or conducting tissue by an artificial, electric, external pacemaker.","In 1952, Zoll described an effective way of supporting the patients with cardiac pacemaker activity and/or conducting tissue by an artificial, electric, external pacemaker.","In 1952, Zoli described a means of supporting patients with internal heart-related pacemaker activity and/or conducting electricity across body parts by an artificial, electric, external pacemaker."
1116,summarize: These early observations instilled the idea that cardiac electrical failure can be controlled.,These early observations instilled the idea that cardiac electrical failure can be controlled.,These early observations led to the idea that heart-related electrical failure can be controlled.
1117,summarize: All cardiac pacemakers consist of 2 components: a pulse generator which provides the electrical impulse for myocardial stimulation and 1 or more electrodes or leads which deliver the electrical impulse from the generator to the myocardium.,All cardiac pacemakers consist of 2 components: a pulse generator which provides the electrical impulse for stimulation of the heart and 1 or more electrodes or leads which deliver the electrical impulse from the generator to the heart.,"All heart-related pacemakers have a pulse generator, which gives an electrical impoulse for muscle or heart stimulation, and 1 or more electrodes or contact points to give the electrical impulse from the generator to target body part."
1118,"summarize: Pacemakers are adjustable artificial electrical pulse generators, frequently emitting a pulse with a duration between 0.5 and 25 milliseconds with an output of 0.1 to 15 volts, at a frequency up to 300 times per minute.","Pacemakers are adjustable artificial electrical pulse generators, often emitting a pulse between 0.5 and 25 milliseconds with an output of 0.1 to 15 volts, at a frequency up to 300 times per minute.",Pacemakers are devices that generate artificial electrical pulses.
1119,"summarize: The cardiologist or pacemaker technologist will be able to interrogate and control the pacing rate, the pulse width, and the voltage, whether the device is temporary or permanent.","cardiologist or pacemaker technologist will be able to check and control the pacing rate, pulse width, voltage, and whether the device is temporary or permanent.","A heart specialist or pacemaker technologist will be able to control the pacing rate and other functions, whether the device is temporary or permanent."
1120,"summarize: Most types of CIED use several insulated lead wires with non-insulated tips that are implanted in the heart, either by percutaneous vein insertion or directly by a cardiac surgeon.","most types of CIED use several insulated lead wires with non-insulated tips that are implanted in the heart, either by percutaneous vein insertion or directly by a cardiac surgeon.","Most types of cardiac implantable electronic devices (CIED) use several insulated lead wires with non-insulated tips that are implanted in the heart, either by inserting a catheter into a vein or directly by a heart surgeon."
1121,summarize: The external variety is almost always placed for temporary stabilization of the patient or to facilitate some type of surgical procedure.,The external variety is almost always placed for temporary stabilization of the patient or to facilitate some type of surgical procedure.,The external type is almost always placed for temporary stabilization of the patient or to help some type of surgery.
1122,summarize: This is because every ICD currently implanted has an anti-bradycardia pacing function.,This is because every ICD currently implanted has an anti-bradycardia pacing function.,This difficulty is because every ICD currently implanted aids against a slow heart rate.
1123,summarize: The sinoatrial node acts as the natural pacemaker of the heart.,the sinoatrial node acts as the natural pacemaker of the heart.,The sinoatrial node acts as the natural pacemaker of the heart.
1124,summarize: The failure of this intrinsic electrical conduction in the heart can result in different arrhythmic problems.,The failure of this intrinsic electrical conduction in the heart can result in different arrhythmic problems.,The failure of this internal electrical conduction in the heart can result in different problems with the heart beat.
1125,summarize: Expert opinion: 'physiologic stimulation' technologies should evolve to enable an effective and widespread adoption.,'physiologic stimulation' technologies should evolve to enable an effective and widespread adoption.,The expert opinion is that 'physiologic stimulation' methods should develop to allow effective and far-reaching use.
1126,"summarize: In this article, we review the available data on LPs while advocating for the need for a randomized controlled trial comparing LPs to TV-PPMs.","In this article, we review the available data on LPs while advocating for the need for a randomized controlled trial comparing LPs to TV-PPMs.",This article reviews the available data on leadless pacemakers while promoting the need for a clinical study that compares leadless pacemakers to transvenous pacemakers.
1127,summarize: The optimal method of resuscitation has not been clearly established.,The best method of resuscitation has not been clearly established.,The best method of revival has not been clearly established.
1128,"summarize: Instead, therapy should be aimed at restoring intravascular volume and adequate hemodynamic parameters.","Instead, therapy should be aimed at restoring intravascular volume and adequate hemodynamic parameters.","Instead, therapy should be aimed at restoring blood amount in vessels and blood flow parameters."
1129,summarize: Uncontrolled bleeding is the leading cause of shock in trauma patients and delays in recognition and treatment have been linked to adverse outcomes.,Uncontrolled bleeding is the leading cause of shock in trauma patients and delays in recognition and treatment have been linked to adverse outcomes.,Uncontrolled bleeding is the leading cause of shock in trauma patients. Delays in recognition and treatment have been linked to adverse outcomes.
1130,"summarize: For prompt detection and management of hypovolaemic shock, ATLS(®) suggests four shock classes based upon vital signs and an estimated blood loss in percent.",ATLS(®) suggests four shock classes based on vital signs and an estimated blood loss in percent.,"For quick detection and management of hypovolemic shock, ATLS(®) suggests four shock classes. These classes are based upon vital signs and an estimated blood loss in percent. Hypovolemic shock is due to volume loss with blood vessels or blood vascular system."
1131,"summarize: A retrospective analysis of data derived from the TraumaRegister DGU(®) indicated that only 9.3% of all trauma patients could be allocated into one of the ATLS(®) shock classes when a combination of the three vital signs heart rate, systolic blood pressure and Glasgow Coma Scale was assessed.","only 9.3% of all trauma patients could be placed into one of the ATLS(®) shock classes when a combination of the three vital signs heart rate, systolic blood pressure and Glasgow Coma Scale was assessed.",Evaluation of data derived from the TraumaRegister DGU(®) indicated only 9.3% of all trauma patients could be placed into one of the ATLS(®) shock classes when a combination of the three vital signs was assessed (measured).
1132,summarize: Further analyses including also data from the UK-based TARN registry suggested that ATLS(®) may overestimate the degree of tachycardia associated with hypotension and underestimate mental disability in the presence of hypovolaemic shock.,ATLS(®) may overestimate the degree of tachycardia associated with hypotension and underestimate mental disability in the presence of hypovolemic shock.,Further review included data from the UK-based TARN registry. This evaluation suggested that ATLS(®) may overestimate the degree of tachycardia (high heart rate) associated with low blood pressure and underestimate mental disability in the presence of hypovolemic shock.
1133,"summarize: Interestingly, less than half (48%) of all respondents declared that they would assess a potential circulatory depletion within the primary survey according to the ATLS(®) classification of hypovolaemic shock.","Interestingly, less than half (48%) of all respondents declared that they would assess a potential circulatory depletion within the primary survey according to the ATLS(®) classification of hypovolemic shock.",Less than half of all respondents declared that they would assess a potential circulatory depletion within the primary survey according to the ATLS(®) classification of hypovolemic shock.
1134,"summarize: Compensatory Reserve Index decreased by 33% in a linear fashion across progressive blood volume loss, with no clinically significant alterations in vital signs.","Compensatory Reserve Index decreased by 33% across progressive blood volume loss, with no clinically significant changes in vital signs.","CRI decreased by 33% in a linear trend across increasing blood volume loss, with no changes in vital signs."
1135,summarize: Development of a human model of hemorrhage has provided a unique opportunity to investigate the underlying physiology that defines the individual capacity to avoid the life-threatening clinical condition of inadequate tissue oxygenation known as âshock.â,Developing a human model of hemorrhage has provided a unique opportunity to investigate the underlying physiology that defines the individual's ability to avoid the life-threatening condition of inadequate tissue oxygenation known as âshockâ.,"A human model of hemorrhage (excessive bleeding) provides the opportunity to investigate the underlying mechanisms that can help someone avoid the life-threatening condition of inadequate tissue oxygenation known as ""shock."""
1136,summarize: High tolerance to hemorrhage is defined by a capacity to maintain systemic perfusion pressure and reduce the rate of cerebral hypoperfusion by: (1) protecting cardiac output with greater elevations in heart rate associated with greater cardiac vagal withdrawal and sympathetically mediated adrenergic stimulation; (2) greater increases in systemic peripheral vascular resistance associated with higher sympathetic nerve activation and levels of circulating vasopressor endocrine responses; (3) alternating blood flow between the brain and peripheral tissue with greater sympathetically mediated oscillatory patterns of systemic pressure and flow; and (4) enhancing cardiac filling and cerebral perfusion pressure gradient by optimizing the respiratory pump.,a high tolerance to hemorrhage is defined by a capacity to maintain systemic perfusion pressure and reduce the rate of cerebral hypoperfusion by: (1) protecting cardiac output with greater elevations in heart rate associated with greater cardiac vagal withdrawal and sympathetically mediated adrenergic stimulation; (2) greater increases in systemic peripheral vascular resistance associated with higher sympathetic nerve activation and levels of circulating vasopressor endocrine responses; (3) alternating blood flow between the brain and peripheral tissue with greater sympathetically mediated oscillatory patterns of systemic pressure and flow; and (4) enhancing cardiac filling and cerebral perfusion pressure gradient.,"High tolerance to hemorrhage is defined by maintaining body wide blood flow pressure and prevent decreased brain blood pressure. This is done by one of four ways. First, by protecting cardiac output with greater elevations in heart rate associated with greater cardiac vagal withdrawal and sympathetically mediated adrenergic stimulation. Second, a greater increases in systemic peripheral vascular resistance (blood vessel resistance) associated with higher sympathetic nerve activation (fight-or-flight reaction) and levels of circulating vasopressor endocrine responses (responses from chemical messengers). Third, an alternating blood flow between the brain and peripheral tissue with greater sympathetically mediated oscillatory patterns of"
1137,"summarize: When cardiac filling is no longer adequate to maintain systemic pressure and flow, a reflex-mediated pronounced bradycardia leads to the initiation of decompensatory shock.","When heart filling is no longer enough to maintain systemic pressure and flow, a reflex-mediated bradycardia leads to the initiation of decompensatory shock.","When the body no is longer able to maintain systemic pressure and flow, a decreased heart rate leads to the initiation of decompensatory shock."
1138,summarize: The thigh itself can hold up to 1 L to 2 L of blood.,the thigh itself can hold up to 1 L to 2 L of blood.,The thigh can hold up to 1 L to 2 L of blood.
1139,"summarize: In the latter process, pyruvate is produced and converted to lactic acid to regenerate nicotinamide adenine dinucleotide (NAD+) to maintain some degree of cellular respiration in the absence of oxygen.","pyruvate is produced and converted to lactic acid to regenerate nicotinamide adenine dinucleotide (NAD+), which helps maintain some level of cell respiration in the absence of oxygen.","Pyruvate, a chemical product of energy production, is produced and converted to maintain some cellular respiration (energy creation) in the absence of oxygen."
1140,"summarize: Due to sympathetic nervous system activation, blood is diverted away from noncritical organs and tissues to preserve blood supply to vital organs such as the heart and brain.","Due to sympathetic nervous system activation, blood is diverted away from noncritical organs and tissues to preserve blood supply to vital organs such as the heart and brain.","Due to sympathetic nervous system activation, blood is moved away from noncritical organs and tissues. This is done to preserve blood supply to vital organs like the heart and brain."
1141,"summarize: The bodyâs compensation varies by cardiopulmonary comorbidities, age, and vasoactive medications.","The body's compensation varies by heart disease, age, and vasoactive medications.","How the body handles this varies by accompanying heart and lung diseases, age, and blood pressure medications."
1142,"summarize: Methods: NHPs were randomized into five severe pressure-targeted hemorrhagic shock (PTHS)  additional injuries scenarios: 30-min PTHS (PTHS-30), 60-min PTHS (PTHS-60), PTHS-60 + soft tissue injury (PTHS-60+ST), PTHS-60+ ST + femur fracture (PTHS-60+ST+FF), and decompensated PTHS+ST+FF (PTHS-D).","NHPs were randomly placed into five severe pressure-targeted hemorrhagic shock (PTHS)  additional injuries scenarios: 30-min PTHS (PTHS-30), 60-min PTHS (PTHS-60), PTHS-60 + soft tissue injury (PTHS-60+ST), PTHS-60+ ST + femur fracture (PTHS-60+ST+FF), and decompensated PTHS+ST+FF.","NHPs were placed into five pressure-targeted hemorrhagic shock (PTHS) scenarios. The scenarios were as follows: 30-min PTHS (PTHS-30), 60-min PTHS (PTHS-60), PTHS-60 + soft tissue injury (PTHS-60+ST), PTHS-60+ ST + femur (leg) fracture (PTHS-60+ST+FF), and decompensated PTHS+ST+FF (PTHS-D)."
1143,summarize: All animals survived to T = 24 h except one in each of the PTHS-60 and PTHS-60+ST+FF groups and seven in the PTHS-D group.,All animals survived to T = 24 h except one in each of the PTHS-60 and PTHS-60+ST+FF groups and seven in the PTHS-D group.,All animals survived till the end of the study except one in the PTHS-60 and PTHS-60+ST+FF groups. Seven did not survive till the end of the study in the PTHS-D group.
1144,"summarize: Thus, we have successfully established a clinically translatable NHP trauma model for use in testing therapeutic interventions to trauma.","Hence, we have successfully established a clinically translatable NHP trauma model for use in testing therapeutic interventions to trauma.",This study has successfully established a clinically translatable NHP trauma model for use in testing therapeutic interventions to trauma.
1145,"summarize: Hypovolemic hemorrhagic shock impairs the macrocirculation and microcirculation and therefore affects many organ systems (e.g. kidneys, endocrine system and endothelium).","Hypovolemic hemorrhagic shock impairs the macrocirculation and microcirculation and therefore affects many organ systems (e.g. kidneys, endocrine system and endothelium).","Hypovolemic shock is due to volume loss with blood vessels or blood vascular system. Hypovolemic hemorrhagic shock impairs blood circulation. Because of this, this type of shock affects many organ systems."
1146,"summarize: The term ""shock"" refers to a life-threatening circulatory failure caused by an imbalance between the supply and demand of cellular oxygen.","the term ""shock"" refers to a life-threatening circulatory failure caused by an imbalance between the supply and demand of oxygen in cells.","The term ""shock"" refers to a life-threatening blood-flow-related failure caused by an imbalance between supply and demand of oxygen for cells."
1147,"summarize: When these mechanisms are overwhelmed, hemodynamic instability and circulatory collapse will follow.","When these mechanisms are overwhelmed, hemodynamic instability and circulatory collapse will follow.","When these mechanisms are overwhelmed, unstable blood pressure, and circulatory failure will follow."
1148,"summarize: Measurements of the CR have also been used in clinical studies involving patients with traumatic injuries or bleeding, and the results from these studies have been promising.","Measurements of the CR have also been used in clinical studies involving patients with trauma injuries or bleeding, and the results from these studies have been promising.",CR measurements have also been used in clinical studies involving patients with traumatic injuries or bleeding. The results from these clinical studies have been promising.
1149,"summarize: Moreover, these measurements can be made at the bedside, and they provide a real-time assessment of hemodynamic stability.","Moreover, these measurements can be made at the bedside, and they provide a real-time assessment of hemodynamic stability.",CR measurements can be made at the bedside. They also provide a real-time assessment of blood flow.
1150,"summarize: Within this framework, we present evidence to support the notion that the use of the CR could potentially improve the outcomes of ICU patients by alerting intensivists to impending hypovolemic shock before its onset.","In this study, we present evidence to support the idea that the use of the CR could potentially improve the outcomes of ICU patients by alerting intensivists to impending hypovolemic shock before its start.","Within this framework, the authors present evidence to support the how the use of the CR could potentially improve the outcomes of ICU patients. CR could improve alerting doctors to impending hypovolemic shock before its onset."
1151,"summarize: Results: There are only four major categories of shock, each of which is mainly related to one of four organ systems.","There are only four major categories of shock, each of which is related to one of four organ systems.",There are four major categories of shock. Each category is mainly related to one of four organ systems.
1152,summarize: Hypovolemic shock relates to the blood and fluids compartment while distributive shock relates to the vascular system; cardiogenic shock arises from primary cardiac dysfunction; and obstructive shock arises from a blockage of the circulation.,Hypovolemic shock relates to the blood and fluids compartment while distributive shock relates to the heart. Cardiogenic shock arises from primary cardiac dysfunction; and obstructive shock arises from a blockage of the circulation.,"One category, known as hypovolemic shock, relates to the blood and fluids compartment. Distributive shock relates to the vascular system or blood vessels. Cardiogenic shock arises from primary cardiac or heart dysfunction. Obstructive shock arises from a blockage of circulation."
1153,"summarize: Pathogenesis and pathophysiology: The characteristic feature of both, hemorrhagic and traumatic hemorrhagic shock is bleeding.",hemorrhagic and traumatic hemorrhagic shock is bleeding.,Both hemorrhagic (excessive bleeding from a ruptured blood vessel) and traumatic hemorrhagic (internal bleeding from an injury) shock feature bleeding.
1154,summarize: Statistical analysis was performed after calculation of SI.,Statistical analysis was performed after calculation of SI.,Statistical analysis was performed after calculation of SI.
1155,summarize: Changes in pre-/post-donation blood pressure (BP) and heart rate (HR) also reached statistical difference but represented a clinically poor relevance.,Changes in pre-/post-donation blood pressure (BP) and heart rate (HR) also reached statistical difference but represented a clinically poor relevance.,"Changes in pre-/post-donation blood pressure and heart rate were also different. However, the difference was of clinically poor relevance."
1156,"summarize: The multivariate analysis showed no significant associations between SI variations and age, sex, body mass index (BMI), sport activities, blood donation volume, and enteral volume replacement (EVR).","The analysis showed no significant links between SI variations and age, sex, body mass index (BMI), sport activities, blood donation volume, and enteral volume replacement (EVR).","A statistical analysis showed no significant associations between SI variations and age, sex, body mass index (BMI), sport activities, blood donation volume, and enteral (intestinal) volume replacement (EVR)."
1157,"summarize: The network included 21 different interventions (13 dressings, 6 topical agents and 2 supplementary linking interventions) and was informed by 39 studies in 2127 participants, of whom 783 had completely healed wounds.","the study included 21 different treatments (13 dressings, 6 skin-level agents and 2 additional linking treatments) and was informed by 39 studies in 2127 participants, of whom 783 had completely healed wounds.","We compared 21 different treatments (13 dressings, 6 medicines applied to the skin and 2 mixed treatments) and looked at 39 studies in 2127 people, 783 of whom had completely healed wounds."
1158,"summarize: The consequence of this sparseness is high imprecision in the evidence, and this, coupled with the (mainly) high risk of bias in the studies informing the network, means that we judged the vast majority of the evidence to be of low or very low certainty.","the result of this sparseness is high imprecision in the evidence, and this, coupled with the (mainly) high risk of bias in the studies that form the network, means that we judged the vast majority of the evidence to be of low or very low certainty.",We thought that most of the data were low or very low quality due to unclear data combined with high likelihood of misleading results.
1159,"summarize: We have no confidence in the findings regarding the rank order of interventions in this review (very low-certainty evidence), but we report here a summary of results for some comparisons of interventions compared with saline gauze.","the authors have no confidence in the results regarding the rank order of treatments in this review (very low-certainty evidence), but we report here a summary of results for some comparisons of treatments compared with saline gauze.","We are not sure our ranking of interventions (treatments) is correct, but we summarize our results to compare treatments to saline gauze often used to as a wound dressing."
1160,"summarize: We judged the network to be sparse: overall, there were relatively few participants, with few events, both for the number of interventions and the number of mixed treatment contrasts; most studies were small or very small.","the study was small or very small. Overall, there were relatively few participants, with few events, both for the number of treatments and the number of mixed treatment contrasts.","We judged the study network to be scattered. Overall, there were few participants, with few events, both for number of treatments and mixed treatment analysis. Most studies were small or very small."
1161,summarize: The primary outcomes included the wound surface area (WSA) and pressure ulcer scale for healing (PUSH) tool.,The primary outcomes included the wound surface area (WSA) and pressure ulcer scale for healing (PUSH) tool.,The most important outcomes were wound surface area and a common bedsore scoring tool.
1162,"summarize: The secondary outcomes included a visual analog scale (VAS), questionnaire of ulcer status, and adverse effects.","secondary outcomes included a visual analog scale (VAS), questionnaire of ulcer status, and adverse effects.","We also looked at a common scoring tool for pain, questionnaire of ulcer (sore) status, and side effects."
1163,summarize: Multivariable analysis was used to compare the frequency of inpatient and outpatient revisits up to 6 months after an index encounter for CCO- vs medicinal honey-treated PUs.,Statistical analysis was used to compare the frequency of inpatient and outpatient visits up to 6 months after an index encounter for CCO- vs medicinal honey-treated PUs.,We used statistical models to compare how often patients who did and did not stay at least one night in the hospital returned to the hospital up to 6 months after bedsore treatment with either CCO or medical honey.
1164,"summarize: In adjusted models, those treated with CCO had lower odds for inpatient readmissions (OR = 0.86, 95% CI = 0.80-0.94) after inpatient index visits, and outpatient re-encounters both after inpatient (OR = 0.73, 95% CI = 0.67-0.79) and outpatient (OR = 0.78, 95% CI = 0.64-0.95) index visits in 6 months of follow-up.","Those treated with CCO had lower odds for inpatient readmissions after inpatient index visits, and outpatient re-encounters both after inpatient and outpatient index visits in 6 months.","Based on models, patients treated with CCO were less likely to be readmitted to the hospital after being admitted, and to return to the hospital but not stay a night after either going to the hospital and staying or not staying at least one night over the following 6 months."
1165,summarize: Results: A total of 112 adult patients were enrolled in the study.,112 adult patients were enrolled in the study.,We studied a total of 112 adult patients.
1166,summarize: Objective: To evaluate the effectiveness of topical pentoxifylline (PTX) on pressure ulcer (PU) healing in critically ill patients.,Objective: To evaluate the effectiveness of pentoxifylline (PTX) applied to the skin on pressure ulcer (PU) healing in critically ill patients.,"The study's objective is to evaulate the success of topical pentoxifylline (PTX) (a blood flow medication) on pressure ulcer (PU), or bedsore, healing in very ill patients."
1167,"summarize: The category of the PU was determined by the Stirling Pressure Ulcer Severity Scale (two-digit) at baseline (day zero), day seven and day 14 of treatment.","The severity of the PU was measured by measuring the severity of the ulcer at the start, day 7, and day 14 of treatment.","The severity of PU was determined with a special scale at starting (day zero), day seven, and day 14 of the treatment."
1168,summarize: Conclusion: The severity and size of PUs improved significantly in patients who received topical PTX 5% ointment twice a day for 14 days compared with those in the placebo group.,the severity and size of PUs improved significantly in patients who received topical PTX 5% ointment twice a day for 14 days compared with those in the placebo group.,The severity and size of PUs improved greatly in patients who received skin-level PTX 5% ointment twice a day for 14 days compared to those in the dummy treatment group.
1169,summarize: Topical PTX may be considered as a potential option in the treatment of categories I and II PUs in critically ill patients.,Topical PTX may be considered as a potential option in the treatment of categories I and II PUs in critically ill patients.,Skin-level PTX may be a possible option to treat mild and moderate PUs in very ill patients.
1170,"summarize: However, laboratory evidence, albeit limited, indicates that a concentrated cyanoacrylate produced a more substantial and adherent layer on a porcine explant when compared with a diluted cyanoacrylate and was more effective at protecting skin from abrasion and repeated exposure to moisture than a film-forming polymer.",cyanoacrylate is more effective at protecting skin from abrasion and repeated exposure to moisture than a film-forming polymer.,Limited lab data suggest that a concentrated cyanoacrylate made a more notable layer that stuck more to pig tissue than a less-concentrated cyanoacrylate and protected the skin from rubbing and moisture better than a film-forming polymer.
1171,summarize: Chronic wounds unresponsive to existing treatments constitute a serious disease burden.,Chronic wounds unresponsive to existing treatments constitute a serious disease burden.,Long-lasting wounds that do not respond to available treatments have serious impacts.
1172,summarize: Future clinical investigations assessing the wound healing efficacy of the C oestroides olive oil extract are warranted.,future clinical studies assessing the wound healing effectiveness of the C oestroides olive oil extract are warranted.,Future studies looking at how well C oestroides olive oil extract works to heal wounds are needed.
1173,"summarize: Study design: This was a randomized, double-blind, placebo-controlled clinical.","this was a randomized, double-blind, placebo-controlled clinical study.",This was a medical study involving human participants in which neither side knew who was getting what treatment and ointment with no medicine was given to a control group.
1174,"summarize: Results: In total, 83 patients in each group completed the study.",83 patients in each group completed the study.,"In total, 83 patients in each group completed the study."
1175,summarize: Changes in the size and stage of the ulcers were considered as primary outcome of the study.,Changes in the size and stage of the ulcers were considered as primary outcome of the study.,Changes in the size and severity of ulcers were the main measures of the study.
1176,summarize: The stage of the ulcers at baseline and on day 7 and day 14 of study was determined by using 2-digit stirling scale.,The stage of the ulcers at the start and on day 7 and day 14 of study was determined by using a 2-digit stirling scale.,"The severity of ulcers at baseline, on day 7, and on day 14 of the study was measured."
1177,"summarize: Furthermore, the mean decrease in the surface area of PU was significantly higher in the nifedipine group compared with the placebo group on day 7 (-1.44 vs. -0.32, respectively, P  0.001) and day 14 (-2.51 vs. -0.24, respectively, P  0.001) of study.","Moreover, the average decrease in the surface area of PU was significantly higher in the nifedipine group compared with the placebo group on day 7 and day 14.","Also, the average decrease in the area of PU was higher in the nifedipine group compared with the sham treatment group on day 7 and 14 of the study."
1178,"summarize: Conclusions: Using specialist dressings results in a significant decrease in the decubitus ulcer surface area, depending on the type of dressing and active substances contained within, while silver ions support curative effectiveness of the dressing used.","Using specialist dressings results in a significant decrease in the decubitus ulcer surface area, depending on the type of dressing and active substances contained within, while silver ions support the treatment effectiveness of the dressing used.","We conclude that specialist dressings significantly decrease bedsore surface area, and dressings with silver ions work better than those without."
1179,"summarize: There was no significant difference in the general data of patients in MY group, PP group, and MP group.","There was no significant difference in the general data of patients in MY group, PP group, and MP group.",Patients in the three groups generally were similar.
1180,"summarize: However, the mechanism of the SBMA hydrogel in promoting ECM rebuilding is unclear.","Nevertheless, the mechanism of the SBMA hydrogel in promoting ECM rebuilding is unclear.","However, scientists are unsure how SBMA hydrogel rebuilds ECM."
1181,summarize: Further investigation reveals that the decreased MMP-2 expression of zwitterionic SBMA hydrogel treatment is due to the activation of autophagy through the inhibited PI3K/Akt/mTOR signaling pathway and reduced inflammation.,the decreased MMP-2 expression of zwitterionic SBMA hydrogel treatment is due to the activation of autophagy through the inhibited PI3K/Akt/mTOR signaling pathway and reduced inflammation.,nan
1182,summarize: Results: We demonstrate that CAL is an ER localized protein that binds to ÎF508 CFTR and is degraded in the 26S proteasome.,CAL is an ER localized protein that binds to ÎF508 CFTR and is degraded in the 26S proteasome.,We show that CAL binds to ÎF508 CFTR in one location of the cell and is destroyed in another location of the cell.
1183,"summarize: When CAL is inhibited, ÎF508 CFTR retention in the ER decreases and cell surface expression of mature functional ÎF508 CFTR is observed alongside of enhanced expression of plasma membrane scaffolding protein NHERF1.","When CAL is inhibited, ÎF508 CFTR retention in the ER decreases and cell surface expression of mature functional ÎF508 CFTR is observed alongside of enhanced expression of plasma membrane scaffolding protein NHERF1.","When CAL is stopped, the amount of ÎF508 CFTR held within the cell decreases and working ÎF508 CFTR is seen on the cell surface."
1184,"summarize: Key to the CFTR's switch from pump to channel function may have been the appearance of one or more ""lateral portals.""","key to the CFTR's switch from pump to channel function may have been the appearance of one or more ""lateral portals.""","One or more ""lateral portals"" may have appeared, switching the active pump to a channel."
1185,summarize: Mutagenesis-mediated neutralization of several charged side chains reduced single-channel Cl- conductance.,Mutagenesis-mediated neutralization of several charged side chains reduced single-channel Cl- conductance.,Neutralization of many charged side chemical groups caused by gene sequence changes reduced movement of Cl- through a single channel.
1186,"summarize: However, these same mutations differentially affected channel blockade by cytoplasmic suramin and Pt(NO2)42- anions.","Nevertheless, these same mutations differentially affected channel blockade by cytoplasmic suramin and Pt(NO2)42- anions.","However, these gene sequence changes affected channel blockade by negatively charged atoms differently."
1187,summarize: The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl- channel that apparently has evolved from an ancestral active transporter.,cystic fibrosis transmembrane conductance regulator (CFTR) is a calcium channel that appears to have evolved from an active transporter.,The cystic fibrosis transmembrane conductance regulator (CTFR) is a chloride transporter that apparently has evolved from an ancestral active transporter.
1188,"summarize: Background and purpose: Cystic fibrosis (CF) is a lethal autosomal recessive genetic disease that originates from the defective function of the CF transmembrane conductance regulator (CFTR) protein, a cAMP-dependent anion channel involved in fluid transport across epithelium.","Cystic fibrosis (CF) is a lethal genetic disease that originates from the defective function of the CF transmembrane conductance regulator (CFTR) protein, involved in fluid transport across epithelium.","Cystic fibrosis (CF) is a deadly disease inherited from both parents that is caused when the CF transmembrane conductance regulator (CFTR) protein does not work correctly, a channel involved with movement of ions (charged atoms) and fluids in epithelial cells (cells that cover the outer surface of the internal organs)."
1189,summarize: Cystic fibrosis (CF) is an autosomal recessive disease caused by the loss of function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein which primarily acts as a chloride channel.,Cystic fibrosis (CF) is an autosomal recessive disease caused by the loss of function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein which primarily acts as a chloride channel.,"Cystic fibrosis (CF) is a disease inherited from both parents caused when the CF transmembrane conductance Regulator (CFTR) protein no longer functions, which acts as a compound (chloride) channel."
1190,"summarize: It could contribute to different aspects of the disease including cardiovascular symptoms, excessive blood vessel formation, pulmonary and portal hypertension and CF-related diabetes.","It could contribute to different aspects of the disease including heart symptoms, excessive blood vessel formation, pulmonary and portal hypertension and CF-related diabetes.","It could contribute to different aspects of the disease like heart-related symptoms, excessive blood vessel formation, lung and vein-related high blood pressure and CF-related diabetes."
1191,"summarize: Despite the important role of vascular endothelium in many biological processes, it has largely been under investigated in CF.","Despite the important role of vascular endothelium in many biological processes, it has largely been understudied in CF.","Despite the important role of blood vessel boundary cells in many biological processes, it has largely been under-investigated in CF."
1192,"summarize: Human primary bronchial epithelial cells differentiated in vitro represent a valuable tool to study lung diseases such as cystic fibrosis (CF), an inherited disorder caused by mutations in the gene coding for the Cystic Fibrosis Transmembrane Conductance Regulator.","bronchial epithelial cells (cells that protect the airway) differentiated in vitro represent a valuable tool to study lung diseases such as cystic fibrosis (CF), an inherited disorder caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator gene.","Cells on the surface of the bronchi (two tubes that carry air to your lungs) extracted from humans and grown in the lab are a valuable tool to study lung disease such as cystic fibrosis (CF), an inherited disease caused by a change in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein which helps transport chloride."
1193,"summarize: In addition, we found that apical plasma membrane of differentiated bronchial cells is characterized by a higher content of sphingolipids in comparison to the other cell membranes and that activity of sphingolipids catabolic enzymes associated with this membrane results altered with respect to the total cell activities.","In addition, we found that the apical plasma membrane of differentiated bronchial cells is characterized by a higher amount of sphingolipids in comparison to the other cell membranes. The activity of sphingolipids catabolic enzymes associated with this membrane results in changes in cell activities.",Cells on the surface of the bronchi have more sphingolipids compared to surfaces of other cells.
1194,"summarize: On this basis, our data further support the role of sphingolipids in the onset of CF lung pathology.","On this basis, our data further support the role of sphingolipids in the start of CF lung disease.",Our results support the role of sphingolipids in the onset of CF lung problems.
1195,summarize: Unsaturated Fatty Acid (UFA) deficiency has been a persistent observation in tissues from patients with CF.,Unsaturated Fatty Acid (UFA) deficiency has been a persistent observation in tissues from patients with CF.,Not enough Unsaturated Fatty Acid (UFA) has continually been seen in CF patients.
1196,"summarize: Cystic Fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane regulator (CFTR) gene, which encodes a chloride channel located at the apical surface of epithelial cells.","Cystic Fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane regulator (CFTR) gene, which encodes a chloride channel located at the surface of epithelial cells.","Cystic Fibrosis (CF) is an inherited disease, which leads to mucus buildup in many organs, caused by mutations in a specific gene, which encodes a channel located at the surface of boundary cells."
1197,summarize: Unsaturated Fatty Acid (UFA) deficiency has been a persistent observation in tissues from patients with CF.,Unsaturated Fatty Acid (UFA) deficiency has been a persistent observation in tissues from patients with CF.,"Lack of Unsaturated Fatty Acid (UFA), a certain form of fat, has been a common observation for patients with CF."
1198,"summarize: In a second step, a unifying mechanism for the potential impacts of these fatty acid dysregulations in CF cells, based on alterations of membrane biophysical properties (known as lipointoxication), is proposed.","In a second step, a mechanism for the potential impacts of these fatty acid dysregulations in CF cells is proposed.","In a second step, how the possible effects of this fatty acid impairment occur in CF cells, based on changes in cell boundary properties, is explored."
1199,"summarize: In addition to routine therapies, today drugs called correctors are available for mutations such as ÎF508-CFTR as well as for others less frequent ones.","In addition to routine treatments, today drugs called correctors are available for mutations such as ÎF508-CFTR and others less frequent ones.","In addition to normal treatments, drugs called correctors are available for changes like ÎF508-CFTR and other less common changes."
1200,"summarize: We now have evidence that Matrine and Lumacaftor not only restore the transport of mutant CFTR protein, but probably also counteract the inflammatory process by improving the course of the disease.","Matrine and Lumacaftor not only restore the transport of mutant CFTR protein, but probably also counteract the inflammation process by improving the course of the disease.","We now have proof that Matrine and Lumacaftor, another drug, not only allow the changed CFTR to move, but probably neutralize inflammation by improving the course of the disease."
1201,"summarize: ALP levels were inversely correlated with serum calcium (r=-0.38, p=0.012), pyridoxal phosphate (PLP; r=-0.51, p=0.001) and urine phosphoethanolamine (PEA; r=-0.49, p=0.001).","ALP levels were inversely linked with serum calcium, pyridoxal phosphate (PLP), and urine phosphoethanolamine (PEA).","ALP levels trended oppositely with blood calcium, pyridoxal phosphate (PLP) or active vitamin B6, and urine phosphoethanolamine (PEA), a key molecule to build cell boundaries."
1202,"summarize: Mutations in ALPL were found in 21 subjects (50%), including six novel mutations.","Mutations in ALPL were found in 21 subjects (50%), including six new mutations.","Gene sequence changes in ALPL, the gene encoding ALP, were found in 21 subjects (50%), including six new changes."
1203,summarize: Missense mutations were the most common (present in 18 subjects; 86%) and the majority were predicted to have a damaging effect on protein activity.,Missense mutations were the most common (present in 18 subjects; 86%) and the majority were predicted to have a damaging effect on protein activity.,Mutations that change a protein segment were the most common (present in 18 subjects; 86%). The majority were predicted to have a harmful effect on protein activity.
1204,summarize: Ten individuals (24%) had PLP levels above the reference range; all carried a mutated allele.,10 individuals (24%) had PLP levels above the reference range. All carried a mutated allele.,Ten people had above-average PLP levels. All had a mutated gene.
1205,summarize: Elevated circulating PLP is a sensitive and specific biochemical marker for HPP.,Elevated circulating PLP is a sensitive and specific biochemical marker for HPP.,"Elevated circulating PLP is a sensitive and specific biological marker, or a measurable compound in the body that can indicate health status, for HPP."
1206,summarize: Asfotase alfa was approved by regulatory agencies multinationally in 2015 typically for pediatric-onset HPP.,Asfotase alfa was approved by regulatory agencies in 2015 typically for pediatric-onset HPP.,Asfotase alfa was approved by regulatory agencies around the world in 2015 typically for pediatric-onset HPP.
1207,summarize: These adults may fall within the spectrum of the adult form of hypophosphatasia.,"Adults may have hypophosphatasia, a condition where the body cannot properly balance nutrients.","These adults may suffer from the adult form of hypophosphatasia, an inherited disorder that affects bone and tooth development."
1208,summarize: Some adults with persistent hypophosphatasemia share clinical and radiographic features with the adult form of hypophosphatasia (HPP).,Some adults with persistent hypophosphatasemia share clinical and imaging features with the adult form of hypophosphatasia (HPP).,Some adults with hypophosphatasemia share observable or radiographic (seen through x-ray) features with the adult form of hypophosphatasia (HPP).
1209,summarize: Mutational analyses were performed using PCR and Sanger sequencing methods.,Mutational analyses were performed using PCR and sequencing methods.,Analysis to determine ALPL mutations were performed.
1210,"summarize: Of the remaining 42 subjects, 67% were heterozygous for a P variant, 19% for an LP variant, and 14% for a VUS.","Of the remaining 42 patients, 67% were heterozygous for a P variant, 19% for an LP variant, and 14% for a VUS.","Of the remaining 42 subjects, 67% were heterozygous for a P variant, 19% for an LP variant, and 14% for a VUS."
1211,summarize: A majority of adults with persistently low serum alkaline phosphatase values carry a pathogenic or likely pathogenic variant in the ALPL gene and also have elevated alkaline phosphatase substrate values in serum and urine.,a majority of adults with persistently low blood alkaline phosphatase values carry a pathogenic or likely pathogenic gene in the ALPL gene and also have elevated alkaline phosphatase substrate values in serum and urine.,"Many adults with persistently low blood levels of alkaline phosphatase, a protein that influences levels of the high-energy molecule phosphate, possibly have a mutation in the ALPL gene that encodes alkaline phosphatase. Many adults also have increased phosphate-carrying compounds in blood and urine."
1212,"summarize: Methods: Biochemical analyses, including serum ALP activity, bone-specific ALP, plasma PLP, and urine PEA, were performed in adults with persistent hypophosphatasemia.","ALP activity, bone-specific ALP, plasma PLP, and urine PEA were performed in adults with persistent hypophosphatasemia.","Blood ALP activity, bone-specific ALP, blood PLP, and urine PEA were measured in adults with persistently low levels of ALP."
1213,summarize: Results: Fifty subjects completed all mutational and biochemical analyses.,Fifty subjects completed all mutational and biochemical analyses.,Fifty subjects completed all the tests.
1214,"summarize: Of the remaining 42 subjects, 67% were heterozygous for a P variant, 19% for an LP variant, and 14% for a VUS.","Of the remaining 42 patients, 67% were heterozygous for a P variant, 19% for an LP variant, and 14% for a VUS.","Of the remaining 42, 67% had at least one copy of the P variant, 19% for an LP variant, and 14% for a VUS."
1215,summarize: Subjects harboring Positive ALPL variants showed lower ALP and BSAP and higher PLP and PEA values compared with subjects harboring only Negative ALPL variants.,Subjects harboring Positive ALPL variants showed lower ALP and BSAP and higher PLP and PEA values compared with subjects harboring only Negative ALPL variants.,Those with Positive ALPL variants had lower ALP and bone-specific ALP and had higher PLP and PEA than those with Negative ALPL variants.
1216,"summarize: Purpose: The study aimed to define the clinical, biochemical and genetic features of adult patients with osteopenia/osteoporosis and/or bone fragility and low serum alkaline phosphatase (sALP).","The study aimed to define the clinical, biochemical and genetic features of adult patients with osteopenia/osteoporosis (a condition where bones become weaker or weaker) and/or bone fragility and low serum alkaline phosphatase (sALP), a protein in the blood that helps prevent inflammation.","The study aimed to define the health, biochemical, and genetic features of adult patients with bone strength issues and low serum (blood) alkaline phosphatase (sALP), a protein that helps bone strength."
1217,summarize: Methods: Twenty-two patients with at least two sALP values below the reference range were retrospectively enrolled after exclusion of secondary causes.,20-two patients with at least two sALP values below the reference range were enrolled after exclusion of secondary causes.,Twenty-two patients with at least two sALP measurements below the desired range were enrolled. Any patients with additional disease or health complications were excluded.
1218,"summarize: Data about clinical features, mineral and bone markers, serum pyridoxal-5'-phosphate (PLP), urine phosphoethanolamine (PEA), lumbar and femur bone densitometry, and column X-ray were collected.","Data about clinical features, mineral and bone markers, serum pyridoxal-5'-phosphate (PLP), urine phosphoethanolamine (PEA), lumbar and femur bone densitometry, and column X-ray were collected.",Several data points for patient health and biological indicators of disease status were collected.
1219,"summarize: Results: Pathogenic ALPL variants (pALPL) occurred in 23% and benign variants in 36% of patients (bALPL), while nine patients harbored wild-type alleles (wtALPL).",ALPL variants (pALPL) occurred in 23% of patients and benign variants in 36% of patients. Nine patients had wild-type alleles (wtALPL).,"Several types of mutations within the ALPL gene were found amongst the participant population. These variants include pathogenic (harmful) ALPL variants (pALPL), benign (harmless) variants (bALPL), and wild-type (normal) variants (wtALPL). pALPL are variants that increases a person's chance to get sick from a disease. bALPL are mutations that do not impact human health. wtALPL variants are genes that are not mutated or changed in form."
1220,summarize: Fragility fractures and dental anomalies were more frequent in patients harboring pALPL and bALPL than in wtALPL patients.,Fragility fractures and dental anomalies were more frequent in patients with pALPL and bALPL than in patients without pALPL.,Bone and tooth damage were more frequent in patients harboring pALPL and bALPL than in wtALPL patients.
1221,"summarize: Background: Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae.","Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae.","Severe hypercalcemia, or too high calcium blood levels, is rare in newborns. Even though hypercalcemia often shows no symptoms, it may have important effects on overall health."
1222,"summarize: Eventually, the infant experienced symptomatic hypocalcaemia (ionized Ca 3.4 mg/dl), likely exacerbated by contemporary infusion of albumin.","Eventually, the infant experienced hypocalcaemia (low levels of calcium in the blood), likely exacerbated by current infusions of albumin.","Eventually, the infant experienced symptoms of hypocalcemia. This was likely worsened by infusion of albumin, a blood protein."
1223,summarize: Low levels of alkaline phosphatase (ALP) are a biochemical hallmark of the disease.,Low levels of alkaline phosphatase (ALP) are a biochemical marker of the disease.,Low levels of alkaline phosphatase (ALP) are a hallmark of the disease.
1224,"summarize: Methods: A biochemical database containing ALP measurements of 26,121 individuals was reviewed to identify adults above 18 years of age with persistently low levels of ALP beneath range (â 35  2.7 U/L).","A database with ALP measurements of 26,121 individuals was reviewed to identify adults over 18 years of age with persistently low levels of ALP below range.","A database containing ALP measurements of 26,121 individuals was reviewed to identify adults above 18 years of age with persistently low levels of ALP."
1225,summarize: Patients with a variant in ALPL had significantly higher PLP levels than healthy controls (p = 0.002).,patients with a variant in ALPL had significantly higher PLP levels than healthy controls.,Patients with a variant in ALPL had significantly higher PLP levels than control patients.
1226,"summarize: We observed normal ALP activity in some patients classified as mild HPP, and slightly increased levels of PLP in two subjects with normal genetic screening and four healthy controls.","ALP activity was normal in some patients classified as mild HPP, and slightly increased levels of PLP in two subjects with normal genetic screening and four healthy controls.",Normal ALP activity was observed in some patients classified as mild HPP. A slightly increased level of PLP was found in two subjects with normal genetic screening and four healthy controls.
1227,summarize: Conclusions: Pathogenic variants in ALPL are common among patients with endocrinological diagnoses and low ALP.,ALPL is common among patients with endocrinological diagnoses and low ALP.,Genetic variations in ALPL are common among patients with endocrine disorders and low ALP.
1228,"summarize: Scarce knowledge about the prevalence of HPP in Scandinavia exists, and the variable clinical presentations make diagnostics challenging.","HPP is rare in Scandinavia, and the different symptoms make diagnosis difficult.",Little is known about the amount of HPP in Scandinavia. The diverse symptoms make identification challenging.
1229,"summarize: Results: Among 24 participants, thirteen subjects (54.2%) revealed a disease-causing variant in ALPL and reported mild clinical features of HPP, of which musculoskeletal pain was the most frequently reported (n = 9).","Among 24 participants, thirteen showed a disease-causing variant in ALPL and reported mild symptoms of HPP, of which musculoskeletal pain was the most frequently reported.","Among 24 patients, thirteen (54.2%) had a disease-causing variant in ALPL and mild symptoms of HPP, of which musculoskeletal pain was the most frequent."
1230,summarize: Patients with a variant in ALPL had significantly higher PLP levels than healthy controls (p = 0.002).,patients with a variant in ALPL had significantly higher PLP levels than healthy controls.,Patients with an ALPL mutation had much higher PLP levels than healthy patients.
1231,summarize: Conclusions: Pathogenic variants in ALPL are common among patients with endocrinological diagnoses and low ALP.,ALPL is common among patients with endocrinological diagnoses and low ALP.,Disease-causing mutations in ALPL are common in patients with hormonal diagnoses and low ALP.
1232,summarize: Summary: Hypophosphatasia (HPP) is a rare and under-recognised genetic defect in bone mineralisation.,Hypophosphatasia (HPP) is a rare and under-recognised genetic defect in bone mineralisation.,Hypophosphatasia (HPP) is a rare and under-recognized genetic defect in bone mineralization. Bone mineralization is when bone become calcified.
1233,summarize: The patient was treated with teriparatide given the unavailability of ALP enzyme-replacement therapy (asfotase alfa).,the patient was treated with teriparatide given the lack of ALP enzyme-replacement therapy (asfotase alfa).,The patient was treated with teriparatide (an osteoporosis drug) due to the unavailability of ALP enzyme-replacement therapy.
1234,summarize: Antiresorptive therapy is contraindicated in HPP.,Antiresorptive therapy is not recommended in HPP.,Antiresorptive therapy is not recommended in HPP treatment.
1235,summarize: Canonical signs or symptoms of B6 deficiency or toxicity were absent.,Symptoms of B6 deficiency or toxicity were absent.,Signs or symptoms of B6 deficiency or toxicity were absent.
1236,summarize: Only laboratory values of subjects older than 18 years of age were included.,only laboratory values of subjects older than 18 years of age were included.,Only laboratory values of subjects older than 18 years of age were included.
1237,summarize: Conclusion: These data support the genetic estimation that the prevalence of moderate forms of HPP may be significantly higher than expected.,Conclusion: These data support the genetic estimate that the prevalence of moderate forms of HPP may be significantly higher than expected.,These data support the estimation that the prevalence of moderate forms of HPP is higher than expected.
1238,"summarize: Based on these data, we recommend automatically measurement of PLP in the case of low ALP activity and a notification to the ordering physician that HPP should be included in the differential diagnosis and further exploration is recommended.","Using these data, we recommend automatically measuring PLP in the case of low ALP activity and a notification to the ordering physician that HPP should be included in the differential diagnosis and further exploration is recommended.",The authors recommend automatic measurement of PLP in cases of low ALP activity. Physicians should be notified that HPP should be included in the diagnosis and further exploration is recommended.
1239,summarize: Relationships between exposure and key safety events were assessed graphically.,Relationships between exposure and key safety events were assessed graphically.,Relationships between exposure to the medication and key safety events are assessed graphically.
1240,"summarize: Methods: TULIP-1 and TULIP-2 were randomized, placebo-controlled, 52-week trials of intravenous anifrolumab (every 4 weeks for 48 weeks).",TULIP-1 and TULIP-2 were 52-week trials of anifrolumab (every 4 weeks for 48 weeks).,"We analyzed two randomized, 52-week trials, called TULIP-1 and TULIP-2, which involved injected anifrolumab treatment (every 4 weeks for 48 weeks)."
1241,"summarize: In the exposure-efficacy analyses, BICLA and SRI(4) treatment differences favoring anifrolumab 300 mg vs placebo were observed across Cave subgroups and all analysis populations.","In the exposure-efficacy analyses, BICLA and SRI(4) treatment differences favoring anifrolumab 300 mg vs placebo were observed across subgroups and all analysis populations.",Patient health favored anifrolumab 300 mg vs dummy treatment across all analuzed populations.
1242,summarize: There was no evidence of exposure-driven incidence of key safety events through week 52 in patients receiving anifrolumab 150 or 300 mg.,there was no evidence of key safety events through week 52 in patients receiving anifrolumab 150 or 300 mg.,There was no evidence of treatment-related safety events through week 52 in patients receiving anifrolumab 150 or 300 mg.
1243,"summarize: We present the case of a childbearing age woman with SLE, who developed refractory LN despite all the indicated therapeutic options.","the study presents the case of a childbearing age woman with SLE, who developed refractory LN despite all the indicated treatments.",The case is of a childbearing age woman with lupus who developed lupus nephritis and did not respond to available treatment.
1244,"summarize: We currently know that cytokines play a major role in tissue damage and interleukin-17 (IL-17) seems to be a fundamental key in SLE and LN, having shown its expression in renal glomeruli and urinary sediment.","cytokines play a major role in tissue damage. Interleukin-17 (IL-17) seems to be a fundamental key in SLE and LN, having shown its expression in kidney glomeruli and urinary sediment.",Interleukin-17 (IL-17 - a chemical messenger) seems to be a basic key in lupus and lupus nephritis.
1245,"summarize: Results: Six RCTs (2,757 patients) were included in this study.","Six RCTs (2,757 patients) were included in this study.","Six studies (2,757 patients) were analyzed."
1246,"summarize: Methods: Patients with LN receiving mycophenolate and corticosteroids were randomised to obinutuzumab 1000 mg or placebo on day 1 and weeks 2, 24 and 26, and followed through week 104.","Patients with LN receiving mycophenolate and corticosteroids were randomly given obinutuzumab 1000 mg or placebo on day 1 and weeks 2, 24 and 26, and followed through week 104.","Patients with lupus nephritis receiving standard treatments such as steroids are randomly put in a group to either receive obinutuzumab or a placebo. The drug or placebo are given on day 1 and weeks 2, 24 and 26, and followed through week 104."
1247,summarize: The primary endpoint was complete renal response (CRR) at week 52.,the primary endpoint was complete renal response (CRR) at week 52.,The main result is complete kidney response at week 52.
1248,"summarize: Improvements in other renal response measures, serologies, estimated glomerular filtration rate and proteinuria were greater with obinutuzumab.","obinutuzumab improved other kidney response measures, such as serologies, estimated glomerular filtration rate and proteinuria.",Improvements in other kidney and blood tests are greater with obinutuzumab.
1249,summarize: Conclusions: Improved renal responses through week 104 were observed in patients with LN who received obinutuzumab plus standard therapies compared with standard therapies alone.,Improved kidney responses through week 104 were observed in patients with LN who received obinutuzumab plus standard treatments compared with standard therapies alone.,"In conclusion, improved kidney responses through week 104 are observed in patients with lupus nephritis who received obinutuzumab plus standard treatment compared with standard treatments alone."
1250,"summarize: Anti-ds DNA was decreased from 27.9 (IQR 7.6-40.28) IU/ml at baseline to 14.1 (IQR 7.3-20.12) IU/ml (P = 0.021) at week 12, while complements C3 and C4 were slightly increased (P = 0.445, P = 0.241, respectively).","anti-ds DNA was decreased from 27.9 IU/ml at the start of the study to 14.1 IU/ml at week 12, while complements C3 and C4 were slightly increased.","An antibody (infection-fighting molecule) associated with lupus called anti-ds DNA decreased from the start of the study to week 12, while protein complements C3 and C4 used to monitor the immune systems are slightly increased."
1251,summarize: It may be used as multi-target combination therapy in clinical practice.,It may be used as multi-target combination therapy in clinical practice.,Low-dose IL-2 may be used in combination with other medicines in clinical practice.
1252,"summarize: Finally, the identification of biomarkers to predict treatment outcomes would be of great value.",Identifying biomarkers to predict treatment outcomes would be of great value.,"Finally, the identification of specific biological factors to predict treatment outcomes would be of great value."
1253,"summarize: The primary target of metformin, the electron transport chain complex I in the mitochondria, is associated with redox homeostasis in immune cells, which plays a critical role in the pathogenesis of autoimmune diseases.","metformin is linked to redox homeostasis in immune cells, which plays a critical role in the development of autoimmune diseases.","The primary target of metformin, a specific energy-generator in the cell, is linked with electrical balance in immune cells, which influence the creation of diseases in which immune cells mistakely attack healthy cells."
1254,summarize: Recent Advances: Clinical trials in SLE patients with mild to moderate disease activity and preclinical studies in mice have provided encouraging results for metformin.,Recent Advances: Clinical trials in SLE patients with mild to moderate disease activity and studies in mice have provided encouraging results for metformin.,Clinical trials in SLE patients with mild to moderate disease severity and mice studies show encouraging results for metformin.
1255,"summarize: Critical issues: The major knowledge gaps are whether the efficacy of metformin is linked to a restored redox homeostasis in the immune system, and if it does, in which cell types it occurs?","the major knowledge gaps are whether the effectiveness of metformin is linked to a restored balance in the immune system, and if it does, in which cell types it occurs.","The major knowledge gaps are whether the success of metformin is linked to a restored electrical balance in the immune system. If it does, in which cell types it occurs?"
1256,summarize: We propose various MSC modification methods that may be beneficial in enhancing the immunosuppression of MSCs in SLE.,Several MSC modification methods may be helpful in improving the immune suppression of MSCs in SLE.,Researchers suggest various changes in MSC methods that may be beneficial in slowing the immune effect of MSCs in lupus.
1257,"summarize: However, their safety and protective effects in patients with SLE still need to be confirmed by further experimental and clinical evidence.","However, their safety and protective effects in patients with lupus still need to be confirmed by further experimental and clinical evidence.","However, their safety and protective effects in patients with lupus still need to be confirmed by more evidence."
1258,"summarize: As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases with severe disease.","As treatment options in advanced lupus erythematosus (LUP), a chronic lung disease, are limited, there is an urgent need for new and effective treatments for selected cases with severe disease.","Because treatment options in advanced systematic lupus erythematosus (lupus - when your immune system attacks healthy cells) are limited, there is an urgent need for new and effective treatment alternatives for selected cases with severe disease."
1259,summarize: Reduction of global disease activity was recorded by decreasing SLEDAI-2K scores over time and remained significantly reduced at the 6-month (p=0.007) and the 12-month (p=0.008) follow-up visits.,Reduction of global disease activity was recorded by decreasing SLEDAI-2K scores over time and remained significantly reduced at the 6-month and 12-month follow-up visits.,Reduction of global disease activity is recorded by decreasing scores over time of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI-2K) that tracks disease activity and remained significantly reduced at the 6-month and the 12-month follow-up visits.
1260,summarize: Reduction of proteinuria was observed over time as well as seroconversion of some autoantibody specificities.,Reduction of proteinuria was observed over time as well as seroconversion of some autoantibody specificities.,Reduction of proteinuria (elevated protein in urine) was observed over time as well as changes to specific antibodies.
1261,summarize: Type I interferons upregulate interferon gene signatures and mediate critical antiviral responses.,Type I interferons upregulate interferon gene signatures and mediate critical antiviral responses.,Type I interferons increase the amount of certain signaling proteins and influence important antiviral responses.
1262,summarize: Eczematous (stasis) dermatitis can be managed with emollients and topical steroid creams.,Eczematous (stasis) dermatitis can be managed with emollients and topical steroid creams.,Inflamed skin in the lower legs called eczematous (stasis) dermatitis is a kind of eczema (skin swelling) caused by poor circulation and can be helped with moisturizers and topical steroid creams.
1263,"summarize: Edema is an accumulation of fluid in the interstitial space that occurs as the capillary filtration exceeds the limits of lymphatic drainage, producing noticeable clinical signs and symptoms.","Edema is an accumulation of fluid in the interstitial space that occurs as the capillary filtration exceeds the limits of lymphatic drainage, producing noticeable signs and symptoms.","Edema is a buildup of fluid in the body that occurs as the filtration rate exceeds the drainage rate, producing noticeable symptoms."
1264,summarize: Eczematous (stasis) dermatitis can be managed with emollients and topical steroid creams.,Eczematous (stasis) dermatitis can be managed with emollients and topical steroid creams.,Skin inflammation from swelling in the legs can be managed with specific moisturizers and steroid creams.
1265,"summarize: If clinical suspicion for deep venous thrombosis remains high after negative results are noted on duplex ultrasonography, further investigation may include magnetic resonance venography to rule out pelvic or thigh proximal venous thrombosis or compression.","if suspicion for deep vein thrombosis remains high after negative results are noted on duplex ultrasound, further investigation may include magnetic resonance venography to rule out pelvic or thigh proximal venous thrombosis or compression.","If clinicians remain suspicious of deep venous thrombosis even when lab tests do not detect it, further lab tests may be performed to rule out other forms of blood clotting and compression."
1266,summarize: Obstructive sleep apnea may cause bilateral leg edema even in the absence of pulmonary hypertension.,Obstructive sleep apnea may cause leg swelling even in the absence of high blood pressure.,Obstructuve sleep apnea (disorder in which breathing is consistently interrupted during sleep by a blockage) may cause swelling in both legs even without lung-related high blood pressure.
1267,"summarize: Possible secondary causes of lymphedema include tumor, trauma, previous pelvic surgery, inguinal lymphadenectomy, and previous radiation therapy.","Possible secondary causes of lymphedema include tumor, trauma, previous pelvic surgery, inguinal lymphadenectomy, and previous radiation therapy.","Possible secondary causes of lymphedema include tumor, blunt force, previous hip surgery, lymph node (immune system organ) removal, and previous radiation therapy."
1268,"summarize: Methods: The severity of pitting edema was assessed at 3 points, namely, the pretibial edge, medial malleolus, and the dorsum of the foot.","the severity of pitting edema was assessed at 3 points, namely, the pretibial edge, medial malleolus, and the dorsum of the foot.","The severity of pitting edema, a condition where excess fluid builds up in one part of the body and pressing into the swollen area leaves a pit or indentation, is assessed at 3 places: the shins, the bony bump on the inside of the ankle, and the top part of the foot that faces up when standing."
1269,"summarize: Furthermore, leg edema should be seriously considered along with nutritional assessment because edema could influence various anthropometric parameters.",Leg edema should be seriously considered along with nutritional assessment because edema could influence various anthropometric parameters.,"Furthermore, leg edema should be seriously considered along with evaluating the diet of patients because edema could influence various physical measurements of the body."
1270,summarize: Basic tests and drug history are usually sufficient to exclude a host of general causes of the edema.,Basic tests and drug history are usually enough to exclude a host of general causes of the edema.,Basic tests and drug history are usually enough to exclude a number of general causes of the edema.
1271,"summarize: 46 year old male with past medical history of schizoaffective disorder and chronic lower back pain, was admitted for management of worsening depression and anxiety.",46 year old male with past medical history of schizoaffective disorder and chronic lower back pain was admitted for treatment of worsening depression and anxiety.,"A 46 year old male with past medical history of schizoaffective (reality-distorting) disorder, a mental disorder, and chronic lower back pain, is admitted to a medical facility to manage worsening depression and anxiety."
1272,summarize: He did not have any cardiovascular related symptoms.,He did not have any heart-related symptoms.,He does not have any cardiovascular (heart) related symptoms.
1273,"summarize: 46 year old male with past medical history of schizoaffective disorder and chronic lower back pain, was admitted for management of worsening depression and anxiety.",46 year old male with past medical history of schizoaffective disorder and chronic lower back pain was admitted for treatment of worsening depression and anxiety.,We admitted a 46 year old male to treat his worsening depression and anxiety. He had a prior history of symptoms of schizophrenia and mood disorders and long-lasting lower back pain.
1274,summarize: His only other medication was hydrocodone.,Severe's only other medication was hydrocodone.,"His only other medication was hydrocodone, a pain and cough medication."
1275,summarize: Incidence of pedal edema with gabapentin use is approximately 7 to 7.5% with all studies being in elderly patients receiving doses above 1200 mg/day.,the frequency of pedal edema with gabapentin use is about 7 to 7.5% with all studies being in elderly patients receiving doses above 1200 mg/day.,Frequency of leg swelling with gabapentin use is around 7 to 7.5% with all studies being in elderly patients receiving doses above 1200 mg/day.
1276,"summarize: Background: Leg edema is a common adverse effect of dihydropyridine Calcium Channel Blockers (CCB) that may need dose reduction or drug withdrawal, adversely affecting the antihypertensive efficacy.","Leg edema is a common side effect of dihydropyridine Calcium Channel Blockers (CCB) that may need dose reduction or drug withdrawal, negatively affecting the effectiveness of antihypertensive drugs.","Leg edema is a common side effect of dihydropyridine Calcium Channel Blockers (CCB), medicines taken to control blood pressure and other conditions. The dose amount of CBB drugs may need to be reduced or stopped, negatively impacting the drugs' use to control blood pressure."
1277,summarize: Leg edema is reported to occur less often with (S)-amlodipine compared to conventional racemic amlodipine.,Leg edema is reported to occur less often with (S)-amlodipine compared to conventional amlodipine.,Leg edema (fluid swelling) is reported to occur less often with a type of CBB medicine called (S)-amlodipine compared to the regular racemic amlodipine medicine.
1278,summarize: Fischer's exact test was applied to observe difference between responder rates and proportions of subjects having peripheral edema in the two groups.,Fischer's exact test was applied to observe difference between responder rates and proportions of subjects having peripheral edema in the two groups.,Data are analyzed to observe the difference between the two groups on how they responded to the treatment and the number of people who develop peripheral edema (swelling in lower legs and hands).
1279,"summarize: Results: Altogether 146 patients (amlodipine, n = 76 and (S)-amlodipine, n = 70) completed 120 days treatment.",146 patients completed 120 days of treatment.,Altogether 146 patients completed 120 days treatment: 76 patients in the standard amlodipine group and 70 in the (S)-amlodipine group.
1280,summarize: Two serious AEs occurred unrelated to therapy.,two serious side effects occurred unrelated to therapy.,Two serious side effects occur that are unrelated to therapy.
1281,"summarize: Conclusions: In hypertensive patients not controlled on prior BB and ACEI/ARB therapy, addition of (S)-amlodipine besylate at half the dose of conventional amlodipine provides better tolerability with reduced incidence of peripheral edema, and equal antihypertensive efficacy compared to amlodipine given at usual doses.","(S)-amlodipine besylate at half the dose of conventional amlodipine provides better tolerability with reduced incidence of peripheral edema, and equal antihypertensive effectiveness compared to amlodipine given at usual doses.","In patients with high blood pressure not controlled on prior BB and ACEI/ARB therapy, adding (S)-amlodipine besylate at half the dose of standard amlodipine provides few side effects. There is also a reduced number of peripheral edema, and equal ability to lower blood pressure compared to amlodipine given at usual doses."
1282,"summarize: After daily treatment with 15 mg prednisolone, the refractory edema symptom dramatically improved.","after daily treatment with 15 mg prednisolone, the refractory edema symptom dramatically improved.","After daily treatment with a steroid medication called prednisolone, the edema symptom greatly improved."
1283,"summarize: In particular, cardiologists usually tend to prescribe diuretics for patients with pitting edema in their legs.",Cardiologists usually prescribe diuretics for patients with pitting edema in their legs.,"In particular, heart specialists (cardiologists) usually tend to prescribe diuretics for patients with pitting edema in their legs."
1284,summarize: This condition predisposes the patient to deep venous thrombosis (DVT).,Deep vein thrombosis (DVT) is a condition where blood clots in the vein lead to deep vein thrombosis.,"Having this condition makes it easier for the patient to develop deep venous thrombosis (DVT), a serious condition where a blood clot forms in the vein."
1285,summarize: May-Thurner syndrome (MTS) is a clinical condition characterized by the compression of the left iliac vein by the right iliac artery.,May-Thurner syndrome (MTS) is characterized by the compression of the left iliac vein by the right iliac artery.,May-Thurner syndrome (MTS) is a condition in which the main right leg blood vessel compresses the main left leg blood vessel.
1286,summarize: Her calf muscle was tender to palpation.,Her calf muscle was tender to palpation.,Her lower leg calf muscle was tender to touch.
1287,"summarize: BACKGROUND In lymphedema, an imbalance in the formation and absorption of lymph causes accumulation of protein-rich fluid in the interstitium of the most gravity-dependent parts of the body.","BACKGROUND In lymphedema, an imbalance in the formation and absorption of lymph causes accumulation of protein-rich fluid in the interstitium of the most gravity-dependent parts of the body.","In lymphedema, an imbalance of a fluid called lymph causes a build up of protein-rich fluid, usually in the arms and legs."
1288,"summarize: The condition was inherited through an autosomal dominant pattern, as his father, elder brother, and nephew were diagnosed with the same disease.","the condition was passed down through his father, elder brother, and nephew.","The condition was inherited, as his father, elder brother, and nephew were diagnosed with the same disease."
1289,"summarize: This report is of a 41-year old woman with Stage 3 lipedema and lipo-lymphedema with excessive fat of the lower body since puberty, with progression to swollen ankles and feet despite dietary caloric restriction.","a 41-year old woman with Stage 3 lipedema and lipo-lymphedema with excessive fat of the lower body since puberty, with progression to swollen ankles and feet despite dietary restrictions.",This report is of a 41-year old woman with Stage 3 lipedema and lipo-lymphedema with excessive fat of the lower body since puberty. The woman's condition has advanced to swollen ankles and feet despite being on a low calorie diet.
1290,"summarize: Laboratory test results showed hypoalbuminemia (2.0 g/dL), lymphopenia, and hypolipoproteinemia.","Laboratory test results showed hypoalbuminemia (2.0 g/dL), lymphopenia, and low levels of lipoproteins.","Lab test results showed hypoalbuminemia (low levels of the albumin protein in the blood), making it harder to move substances in the body. Tests also show low levels of white blood cells and low levels of fat lipids in the blood."
1291,"summarize: We therefore prospectively measured the serum C-reactive protein in 17 patients with active pulmonary sarcoidosis, 10 patients with other chronic interstitial lung diseases of unknown etiology, 11 patients with active lung tuberculosis, and 10 healthy volunteers.","the study measured the blood C-reactive protein in 17 patients with active pulmonary sarcoidosis, 10 patients with other chronic lung diseases of unknown cause, 11 patients with active lung tuberculosis, and 10 healthy volunteers.",Serum (blood) C-reactive protein was measured in 48 patients. Seventeen of the patients had active sarcoidosis in the lung. Ten patients had other lung diseases of unknown origin. Eleven patients had active lung tuberculosis (a serious lung infection). Ten patients were healthy volunteers.
1292,summarize: Serum C-reactive protein was assayed by enzymoimmunodiffusion test.,Serum C-reactive protein was measured by a blood test.,Serum C-reactive protein was measured.
1293,summarize: The serum C-reactive protein was negative in 13 patients suffering from active sarcoidosis and positive in four.,13 patients with active sarcoidosis had negative C-reactive protein in their blood and four had positive C-reactive protein.,The serum C-reactive protein was negative (no detection) in 13 patients suffering from active sarcoidosis and positive in four.
1294,summarize: The analyses of C-reactive protein in patients with sputum positive lung tuberculosis were positive in 10 cases.,"C-reactive protein was detected in patients with lung tuberculosis, a disease where the body's immune system attacks healthy cells.",The analyses of C-reactive protein in patients with lung tuberculosis were positive in 10 cases.
1295,"summarize: In this respect, the measurements of serum C-reactive protein are valuable in the differentiation of sarcoidosis and other chronic interstitial lung diseases of unknown etiology from tuberculosis and other diseases which are known to induce an acute phase response.","In this respect, the measurements of serum C-reactive protein are valuable in the differentiation of sarcoidosis and other chronic lung diseases of unknown causes from tuberculosis and other diseases known to cause an acute phase response.",Levels of serum C-reactive protein are valuable in the identification of sarcoidosis and other lung diseases of unknown origin from tuberculosis and other diseases.
1296,summarize: The activated macrophage in sarcoidosis produces interleukin-1 (II-1).,the activated macrophage in sarcoidosis produces interleukin-1 (II-1).,"The activated macrophage, a specialized white blood cell defender against invaders, in sarcoidosis produces interleukin-1 (Il-1), a molecule which signals inflammation."
1297,summarize: Hospital survival rate in the patients with chronic dissection was 100% (14/14).,hospital survival rate in patients with chronic dissection was 100% (14/14).,Hospital survival rate in the patients with chronic dissection was 100%.
1298,summarize: Hospital survival rate in the patients with acute dissection was 96% (27/28).,hospital survival rate in patients with acute dissection was 96% (27/28).,Hospital survival rate in patients with acute dissection was 96% (27/28).
1299,summarize: Pathologic evidence of chorioamnionitis was present in 32.9% of 310 preterm deliveries as compared to only 22.3% of 1631 term deliveries.,Symptoms of chorioamnionitis was present in 32.9% of 310 preterm deliveries as compared to only 22.3% of 1631 term deliveries.,"Evidence of chorioamnionitis, an infection within the membranes surrounding a fetus, was present in 32.9% of 310 preterm deliveries. Evidence of chorioamnionitis was only found in 22.3% of 1631 term deliveries."
1300,summarize: The bacterial etiology was non-specific.,the bacterial cause was non-specific.,The cause of the bacterial infections were not specified.
1301,summarize: Diagnosis of bacterial infection was made a posteriori by an adjudicating process (consensus of experts unaware of the results of procalcitonin and C-reactive protein).,Detection of bacterial infection was made a posteriori by an adjudicating process (consensus of experts unaware of the results of procalcitonin and C-reactive protein).,Diagnosis of bacterial infection was made following examination of the cultures.
1302,summarize: Diagnostic accuracy could be enhanced by combining these tests with bedside clinical judgment.,Diagnostic accuracy could be enhanced by combining these tests with bedside clinical judgment.,Diagnostic accuracy could be enhanced by combining these tests with bedside clinical judgment.
1303,summarize: Procalcitonin levels were significantly higher in patients with bacterial infection compared with patients without bacterial infection (p =.01).,Procalcitonin levels were significantly higher in patients with bacterial infection compared with patients without bacterial infection.,Procalcitonin levels were higher in patients with bacterial infection than those without.
1304,"summarize: The area under the receiver operating characteristic curve for procalcitonin was greater than that for C-reactive protein (0.71 vs. 0.65, respectively).",the area under the receiver operating characteristic curve for procalcitonin was greater than that for C-reactive protein.,Accuracy was higher for procalcitonin than for C-reactive protein.
1305,"summarize: Ages ranged from 4 days to 17.8 years (median 19.0, mean 46  56 months).",Ages ranged from 4 days to 17.8 years.,Ages ranged from 4 days to 17.8 years.
1306,summarize: A highly significant interaction was found in the change in CRP over time by FWI group compared with FNI group (P .001).,a highly significant interaction was found in the change in CRP over time by FWI group compared with FNI group.,A highly significant interaction was found in the change in CRP over time by the FWI group compared with the FNI group.
1307,summarize: A CRP velocity of 4 mg/dL per d had a positive predictive value (PPV) of 85.7% for bacterial infection with 95.2% specificity.,a CRP velocity of 4 mg/dL per day had a positive predictive value (PPV) of 85.7% for bacterial infection with 95.2% specificity.,Specific CRP velocity could positively predict bacterial infection with 95.2% specificity (accuracy).
1308,"summarize: The predictors analysed were gender, age, time from ulcerative colitis diagnosis, months of steroid or/and azathioprine therapy before onset of the severe phase, smoking habits, extension of the disease, laboratory analyses and Mayo score.","the predictors were gender, age, time from ulcerative colitis diagnosis, months of steroid or/and azathioprine therapy before severe phase, smoking habits, extension of the disease, lab tests and Mayo score.","The predictors evaluated were gender, age, time from ulcerative colitis diagnosis, months of steroid or/and azathioprine therapy before onset of the severe phase, smoking habits, extension of the disease, laboratory analyses and Mayo score. Azathioprine is a medication given to improve immune function."
1309,summarize: A total of 67 patients with mRCC who received first-line molecular targeted therapy were included in this study.,67 patients with mRCC who received first-line molecular targeted therapy were included in this study.,A total of 67 patients with mRCC who received molecular targeted therapy were included in this study.
1310,"summarize: The patients who achieved 0% or more at the initial evaluation had longer survival than those who had no tumor reduction (40.0 months vs 12.0 months, p0. 001).",the patients who achieved 0% or more at the initial evaluation had longer survival than those who had no tumor reduction.,The patients who achieved 0% or more at the initial evaluation had longer survival times than those who had no tumor reduction.
1311,summarize: Background: Corona virus disease 2019 has become a global health issue.,Corona virus disease 2019 has become a global health issue.,"Corona virus disease 2019, or COVID-19 (a viral, respiratory illness), has become a global health issue."
1312,summarize: The outcome variable was mortality of patients undergoing invasive mechanical ventilation and factors associated with it during intensive care unit stay.,The outcome variable was death of patients undergoing invasive mechanical ventilation and factors associated with it during intensive care unit stay.,The studied variable of interest was death of the patients undergoing invasive mechanical ventilation and factors associated with death during intensive care unit stay.
1313,"summarize: The titres in some were shown to rise and fall over the years, while in others they remained remarkably constant.","the levels in some were shown to rise and fall over the years, while in others they remained remarkably constant.",I.C.Ab measurements rose and fell in some patients and stayed constant in other patients.
1314,"summarize: In addition to acting as a marker for asymptomatic and latent diabetes and prediabetes, it seems that the presence of I.C.Ab in the serum may define a new group of potential diabetics with normal G.T.T.S.","In addition to acting as a marker for asymptomatic and latent diabetes and prediabetes, it seems that the presence of I.C.Ab in the blood may define a new group of potential diabetics with normal G.T.T.S.",I.C.Ab in the blood can indicate diabetes without symptoms and slow-progressing diabetes and prediabetes and may signal a new group of possible diabetics with normal G.T.T.S.
1315,summarize: Time series analysis was used to demonstrate oscillatory patterns in plasma insulin.,Time series analysis was used to show oscillatory patterns in blood insulin.,We looked at blood insulin over time to see how it rises and falls.
1316,summarize: Islet cell antibodies (ICA; proteins made against insulin-producing cells) are a marker of insulin-dependent diabetes mellitus (IDDM).,Islet cell antibodies (ICA; proteins made against insulin-producing cells) are a marker of insulin-dependent diabetes mellitus (IDDM).,Islet cell antibodies (ICA) are an indicator of type 1 diabetes.
1317,summarize: The presence of ICA in patients with non-insulin-dependent diabetes mellitus (NIDDM) indicates that the patients are likely to develop IDDM.,The presence of ICA in patients with non-insulin-dependent diabetes mellitus (NIDDM) indicates that the patients are likely to develop IDDM.,Type 2 diabetics with ICA are likely to develop type 1 diabetes.
1318,"summarize: Rats were fed for 10 days with glipizide or diazoxide, in order to stimulate or inhibit insulin release, respectively.","Rats were fed for 10 days with glipizide or diazoxide, in order to stimulate or inhibit insulin release.","We fed rats glipizide or diazoxide (insulin-treating drugs) for 10 days to increase or decrease insulin release, respectively."
1319,summarize: Frozen sections of pancreata were incubated with ten ICA-positive IDDM sera and analyzed by indirect immunofluorescence.,Frozen sections of pancreata were incubated with ten ICA-positive IDDM samples and analyzed by indirect immunofluorescence.,Sections of the pancreas were analyzed.
1320,"summarize: Intermediate titres were seen in control animals and the lowest titres were observed on pancreata from diazoxide-treated rats, regardless of the serum used.","the lowest levels were seen on the pancreas from diazoxide-treated rats, regardless of the serum used.","We saw medium measurements in animals not given drugs, and the lowest measurements in rats given diazoxide."
1321,"summarize: Conflicting results concerning ICSA in previous reports and our failure to show a glucose regulation of ICSA reactivity, indicate that ICSA is a phenomenon with a low degree of specificity.","conflicting results concerning ICSA in previous reports and our failure to show a glucose regulation of ICSA reactivity, indicate that ICSA is a phenomenon with a low degree of specificity.","Conflicting results concerning ICSA in previous reports and our failure to show an energy regulation of ICSA reactivity, indicate that ICSA is a phenomenon with a low degree of specific detection."
1322,summarize: Four months after subtotal pancreatectomy all LEW.Han rats had developed mononuclear infiltration of islets and 9 of 14 rats were positive for islet-cell antibodies.,"four months after subtotal pancreatectomy, all LEW.Han rats had developed mononuclear infiltration of islets and 9 out of 14 rats were positive for islet-cell antibodies.","Four months after removal of almost all of the pancreas, all rats had developed signs of long-term inflammation (infection-fighting) response of islets (clusters of cells that produce hormones) and 9 of 14 rats had islet-cell antibodies (proteins made against insulin-producing cells)."
1323,"summarize: During the observation period insulitis was not associated with overt diabetes but was accompanied by substantial enlargement of islets and of beta-cell mass, as shown by morphometry.","During the observation period insulitis was not associated with overt diabetes but was accompanied by substantial enlargement of islets and beta-cell mass, as shown by morphometry.","During the observation period, insulitis was not related to diabetes, but we saw a sizeable increase in the sizes of islets and beta-cell mass."
1324,summarize: The findings indicate induction of islet autoimmunity in response to 90% but not to 10% pancreatectomy.,The findings suggest induction of islet autoimmunity in response to 90% but not to 10% pancreatectomy.,The results suggest removing 90% but not 10% of the pancreas causes the body to mistakenly destroy its islets.
1325,"summarize: Blood samples of 114 newly diagnosed IDDM patients, aged 12 +/- 5 yrs (range 2 months-29 years) were tested for ICA (indirect immunofluorescence), IAA, GADA and ICA512A (radiobinding assay).","114 newly diagnosed IDDM patients, aged 12 +/- 5 years, were tested for ICA, IAA, GADA, and ICA512A (radiobinding assay).","We tested blood samples of 114 newly diagnosed type 1 diabetes patients, aged 12 plus or minus 5 years (ranging from 2 months to 29 year) for ICA, IAA, GADA, and ICA512A."
1326,summarize: Generalized estimating equations for longitudinal data analysis revealed that (i) BMI z-score and diastolic blood pressure (DBP) were significantly affected by duration of diabetes; (ii) systolic blood pressure (SBP) and ALT were affected by changes in BMI z-score; and (iii) changes in HbA1c had an effect on lipid profile and cardiometabolic risk factors regardless of antibody status.,estimating equations for longitudinal data analysis revealed that (i) BMI z-score and diastolic blood pressure (DBP) were significantly affected by duration of diabetes; (ii) systolic blood pressure (SBP) and ALT were affected by changes in BMI z-score; and (iii) changes in HbA1c had an effect on lipid profile and cardiometabolic risk factors regardless of antibody status.,"We found that: (i) length of diabetes affected BMI score adjusted for weight and gender and diastolic blood pressure, (ii) changes In BMI score adjusted for weight and gender affected systolic blood pressure and ALT (alanine transaminase; released into the blood when liver cells are damaged), and (iii) changes in HbA1c affected lipid profile (panel of blood tests used to find abnormalities in lipids, such as cholesterol and triglycerides) and risk factors for heart disease and metabolic disorders independent of antibody (infection-fighting protein) status."
1327,summarize: Turner syndrome is a sex chromosome aneuploidy with characteristic malformations.,Turner syndrome is a sex chromosome aneuploidy with characteristic malformations.,Turner syndrome is a condition where there is an abnormal number of chromosomes (genetic material).
1328,"summarize: Manual curation of the differentially expressed gene list identified genes of possible pathologic significance, including NFATC3, IGFBP5, and LDLR.","Manual curation of the differentially expressed gene list identified genes of possible pathologic significance, including NFATC3, IGFBP5, and LDLR.",Organization of the differentially expressed gene list identified genes of possible disease development significance.
1329,summarize: The hematologic/immune system differences may play a role in early-onset autoimmune dysfunction.,The hematologic/immune system differences may play a role in early-onset autoimmune dysfunction.,The hematologic/immune system differences may play a role in early-onset autoimmune dysfunction (in which infection-fighting cells attack healthy cells).
1330,"summarize: Functional analysis revealed that these differentially expressing genes are associated with bone differentiation, glucose metabolism and gonadal development pathways.","Functional analysis revealed that these differentially expressing genes are associated with bone differentiation, glucose metabolism and gonadal development pathways.","Analysis revealed that these differentially expressing genes are associated with bone differentiation, glucose metabolism, and gonadal development pathways."
1331,summarize: Turner Syndrome (TS) is an unfavorable genetic condition with a prevalence of 1:2500 in newborn girls.,Turner Syndrome (TS) is an unfavorable genetic condition with a prevalence of 1:2500 in newborn girls.,Turner Syndrome (TS) is a genetic condition found in 1 out of every 2500 newborn girls. Turner syndrome is a condition where there is an abnormal amount of chromosomes (genetic material).
1332,"summarize: The aim of the present study was to propose a feasible and practical molecular diagnostic tool for newborn screening by quantifying the gene dosage of the SHOX, VAMP7, XIST, UBA1, and SRY genes by quantitative polymerase chain reaction (qPCR) in individuals with a diagnosis of complete X monosomy, as well as those with TS variants, and then compare the results to controls without chromosomal abnormalities.","the aim of this study is to propose a feasible and practical molecular diagnostic tool for newborn screening by quantifying the gene dosage of the SHOX, VAMP7, XIST, UBA1, and SRY genes in individuals with complete X monosomy (complete X monosomy), as well as those with TS variants. The results are then compared to controls without chromosomal abnormalities.","The aim of the study was to propose a feasible and practical diagnostic tool for newborn screening. The screening would be completed by quantifying (measuring) the dosage of specific genes in individuals with a diagnosis of complete X monosomy and TS variants. The gene doses would be compared to controls without chromosomal abnormalities. Monosomy indicates there is an absence of one member of a chromosome pair; instead of 46 chromosomes in each cell of the body, there is 45."
1333,"summarize: Therefore, we conclude that these markers are useful for early detection in aneuploidies involving sex chromosomes.","Hence, we conclude that these markers are useful for early detection in aneuploidies involving sex chromosomes.","The authors concluded that these markers are useful for early detection in chromosomal imbalances, specifically those involving sex chromosomes."
1334,"summarize: Turner syndrome (TS) is one of the most common sexual chromosome abnormalities and is clearly associated with an increased risk of autoimmune diseases, particularly thyroid disease and coeliac disease (CD).","Turner syndrome (TS) is one of the most common sexual chromosome abnormalities and is clearly associated with an increased risk of autoimmune diseases, particularly thyroid disease and coeliac disease (CD).","Turner syndrome (TS) is one of the most common sexual chromosome abnormalities. TS is associated with an increased risk of autoimmune diseases (in which immune cells attack healthy cells), particularly metabolism-affecting thyroid disease and coeliac disease (CD)--gluten sensitivity."
1335,summarize: Our aim was to study the functional polymorphic variants of PTPN22 and ZFAT in relation to thyroid disease and those of MYO9B in relation to CD.,PTPN22 and ZFAT are related to thyroid disease and MYO9B is related to CD.,"This report aimed to study the genetic variants of PTPN22 and ZFAT (protein-coding genes) in relation to thyroid disease. Additionally, this study evaluated the variants (gene types) of MYO9B (another protein-coding gene) to CD."
1336,"summarize: In conclusion, these KRs and identified interologs are expected to regulate the TS network signifying their biological importance.",KRs and identified interologs are expected to regulate the TS network signifying their biological importance.,"In conclusion, these KRs and identified interologs are expected to regulate the TS network. This data demonstrates their biological importance."
1337,"summarize: We now demonstrate that escape from inactivation for RPS4X is already established by embryonic Day 9.5, and that both silencing and escape are faithfully maintained across the lifespan.","We now show that escape from inactivation for RPS4X is already established by embryonic Day 9.5, and that both silencing and escape are faithfully maintained throughout the lifespan.","The study showed that escape from inactivation for RPS4X is already established by embryonic Day 9.5. Additionally, the study demonstrated that both silencing and escape are maintained across the entire lifespan."
1338,summarize: The pathogenesis of Turner syndrome (TS) and the genotype-phenotype relationship has been thoroughly investigated during the last decade.,The development of Turner syndrome (TS) and the relationship between genotype and physical characteristics has been thoroughly investigated during the last decade.,"The disease development of Turner syndrome (TS), and how gene expression effects physical appearance, has been heavily investigated over the last decade. Turner syndrome is a condition where there is an abnormal amount of chromosomes (genetic material)."
1339,summarize: It has become evident that the phenotype seen in TS does not only depend on simple gene dosage as a result of X chromosome monosomy.,It has become evident that the physical appearance seen in TS does not only depend on simple gene dosage as a result of chromosome monosomy.,"Phenotype (observable characteristics) seen in TS does not only depend on the number of copies of a gene as a result of X chromosome monosomy. Monosomy indicates there is an absence of one member of a chromosome pair; instead of 46 chromosomes in each cell of the body, there is 45."
1340,"summarize: Methods: In our study, we used the online Gene Expression Omnibus (GEO) microarray expression profiling dataset GSE46687 to identify differentially expressed genes (DEGs) between monosomy X TS patients and normal female individuals.","Methods: In this study, we used the online Gene Expression Omnibus (GEO) microarray expression profiling dataset GSE46687 to identify differentially expressed genes (DEGs) between monosomy X TS patients and normal female individuals.","In this study, an online database was used to identify differentially expressed (functionally unique) genes (DEGs) between monosomy X TS patients (one chromosome lacks its partner) and normal female individuals."
1341,"summarize: 47,XXX (triple X) and Turner syndrome (45,X) are sex chromosomal abnormalities with detrimental effects on health with increased mortality and morbidity.","47,XXX (triple X) and Turner syndrome (45,X) are sex chromosomal abnormalities with harmful effects on health with increased death and illness.","47,XXX (triple X) and Turner syndrome (45,X) are sex chromosomal (gene material) abnormalities with detrimental effects on health. Both syndromes are associated with increased death and disease suffering."
1342,"summarize: In 47,XXX and Turner syndrome a gene dosage imbalance may ensue from increased or decreased expression from the genes that escape X inactivation, as well as from incomplete X chromosome inactivation in 47,XXX.","In 47,XXX and Turner syndrome, a gene dosage imbalance may result from increased or decreased expression from the genes that escape X inactivation. Also, there may be incomplete X chromosome inactivation in 47,XXX.","In both syndromes, a gene dosage imbalance may be caused by increased or decreased expression from the genes that escape X inactivation. A gene dosage imbalance may also be caused by incomplete X chromosome inactivation in 47,XXX."
1343,"summarize: We aim to study genome-wide DNA-methylation and RNA-expression changes can explain phenotypic traits in 47,XXX syndrome.","We aim to study genome-wide DNA-methylation and RNA-expression changes can explain physical traits in 47,XXX syndrome.","This study aimed to evaluate genome-wide DNA-methylation (addition of methyl groups to DNA) and RNA (genetic material)-expression changes. This was done in the hope that these alterations may explain phenotypic traits, or observable character traits, associated with 47,XXX syndrome."
1344,summarize: Six African-American FDRs with normal glucose tolerance and 12 matched normal control subjects (who had no family history of diabetes) were exposed to 48 h of hyperglycemic clamping (approximately 12 mmol/l).,Six African-American FDRs with normal glucose tolerance and 12 matched normal control subjects (who had no family history of diabetes) were exposed to 48 hours of hyperglycemic clamping.,"Six African-American first-degree relatives with normal blood sugar level and 12 normal control participants (who had no family history of diabetes) were exposed to 48 hours of hyperglycemic clamping, a technique to keep blood sugar levels stable."
1345,summarize: Detrending and smoothing of data (z-scores) and computation of autocorrelation functions were used to identify ISR cycles.,Detrending and smoothing of data (z-scores) and computation of autocorrelation functions were used to identify ISR cycles.,nan
1346,"summarize: During the initial hours after start of glucose infusions, ISRs were approximately 60% higher in FDRs than in control subjects (585 vs. 366 nmol/16 h, P  0.05), while rates of glucose uptake were the same (5.6 mmol x kg(-1) x h(-1)), indicating that the FDRs were insulin resistant.","During the first hours after start of glucose infusions, insulin resistance was about 60% higher in FDRs than in control patients. Rates of glucose uptake were the same, suggesting that the FDRs are insulin resistant.","During the initial hours after giving people infusions of sugar (glucose), insulin secretion rates are about 60% higher in first-degree relatives than in the comparison (control) subjects, while rates of sugar uptake are the same. This finding suggests that the first-degree relatives are insulin resistant, which is when the body doesn't respond well to the insulin hormone and can't use blood sugar for energy."
1347,summarize: The combination of both forms of exercise may have a moderating effect on glycaemia in recovery.,The combination of both forms of exercise may have a mild effect on blood sugar in recovery.,The combination of both moderate and high-intensity exercise may have an effect on blood sugar levels.
1348,summarize: The pattern of hyperglycemia induced by prednisolone has not been well characterized.,the pattern of hyperglycemia caused by prednisolone has not been well characterized.,"The pattern of hyperglycemia (high blood sugar) caused by prednisolone, a steroid drug made to act like the cortisol hormone, has not been well described."
1349,"summarize: Participants: Participants included 60 consecutive consenting subjects with chronic obstructive pulmonary disease admitted to hospital: 13 without known diabetes admitted for other indications and not treated with glucocorticoids (group 1), 40 without known diabetes admitted with an exacerbation of chronic obstructive pulmonary disease and treated with prednisolone (group 2, prednisolone = 30  6 mg/d), and seven with known diabetes treated with prednisolone (group 3, prednisolone = 26  9 mg/d).","Participants included 60 consecutive consenting patients with chronic obstructive pulmonary disease admitted to hospital: 13 without known diabetes admitted for other indications and not treated with glucocorticoids (group 1), 40 without known diabetes admitted with an exacerbation of chronic obstructive pulmonary disease and treated with prednisolone (group 2, prednisolone), and seven with known diabetes treated with prednisolone.","Participants include 60 people with chronic obstructive pulmonary disease (COPD), a lung disease making it difficult to breathe, admitted to the hospital and placed into groups. Thirteen participants (group 1) without known diabetes are admitted for other problems and not treated with glucocorticoids, drugs used to fight inflammation (effects of infection-fighting). Forty participants without known diabetes are admitted with an extreme COPD and treated with prednisolone (group 2). Seven participants with known diabetes are treated with prednisolone (group 3)."
1350,"summarize: Results: Significantly more subjects in group 2 [21 of 40 (53%), P = 0.02] and group 3 [seven of seven (100%), P = 0.003] recorded a glucose of at least 200 mg/dl (â11.1 mmol/liter) during continuous glucose monitoring than in group 1 [one of 13 (8%)].",more patients in group 2 and group 3 recorded a blood sugar of at least 200 mg/dl during continuous glucose monitoring than in group 1.,Significantly more participants in group 2 and group 3 recorded a glucose of at least 200 mg/dl during continuous glucose monitoring than in group 1.
1351,summarize: Objectives: Afternoon napping is a common habit in China.,Afternoon napping is a common habit in China.,Afternoon napping is a common habit in China.
1352,"summarize: After adjusting for possible confounders, longer nap duration (>60 min; all P.05) was still significantly associated with increased risk for IFG, and longer nap duration (>30 min) was associated with increased risk for DM; however, this finding was not significant in the group with a nap duration of 60-90 min.","after adjusting for possible confounders, longer nap duration (>60 min) was still significantly associated with increased risk for IFG, and longer nap duration (>30 min) was associated with increased risk for DM. However, this finding was not significant in the group with a nap duration of 60-90 minutes.","After adjusting the analysis to account for things that impact the results, longer nap duration (>60 minutes) is still significantly associated with increased risk for pre-diabetes. Also, longer nap duration (>30 minutes) is associated with increased risk for diabetes; however, this finding is not significant in the group with a nap duration of 60-90 minutes."
1353,summarize: Results: Thirty-five subjects (mean age 30.31  12.66 years) participated in the study.,35 people (average age 30.31  12.66 years) participated in the study.,This study included 35 participants.
1354,"summarize: The rate of hypoglycemia was significantly lower following morning versus afternoon exercise sessions (5.6 vs 10.7 events per patient, incidence rate ratio, 0.52; 95% CI, 0.43-0.63; P .0001).",the rate of hypoglycemia was significantly lower following morning versus afternoon exercise sessions.,The rate of hypoglycemia is significantly lower following morning versus afternoon exercise sessions.
1355,summarize: Time-restricted feeding (TRF) is a form of intermittent fasting that involves having a longer daily fasting period.,Time-restricted feeding (TRF) is a form of intermittent fasting that involves having a longer daily fasting period.,Intermittent fasting is a type of eating schedule where a person doesn't eat any calories for a period of time. Time-restricted feeding is a form of intermittent fasting that involves having a longer daily fasting period.
1356,summarize: Preliminary studies report that TRF improves cardiometabolic health in rodents and humans.,Preliminary studies report that TRF improves cardiometabolic health in rodents and humans.,Early studies report that time-restricted feeding improves the health of the heart and metabolism in rodents and humans.
1357,"summarize: Here, we performed the first study to determine how TRF affects gene expression, circulating hormones, and diurnal patterns in cardiometabolic risk factors in humans.","the first study to determine how TRF affects gene expression, circulating hormones, and diurnal patterns in cardiometabolic risk factors in humans.","In this study, researchers perform the first study to determine how time-restricted feeding affects how information from genes are used, how circulating hormones that travel in blood and attach to cells can change the cell function, and how daily patterns in the heart and metabolism can be risk factors in humans."
1358,"summarize: Venous blood samples were collected immediately preexercise, immediately postexercise, and 60 minutes postexercise.","Venous blood samples were collected immediately before, immediately after, and 60 minutes after exercise.","Blood samples are collected immediately before exercise, immediately after exercise, and 60 minutes after exercise."
1359,"summarize: Moreover, the rate of change in the peak tissue glucose level at breakfast was significantly decreased in the MG compared to the EG (p = 0.027).","Moreover, the rate of change in the peak tissue glucose level at breakfast was significantly decreased in the MG compared to the EG.","Additionally, the rate of change in the max tissue blood sugar level at breakfast is significantly decreased in the morning group compared to the evening group."
1360,summarize: A greater decrease was observed in the change in the blood glucose level after the ingestion of Helianthus tuberosus in the MG than in the EG.,a greater decrease was observed in the change in blood sugar level after taking Helianthus tuberosus in the MG than in the EG.,A greater decrease is observed in the change in the blood sugar level after the ingestion of Jerusalem artichoke in the morning group than in the evening group.
1361,summarize: Results: Significant differences were observed in mean 24-h blood glucose levels on day 2 between the two groups (p = 0.034).,significant differences were observed in average 24-h blood sugar levels on day 2 between the two groups.,Significant differences are observed in the average 24 hour blood sugar levels on day 2 between the two groups.
1362,summarize: There was a significant decrease in the postprandial respiratory quotient 30 min and 60 min after breakfast on day 3 in the early dinner group compared with the late dinner group (p  0.05).,there was a significant decrease in the post-dinner respiratory quotient 30 min and 60 min after breakfast on day 3 in the early dinner group compared with the late dinner group.,"There was a big decrease in the respiratory quotient, a measure of how nutrients are used and a measure oxygen absorbed in the body, 30 min and 60 min after breakfast on day 3 in the early dinner group compared with the late dinner group."
1363,"summarize: Objective: The aim of this study was to investigate whether subfertility, measured as longer time-to-pregnancy (TTP) in spontaneously conceived pregnancies, affects the first trimester levels of pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotrophin (Î2-hCG) and hence the risk estimates in Down syndrome screening.","The aim of this study was to investigate whether subfertility, measured as longer time-to-pregnancy (TTP) in spontaneously conceived pregnancies, affects the first trimester levels of pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotrophin (Î2-hCG), and hence the risk estimates in Down syndrome screening.","The aim of this study was to investigate if subfertility affects the first trimester levels of pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotrophin (Î2-hCG - a pregnancy hormone). From this, the study aimed to determine the risk estimates in Down syndrome screening."
1364,summarize: The alteration of serum Intact/Total tended to be similar to that of U-hCG.cor/S-hCG in clinical course.,The changes of blood Intact/Total tended to be similar to that of U-hCG.cor/S-hCG in clinical course.,Serum measurements tended to be similar to that of urinary/serum hCG levels.
1365,"summarize: Because urinary hCG levels are inconsistent depending on whether spot urine is concentrated or diluted, the levels of hCG in spot urine do not always correlate with serum levels of hCG.","hCG levels in urine are inconsistent depending on whether spot urine is concentrated or diluted, the levels of hCG in spot urine do not always correlate with serum levels of hCG.","Urinary hCG levels are inconsistent depending on whether spot urine is concentrated or diluted. Because of this, hCG levels in spot urine do not always correlate with serum levels of hCG."
1366,"summarize: Moreover, a better understanding of gestational hCG physiology can improve current screening programs and future clinical management.","Moreover, a better understanding of gestational hCG physiology can improve current screening programs and future clinical management.","Also, a better understanding of gestational hCG function can improve current screening programs and future clinical management."
1367,summarize: We also investigated which pregnancy characteristics were associated with hCG levels.,We also investigated which pregnancy characteristics were associated with hCG levels.,The study also investigated which pregnancy characteristics were associated with hCG levels.
1368,"summarize: Free Î2-hCG levels of  0.5, > 0.5 and  2.0, and â 2.0 MoM were categorised as low, normal and high, respectively.","Free Î2-hCG levels of  0.5, > 0.5 and  2.0, and â 2.0 MoM were categorised as low, normal and high, respectively.","Free Î2-hCG levels of  0.5, > 0.5 and  2.0, and â 2.0 MoM were categorized as low, normal and high, respectively."
1369,"summarize: Among women who had Beta hCG estimations 48 hours apart, plateauing was observed in 22.5% while decrease >15% was noted in 26.8%.","Among women who had Beta hCG estimations 48 hours apart, plateauing was observed in 22.5% while decrease >15% was noted in 26.8%.","Among women who had Beta hCG estimations 48 hours apart, plateauing was observed in 22.5% while decreased levels were noted in 26.8%."
1370,"summarize: In 23.9% of these women, there was a rise >53% similar to intrauterine pregnancy.","In 23.9% of these women, there was a rise >53% similar to intrauterine pregnancy.","In 23.9%, there was a rise >53% similar to intrauterine (normal) pregnancy."
1371,"summarize: The patients age was not proven to be of significant influence, the hCG level slightly decreased with higher age.","The patients age was not shown to be of significant influence, the hCG level slightly decreased with higher age.",Patients age was not proven to be of significant influence. The hCG level slightly decreased with higher age.
1372,"summarize: Subsequently, her condition improved with her Î2hCG showing a downward trend.","Subsequently, her condition improved with her Î2hCG showing a downward trend.",Her condition improved with her Î2hCG showing a downward trend.
1373,"summarize: The trial was parallel in design and patients were evaluated at entry, one month and three months.","the trial was parallel in design and patients were evaluated at entry, one month and three months.","Patients were evaluated before treatment, after one month, and after three months."
1374,summarize: At 3 months the corresponding figures were 85% and 17% (p less than 0.0001) since the placebo group had reverted towards the baseline state while those in the active group showed continued improvement.,at 3 months the corresponding figures were 85% and 17% since the placebo group had returned to the baseline state while those in the active group showed continued improvement.,At 3 months the corresponding figures were 85% and 17%. This is because the placebo group had reverted towards the baseline state while those in the active group showed continued improvement.
1375,summarize: Abnormalities of Essential Fatty Acid (EFA) incorporation into phospholipid are found in chronic diseases.,Abnormalities of Essential Fatty Acid (EFA) incorporation into phospholipids are found in chronic diseases.,Abnormalities of Essential Fatty Acid (EFA) incorporation into phospholipid (fatty molecules that build a cell's wall) are found in chronic diseases.
1376,"summarize: Literature review of chronic fatigue syndrome (CFS) shows hyper and hypo-responsiveness in immune function, several Hypothalamo-Pituitary (HP) axes and sympathetic nervous system, all relatable to dysfunctional changes in EFA metabolism.","a review of chronic fatigue syndrome (CFS) shows hyper-responsiveness in immune function, several hypothalamo-Pituitary (HP) axes and sympathetic nervous system, all related to dysfunctional changes in EFA metabolism.",Literature review of chronic fatigue syndrome (CFS - long-lasting tiredness) shows several abnormal biological response related to dysfunctional changes in EFA metabolism.
1377,"summarize: For the first time, we explain chronic immune system activation and hypo-responsive immune function in CFS; through EFAMs.","For the first time, we explain chronic immune system activation and low-responsive immune function in CFS through EFAMs.",This study explains chronic immune system activation and hypo-responsive immune function in CFS through EFAMs.
1378,"summarize: The gamma-linolenic acid can readily be converted into dihomo-gamma-linolenic acid and thence arachidonic acid, while triterpenes have important free radical scavenging, cyclo-oxygenase and neutrophil elastase inhibitory activities.","gamma-linolenic acid can easily be converted into dihomo-gamma-linolenic acid and thence arachidonic acid, while triterpenes have important free radical scavenging, cyclo-oxygenase and neutrophil elastase inhibitory activities.",The resulting acid and triterpenes would be further converted into beneficial compounds.
1379,"summarize: Furthermore, both arachidonic acid and eicosapentaenoic acid are, at relatively low concentrations, directly virucidal.","Moreover, both arachidonic acid and eicosapentaenoic acid are, at relatively low concentrations, directly virucidal.","Furthermore, the resulting compounds are virucidal or can destroy inactive viruses."
1380,summarize: Background: Phosphatidylserine (PS) may have beneficial effects on cognitive functions.,Phosphatidylserine (PS) may have beneficial effects on cognitive functions.,"Phosphatidylserine (PS), a fatty substance, may have beneficial effects on cognitive (or thinking-related) functions."
1381,summarize: Methods: 157 participants were randomized to receive either PS-DHA or placebo for 15 weeks.,157 participants were randomly assigned to receive either PS-DHA or placebo for 15 weeks.,The study evaluated 157 participants. The participants were randomly assigned one of two treatment groups: PS-DHA or placebo (sham treatment). Treatments were given for 15 weeks.
1382,summarize: Results: 131 participants completed the study although 9 were excluded from the efficacy analysis due to protocol violation.,131 participants completed the study although 9 were excluded from the effectiveness analysis due to protocol violation.,"131 participants completed the study. However, 9 were excluded as they did not follow the study rules."
1383,"summarize: Background: Attention-deficit hyperactivity disorder (ADHD) is the most commonly diagnosed behavioural disorder of childhood, affecting 3-5% of school-age children.","Attention-deficit hyperactivity disorder (ADHD) is the most commonly diagnosed behavioural disorder of childhood, affecting 3-5% of school-age children.",Attention-deficit hyperactivity disorder (ADHD) is the most commonly diagnosed behavioral disorder of childhood. It affects 3-5% of school-age children.
1384,summarize: No significant differences were observed in other measurements and in the placebo group.,No significant differences were observed in other measurements and in the placebo group.,No significant differences were observed in other measurements and in the placebo group.
1385,"summarize: Several components of this system require routine replacement, and this need can be facilitated with natural supplements.","Several components of this system need regular replacement, and this need can be helped with natural supplements.",Several components of this system require routine replacement. This system can be assisted with natural supplements.
1386,summarize: Thirty-nine subjects (n = 18 men and 21 women) were age- and sex-matched normal controls.,18 men and 21 women were normal controls.,Thirty-nine subjects (18 men and 21 women) were age- and sex-matched normal controls.
1387,"summarize: Results: Topological analysis revealed associations between IBS co-morbidity, body mass index, fecal bacterial composition, and bacterial metabolic pathways but not plasma immune molecules.","Results: Topological analysis revealed links between IBS co-morbidity, body mass index, fecal bacterial composition, and bacterial metabolic pathways but not plasma immune molecules.","Analysis revealed associations between IBS co-morbidity, body mass index, fecal (poop) bacterial composition, and bacterial metabolic pathways. No associated was found between ME/CFS status and plasma (blood) immune molecules."
1388,summarize: IBS co-morbidity was the strongest driving factor in the separation of topological networks based on bacterial profiles and metabolic pathways.,IBS co-morbidity was the strongest driving factor in the separation of topological networks based on bacterial profiles and metabolic pathways.,IBS co-morbidity (co-diagnosis) was the most strongly associated endpoint with ME/CFS status.
1389,summarize: Increased abundance of unclassified Alistipes and decreased Faecalibacterium emerged as the top biomarkers of ME/CFS with IBS; while increased unclassified Bacteroides abundance and decreased Bacteroides vulgatus were the top biomarkers of ME/CFS without IBS.,Increased abundance of unclassified Alistipes and decreased Faecalibacterium emerged as the top biomarkers of ME/CFS with IBS; while increased unclassified Bacteroides abundance and decreased Bacteroides vulgatus were the top biomarkers of ME/CFS without IBS.,"Two bacteria, Alistipes and Faecalibacterium, emerged as the top biomarkers of ME/CFS with IBS. Two bacteria, Bacteroides and Bacteroides vulgatus, were the top biomarkers of ME/CFS without IBS."
1390,summarize: Increased vitamin B6 biosynthesis/salvage and pyrimidine ribonucleoside degradation were the top metabolic pathways in ME/CFS without IBS as well as in the total ME/CFS cohort.,Increased vitamin B6 biosynthesis/salvage and pyrimidine ribonucleoside degradation were the top metabolic pathways in ME/CFS without IBS as well as in the total ME/CFS cohort.,Increased vitamin B6 biosynthesis/salvage and pyrimidine ribonucleoside (DNA building blocks) degradation were the top metabolic pathways in ME/CFS without IBS. These pathways were also top in the total ME/CFS cohort.
1391,"summarize: In ME/CFS subgroups, symptom severity measures including pain, fatigue, and reduced motivation were correlated with the abundance of distinct bacterial taxa and metabolic pathways.","In ME/CFS subgroups, symptom severity measures including pain, fatigue, and reduced motivation were linked with the abundance of distinct bacteria and metabolic pathways.","In ME/CFS subgroups, symptom severity measures were correlated with the abundance of distinct bacterial taxa and metabolic pathways."
1392,summarize: Membrane Lipid Replacement is the use of functional oral supplements containing cell membrane glycerolphospholipids and antioxidants to safely replace damaged membrane lipids that accumulate during aging and in various chronic and acute diseases.,Membrane Lipid Replacement is the use of functional oral supplements containing cell membrane glycerolphospholipids and antioxidants to safely replace damaged membrane lipids that accumulate during aging and in various chronic and acute diseases.,"Membrane Lipid Replacement is a treatment that uses oral (by mouth) supplements to safely replace damaged membrane lipids (fatty substances on cell boundaries). Lipids are organic compounds such as fats, waxes, oils, and hormones. These damaged lipids accumulate during aging and various diseases."
1393,"summarize: Most if not all clinical conditions and aging are characterized by membrane phospholipid oxidative damage, resulting in loss of membrane and cellular function.","most if not all clinical conditions and aging are characterized by membrane phospholipid oxidative damage, resulting in loss of membrane and cell function.",The majority of clinical conditions and aging are characterized by membrane phospholipid oxidative damage. This damage results in loss of membrane and cellular function.
1394,"summarize: Possible triggering events, such as infections followed by an immune dysregulation resulting have also been proposed.","Possible triggering events, such as infections followed by an immune dysregulation resulting from infection have also been suggested.","Possible triggering events, such as infections followed by an immune dysregulation, have been proposed as potential causes."
1395,"summarize: In fact, ME/CFS was first described following Epstein Barr virus (EBV) infections, but it was later determined that it was not always preceded by EBV infection.","ME/CFS was first described following Epstein Barr virus (EBV) infections, but it was later determined that it was not always preceded by EBV infection.",ME/CFS was first described following Epstein Barr virus (EBV - herpes virus) infections. It was later determined that it was not always preceded by EBV infection.
1396,"summarize: Treatment ranges from conservative, such as cognitive behavioral therapy (CBT) and antidepressants, to minimally invasive management.","Treatment ranges from conservative, such as cognitive behavioral therapy (CBT) and antidepressants, to minimally invasive management.",Treatment ranges from conservative (e.g. antidepressants) to minimally invasive (surgical) management.
1397,summarize: We report on three infants with hand anomalies and congenital hypopituitarism.,the authors report on three infants with hand abnormalities and congenital hypopituitarism.,"We report on three infants born with hands born with hand defects and defects of the pituitary gland, which regulates body functions and growth through chemical substances called hormones."
1398,"summarize: In two of the cases, a hypothalamic tumor was found; the third infant died without postmortem brain studies.","in two of the cases, a hypothalamic tumor was found; the third infant died without brain studies.",Two of the newborns had hypothalamic tumors (noncancerous growths in the base of their brains). The brain of the third newborn was not examined.
1399,summarize: These three cases were conceived between March 10th and April 17th in three different years in three geographically contiguous counties of Vermont.,These three cases were conceived between March 10th and April 17th in three different years in three geographically contiguous counties of Vermont.,These three babies were conceived between March 10th and April 17th in three different years in three neighboring counties of Vermont.
1400,"summarize: Clustering in time and space and possible familial recurrence, in one of these cases, suggest a possible gene/environment interaction.","Clustering in time and space and possible familial recurrence, in one of these cases, suggest a possible gene/environment interaction.",Close locations and possible other PHS cases in one of these families suggest inheritance and environment might interact.
1401,"summarize: Both PHS and GCPS have polysyndactyly, abnormal craniofacial features and are inherited in an autosomal dominant pattern, but they are clinically distinct.","Both PHS and GCPS have abnormal facial features and are passed down through both parents, but they are clinically distinct.","Patients with both PHS and GCPS have extra or merged fingers and toes, and abnormal heads and faces. Both PHS and GCPS are passed down from either parent, but the clinical signs of these diseases are different."
1402,summarize: No reported cases of GCPS have hypothalamic hamartoma and PHS does not cause hypertelorism or broadening of the nasal root or forehead.,No reported cases of GCPS have hypothalamic hamartoma (an abnormal brain function) and PHS does not cause hypertelorism or broadening of the nose or forehead.,"No reported cases of GCPS have non-cancer growth in the lower part of the brain, and PHS does not cause increased distance between the eyes or broadening of the nose or forehead."
1403,"summarize: The evaluation included detailed clinical interviews, clinician-rated and self-report instruments, and a battery of neuropsychological tests.","the evaluation included detailed clinical interviews, clinician-rated and self-reported instruments, and a battery of neuropsychological tests.","The evaluation included clinical examination, patients' reports and tests of brain functions."
1404,"summarize: However, we found no characteristic psychiatric phenotype associated with PHS, and the frequency of each of the diagnoses observed in these subjects was not different from that expected in this size sample.","However, we found no characteristic psychiatric phenotype associated with PHS. The frequency of each of the diagnoses observed in these subjects was not different from that expected in this sample.",We did not find mental health problems specifically associated with PHS. The frequency of each of the problems in these patients was the same as expected in the group of 19 people.
1405,summarize: The general issue of psychiatric evaluation of rare genetic syndromes is discussed in light of this negative result.,the general issue of psychiatric evaluation of rare genetic syndromes is discussed in light of this negative result.,nan
1406,summarize: Individuals with mild PHS may be incorrectly diagnosed as having isolated postaxial polydactyly type A.,Individuals with mild PHS may be incorrectly diagnosed as having isolated postaxial polydactyly type A.,"Mild PHS might be confused with babies having one or more extra finger or toe at birth, called postaxial polydactyly type A."
1407,summarize: Individuals with PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency.,Individuals with PHS can have pituitary insufficiency and may die as newborns from undiagnosed and untreated adrenal insufficiency.,"In people with PHS pituitary gland, located in the brain, might not produce enough hormones (substances that regulate growth, metabolism and other functions). People with PHS may have adrenal insufficiency, a condition in which the adrenal glands do not produce enough hormones to control blood pressure, metabolism and the immune system. If these conditions are not recognized and treated in newborns, they may die."
1408,"summarize: Bifid epiglottis, the most common abnormality, typically does not need treatment.","Bifid epiglottis, the most common abnormality, usually does not need treatment.","Bifid epiglottis, the split in the flap that covers the windpipe, typically does not need treatment."
1409,summarize: Individuals with PHS may have an affected parent or may have the disorder as the result of a de novo pathogenic variant.,Individuals with PHS may have an affected parent or may have the disorder as the result of a new pathogenic variant.,A child will have PHS if either parent passes down the disease or if a new variant develops before birth.
1410,summarize: The embryologic mechanisms controlled by GLI3R that result in these pathologic phenotypes are undefined.,The embryologic mechanisms controlled by GLI3R that result in these disease-causing phenotypes are unknown.,It is not known how the specific problems arise
1411,summarize: Mice with conditional expression of GLI3R were utilized to identify lineage-specific effects of GLI3R.,Mice with conditional expression of GLI3R were used to identify lineage-specific effects of GLI3R.,nan
1412,"summarize: In the ureteric bud, GLI3R expression decreased branching morphogenesis.","In the ureteric bud, GLI3R expression decreased branching development.",nan
1413,"summarize: Shortly after familial cases were recognized, the responsible gene was identified at GLI3.","Shortly after familial cases were recognized, the responsible gene was identified at GLI3.","Shortly after, it was recognized that the disease runs in the families due to changes in the gene called GLI3."
1414,summarize: Pallister Hall syndrome is autosomal dominant disorder usually diagnosed in infants and children.,Pallister Hall syndrome is inherited disorder usually diagnosed in infants and children.,Pallister Hall syndrome is passed down by one of the parents. It is usually diagnosed in infants and children.
1415,summarize: The seizures were controlled medically.,seizures were controlled medically.,The seizures were under control.
1416,summarize: Repeat MRI showed slight expansion of the mass with formal visual field testing demonstrating bitemporal hemianopsia.,Repeat MRI showed slight expansion of the mass with formal visual field testing showing bitemporal hemianopsia.,MRI showed the mass has expanded slightly and the patient's vision was missing in the outer half of both the right and left eye.
1417,"summarize: However, it can be a marker of a wide variety of neurological and systemic abnormality.","However, it can be a marker of a wide variety of neurological and systemic abnormalities.",It can be a sign of different problems with the nervous and other systems.
1418,"summarize: Hence, it is important for pediatrician and physician to have insight into the various association of this apparently innocuous anomaly.","Hence, it is important for pediatrician and physician to understand the various links of this seemingly harmless anomaly.",Doctors need to know about the conditions that cause extra fingers and toes.
1419,"summarize: A 10-month-old male child born by lower segment cesarean section presented with global delay associated with microcephaly, frontal bossing, hypertelorism, flat nose, short philtrum, incomplete cleft in the upper lip and hard palate, polydactyly, and syndactyly.","10-month-old male child born by lower segment cesarean section had global delay associated with microcephaly, frontal bossing, hypertelorism, flat nose, short philtrum, incomplete cleft in the upper lip and hard palate, polydactyly, and syndactyly.","A 10-month-old male child had a small head, unusually prominent forehead, increased distance between the eyes, flat nose, a shorter than normal distance between the upper lip and the nose, incomplete cleft (slit) in the upper lip and the roof of the mouth, extra fingers, and fused fingers."
1420,summarize: He did not have a history of seizures or central precocious puberty.,he did not have seizures or puberty.,He did not have seizures or premature puberty.
1421,"summarize: Quick and correct diagnosis would help in planning treatment during childhood and giving family counseling, including prenatal advice regarding the next pregnancy of the child's mother.","Quick and correct diagnosis would help in planning treatment during childhood and giving family counseling, including prenatal advice regarding the next pregnancy of the child's mother.",Quick and correct diagnosis would help in planning treatment for the child and advise the family regarding the next pregnancy of the child's mother.
1422,summarize: This form of therapy may be used individually or in combination with other pharmacologic interventions in the treatment of traumatic trigeminal dysesthesia.,Trigeminal dysesthesia is a type of pain medication that may be used alone or in combination with other drugs to treat trigeminal dysesthesia.,Drugs that lower the amount of Substance P in the body may be used alone or together with other medications to treat traumatic trigeminal dysesthesia (an unpleasant abnormal sensation after injury to the trigeminal nerve.)
1423,"summarize: In this feasibility study, pilot evidence was gathered in a cohort of ten subjects suffering from a combination of chronic headaches, facial pain for at least 15 days per month and for at least 4h/day.","During this feasibility study, evidence was collected in a group of ten patients suffering from a combination of long-lasting headaches, facial pain for at least 15 days per month and for at least 4h/day.",This study included ten patients who experienced chronic headaches and facial pain for four or more hours a day and at least 15 days a month.
1424,summarize: Electrode location and total number of electrodes used per subject varied across the cohort.,Electrode location and total number of electrodes used per patient varied across the study.,The patients had different numbers of wires and implant locations.
1425,summarize: It was almost idiopathic and occurred unexpected.,It was almost idiopathic and occurred unexpectedly.,It arises spontaneously and unexpected.
1426,summarize: The upper cervical spinal cord contains the spinal trigeminal tract and nucleus.,the upper cervical spinal cord contains the spinal trigeminal tract and nucleus.,"The spinal cord is the bundle of nerve tissues that connects the brain with the body. In the upper neck region, it contains parts of the trigeminal nerve."
1427,"summarize: We experienced a rare patient with facial pain, which was paroxysmal attack with severe pain after a clear event, cervical spinal injury (C2).","a rare patient with facial pain, which was paroxysmal attack with severe pain after a clear event, cervical spinal injury (C2).",A rare patient had severe repeated bouts of facial pain after an injury to the second vertebrae at the top of the neck region.
1428,"summarize: So, this case reminds us of a possible cause of trigeminal neuralgia after a trauma of the head and neck.","Hence, this case reminds us of a possible cause of trigeminal neuralgia after a trauma of the head and neck.",This patient reminds us that trigeminal neuralgia may be caused by injuries to the head and neck.
1429,"summarize: However, up to 50% of patients also experiences concomitant continuous pain.","However, up to 50% of patients also experience continuous pain.",Up tp half of the patients also experience continuous pain.
1430,summarize: Methods: We enrolled 73 patients with a definitive diagnosis of classical and idiopathic trigeminal neuralgia and 40 healthy participants.,73 patients with trigeminal neuralgia and 40 healthy participants were included in the study.,We studied 73 patients with trigeminal neuralgia (nerve pain) and 40 healthy participants.
1431,"summarize: Results: In most patients with concomitant continuous pain, this type of pain, described as burning, throbbing or aching, manifested at the disease onset.","Results: In most patients with concomitant continuous pain, this type of pain, described as burning, throbbing or aching, manifested at the start of the disease.","In most patients with continuous pain it started as burning, throbbing or aching sensation."
1432,"summarize: Conversely, trigeminal nerve root atrophy was more severe in patients with concomitant continuous pain than in those with purely paroxysmal pain (p = 0.006).","Similarly, trigeminal nerve root atrophy was more severe in patients with continuous pain than in those with purely paroxysmal pain.","On the contrary, patients with both the bursts and continuous pain had more atrophy ((decrease in size) of the trigeminal nerve than the patients with bursts only."
1433,summarize: Aim: To identify the case mix presenting to a specialist tertiary care facial pain clinic.,Aim: To identify the case mix presenting to a specialist facial pain clinic.,The study's aim was to identify the mix of patient cases at a specialist facial pain clinic.
1434,summarize: Methods: A retrospective review of 112 patient records was undertaken.,Methods: A retrospective review of 112 patient records was undertaken.,We reviewed the records of 112 patients who visited the specialists at the facial pain clinic.
1435,summarize: Trends in provisional diagnoses from referrers and the correlation to diagnoses made following specialist consultation were reviewed.,Trends in preliminary diagnoses from referrers and the correlation to diagnoses made after specialist consultation were reviewed.,We compared the reasons for specialist consultation given by the primary doctors to the diagnoses made by the specialists.
1436,"summarize: Following assessment, only one case was not given a definitive diagnosis and no patients were diagnosed with PIFP.",only one case was not given a definitive diagnosis and no patients were diagnosed with PIFP.,The specialist could not diagnose only one patient and have not diagnosed any patients with unspecified facial pain.
1437,"summarize: Objectives: The objective of this review was to summarize available evidence behind RF ablation for facial pain, including pain outcome measures, secondary outcomes, and complications.","the objective of this review was to summarize available evidence behind RF ablation for facial pain, including pain outcome measures, secondary outcomes, and complications.","We summarize what is known about RF ablation for facial pain, including treatment results and complications."
1438,summarize: Setting: This systematic review examined studies that applied the use of RF ablation for management of facial pain.,This review looked at studies that used RF ablation to treat facial pain.,nan
1439,summarize: Methods: This systematic review was reported following the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).,Methods: This systematic review was reported following the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).,nan
1440,"summarize: Common complications of treatment included facial numbness, masseter weakness, cheek hematomas, diminished corneal reflex, and dry eyes.","Common side effects of treatment included facial numbness, muscle weakness, cheek hematomas, decreased eye reflex, and dry eyes.","Common complications of the treatment included facial numbness, weakness of facial muscles, bruised cheeks, failure to blink when the eye is touched, and dry eyes."
1441,"summarize: Methods: A literature search was performed through different databases (PubMed, Scopus, and Embase) according to PRISMA guidelines using the following terms in any possible combination: ""facial pain"" or ""trigeminal"" or ""anaesthesia dolorosa"" and ""motor cortex stimulation.""","Using the following terms in any possible combination: ""facial pain"" or ""trigeminal"" or ""anaesthesia dolorosa"" and ""motor cortex stimulation.""",nan
1442,"summarize: Results: 111 articles were reviewed, and 12 studies were included in the present analysis for a total of 108 patients.","111 articles were reviewed, and 12 studies were included in the present analysis for a total of 108 patients.",We found information about 108 patients.
1443,"summarize: Moreover, the younger age emerged as a positive prognostic factor for definitive implantation.","Moreover, the younger age emerged as a positive prognostic factor for definitive implantation.",Younger patients were more likely to get permanent implanted devices.
1444,summarize: Surgical decompression through resection of the obliquus capitis inferior is the definitive treatment however there are significant risks associated with this procedure.,Surgical decompression through resection of the obliquus capitis inferior is the definitive treatment however there are significant risks associated with this procedure.,"Surgeons may permanently relieve the pressure on the nerve by removing a small muscle between the neck vertebra at the base of the head, but this treatment is risky."
1445,"summarize: Moreover, SARS-CoV-2-specific adaptive immunity was also analysed in 234 COVID-19 recovered subjects, 28 uninfected BNT162b2-vaccinees and 30 uninfected healthy controls.","Moreover, SARS-CoV-2-specific adaptive immunity was also analysed in 234 recovered COVID-19 patients, 28 uninfected BNT162b2-vaccinees and 30 healthy controls.","Immune response was also studied in 234 COVID-19 recovered subjects, 28 uninfected BNT162b2 (Pfizer)-vaccinees and 30 uninfected healthy unvaccinated people."
1446,summarize: The S1-specific cellular response measured at hospital arrival was an independent predictive factor against severity.,The S1-specific cellular response measured at hospital arrival was an independent predictive factor against severity.,Immunity in patients was measured at hospital arrival. Patients with a strong cellular immune response against the virus spike protein had a less severe illness.
1447,"summarize: Thus, measurement of both humoral and cellular responses provides information on prognosis and protection from infection, which may add value for individual and public health recommendations.","Hence, measurement of both humoral and cellular responses provides information on how well the body is doing and protection from infection. This may add value for individual and public health recommendations.",Our study of the cellular immune response and the antibody response provides information about protection from infection and the likelihood of developing severe infection. This information could be used to influence public health recommendations.
1448,summarize: Nearly half of the global population has received at least one dose.,Nearly half of the global population has received at least one dose.,Nearly half of the global population has received at least one dose.
1449,"summarize: Two 0.5-mL doses of the vaccine were administered intramuscularly, containing 5 x 1010 viral particles 28 to 30 days between doses.","two 0.5-mL doses of the vaccine were given intramuscularly, containing 5 x 1010 viral particles 28 to 30 days between doses.","Two doses of the vaccine were injected into the upper arm, with 28 to 30 days between doses."
1450,summarize: The only significant predictor of IgG titers at six months was SARS-CoV-2 infection on mixed model analysis.,the only significant predictor of IgG titers at six months was SARS-CoV-2 infection.,The only people who maintained high levels of antibodies at 6 months were in people who had been infected with SARS-CoV2.
1451,summarize: History of prior COVID-19 was the only significant factor in antibody levels at six months.,History of prior COVID-19 was the only significant factor in antibody levels at six months.,A history of prior COVID-19 infection was the only significant reason for high antibody levels at six months.
1452,"summarize: The VISION Network examined VE by analyzing 222,772 encounters from 383 emergency departments (EDs) and urgent care (UC) clinics and 87,904 hospitalizations from 259 hospitals among adults aged â°18 years across 10 states from August 26, 2021 to January 5, 2022.","VISION Network examined VE by analyzing 222,772 encounters from 383 emergency departments (EDs) and urgent care (UC) clinics and 87,904 hospitalizations from 259 hospitals among adults aged 18 years or older across 10 states from August 26, 2021 to January 5, 2022.","From August 26, 2021 to January 5, 2022, the VISION Network examined vaccine effectiveness among adults 18 and older across 10 states in the US by studying over 222,000 patients in 383 emergency departments and urgent care clinics, and over 87,000 hospitalized inpatients from 259 hospitals."
1453,summarize: Analyses were stratified by the period before and after the Omicron variant became the predominant strain (>50% of sequenced viruses) at each study site.,Analyses were grouped by the period before and after the Omicron variant became the predominant strain (>50% of sequenced viruses) at each study site.,The analysis was split apart at each study site by looking at the periods before and after the Omicron strain became the most common strain.
1454,"summarize: During the period of Delta variant predominance, VE against laboratory-confirmed COVID-19-associated hospitalizations was 90% 14-179 days after dose 2, 81% â°180 days after dose 2, and 94% â°14 days after dose 3.","During the period of Delta variant predominance, VE against laboratory-confirmed COVID-19-associated hospitalizations was 90% 14-179 days after dose 2, 81% â°180 days after dose 2, and 94% â°14 days after dose 3.","In hospitalized patients, during the Delta strain period vaccine effectiveness was 90% 14-179 days after dose 2, 81% 180 days or longer after dose 2, and 94% 14 days or more after dose 3."
1455,summarize: All unvaccinated persons should get vaccinated as soon as possible.,All unvaccinated persons should get vaccinated as soon as possible.,"Based on this data, we recommed that all unvaccinated persons should get vaccinated as soon as possible."
1456,summarize: Background: Vaccine effectiveness against COVID-19 beyond 6 months remains incompletely understood.,Vaccine effectiveness against COVID-19 beyond 6 months is incompletely understood.,The effectiveness of a vaccine against COVID-19 6 months after vaccination is not fully understood.
1457,"summarize: We aimed to investigate the effectiveness of COVID-19 vaccination against the risk of infection, hospitalisation, and death during the first 9 months after vaccination for the total population of Sweden.","the study aimed to investigate the effectiveness of COVID-19 vaccination against the risk of infection, hospitalization, and death during the first 9 months after vaccination for the total population of Sweden.","We studied the effectiveness of COVID-19 vaccination against the risk of infection, hospitalisation, and death during the first 9 months after vaccination for the total population of Sweden."
1458,"summarize: Methods: This retrospective, total population cohort study was done using data from Swedish nationwide registers.","Using data from Swedish nationwide registers, this study looked at the entire population.",We took our data from Swedish nationwide registers.
1459,"summarize: The second was severe COVID-19, defined as hospitalisation for COVID-19 or all-cause 30-day mortality after confirmed infection, from March 15 to Sept 28, 2021.","the second was severe COVID-19, defined as hospitalization for COVID-19 or all-cause 30-day death after confirmed infection, from March 15 to Sept 28, 2021.","The second was severe COVID-19, defined as hospitalisation for COVID-19 or death from any cause 30 days after confirmed infection, from March 15 to Sept 28, 2021."
1460,"summarize: Interpretation: We found progressively waning vaccine effectiveness against SARS-CoV-2 infection of any severity across all subgroups, but the rate of waning differed according to vaccine type.","Increasingly waning vaccine effectiveness against SARS-CoV-2 infection of any severity across all subgroups, but the rate of waning vaccine effectiveness differed according to vaccine type.","We found progressively reduced vaccine effectiveness against SARS-CoV-2 infection of any severity across all subgroups of patients, but the rate of reduction differed according to vaccine type."
1461,"summarize: Background: Immunization against SARS-CoV-2, the causative agent of coronavirus disease-19 (COVID-19) occurs via natural infection or vaccination.","Background: Immunization against SARS-CoV-2, the cause of coronavirus disease-19 (COVID-19), occurs via natural infection or vaccination.","Immunity to SARS-CoV-2, the virus that causes coronavirus disease-19 (COVID-19) occurs from natural infection or vaccination."
1462,"summarize: We also found that a booster injection is efficacious in reactivating immunological memory to spike protein in na ve subjects, while it results ineffective in previously SARS-CoV-2 infected individuals.","a booster injection is effective in reactivating immune system memory to spike protein in nave subjects, while it results ineffective in previously SARS-CoV-2 infected individuals.","We also found that a booster shot is effective in reactivating immunity to the virus spike protein in previously unexposed people, while it is ineffective in people who were previously infected with SARS-CoV-2."
1463,"summarize: A booster dose restores optimal anti-spike immunity in na ve subjects, while the need for vaccinated COVID-19 recovered subjects has yet to be defined.","A booster dose restores optimal anti-spike immunity in nave subjects, while the need for recovered COVID-19 patients who have been vaccinated has yet to be defined.","A booster dose restores the strongest immunity against the viral spike protein in unexposed people, but it is not clear if people who have recovered from COVID-19 need to have a booster."
1464,"summarize: Compared with younger age groups, individuals 80 years of age or older had lower protection after the second dose but similar protection after the booster.","Compared with younger age groups, individuals 80 years of age or older had lower protection after the second dose but similar protection after the booster.","Compared with younger age groups, individuals 80 years of age or older had lower protection after the second dose but similar protection after the booster."
1465,"summarize: Setting: Italy, 27 December 2020 to 7 November 2021.","Setting: Italy, 27 December 2020 to 7 November 2021.",nan
1466,summarize: Data were divided by weekly time intervals after vaccination.,the data were divided by weekly time intervals after vaccination.,The data was calculated for each week following vaccination.
1467,"summarize: Adjusted vaccine effectiveness was calculated as (1-IRR)â100, where IRR=incidence rate ratio, with the time interval 0-14 days after the first dose of vaccine as the reference.",the time interval 0-14 days after the first dose of vaccine was used as the reference.,"Using infection rates at 0-14 days after the first dose of vaccine as our starting point, we followed the trend of vaccine effectiveness"
1468,"summarize: High risk people (vaccine effectiveness -6%, -28% to 12%), those aged â°80 years (11%, -15% to 31%), and those aged 60-79 years (2%, -11% to 14%) did not seem to be protected against infection at 27-30 weeks after the second dose of vaccine.","high risk people, those aged â80 years, and those aged 60-79 years did not seem to be protected against infection at 27-30 weeks after the second dose of vaccine.","High risk people, those aged more than 80 years old, and those aged 60-79 years did not seem to be protected against infection at 27-30 weeks after the second dose of vaccine."
1469,"summarize: The primary analysis was done in the per-protocol population, who were seronegative at baseline.","the primary analysis was done in the per-protocol population, who were seronegative at the start.",Protection against COVID-19 was measured in all participants.
1470,"summarize: The mean age of participants was 578 years (SD 47), with 212 (46%) female participants and 117 (25%) from ethnic minorities.","the average age of participants was 578 years, with 212 (46%) female participants and 117 (25%) from minorities.",The participants were 54 to 65 years old. About half (212) were women and a quarter (117) were from ethnic minorities.
1471,"summarize: At day 28 post boost, the geometric mean concentration of SARS-CoV-2 anti-spike IgG in ChAd/BNT recipients (12 906 ELU/mL) was non-inferior to that in ChAd/ChAd recipients (1392 ELU/mL), with a GMR of 92 (one-sided 975% CI 75 to â).","at day 28 post-booster, the average amount of anti-spreading antibodies in patients with ChAd/BNT was similar to that in people with ChAd/ChAd.","28 days after the booster, in people who got boosted with Pfizer after AstraZeneca, protection against the SARS-CoV-2 virus was not worse than in those who got the same AstraZeneca booster."
1472,"summarize: Four serious adverse events occurred across all groups, none of which were considered to be related to immunisation.","four serious side effects occurred across all groups, none of which were considered to be related to immunisation.",Four people had serious health problems during the trial. The problems were not related to getting the vaccines.
1473,"summarize: Methods: In this phase 1/2 open-label clinical trial conducted at ten U.S. sites, adults who received one of three EUA Covid-19 vaccines at least 12 weeks prior to enrollment and had no reported history of SARS-CoV-2 infection received a booster injection with one of three vaccines (Moderna mRNA-1273 100-Î14g, Janssen Ad26.COV2.S 510 10 virus particles, or Pfizer-BioNTech BNT162b2 30-Î14g; nine combinations).","In this study, adults who received one of three Covid-19 vaccines at least 12 weeks prior to enrollment and had no reported history of SARS-CoV-2 infection got a booster injection with one of three vaccines.","In this clinical trial, adults in ten U.S. locations got Moderna, Janssen or Pfizer boosters at least 12 weeks after getting the first vaccine."
1474,"summarize: Day 15 neutralizing and binding antibody titers varied by 28.7-fold and 20.9-fold, respectively, across the nine prime-boost combinations.","Day 15 antibody titers varied by 28.7-fold and 20.9-fold, respectively, across the nine prime-boost combinations.",nan
1475,"summarize: Background: Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied mixed priming schedules incorporating an adenoviral-vectored vaccine (ChAdOx1 nCoV-19 [ChAd], AstraZeneca), two mRNA vaccines (BNT162b2 [BNT], Pfizer-BioNTech, and mRNA-1273 [m1273], Moderna) and a nanoparticle vaccine containing SARS-CoV-2 spike glycoprotein and Matrix-M adjuvant (NVX-CoV2373 [NVX], Novavax).","Considering the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied mixed priming schedules. These included an adenoviral-vectored vaccine (ChAdOx1 nCoV-19 [ChAd], AstraZeneca), two mRNA vaccines (BNT162b2 [BNT], Pfizer-BioNTech, and Moderna) and a nanoparticle vaccine containing SARS-CoV-2 spike glycoprotein (NVX-CoV2373 [NVX, Novavax adjuvants).","It is important to have flexibility in using different COVID-19 vaccines for additional doses. We studied mixing AstraZeneca, Pfizer, Moderna and Novavax, which work differently."
1476,"summarize: The primary endpoint was the geometric mean ratio (GMR) of serum SARS-CoV-2 anti-spike IgG concentrations measured by ELISA in heterologous versus homologous schedules at 28 days after the second dose, with a non-inferiority criterion of the GMR above 063 for the one-sided 9875% CI.",the primary endpoint was the geometric mean ratio (GMR) of serum SARS-CoV-2 anti-spike IgG concentrations measured by ELISA at 28 days after the second dose.,"28 days after the second dose, chemicals the body produces to protect itself against COVID-19 were measured in the blood."
1477,"summarize: The trial is registered with ISRCTN, number 27841311.","The trial is registered with ISRCTN, number 27841311.",nan
1478,"summarize: Multiple vaccines are appropriate to complete primary immunisation following priming with BNT or ChAd, facilitating rapid vaccine deployment globally and supporting recognition of such schedules for vaccine certification.","Multiple vaccines are appropriate to complete primary immunisation after priming with BNT or ChAd, facilitating rapid vaccine deployment globally and supporting recognition of such schedules for vaccine certification.",Many vaccines can be used as the second dose after getting the first dose of AstraZeneca or Pfizer. This should help distributing vaccines around the world.
1479,summarize: The present review explores the science behind such an approach for candidate COVID-19 vaccines developed using eleven different platforms approved by the World Health Organization.,The present review explores the science behind such an approach for candidate COVID-19 vaccines developed using eleven different platforms approved by the World Health Organization.,We will try to understand why this approach might work for COVID-19.
1480,"summarize: After the second immunisation, a subgroup of 26 age- and gender-matched sera (AZD1222/mRNA, n = 9; AZD1222/AZD1222, n = 9; BNT162b2/BNT162b2, n = 8) was also tested for VNA against VOC B.1.617.2 (delta) in the cVNT.","after the second immunisation, a subgroup of 26 age- and gender-matched blood samples was also tested for VNA against VOC B.1.617.2 (delta) in the cVNT.",nan
1481,summarize: The anti-SARS-CoV-2 IgG concentrations and the B.1.1.7-neutralising titres were significantly higher after heterologous vaccination compared to the homologous AZD1222 scheme.,the anti-SARS-CoV-2 IgG concentrations and the B.1.1.7-neutralizing antibodies were significantly higher after a different vaccine compared to the same AZD1222 vaccine.,Vaccination with different boosters caused the blood to produce more anti-COVID-19 chemicals that boosting with the same AstraZeneca vaccine.
1482,"summarize: More than half the recipients reported having injection-site pain, malaise, headache, or myalgia.","more than half of the recipients reported having injection-site pain, malaise, headache, or muscle pain.","More than half had injection-site pain, general discomfort, headache, or muscle aches."
1483,"summarize: While two doses of mRNA vaccine only achieved adequate humoral immunity in a minority, the third vaccination boosts the development of virus-neutralizing quantities of SARS-CoV-2 spike antibodies (against wild type SARS-CoV-2) in almost all patients.","two doses of mRNA vaccine only achieved adequate humoral immunity in a minority, the third vaccination boosts the development of virus-neutralizing antibodies (against wild type SARS-CoV-2) against the virus in almost all patients.","While the first two doses of Moderna or Pfizer vaccine gave adequate protection to some patients, the booster increased protection against the COVID-19 virus in almost all patients."
1484,summarize: Both heterologous regimens induced responses earlier and with a higher amplitude than homologous ChAdOx1 nCoV-19.,nCoV-19 and ChAdOx1 nCoV-19 were more effective than the same drug.,Different boosters had earlier and stronger protection than boosting with the same AstraZeneca vaccine.
1485,summarize: There was no difference in latency between the IgG and IgA responses.,There was no difference in latency between the IgG and IgA responses.,The body produced different protective chemicals at the same time.
1486,summarize: Increases in the surrogate neutralization assay were the first changes to be detectable for all regimens and the only significant change seen for homologous ChAdOx1 nCoV-19.,Increases in the surrogate neutralization assay were the first changes to be detectable for all regimens and the only significant change seen for homologous ChAdOx1 nCoV-19.,nan
1487,summarize: The government sponsored a clinical trial (CombiVacS) to assess the immunogenicity response to a Pfizer/BioNTech vaccine dose in adults primed with the AstraZeneca vaccine.,the government sponsored a clinical trial (CombiVacS) to assess the immune response to a Pfizer/BioNTech vaccine dose in adults primed with the AstraZeneca vaccine.,The government sponsored a clinical trial to evaluate if a dose of Pfizer vaccine works in adults who first got the AstraZeneca vaccine.
1488,"summarize: Eventually, it was decided that these essential workers could choose the vaccine but signing an informed consent form.","Eventually, it was decided that these essential workers could choose the vaccine but signing an informed consent form.",Later these essential workers could choose the vaccine but still sign an informed consent form.
1489,summarize: Exercising individual autonomy may contribute to the success of future COVID-19 booster vaccination campaigns.,Exercising individual autonomy may contribute to the success of future COVID-19 booster vaccination campaigns.,Giving people a choice may make future COVID-19 boosters more successful.
1490,summarize: Reports of waning antibody levels and breakthrough infections among vaccinated individuals1 have prompted the recommendation for vaccine boosters to prevent SARS-CoV-2 infections.,reports of waning antibody levels and breakthrough infections among vaccinated individuals1 have prompted the recommendation for vaccine boosters to prevent SARS-CoV-2 infections.,"Boosters to prevent SARS-CoV-2 infections in those who had the first vaccines are needed because the amount of body substances that protect against the virus goes down and people get COVID-19, which is called breakthrough infections."
1491,"summarize: Despite more than 80% of the population in Singapore having received 2 doses of a COVID-19 vaccine, cases surged in September 2021 with the relaxation of social distancing and quarantine measures.","Despite more than 80% of the population in Singapore having received 2 doses of a Covid-19 vaccine, cases surged in September 2021 with the relaxation of social distancing and quarantine measures.","Although 80 out of 100 people in Singapore had 2 doses of a COVID-19 vaccine, COVID-19 surged in September 2021 as the social distancing and quarantine rules were relaxed."
1492,summarize: Person-days at risk were reported because individuals could contribute observations to both the nonbooster and booster groups.,Person-days at risk were reported because individuals could contribute observations to both the nonbooster and booster groups.,"Depending on the day of observation, a person could be in either group."
1493,"summarize: Using a Poisson regression, we estimated the incidence rate ratio (IRR) of confirmed infections and severe disease between booster and nonbooster groups by type of vaccine received for the primary series (BNT162b2 or mRNA-1273).","Using a statistical analysis, we estimated the frequency rate ratio (IRR) of confirmed infections and severe disease between booster and nonbooster groups by type of vaccine received for the primary series.",We estimated getting infected and severe disease between booster and non-booster groups that got the first vaccination with Pfizer or Moderna.
1494,summarize: We obtained IRRs for individuals receiving the same vaccine as a booster (homologous boosted) and those receiving a different vaccine (heterologous boosted).,the same vaccine as a booster and those receiving a different vaccine.,We observed the rate of infection in those who got the same booster as the first vaccine and a different vaccine as booster.
1495,"summarize: The study included 22â 643â 521 and 9â 339â 981 person-days among the nonbooster and booster groups, respectively.","The study included 22 person-days and 9 person-days among the nonbooster and booster groups, respectively.",nan
1496,"summarize: For the heterologous-boosted individuals, the incidences of confirmed and severe infections were 147.9 and 2.3 cases per million person-days, respectively, with IRRs of 0.177 (95% CI, 0.138-0.227) and 0.078 (95% CI, 0.011-0.560).","147.9 and 2.3 cases per million person-days, respectively, with IRRs of 0.177 and 0.078.","Among those who had a different booster, about 150 people got COVID-19 and about 2 had severe disease."
1497,"summarize: PCR testing for SARS-CoV-2 from a nasopharyngeal specimen was negative twice, and rapid immunochromatographic antibody test (RIAT) using a commercially available kit for IgM and IgG against SARS-CoV-2 showed him turning positive for IgG against SARS-CoV-2.",PCR testing for SARS-CoV-2 from a nasal specimen was negative twice. A rapid immunochromatographic antibody test (RIAT) using a commercially available kit for antibodies against SARS-CoV-2 showed him turning positive for antibodies against SARS-CoV-2.,"His nasal swab test for COVID-19 virus was negative twice, but his antibody (chemicals the body produces to fight the virus) test was positive."
1498,"summarize: Results: In total, 374 patients in 14 primary care centers received CovPCR and were included in this analysis.","In total, 374 patients in 14 primary care centers received CovPCR and were included in this analysis.",We studied 374 patients who got rapid COVID tests.
1499,summarize: Antigen-detecting rapid diagnostic tests (Ag-RDTs) can complement molecular diagnostics for COVID-19.,Antigen-detecting rapid diagnostic tests (Ag-RDTs) can complement molecular diagnostics for COVID-19.,Rapid diagnostic tests can support other COVID-q9 tests.
1500,summarize: This study explored whether factors other than the nucleic acid amplification test (NAAT) contribute to positive retest results.,This study explored whether other factors contribute to positive retest results.,We studied what causes positive test results.
1501,summarize: The positive retest group showed shorter durations between symptom onset and hospitalization (P  0.001) and symptom onset and the first positive NAAT (P = 0.033).,the positive retest group showed shorter durations between symptoms beginning and hospitalization and symptoms starting and the first positive test.,Patients who had symptoms and repeated positive tests were admitted to the hospital and had positive test results earlier.
1502,summarize: Coughing and serum chloride concentrations were independent risk factors for positive NAAT retest results.,Coughing and blood chloride concentrations were independent risk factors for positive NAAT results.,Coughing and a certain blood test result were each associated with a positive retest result.
1503,summarize: Antigen-based rapid diagnostics tests (Ag-RDTs) are useful tools for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection.,"Antigen-based rapid diagnostics tests (Ag-RDTs) are useful tools for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a viral breathing-related disease.",Rapid diagnostics tests are useful for detecting COVID-19 virus.
1504,"summarize: However, misleading demonstrations of the Abbott Panbio coronavirus disease 2019 (COVID-19) Ag-RDT on social media claimed that SARS-CoV-2 antigen could be detected in municipal water and food products.","Covid-19 is a viral, breathing-related disease.",Misleading demos of the rapid test on social media showed it can find COVID-19 virus in the tap water and food.
1505,"summarize: To offer a scientific rebuttal to pandemic misinformation and disinformation, this study explored the impact of using the Panbio SARS-CoV-2 assay with conditions falling outside manufacturer recommendations.",Using the Panbio SARS-CoV-2 assay with conditions that are not recommended by the manufacturer is a scientific rebuttal to pandemic misinformation and disinformation.,"To fight misleading information, we studied the results of the rapid tests that did not follow testing rules."
1506,summarize: Direct sample testing (without the kit buffer) resulted in false-positive signals resembling those obtained with SARS-CoV-2 positive controls tested under proper conditions.,Using the kit to test for COVID-19 resulted in false positive results similar to those obtained with healthy controls tested under proper conditions.,Doing the test wrong caused false positive results saying there is COVID-19 virus in the materials that did not have it.
1507,"summarize: We included 7074 paired conclusive tests (n = 3461, female: 50.7%).","n = 3461, female: 50.7%.",We had 7074 paired reliable tests of which about half was for females.
1508,"summarize: The prevalence was 0.9%, that is, 66 tests were positive on RT-PCR.",66 tests were positive on RT-PCR.,66 traditional throat tests (less than 1 percent) were positive.
1509,summarize: Thirty-two had a paired positive Ag test.,32 had a positive Ag test.,"For 32 of these, the rapid nasal test was also positive."
1510,summarize: The sensitivity was 48.5% and the specificity was 100%.,the sensitivity was 48.5% and the specificity was 100%.,nan
1511,summarize: This report describes the findings of an internal investigation conducted by the CDC to identify the cause(s) of the N1 and N3 false-positive reactivity.,this report describes the findings of an internal investigation conducted by the CDC to identify the cause(s) of the N1 and N3 false-positive reactivity.,We report the results of the CDC analysis of the false positive tests..
1512,"summarize: Enzyme-linked immunosorbent assay (ELISA) was used to detect SARS-CoV-2 IgM/IgG in sera of 200 patients without COVID-19 infection, including rheumatoid factor (RF) positive group, antinuclear antibody (ANA) positive group, pregnant women group, and normal senior group, with 50 in each group and 100 normal controls.",ELISA was used to detect SARS-CoV-2 IgM/IgG in blood samples of 200 patients without COVID-19 infection.,"Blood of 200 patients without COVID-19 infection was tested for proteins that protect against COVID-19 virus. 100 of the patients were healthy, the others had proteins that could attack their own bodies or proteins associated with pregnancy, 50 each."
1513,"summarize: Methods: A cross-sectional study was conducted from April to June, 2021 on 279 respiratory swabs originating from community surveillance, contact cases and suspect cases.","Methods: A cross-sectional study was conducted from April to June, 2021 on 279 respiratory swabs originating from community surveillance, contact cases and suspect cases.","From April to June 2021 we got 279 nasal swabs from community testing, contact cases and suspected cases."
1514,summarize: Moderate to substantial level of agreement was reported among the three assays with kappa value between 0.55 and 0.72.,Moderate to substantial agreement was reported among the three assays with kappa value between 0.55 and 0.72.,The tests agreed ranging from moderate to strong agreement.
1515,summarize: These results help adjust the apparent prevalence determined by the three RT-PCRs and thus support public health decisions in resource limited settings and consider alternatives as per their prioritization matrix.,These results help adjust the apparent prevalence determined by the three RT-PCRs and thus support public health decisions in resource limited settings and consider alternatives.,nan
1516,summarize: The comparative absorption of zinc after oral administration of three different complexed forms was studied in 15 healthy human volunteers in a double-blind four-period crossover trial.,the absorption of zinc after taking three different forms by mouth was studied in 15 healthy human volunteers.,This study compared three different types of zinc drugs. The study included 15 healthy people.
1517,summarize: The results of this study suggest that zinc absorption in humans can be improved by complexing zinc with picolinic acid.,the results of this study suggest that zinc absorption in humans can be improved by combining zinc with picolinic acid.,This means that zinc picolinate is the best pill to take to get more zinc into a person's body.
1518,summarize: The comparative absorption of zinc after oral administration of three different complexed forms was studied in 15 healthy human volunteers in a double-blind four-period crossover trial.,the absorption of zinc after taking three different forms by mouth was studied in 15 healthy human volunteers.,We studied how much zinc gets into the body of 15 healthy volunteers after they took different supplements.
1519,"summarize: There was no significant change in any of these parameters from zinc gluconate, zinc citrate or placebo administration.","There was no significant change in any of these parameters from zinc gluconate, zinc citrate or placebo treatment.","There was no change in the levels of zinc in the body after taking zinc gluconate, zinc citrate or placebo."
1520,"summarize: There was a small, insignificant rise in serum zinc during zinc picolinate, zinc citrate and placebo supplementation.","there was a small, insignificant increase in serum zinc during zinc picolinate, zinc citrate and placebo supplementation.","There was a small rise in the levels of zinc in the clear liquid part of the blood after taking zinc picolinate, zinc citrate and placebo."
1521,summarize: Objective: To examine whether zinc salts with low stability constants were more suitable as sources of zinc in zinc lozenges than zinc salts with high stability constants.,Objective: To examine whether zinc salts with low stability constants were more suitable as sources of zinc in zinc lozenges than zinc salts with high stability constants.,"The objective of this study was to see which type of zinc lozenges work best, the type that has what is called high stability constants or the type that has low stability constants."
1522,summarize: Results and conclusion: The lozenge with the highest stability constant was as effective as those with very low stability constants.,the lozenge with the highest stability constant was as effective as those with very low stability constants.,The results show that the zinc lozenges were effective no matter the stability constant.
1523,summarize: The anti-VSC (volatile sulphur compounds) effect of zinc is known to be associated with free zinc ions.,the anti-VSC (volatile sulphur compounds) effect of zinc is known to be associated with free zinc ions.,"Zinc is known to interfere with volatile sulphur compounds, chemicals that have rotten egg smell and barnyard smell."
1524,summarize: Objective: To examine whether zinc salts with low stability constants were more suitable as sources of zinc in zinc lozenges than zinc salts with high stability constants.,Objective: To examine whether zinc salts with low stability constants were more suitable as sources of zinc in zinc lozenges than zinc salts with high stability constants.,We studied which zinc salts are better to use in zinc lozenges.
1525,"summarize: The former provide free zinc ions upon dissolution in water, whereas the latter provide few such ions.","the former provide free zinc ions upon dissolution in water, while the latter provide few such ions.",Some zinc salts break down in water more easily and let out more free zinc.
1526,"summarize: Design and participants: Identical lozenges were produced which contained either zinc acetate, zinc gluconate (low stability constants), zinc citrate or amino-acid chelated zinc (extremely high stability constants).","Identical lozenges were produced which contained either zinc acetate, zinc gluconate (low stability constants), zinc citrate or amino-acid chelated zinc (extremely high stability constants).",We prepared similar lozenges that contained one of the zinc salts that easily let out zinc (zinc acetate or zinc gluconate) or the chemicals that do not let zinc out easily (zinc citrate or amino-acid chelated zinc).
1527,summarize: These findings may be explained by the possibility that alternative ligands with stronger affinity for zinc than the original ligands in the lozenges may be present in the oral cavity.,These findings may be explained by the possibility that alternative ligands with stronger affinity for zinc than the original ligands in the lozenges may be present in the mouth.,Similar results for all lozenges may be due to some chemicals in the mouth interacting with zinc stronger than the salts in the lozenges.
1528,"summarize: Therefore, the pharmacokinetics of zinc gluconate (organic) were compared with those of zinc oxide (inorganic).",Gluconate (organic) and zinc oxide (inorganic) are compared.,"This study compares using two different forms of zinc, zinc gluconate and zinc oxide."
1529,summarize: It was concluded that organic Zn yeast supplements are more biologically available than Zn gluconate salts.,Zn yeast supplements are more biologically available than zinc gluconate salts.,"In conclusion, the yeast with zinc supplement gave the body more zinc than the zinc gluconate supplement."
1530,summarize: The net Zn balance and the relative bioavailability were calculated.,the net zinc balance and the relative bioavailability were calculated.,We measured the total amount of zinc and its availability in the body.
1531,summarize: Zinc yeast also increased in blood with time but showed significantly less loss in the feces.,Zinc yeast also increased in blood with time but showed significantly less loss in the feces.,Zinc yeast also increased in blood with time but was removed less with the stools.
1532,"summarize: At concentrations between 0.1 and 0.3 mM Zn(2+) a significant decrease in GSH and ATP levels preceded cell death induced by all salts, except of zinc-histidinate.","at concentrations between 0.1 and 0.3 mM Zn(2+) a significant decrease in GSH and ATP levels preceded cell death caused by all salts, except of zinc-histidinate.",All of the various forms of zinc caused cells to die at high amounts except for the form called zinc histidinate.
1533,"summarize: Interestingly, the uptake of Zn(2+) from zinc-sulphate and zinc-citrate was significantly higher than that of other salts, implicating a correlation between uptake and toxicity.","Interestingly, the uptake of zinc from zinc-sulphate and zinc-citrate was significantly higher than that of other salts, suggesting a link between uptake and toxicity.",The cells absorbed more zinc from the zinc-sulphate and zinc-citrate forms. This means that there may be a relationship between the amount of zinc absorbed and how bad it is for the cells.
1534,"summarize: In conclusion, Zn(2+)-salts could be divided into three categories with high (zinc-citrate, zinc-sulphate), moderate (zinc-orotate, zinc-acetate, zinc-chloride(,) zinc-gluconate) and low cytotoxicity (zinc-histidinate).","Zn(2+)-salts could be divided into three categories with high (zinc-citrate, zinc-sulphate), moderate (zinc-orotate, zinc-acetate, zinc-chloride, zinc-gluconate) and low cytotoxicity (zinc-histidinate).",The forms of zinc can be divided into three different categories based on how toxic they are to cells.
1535,"summarize: Several physiologic factors, most notably the quantity of zinc ingested, determine the quantity of zinc absorbed and the efficiency of absorption.","Several physical factors, most notably the amount of zinc taken in, determine the amount of zinc absorbed and how well it absorbs.",Many factors determine how much and how well zinc is absorbed by the body. The most important factor is the amount of zinc a person gets.
1536,summarize: Zinc from supplements has not been shown to be absorbed differently from that taken with meals that lack inhibitors of zinc absorption.,Zinc from supplements has not been shown to be absorbed differently from that taken with meals that lack inhibitors of zinc absorption.,The amount of zinc absorbed by the body is not different whether the zinc comes from supplements like pills or from food.
1537,summarize: The quantitative relation of intestinal excretion of endogenous zinc to zinc absorption is currently considered to be of major importance in the determination of zinc requirements.,The relationship between the amount of zinc in the body excreted from the food and how much zinc it absorbs is considered to be of major importance in determining zinc requirements.,How much zinc is lost and how much is absorbed is important to know so that people get the right amount of zinc.
1538,"summarize: Regulation of absorption by zinc transporters in the enterocyte, together with saturation kinetics of the absorption process into and across the enterocyte, are the principal means by which whole-body zinc homeostasis is maintained.","Regulation of zinc absorption by zinc transporters in the enterocyte, together with the amount of zinc absorbed into and across the enterocyte, are the main ways by which whole-body zinc homeostasis is maintained.",The body maintains the balance of zinc through special chemicals that take the zinc into cells according to needs.
1539,summarize: Zinc from supplements has not been shown to be absorbed differently from that taken with meals that lack inhibitors of zinc absorption.,Zinc from supplements has not been shown to be absorbed differently from that taken with meals that lack inhibitors of zinc absorption.,There is no difference between the ways zinc from supplements and the meals are taken into the body.
1540,summarize: Modeling of zinc absorption as a function of dietary zinc and phytate accounts for >80% of the variability in the quantity of zinc absorbed.,Modeling of zinc absorption as a function of diet zinc and phytate accounts for >80% of the variability in the amount of zinc absorbed.,Models show that the majority of differences in how much zinc will get into the body is due to the presence of zinc and phytate in the food.
1541,"summarize: Fitting the model to new data has resulted in continual improvement in parameter estimates, which currently indicate a maximal absorption in adults of approximately 6 mg Zn/d and that the average estimated dietary requirement doubles with 1000 mg dietary phytate/d.","Fitting the model to new data has resulted in continual improvement in parameter estimates, which currently indicate a maximum absorption in adults of about 6 mg zinc/day and that the average estimated dietary requirement doubles with 1000 mg phytate/day.","Our model shows that an adult body takes in about 6 milligrams a day. If the daily meals contain a gram of phytate, twice the recommended daily amount of zinc is needed."
1542,"summarize: Supplemental zinc taken with water in the post-absorptive state initially is absorbed more efficiently than food zinc, but absorption efficiency declines within 24 hours presumably due to down-regulation of the zinc transporters.","Supplemental zinc taken with water in the post-absorptive state is absorbed more efficiently than food zinc, but absorption efficiency declines within 24 hours.",The zinc in zinc supplements is better absorbed than zinc brought into the body by food. The different in absorption disappears within 24 hours though.
1543,summarize: More research is needed to understand the effect of physiological state on zinc absorption.,More research is needed to understand the effect of physiological state on zinc absorption.,More research needs to be done to understand how the body absorbs zinc in different situations.
1544,"summarize: There is no evidence that past zinc intakes, or status, influences zinc absorption.","There is no evidence that past zinc intakes, or status, influences zinc absorption.",The process of taking in zinc does not depend on how much zinc the body took in the past or currently has.
1545,"summarize: Instead, current zinc intake is the chief determinant of zinc absorption.","Instead, current zinc intake is the main determinant of zinc absorption.","Instead, zinc consumed with food determines how much zinc will get into the body."
1546,"summarize: We used the double-isotope tracer method with (67) Zn and (70) Zn to measure zinc absorption from zinc citrate given as supplements containing 10 mg of zinc to 15 healthy adults without food and compared absorption with that from zinc gluconate and zinc oxide (insoluble in water) using a randomized, double-masked, 3-way crossover design.",67 and 70 Zn were used to measure zinc absorption from zinc citrate given as supplements containing 10 mg of zinc to 15 healthy adults without food. We compared absorption with that from zinc gluconate and zinc oxide (insoluble in water).,This study compared how well zinc from zinc citrate is absorbed in the body by giving 15 people 10 mg of the zinc citrate without requiring them to take it along with food. The results were compared to how well zinc gulconate and zinc oxide were absorbed.
1547,"summarize: We conclude that zinc citrate, given as a supplement without food, is as well absorbed by healthy adults as zinc gluconate and may thus be a useful alternative for preventing zinc deficiency and treating diarrhea.","zinc citrate, given as a supplement without food, is as well absorbed by healthy adults as zinc gluconate and may thus be a useful alternative for preventing zinc deficiency and treating diarrhea.",The results show that zinc citrate is as good as zinc gulconate at being absorbed by the human body. It is another good option to prevent lack of zinc in the body and for treating diarrhea.
1548,summarize: The more insoluble zinc oxide is less well absorbed when given as a supplement without food and may be minimally absorbed by some individuals.,the more insoluble zinc oxide is less well absorbed when given as a supplement without food and may be minimally absorbed by some individuals.,The zinc oxide form is not absorbed as well by the human body when given without food. Some people may not absorb any zinc at all or may barely absorb any.
1549,"summarize: Zinc citrate is an alternative compound with high zinc content, slightly soluble in water, which has better sensory properties in syrups but no absorption data in humans.","Zinc citrate is an alternative compound with high zinc content, slightly soluble in water. It has better sensory properties in syrups but no data on how well it absorbs zinc in humans.","Another source of zinc is zinc citrate that somewhat dissolves in water. It tastes better in syrups, but it is not known if it gets into the body."
1550,"summarize: We used the double-isotope tracer method with (67) Zn and (70) Zn to measure zinc absorption from zinc citrate given as supplements containing 10 mg of zinc to 15 healthy adults without food and compared absorption with that from zinc gluconate and zinc oxide (insoluble in water) using a randomized, double-masked, 3-way crossover design.",67 and 70 Zn were used to measure zinc absorption from zinc citrate given as supplements containing 10 mg of zinc to 15 healthy adults without food. We compared absorption with that from zinc gluconate and zinc oxide (insoluble in water).,"We measured how much zinc gets into the body of 15 healthy adults after they took zinc supplements without food. The supplements were zinc citrate, zinc gluconate and zinc oxide, which does not mix with water)."
1551,"summarize: We conclude that zinc citrate, given as a supplement without food, is as well absorbed by healthy adults as zinc gluconate and may thus be a useful alternative for preventing zinc deficiency and treating diarrhea.","zinc citrate, given as a supplement without food, is as well absorbed by healthy adults as zinc gluconate and may thus be a useful alternative for preventing zinc deficiency and treating diarrhea.",Zinc citrate supplement taken without food provided as much zinc to healthy adults as zinc gluconate. It may be another useful supplement for preventing zinc deficiency and treating diarrhea.
1552,summarize: The normal human prostate accumulates the highest levels of zinc (Zn) of any soft tissue in the body.,the normal human prostate accumulates the highest levels of zinc (Zn) of any soft tissue in the body.,Men collect the most zinc in their prostate.
1553,summarize: The pool of zinc available to the body is known to significantly decrease with age.,The amount of zinc available to the body is known to significantly decrease with age.,The amount of zinc in the body decreases as a person gets older.
1554,summarize: The pool of zinc available to the body is known to significantly decrease with age.,The amount of zinc available to the body is known to significantly decrease with age.,The amount of zinc available to the body decreases with age.
1555,summarize: The results show that bioavailability in the prostate differs significantly between individual zinc preparations.,The results show that bioavailability in the prostate differs significantly between individual zinc preparations.,The availability of zinc in the prostate was very different for different zinc supplements.
1556,"summarize: The pomegranate, fruit of the tree Punica granatum L, has since ancient times been linked to activity against infection.","pomegranate, fruit of the tree Punica granatum L, has since ancient times been linked to activity against infection.",The pomegranate fruit has been used to fight infections since ancient times.
1557,summarize: This work probed the activity of pomegranate rind extract (PRE) and co-administered zinc (II) ions.,this work probed the activity of pomegranate rind extract (PRE) and co-administered zinc.,This study looked at how zinc and extract from pomegranate rinds (PRE) affect herpes.
1558,"summarize: However, antiviral data showed that punicalagin had significantly lower antiviral activity compared to the activity of PRE (EC50 = 0.56 Î14g mL-1) a value comparable to aciclovir (EC50 = 0.18 Î14g mL-1); however, PRE also demonstrated potency against aciclovir-resistant HSV (EC50 = 0.02 Î14g mL-1), whereas aciclovir showed no activity.","Nevertheless, antiviral data showed that punicalagin had significantly lower antiviral activity compared to the activity of PRE. However, PRE also showed potency against aciclovir-resistant HSV, whereas aciclovir showed no activity.","However, other data showed that punicalagin was less active against viruses than PRE and was comparable to the drug aciclovir. PRE was still effective against drug resistant herpes unlike aciclovir."
1559,summarize: No cytotoxicity was detected with any test solution.,No cytotoxicity was detected with any test solution.,There were no bad effects on the cells from any of the test treatments.
1560,"summarize: The pomegranate, fruit of the tree Punica granatum L, has since ancient times been linked to activity against infection.","pomegranate, fruit of the tree Punica granatum L, has since ancient times been linked to activity against infection.",Pomegranate is considered to help against infection since ancient times.
1561,"summarize: Results: Zinc sulphate, zinc citrate, zinc stearate and zinc gluconate demonstrated similar potentiated virucidal activity with PRE against HSV-1 by up to 4-fold.","Zinc sulphate, zinc citrate, zinc stearate and zinc gluconate showed similar potentiated virucidal activity with PRE against HSV-1 by up to 4-fold.","Zinc sulphate, zinc citrate, zinc stearate and zinc gluconate worked similarly against HSV that causes cold sores, and increased the effect of PKE up to 4-fold."
1562,summarize: Antiviral action of PRE was not influenced by ZnSO4.,PRE's antiviral action was not influenced by ZnSO4.,Zinc sulfate did not affect how PKE worked against the virus and its growth.
1563,"summarize: Drugs used included diphenhydramine HCl (Benadryl), cyproheptadine (Periactin), hydroxyzine HCl (Atarax), and a lactose placebo in identical capsules.","drugs used included diphenhydramine HCl (Benadryl), cyproheptadine (Periactin), hydroxyzine HCl (Atarax), and a lactose placebo in identical capsules.","The drugs in identical capsules included Benadryl, Periactin, Atarax, and a placebo (a pill that contains no drug)."
1564,"summarize: The most common side effect was drowsiness, which occurred with all three drugs.","the most common side effect was drowsiness, which occurred with all three drugs.","The most common side effect was drowsiness, which occurred with all three drugs."
1565,"summarize: Drowsiness, dry mouth, and irritability were significant for hydroxyzine (P =.0001,.001 and.02, respectively) compared with terfenadine or placebo, but less than seen in a previous study of hydroxyzine, 25 mg bid.","Drowsiness, dry mouth, and irritability were significant for hydroxyzine compared with terfenadine or placebo, but less than seen in a previous study of hydroxyzine, 25 mg bid.","Hydroxyzine caused drowsiness, dry mouth and moodiness more than terfenadine or placebo, but less than taking hydroxyzine twice a day."
1566,"summarize: This article reviews clinical pharmacokinetic data on the H1-receptor antagonists, commonly referred to as the antihistamines.","this article reviews clinical data on the H1-receptor antagonists, commonly referred to as the antihistamines.",This is a review of the drugs called antihistamines because they help with allergies caused by the body chemical histamine.
1567,summarize: They also have relatively large apparent volumes of distribution in excess of 4 L/kg.,A relatively large amount of distribution in excess of 4 L/kg is seen.,"These drugs tend to go from the blood into the body tissues, meaning that a higher dose of a drug is needed to keep its levels in the blood."
1568,summarize: Results: Forty-three patients were enrolled; 24 received prednisone and 19 received placebo.,43 patients were enrolled in the study. 24 received prednisone and 19 received placebo.,"Out of f43 patients, 24 got prednisone and 19 placebo."
1569,"summarize: The two groups had similar itch scores at enrollment (prednisone, 8.1 +/- 1.7; placebo, 7.4 +/- 2.1, P =.25 [ANOVA]), but at 2- and 5-day follow-up the prednisone group had significantly lower itch scores (1.3 +/- 1.3 and.0 +/-.0 versus 4.4 +/- 2.2 and 1.6 +/- 1.0, respectively; P .0001 [ANCOVA] at each interval) and greater clinical improvement in rash.","the two groups had similar itch scores at enrollment, but at 2- and 5-day follow-up, the prednisone group had significantly lower itch scores and greater clinical improvement in rash.","All had similar each scores at the beginning. After 2 and 5 days, those who had prednisone had lower itch scores and less rash."
1570,"summarize: Second-generation H1-antagonists, such as terfenadine, astemizole, loratadine and cetirizine, represent a true advance in therapeutics.","second-generation H1-antagonists, such as terfenadine, astemizole, loratadine and cetirizine, represent a true advance in therapeutics.","Second-generation antihistamines, such as terfenadine, astemizole, loratadine and cetirizine, are better."
1571,summarize: We hypothesized that diphenhydramine and hydroxyzine would affect CNS function adversely in this population.,diphenhydramine and hydroxyzine would affect CNS function negatively in this population.,We believe that first generation antihistamines diphenhydramine and hydroxyzine may disturb children's brain function.
1572,summarize: Secondary objectives were to identify risk factors for receiving an inappropriate medication and to determine whether administration is sometimes justified based on diagnosis.,Secondary objectives were to identify risk factors for receiving an inappropriate medication and to determine if taking the drug is sometimes justified based on diagnosis.,We also find out what causes inappropriate use of drugs and if it is sometimes done for a good reason.
1573,summarize: Setting: EDs of U.S. noninstitutionalized general and short-stay hospitals.,Setting: EDs of U.S. noninstitutionalized general and short-stay hospitals.,nan
1574,summarize: Participants: ED survey patients aged 65 and older.,ED survey patients aged 65 and older.,nan
1575,summarize: Measurements: Magnitude and rate of administration of 36 medications.,Measurements: Magnitude and rate of administration of 36 medications.,nan
1576,summarize: Potentially appropriate uses of generally inappropriate drugs cannot account for such administrations.,Potently appropriate uses of generally inappropriate drugs cannot account for such use.,Potentially appropriate uses do not account for the given drugs.
1577,"summarize: Several noncardiac drugs have been linked to cardiac safety concerns, highlighting the importance of post-marketing surveillance and continued evaluation of the benefit-risk of long-established drugs.","Several noncardiac drugs have been linked to cardiac safety concerns, highlighting the importance of post-marketing surveillance and continued evaluation of the benefit-risk of long-established drugs.",Several drugs can cause heart problems. It is important to monitor and evaluate risks of traditional drugs.
1578,"summarize: Aside from intentional overdose, all cases involved underlying medical conditions or concomitant medications that constituted at least 1 additional risk factor for such events.","Aside from intentional overdose, all cases involved underlying medical conditions or concomitant medications that constituted at least 1 additional risk factor for such events.",Some people took too much of the drug (overdose). All other cases had medical problems or were taking other drugs along with hydroxyzine.
1579,"summarize: Subjective feeling, task performances, and brain activity were evaluated during three cognitive tests (word fluency, two-back, and Stroop).","three cognitive tests (word fluency, two-back, and Stroop) were evaluated.","Their well-being, task performances, and brain activity were measured while checking their mental functions."
1580,"summarize: Results: Energy consumption in prefrontal regions was significantly increased after antihistamine administration, especially diphenhydramine, whereas prefrontal hemodynamic responses, evaluated with oxygenated hemoglobin levels, were significantly lower with diphenhydramine treatment.","energy consumption in prefrontal regions was significantly increased after antihistamine treatment, especially diphenhydramine. Prefrontal hemodynamic responses, measured with oxygenated hemoglobin levels, were significantly lower with diphenhydramine treatment.","After diphenhydramine, the brains consumed more energy but responded slower."
1581,summarize: There was no significant difference in subjective sleepiness.,There was no significant difference in subjective sleepiness.,There was no difference in sleepiness.
1582,summarize: Methods: All H1A-induced TdP cases (n = 406) were retrieved from the FAERS database using the preferred term 'Torsade de Pointes' of MedDRA version-22 from 1990 to 2019.,All H1A-induced TdP cases (n = 406) were retrieved from the FAERS database using the preferred term 'Torsade de Pointes' of MedDRA version-22 from 1990 to 2019.,We found 406 reports on Torsade de Pointes and antihistamines.
1583,"summarize: Four data-mining algorithms were used for disproportionality analysis: Reporting Odds Ratio (ROR); Proportional Reporting Ratio (PRR), Empirical Bayes Geometric Mean (EBGM), and Information Content (IC).",Four data-mining algorithms were used for disproportionality analysis.,We used four different statistical methods to study the cases.
1584,"summarize: Moreover, new signals were strongly associated with QT-prolongation, cardiac reactions, and electrolyte abnormalities as compared with old signals.","Moreover, new signals were strongly associated with QT-prolongation, heart reactions, and electrolyte abnormalities as compared with old signals.",The new antihistamines were associated with heart complications stronger than the known ones.
1585,"summarize: We have therefore investigated whether neoadjuvant gefitinib, an EGFR inhibitor, might overcome biologic and clinical resistance to neoadjuvant anastrozole in a phase II placebo-controlled trial.","neoadjuvant gefitinib, an EGFR inhibitor, might overcome resistance to neoadjuvant anastrozole in a phase II trial.","We have studied if giving gefitinib, an EGFR blocker, first might overcome biologic and medical resistance to pre-treatment anastrozole (a drug commonly used for breast cancer) in a medical trial."
1586,"summarize: Mean changes in Ki67 with anastrozole and gefitinib versus anastrozole alone were -77.4% and -83.6%, respectively, between baseline and 16 weeks (geometric mean ratio = 1.37; 95% CI, 0.79 to 2.39; P =.26), -80.1% and -71.3% between baseline and 2 weeks (geometric mean ratio = 0.70; 95% CI, 0.39 to 1.25; P =.22) and -19.3% and -43% (geometric mean ratio = 1.42; 95% CI, 0.86 to 2.35; P =.16) between 2 and 16 weeks.","average changes in Ki67 with anastrozole and gefitinib versus anastrozole alone were -77.4% and -83.6%, respectively, between baseline and 16 weeks, -80.1% and -71.3% between baseline and 2 weeks, and -19.3% and -43% between 2 and 16 weeks.","Average changes in cancer cell growth with anastrozole and gefitinib versus anastrozole alone were -77.4% and -83.6%, respectively, between start and 16 weeks, -80.1% and -71.3% between start and 2 weeks, and -19.3% and -43% between 2 and 16 weeks."
1587,"summarize: One hundred and six received immediate adjuvant aromatase inhibitors (AIs) following surgery, and 75 received extended adjuvant therapy.","one hundred and six received immediate aromatase inhibitors (AIs) after surgery, and 75 received extended therapy.","One hundred and six received immediate, secondary aromatase inhibitors (Ais) (drugs used to treat breast cancer) after surgery. 75 received extended secondary therapy."
1588,summarize: Additional side-effect profiles were collected.,Additional side-effect profiles were collected.,Descriptions of side effects were collected.
1589,summarize: Tamoxifen-na ve patients had a higher mean ES (endocrine symptoms subscale) score at entry versus those having extended therapy (66.0 vs. 61.9; P = 0.001).,Tamoxifen-na ve patients had a higher average ES score at entry versus those with extended therapy.,Pateints treated with tamoxifen (an estrogen-influencing medication) had a higher hormonal symptom score at the start versus those with long-term therapy.
1590,summarize: There were no significant differences in QOL scores between the two drugs.,There were no significant differences in QOL scores between the two drugs.,There were no differences in QOL scores between the two drugs.
1591,"summarize: Endocrine agents are widely used in the treatment and prevention of many solid tumors, principally those of the breast and prostate.","Endocrine agents are widely used in the treatment and prevention of many solid tumors, principally those of the breast and prostate.","Hormonal agents are widely used in the treatment and prevention of many solid tumors, mainly those of the breast and prostrate."
1592,"summarize: The overall relative risk of alopecia in comparison with placebo was 12.88 (p .001), with selective estrogen receptor modulators having the highest risk.","the overall risk of alopecia in comparison with placebo was 12.88, with selective estrogen receptor modulators having the highest risk.","The overall risk of alopecia compared with sham treatment was 12.88, with specific estrogen-receptor influencers having the highest risk."
1593,summarize: Future research should focus on examining these associations in a prospective manner using more detailed and objective measures of hair loss and thinning.,Future research should focus on examining these associations in a prospective manner using more detailed and objective measures of hair loss and thinning.,Future research should examine the links in a future-oriented manner with more detailed and measurable measures of hair loss and thinning.
1594,summarize: We report five cases of pattern alopecia in female patients who are undergoing hormonal anticancer therapy for the prevention of recurrence of breast cancer after surgery.,five cases of pattern alopecia in female patients who are underwent hormonal anticancer therapy to prevent breast cancer from returning after surgery.,We report 5 cases of common alopecia (hair loss or thinning) in female patients undergoing hormonal anticancer therapy to prevent reoccuring breast cancer after surgery.
1595,"summarize: Three patients demonstrated male pattern alopecia with receding frontal hairlines, and two patients demonstrated female pattern alopecia without receding hairlines.","three patients showed male pattern alopecia with receding hairlines, and two patients showed female pattern alopecia without receding hairlines.",Three patients showed alopecia common to males with receding hairlines in the front. Two patients showed alopecia common to females without receding hairlines.
1596,"summarize: Median age was 64 years (35-89), median follow-up 53 months (6-60).","median age was 64 years (35-89), median follow-up time was 53 months (6-60).",Average age was 64 years (ranging from 35 to 89 years). Average treatment follow-up was 53 months (ranging from 6 to 60).
1597,summarize: No differences in the incidence of arthralgia were noted in patients who had received taxanes or anthracyclines.,No differences in the frequency of arthralgia were noted in patients who had received taxanes or anthracyclines.,No differences in the frequency of arthralgia were noted in patients who received taxanes or anthracyclines.
1598,"summarize: In multivariate logistic regression analysis, age (65 years) and HT were independent factors associated with the onset of arthralgia (p = 0.006 and p = 0.008, respectively; OR 2.65, 95% CI 1.32-5.31).","In a statistical analysis, age (65 years) and HT were independent factors associated with the start of arthralgia.","With mathematical analysis, age (65 years) and HT were linked with the start of arthralgia."
1599,summarize: Treatment with topical 5-alpha reductase inhibitors and supplementation of Vitamin C and omega-3 fatty acids are likely appeared to be the most appropriate treatment agents for ETIHL without causing an adverse effect on BC prognosis.,Treatment with topical 5-alpha reductase inhibitors and supplementation of Vitamin C and omega-3 fatty acids are likely the most appropriate treatment for ETIHL without causing an adverse effect on BC.,Treatment with 5-alpha reductase inhibitors (drugs for treating hair loss) applied on skin and Vitamin C and omega-3 fatty acid supplements may be the best treatment for ETIHL without causing serious side effects on BC recovery.
1600,"summarize: A significant negative impact on QoL was reported by patients, despite mostly mild alopecia severity.","A significant negative impact on QoL was reported by patients, despite mostly mild alopecia.","Despite mostly mild alopecia, QoL was negatively impacted for patients."
1601,"summarize: In vivo, consecutive drug plasma kinetics from the final anastrozole transdermal system was tested in beagle dogs.","In beagle dogs, the body's response to anastrozole was tested in vivo.",Drug reactions in blood from the final anastrozole treatment on skin was tested in beagle dogs.
1602,"summarize: Results: After efficient drug loading, a linear and sustained 65% drug release from the TDDS over 48 h was obtained.",TDDS released 65% of the drug over 48 hours.,"After enough drug exposure, a sustained 65% drug release from the skin treatment over 48 hours was obtained."
1603,summarize: Conclusion: These results provide the basis for establishing the transdermal application of anastrozole with improved pharmacokinetics and drug safety as novel therapeutic approach and promising option to treat human BC by decreasing the high burden of unwanted side effects.,Conclusion: These results provide the basis for establishing the transdermal application of anastrozole with improved drug activity and safety as new treatment approach and promising option to treat human BC by decreasing the high burden of unwanted side effects.,"In conclusion, applying anastrozole by skin shows improved drug reactions and safety. The treatment is a promising option to treat human BC by reducing unwanted side effects."
1604,summarize: We investigate the presence of rare and more common variants in epilepsy-related genes as potential modifiers of SCN1A-related disease severity.,We investigate the presence of rare and more common variants in epilepsy-related genes as potential modifiers of SCN1A-related disease severity.,We investigate the presence of rare and more common gene types in epilepsy-related genes as possible influencers of SCN1A-related disease severity.
1605,"summarize: Results and discussion: There are patients with a wide range of gene mutations, the leading of which is a mutation in the SCN1A gene (15%).","results and discussion: There are patients with a wide range of gene mutations, the leading of which is a mutation in the SCN1A gene (15%).","The results show there are patients with a wide range of gene mutations, the leading of which is a mutation in the specific gene called SCN1A (15%)."
1606,"summarize: In most cases, patients with severe (52% have epileptic encephalopathy, 88% have developmental disorders) and pharmacoresistant (mean amount of anti-epileptic drugs - 3.82.2, multitherapy - 70%) syndromes have undergone genetic testing.","In most cases, patients with severe (52% have epileptic encephalopathy, 88% have developmental disorders) and pharmacoresistant syndromes have undergone genetic testing.","In most cases, patients with severe (52% have epileptic encephalopathy, 88% have growth disorders) and drug-resistant (average amount of anti-epileptic drugs - 3.82.2, multi-treatment - 70%) diseases have undergone genetic testing."
1607,"summarize: Our goals were to improve the genetic diagnosis rates of AMC, to evaluate the added value of whole exome sequencing (WES) compared with targeted exome sequencing (TES) and to identify new genes in 315 unrelated undiagnosed AMC families.","Among the goals of this study were to improve the genetic diagnosis rates of AMC, to evaluate the added value of whole exome sequencing (WES) compared with targeted exome sequencing (TES), and to identify new genes in 315 unrelated undiagnosed AMC families.","Our goals were to improve the genetic identification rates of AMC, to test the added value of whole gene labeling compared with targeted gene labeling and to identify new genes in 315 unrelated undiagnosed AMC families."
1608,summarize: Sanger sequencing was performed to identify or validate variants.,Sanger sequencing was performed to identify or validate variants.,Gene sequencing was performed to identify or verify gene variants.
1609,"summarize: Moreover, we identified pathogenic variants in ASXL3 and STAC3 expanding the phenotypes associated with these genes.","Moreover, we identified pathogenic variants in ASXL3 and STAC3 expanding the physical characteristics associated with these genes.","Moreover, we identified disease-causing variants in ASXL3 and STAC3, expanding the physical attributes linked with these genes."
1610,"summarize: In sporadic patients born to non-consanguineous parents (n=60), de novo dominant autosomal or X linked variants were observed in 30 of them (50%).","In 60 patients born to non-consanguineous parents, de novo dominant autosomal or X linked variants were observed in 30 of them (50%).","In irregular patients born to non-related parents (n=60), new, inherited or sex chromosome linked types were observed in 30 of them (50%)."
1611,summarize: A high proportion of de novo variants were observed indicating that this mechanism plays a prominent part in this developmental disease.,"a high proportion of de novo variants were observed, indicating that this mechanism plays a prominent role in this developmental disease.","A high amount of new gene types were observed, indicating that genes plays a prominent part in this developmental disease."
1612,"summarize: The apparent de novo variants may actually be low-level hereditary parental mosaic variants, which could increase the recurrence risk of disease by >50% and is thought to be an underappreciated cause of neurodevelopmental diseases.","the apparent de novo variants may actually be low-level hereditary parent mosaic variants, which could increase the recurrence risk of disease by >50% and is thought to be an underappreciated cause of neurodevelopmental diseases.","These de novo variants may actually be inherited, which could increase the reapparance risk of disease by >50% and is thought to be an underappreciated cause of neurodevelopment diseases."
1613,summarize: A total of 237 patients (and parents) with neurodevelopmental diseases carrying apparent de novo pathogenic or likely pathogenic variants were recruited consecutively.,237 patients (and parents) with neurodevelopmental diseases carrying apparent de novo pathogenic or likely pathogenic variants were recruited.,A total of 237 patients (and parents) with neurodevelopmental diseases carrying apparent de novo disease-causing (pathogenic) or likely pathogenic variants were included.
1614,summarize: Deep next-generation sequencing was performed on parental samples to identify parental mosaicism.,DNA sequencing was performed on parental samples to identify genetic variation in the genes.,Gene labeling was performed on parental samples to identify parental gene make-up.
1615,summarize: Fourteen parental disease-causing mosaicism variants (3.0%) in 11 genes were detected with alternate allele frequency (AAF) 0.22%-34%.,14 parental disease-causing variants (3.0%) in 11 genes were detected with alternate allele frequency (AAF) 0.22%-34%.,Fourteen parental disease-causing gene types (3.0%) in 11 genes were detected with the amount of gene types ranging from 0.22%-34%.
1616,summarize: A review of cohort study on parental mosaicism in neurodevelopmental diseases was performed.,A review of a study on genetic variation in neurodevelopmental diseases was performed.,A review of group study on gene inheritance in neurodevelopmental diseases was performed.
1617,"summarize: Hemiplegic migraine (HM) is a rare form of migraine, defined by headache associated with transient hemiplegia, and can be caused by mutations in either CACNA1A, ATP1A2, or SCN1A.","Hemiplegic migraine (HM) is a rare form of migraine, defined by headache associated with temporary hemiplegia. It can be caused by mutations in either CACNA1A, ATP1A2, or SCN1A.","Hemiplegic migraine (HM) is a rare form of migraine, defined by headache linked with temporary paralysis on one side of the body (hemiplegia). It can be caused by mutations in either CACNA1A, ATP1A2, or SCN1A, specific genes."
1618,"summarize: Case: We report on a girl with GLUT1-DS, due to SLC2A1 mutation, with a mild phenotype.","Case: We report on a girl with GLUT1-DS, due to SLC2A1 mutation, with mild physical characteristics.","We describe a girl with GLUT1-DS, due to SLC2A1 mutation, with mild effects."
1619,"summarize: At the age of 9, the patient reported a first hemiplegic episode, which regressed spontaneously.","at the age of 9, the patient reported a first hemiplegic episode, which returned spontaneously.","At the age of 9, the patient reported a first hemiplegic episode, which healed randomly."
1620,"summarize: Over the next 3 years, two similar episodes occurred, accompanied by headache.","Over the next 3 years, two similar episodes occurred, accompanied by headache.","Over the next 3 years, two similar episodes occurred, followed by headache."
1621,"summarize: Discussion: To our knowledge, among the several cases of GLUT1-DS with HM symptoms described in the literature, genetic testing was only performed in two of them, which eventually proved to be negative.","Among the several cases of GLUT1-DS with HM symptoms described in the literature, genetic testing was only performed in two of them, which eventually proved to be negative.","To our knowledge, among the several cases of GLUT1-DS with HM symptoms in the medical studies, genetic testing was only performed in two of them, which eventually found nothing."
1622,summarize: This study was performed to investigate the genetic etiology of childhood epilepsy and DD.,This study was performed to investigate the genetic causes of childhood epilepsy and DD.,This study was performed to measure the genetic causes of childhood epilepsy and DD.
1623,summarize: These findings further broaden the phenotypic spectrum of SCN1A associated epilepsies and highlight the importance of testing for mosaicism in epileptic encephalopathies.,These findings further broaden the phenotypic spectrum of SCN1A associated epilepsies and highlight the importance of testing for mosaicism in epileptic encephalopathies.,These findings further broaden the spectrum of physical effects of SCN1A linked epilepsies and highlight the importance of testing for inheritance in epileptic encephalopathies.
1624,"summarize: Phenotypes comprise a wide clinical spectrum including the severe childhood epilepsy, Dravet syndrome, characterized by drug-resistant seizures, intellectual disability and high mortality, and the milder genetic epilepsy with febrile seizures plus (GEFS+), characterized by normal cognition.","the severe childhood epilepsy, Dravet syndrome, characterized by drug-resistant seizures, intellectual disability and high death rates, and the milder genetic epilepsy with febrile seizures plus (GEFS+), characterized by normal cognition.","Physical attributes make up a wide spectrum including the severe childhood epilepsy, Dravet syndrome, epilepsy characterized by drug-resistant seizures, lower intelligence, and high death risk, and the milder genetic epilepsy with fever-like seizures plus (GEFS+), characterized by normal intelligence."
1625,summarize: Methods: Retrospective multicenter cohort study comprising data from SCN1A-positive Dravet syndrome and GEFS+ patients consecutively referred for genetic testing (March 2001-June 2020) including age of seizure onset and a newly-developed SCN1A genetic score.,Methods: A retrospective multicenter study involving data from SCN1A-positive Dravet syndrome and GEFS+ patients who had SCN1A in the past were referred for genetic testing (March 2001-June 2020) including age of seizure onset and a newly-developed SCN1A genetic score.,"For the study's methods, it was a multicenter group study comprising data from previous SCN1A-positive Dravet syndrome and GEFS+ patients consistently treated with genetic testing (March 2001-June 2020). Data includes age of seizure start and a newly-developed SCN1A genetic score."
1626,"summarize: A combined 'SCN1A genetic score and seizure onset' model separated Dravet syndrome from GEFS+ more effectively (area under the curve [AUC], 0.89 [95% CI, 0.86-0.92]) and outperformed all other models (AUC, 0.79-0.85; p  0.001).",'SCN1A genetic score and seizure onset' model separated Dravet syndrome from GEFS+ more effectively and outperformed all other models.,A combined 'SCN1A genetic score and seizure onset' model separated Dravet syndrome from GEFS+ more effectively and outperformed all other models.
1627,summarize: Classification of evidence: This study provides Class II evidence that a combined 'SCN1A genetic score and seizure onset' model distinguishes Dravet syndrome from other GEFS+ phenotypes.,'SCN1A genetic score and seizure onset' model distinguishes Dravet syndrome from other GEFS+ symptoms.,This study provides strong evidence that a combined 'SCN1A genetic score and seizure onset' model identifies Dravet syndrome from other GEFS+ phenotypes.
1628,"summarize: Results: Since 2014, biannual meetings have led to the design of four successive versions of a monogenic epilepsy gene panel (PAGEM), increasing from 68 to 144 genes.","Since 2014, biannual meetings have led to the design of four successive versions of a monogenic epilepsy gene panel (PAGEM), increasing from 68 to 144 genes.","Since 2014, biannual meetings have created four successive versions of a single-gene epilepsy gene panel (PAGEM), increasing from 68 to 144 genes."
1629,summarize: A total of 4035 index cases with epileptic disorders have been analyzed with a diagnostic yield of 31% (n = 1265/4035).,a total of 4035 index cases with epileptic disorders have been analyzed with a diagnostic yield of 31%.,A total of 4035 patient cases with epileptic disorders have been analyzed with an identification accuracy of 31% (n = 1265/4035).
1630,"summarize: For each unit increase in plasma DHA, odds of mental retardation decreased by 74 %.","For each unit increase in blood DHA, odds of mental retardation decreased by 74 %.","For each unit increase in blood DHA, odds of mental retardation decreased by 74 %."
1631,"summarize: The interaction between dietary n-6:n-3 ratio and n-3 predicted the number of moves required to solve the most difficult planning problems in children aged 7-9 y and those aged 10-12 y, similar to results from the previous study.","The interaction between dietary n-6:n-3 ratio and n-3 predicted the number of moves needed to solve the most difficult planning problems in children aged 7-9 y and those aged 10-12 y, similar to results from the previous study.","The link between dietary n-6:n-3 ratio and n-3 predicted the number of moves required to solve the most difficult planning problems in children aged 7-9 y and those aged 10-12 y, similar to results from the previous study."
1632,"summarize: Supplementation with this ratio of fatty acids also showed promise as an adjunctive therapy to traditional medications, lowering the dose and improving the compliance with medications such as methylphenidate.","Supplementation with this ratio of fatty acids also showed promise as an adjunctive therapy to traditional medications, lowering the dose and improving the compliance with medications such as methylphenidate.","Supplementation with this ratio of fatty acids also showed promise as a secondary therapy to traditional medications, lowering the dose and improving the compliance with medications such as methylphenidate (stimulant to treat ADHD)."
1633,summarize: Inflammation and deficiency of anti-inflammatory nutrients like omega(n)-3 polyunsaturated fatty acids (PUFA) may contribute to these associations.,inflammation and lack of anti-inflammatory nutrients like omega(n)-3 polyunsaturated fatty acids (PUFA) may contribute to these associations.,Inflammation (infection-fighting processes) and lack of anti-inflammatory nutrients like omega(n)-3 polyunsaturated fatty acids (PUFA) may contribute to these links.
1634,summarize: We sought to determine (1) the associations of obesity with PUFA concentrations and (2) if the systemic response to n-3 supplementation differs by body mass index (BMI).,n-3 supplementation differs by body mass index (BMI).,We sought to determine (1) the links of obesity with PUFA concentrations and (2) if the full-body response to n-3 supplementation differs by body mass index (BMI).
1635,"summarize: Since chronic inflammation is central to obesity and inflammatory pathways are regulated by PUFAs, the objective of this study was to examine whether variants in the NFKB1 gene, an upstream regulator of the inflammatory response, modify the association between the n-6/n-3 ratio (from diet and plasma) and anthropometric traits in a multiethnic/multiracial population of young adults.","The aim of this study is to examine whether variants in the NFKB1 gene, an upstream regulator of the inflammatory response, modify the link between the n-6/n-3 ratio (from diet and plasma) and physical traits in a multiethnic/multiracial population of young adults.","Since chronic (long-lasting) inflammation (infection-fighting processes) is central to obesity and inflammatory pathways are regulated by PUFAs, the objective of this study was to examine whether gene types in the NFKB1 gene, a regulator of the inflammatory response, modify the link between the n-6/n-3 ratio (from diet and blood) and anthropometric traits (human body proportions) in a multiethnic/multiracial group of young adults."
1636,"summarize: Significant interactions were also observed between racial/ethnic groups and three NFKB1 genotypes (rs11722146, rs1609798, and rs230511) for BMI and WC (all p â 0.04).",significant interactions were also observed between racial/ethnic groups and three NFKB1 genotypes for BMI and WC.,Significant links were also found between racial/ethnic groups and three NFKB1 gene types for BMI and WC.
1637,"summarize: Results: Among 1131 women, 67% were African American and 42% had an atopic disease history; 17% of children had atopic dermatitis.","Among 1131 women, 67% were African American and 42% had an atopic disease history; 17% of children had atopic dermatitis.","The results include among 1131 women, 67% were African American and 42% had an atopic disease history; 17% of children had atopic dermatitis."
1638,summarize: Neither prenatal n-3 PUFAs nor n-6:n-3 were associated with child atopic dermatitis.,Neither pre-birth n-3 PUFAs nor n-6:n-3 were associated with child atopic dermatitis.,Neither pre-birth n-3 PUFAs nor n-6:n-3 were linked with child atopic dermatitis.
1639,"summarize: A standardized questionnaire assessing various socio-demographic, clinical, lifestyle, and dietary characteristics was applied via face-to-face interviews.","a questionnaire was used to assess various socio-demographic, clinical, lifestyle, and dietary characteristics.","A standard questionnaire measuring various socio-demographic, clinical, lifestyle, and dietary characteristics was applied via face-to-face interviews."
1640,"summarize: Residents of rural areas had a significantly higher risk compared to women from urban areas (OR=1.8, 95%CI=1.06-3.03).",residents of rural areas had a significantly higher risk compared to women from urban areas.,Residents of rural areas had a much higher risk compared to women from urban areas.
1641,"summarize: In particular, within the PUFAs category, omega-3 (-3) may reduce inflammation, whereas omega-6 (-6) PUFAs are generally considered to have a proinflammatory effect.","omega-3 (-3) may reduce inflammation, whereas omega-6 (-6) PUFAs are generally considered to have a proinflammatory effect.","In particular, within the PUFAs category, omega-3 (-3) may reduce inflammation, whereas omega-6 (-6) PUFAs are generally considered to have an inflammatory effect."
1642,"summarize: In critical age groups such as infants, toddlers and young children, as well as pregnant and lactating women or fish allergic patients, -3 intake may be inadequate.","-3 intake may be inadequate in critical age groups such as infants, toddlers and young children, pregnant and lactating women or fish allergic patients.","In important age groups such as infants, toddlers and young children, as well as pregnant and milk-giving women or fish allergic patients, -3 intake may be improper."
1643,summarize: Data from preclinical studies with PUFAs supplementation show encouraging effects in suppressing allergic response.,PUFAs supplementation shows encouraging effects in suppressing allergic response.,Data from preclinical studies with PUFAs supplementation show encouraging effects in reducing allergic response.
1644,"summarize: Clinical studies results are still conflicting about the best timing and dosages of supplementation and which individuals are most likely to benefit; therefore, it is still not possible to draw firm conclusions.","Clinical studies are still conflicting about the best timing and dosages of supplementation and which individuals are most likely to benefit. Therefore, it is not possible to draw firm conclusions.","Medical study results are still conflicting about the best timing and amounts of supplementation and which individuals are most likely to benefit. Therefore, it is still not possible to draw firm conclusions."
1645,"summarize: In conclusion, more data on the effects of -3 PUFAs supplementation alone or in combination with other nutrients are warranted, both in the general and food allergic population.","In conclusion, more data on the effects of -3 PUFAs supplementation alone or in combination with other nutrients are needed, both in the general and food allergic population.","In conclusion, more data on the effects of -3 PUFAs supplementation alone or in combination with other nutrients are needed, both in the general and food allergic population."
1646,"summarize: A cross-sectional analysis of 402 individuals (63% women, 79.5% with chronic pain) was completed.","63% women, 79.5% with chronic pain) were studied.","An analysis of 402 individuals (63% women, 79.5% with chronic pain) was done."
1647,summarize: Chronic pain was assessed as pain experienced for at least three months.,Chronic pain was measured as pain experienced for at least three months.,Chronic pain was measured as pain experienced for at least three months.
1648,summarize: Most patients with MCNS have favorable outcomes without complications.,Most patients with MCNS have favorable outcomes without complications.,Most people with MCNS can be cured without other issues.
1649,"summarize: However, a few of these children have lesions of focal segmental glomerulosclerosis, suffer from severe and prolonged proteinuria, and are at high risk for complications.","a few of these children have lesions of focal segmental glomerulosclerosis, suffer from severe and prolonged proteinuria, and are at high risk for complications.","However, some children with NS have a different form called focal segmental glomerulosclerosis. Children with this form have excess protein in their urine for long periods of time and are at high risk for additional problems."
1650,"summarize: Disease-associated complications include infections (e.g., peritonitis, sepsis, cellulitis, and chicken pox), thromboembolism (e.g., venous thromboembolism and pulmonary embolism), hypovolemic crisis (e.g., abdominal pain, tachycardia, and hypotension), cardiovascular problems (e.g., hyperlipidemia), acute renal failure, anemia, and others (e.g., hypothyroidism, hypocalcemia, bone disease, and intussusception).","disease-associated complications include infections (e.g., peritonitis, sepsis, cellulitis, and chicken pox), thromboembolism (e.g., blood clots in the veins), hypovolemic crisis (e.g., abdominal pain, tachycardia, and hypotension), cardiovascular problems (e.g., hyperlipidemia), acute kidney failure, anemia, and others.","Problems caused by the disease include infections, blood clots, shock, heart disease, kidney failure, anemia, and others."
1651,"summarize: From this cohort, 61 patients [28 males and 33 females including 29, 19, 6, 4, and 3 patients with membranous nephropathy (MN), minimal change nephrotic syndrome (MCNS), focal segmental glomerulosclerosis (FSGS), membranoproliferative glomerulonephritis (MPGN), and other conditions, respectively] were registered from the representative multi-centers over all districts of Japan, and analyzed retrospectively.","28 males and 33 females including 29, 19, 6, 4, and 3 patients with membranous nephropathy (MN), minimal change nephrotic syndrome (MCNS), focal segmental glomerulosclerosis (FSGS), membranoproliferative glomerulonephritis (MPGN), and other conditions, respectively.","Out of these patients, we looked closer at 61 that had certain types of NS."
1652,"summarize: There were significant differences in the median time to CR among the MCNS, FSGS, and MN patients (median: 26 vs. 271 vs. 461 days, respectively, p  0.001), and between the elderly (65-74 years, n = 7) and very elderly (aged â75 years, n = 12) MCNS patients (7 vs. 22 days, p = 0.037).","MCNS, FSGS, and MN patients had significant differences in the average time to CR among the MCNS, FSGS, and MN patients, and between the elderly (65-74 years) and very elderly (aged â75 years) MCNS patients.","There were meaningful differences in how long it took for different types of NS to be cured. The differences depended both on the type of NS (MCNS, FSGS, or MN) and whether MCNS patients were 75 or older."
1653,summarize: Relapse occurred in two (6.9 %) of the MN and nine (47.4 %) of the MCNS patients.,Relapse occurred in two (6.9 %) of the MN and nine (47.4 %) of the MCNS patients.,The disease came back in 7% of patients with MN and 47% of patients with MCNS.
1654,summarize: Renal dysfunction was observed in five (7.2 %) of the MN patients.,Renal dysfunction was observed in five (7.2 %) of the MN patients.,Seven percent of patients with MN had problems with kidney function.
1655,summarize: Conclusion: Renal biopsy is a valuable diagnostic tool for elderly Japanese NS patients.,Renal biopsy is a valuable diagnostic tool for elderly Japanese NS patients.,Conclusions we can make include the fact that kidney biopsies are valuable for diagnosing NS in older Japanese patients.
1656,"summarize: In this study, most of elderly primary NS patients respond to immunosuppressive therapy with favorable clinical outcomes.","In this study, most of elderly primary NS patients respond to immunosuppressive therapy with favorable clinical outcomes.","Also, in this study, most older NS patients responded well to drugs that suppress the immune system."
1657,summarize: Study design: Case series.,Study design: Case series.,The type of this study is to look at various cases.
1658,summarize: 13 (10%) patients reached remission without immunosuppressive treatment.,13 (10%) patients reached remission without immunosuppressive treatment.,Ten percent of patients were cured without drugs that suppress the immune system.
1659,summarize: Results: Immunosuppressive therapy was administered in 339 (90.6%) patients.,Immunosuppressive therapy was given in 339 (90.6%) patients.,We found that treatment to suppress the immune system was given to 339 patients.
1660,"summarize: The cumulative probabilities of complete remission within 3 years of the baseline visit was â 0.75 in patients with MCD, MN, and FSGS (0.95, 0.77, and 0.79, respectively).","the probability of complete remission within 3 years of the initial visit was â 0.75 in patients with MCD, MN, and FSGS.","For patients with MCD, MN, FSGS, there was more than a 75% chance the disease was completely cured within 3 years."
1661,summarize: Background: Little population-based data exist about adults with primary nephrotic syndrome.,Background: Little data exist about adults with nephrotic syndrome.,Nephrotic Syndrome (NS) is a combination of symptoms relating to the kidneys. There is not much information about how NS exists in the population.
1662,"summarize: Four (50%) went into CR, 1 achieved partial remission and 3 did not respond.","4 (50%) went into CR, 1 achieved partial remission and 3 did not respond.","Four were completely cured, one was partially cured, and three did not respond to the treatment."
1663,"summarize: Background: Although venous thromboembolism is a well-known complication of nephrotic syndrome, the long-term absolute and relative risks of arterial thromboembolism, venous thromboembolism, and bleeding in adults with nephrotic syndrome remain unclarified.","Background: Although venous thromboembolism is a well-known complication of nephrotic syndrome, the long-term risks of blood clots in adults with nephrotic syndrome are unknown.","Blood clots are a well-known problem associated with Nephrotic Syndrome (NS), a group of kidney-related symptoms. However, the risks of blood clots and bleeding in adults with NS is not clear."
1664,"summarize: The 10-year risk of arterial thromboembolism was 14.0% (95% CI 12.8-15.2), of venous thromboembolism 7.7% (95% CI 6.8-8.6), and of bleeding 17.0% (95% CI 15.7-18.3), with highest risks of ischemic stroke (8.1%), myocardial infarction (6.0%), and gastrointestinal bleeding (8.2%).","10-year risk of blood clots in the heart was 14.0%, of venous thromboembolism 7.7%, and of bleeding 17.0%, with highest risks of ischemic stroke (8.1%), myocardial infarction (6.0%), and gastrointestinal bleeding (8.2%).","Within 10 years, the risk of a blood clot in an artery was 14%, the risk of a blood clot in a vein was 8%, and the risk of bleeding was 17%. The highest bleeding risks were of stroke, heart attack, and gastrointestinal bleeding."
1665,"summarize: While the occurrence of these AKI episodes may appear transient, a recurrence of such episodes may be detrimental to the long-term outcome of children with NS.","AKI episodes may appear temporary, but a recurrence of these episodes may be detrimental to the long-term outcome of children with NS.","These instances of serious kidney damage may seem to come and go, but happening repeatedly may cause long-term problems for children with NS."
1666,"summarize: Although initial diagnosis relies on clinical findings as well as urine and blood chemistries, renal biopsy and genetic testing are important diagnostic tools, especially when considering non-MCD NS.","Although initial diagnosis depends on clinical findings as well as urine and blood tests, kidney biopsy and genetic testing are important diagnostic tools, especially when considering non-MCD NS.","The initial diagnosis relies on signs and symptoms observed by a doctor. However, urine and blood tests, kidney tissue samples, and genetic testing are also important for diagnosis. This is especially true for NS not caused by MCD."
1667,summarize: Other alternative therapies found to be successful in inducing and maintaining remission include calcineurin inhibitors and rituximab.,Other alternative therapies found to be successful in causing and maintaining remission include calcineurin inhibitors (a drug that blocks the release of nerve impulses) and rituximab (a drug that helps prevent seizures).,Alternative treatments that have been found to work include calcineurin inhibitors (a class of drugs that suppress the immune system) and rituximab (Rituxan).
1668,"summarize: Given the complex pathogenesis of NS, which remains incompletely understood, complications are numerous and diverse and include infections, electrolyte abnormalities, acute kidney injury, and thrombosis.","Given the complex pathogenesis of NS, which remains incompletely understood, complications are numerous and diverse. These complications include infections, abnormalities in electrolyte levels, immediate kidney injury, and blood clotting.","Since the origin of NS is complicated and not completely understood, there are many associated problems. These include infections, electrolyte problems, serious kidney damage, and blood clots."
1669,summarize: The objectives of the systematic review were as follows: To determine the effectiveness of inpatient physiotherapy after discharge from an acute care hospital compared with outpatient physiotherapy delivered in either a clinic-based or home-based setting for primary total joint replacement patients.,the aim of this systematic review was to determine the effectiveness of inpatient physiotherapy after discharge from an acute care hospital compared with outpatient physiotherapy delivered in either a clinic-based or home-based setting for primary total joint replacement patients.,"Specifically, we wanted to figure out how inpatient PT (during a stay at a care facility) compared with outpatient PT, either at a clinic or at home, for patients that had joint replacements."
1670,summarize: To determine the effectiveness of preoperative exercise for people who are scheduled to receive primary total knee or hip replacement surgery.,"Specifically, the aim of this study is to determine the effectiveness of pre-operation exercise for people who are scheduled to receive knee or hip replacement surgery.","Finally, we aimed to figure out how effective it is to exercise before surgery for people who are scheduled for knee or hip replacement."
1671,summarize: There is low-to-moderate quality evidence from 1 large RCT to support the conclusion that receiving a monitoring phone call from a physiotherapist and practicing home exercises is comparable to receiving clinic-based physiotherapy and practicing home exercises for people who have had primary TKR surgery.,Getting a monitoring phone call from a physiotherapist and practicing home exercises is similar to receiving clinic-based physiotherapy and practicing home exercises for people who have had knee replacement surgery.,There is some evidence from one large study that getting phone call from a physiotherapist and practicing home exercises is comparable to having PT at a clinic and practicing home exercises for people who have had knee replacement.
1672,summarize: Total knee arthroplasty (TKA) is the gold standard treatment for end-stage knee osteoarthritis.,Total knee arthroplasty (TKA) is the gold standard treatment for knee osteoarthritis.,Complete knee replacement surgery is the best known treatment for severe arthritis in the knee.
1673,"summarize: Given the potential positive influence of postoperative rehabilitation and the lack of established standards for prescribing exercise paradigms after TKA, the purpose of this study was to systematically review randomized, controlled studies to determine the effectiveness of postoperative outpatient care on short- and long-term functional recovery.","Given the potential positive influence of rehabilitation after surgery and the lack of established standards for prescribing exercise paradigms after knee replacement, the purpose of this study was to review randomized, controlled studies to determine the effectiveness of outpatient care after surgery on short- and long-term functional recovery.","There is a potential positive influence of rehab after surgery and a lack of established standards for prescribing exercise paradigms after knee replacement. With this in mind, our goal in this review article was to look carefully at studies to determine how effective outpatient care is for regaining function short-term and long-term."
1674,"summarize: Most studies did not accurately describe the ""usual care"" or control groups and information about the dose, frequency, intensity and duration of the rehabilitation protocols were lacking from several studies.","most studies did not accurately describe the ""usual care"" or control groups. Information about the dose, frequency, intensity and duration of the rehabilitation protocols were lacking from several studies.","Most studies did not accurately describe what âusual careâ was used to compare against the programs they were testing. Information about the amount, frequency, intensity and duration of the rehab protocols was also missing from several studies."
1675,"summarize: Background: Rehabilitation, with an emphasis on physiotherapy and exercise, is widely promoted after total knee replacement.","Rehabilitation, with an emphasis on physiotherapy and exercise, is widely promoted after knee replacement.","Rehab, with an emphasis on physiotherapy and exercise, is widely promoted after total knee replacement."
1676,"summarize: Methods: We searched MEDLINE, Embase, PsycInfo, CINAHL and Cochrane CENTRAL to October 4(th) 2013 for randomised evaluations of physiotherapy exercise in adults with recent primary knee replacement.","the authors searched MEDLINE, Embase, PsycInfo, CINAHL and Cochrane CENTRAL to October 4(th) 2013 for randomised evaluations of physiotherapy exercise in adults with recent knee replacement.","We searched several medical literature databases, up to October 4th, 2013, for studies of PT exercise in adults that had knee replacements."
1677,"summarize: Outcomes were: patient-reported pain and function, knee range of motion, and functional performance.","Outcomes were: patient-reported pain and function, knee range of motion, and functional performance.","The outcomes we looked at were: patient-reported pain and function, knee range of motion, and functional performance."
1678,"summarize: Results: Searches identified 18 randomised trials including 1,739 patients with total knee replacement.","Results: Searches identified 18 randomised trials including 1,739 patients with knee replacement.","Our searches found 18 studies including 1,739 patients with total knee replacement."
1679,"summarize: However, for all these evaluations studies were under-powered individually and in combination.","Nevertheless, for all these evaluations studies were under-powered individually and in combination.","However, for all these evaluations, studies did not have enough patients to be sure of their significance, even taken altogether."
1680,"summarize: Future research should target improvements to long-term function, pain and performance outcomes in appropriately powered trials.","Future research should target improvements to long-term function, pain and performance outcomes in appropriately powered trials.","Future research should focus on improving long-term function, pain and performance with larger studies."
1681,summarize: Aim: To investigate whether maximal strength training (MST) is more effective in improving muscle strength than standard rehabilitation (SR) after TKA.,Aim: To investigate whether maximal strength training (MST) is more effective in improving muscle strength than standard rehabilitation (SR) after knee replacement.,Our aim was to investigate whether Maximal Strength Training (MST) is more effective in improving muscle strength than standard rehab knee replacement.
1682,"summarize: Specifically, this study evaluated the following: (1) patient compliance and adherence to the program, (2) time spent performing physical therapy exercises, (3) the usability of the virtual rehabilitation platform, and (4) clinical outcome scores in a selected primary knee arthroplasty cohort.","Specifically, this study evaluated the following: (1) patient compliance and adherence to the program, (2) time spent performing physical therapy exercises, (3) the usability of the virtual rehabilitation platform, and (4) clinical outcome scores in a selected knee replacement cohort.","Specifically, the study looked at: (1) how well patients kept up with the program, (2) time spent performing physical therapy exercises, (3) how easy it was to use the virtual rehab software, and (4) outcomes for a certain group of patients that had knee replacement surgery."
1683,summarize: The usability of the virtual rehabilitation platform (on the patient's end) was evaluated using the system usability scale (SUS) questionnaire.,the usability of the virtual rehabilitation platform (on the patient's end) was evaluated using a questionnaire.,We evaluated how easy it was for patients to use the virtual rehab software using a questionnaire.
1684,summarize: PT records from the terminal episode of care were reviewed and utilization and exercise content data were extracted.,PT records from the terminal episode of care were reviewed and use and exercise content data were extracted.,We reviewed PT records from final sessions to find how much patients used the PT and what exercises were done.
1685,summarize: Content and dose of specific exercises and incidence of progression varied widely.,Content and dose of specific exercises and frequency of progression varied widely.,"The types and amounts of exercises, and how they progressed, varied widely."
1686,summarize: Shorter timed stair climb was associated with greater total number of PT interventions and use and progression of closed chain exercises.,Shorter timed stair climb was associated with greater total number of PT interventions and use and progression of closed chain exercises.,Climbing stairs faster was associated with more PT sessions and the use and progression of body-weight exercises.
1687,"summarize: Methods: We retrospectively identified 2 cohorts of primary TKA patients from July 2016 to December 2017: PT0 (n = 295) received PT on the day of surgery, and PT1 (n = 392) received PT on postoperative day (POD) 1.","PT0 (n = 295) received PT on the day of surgery, and PT1 (n = 392) received PT on postoperative day (POD).","To do this, we looked at 2 past groups of knee replacement patients from July 2016 to December 2017. The first group had 295 patients and had PT on the day of surgery. The second group had 392 patients and received PT on the day after surgery."
1688,"summarize: Therefore, this systematic review focuses on evaluating existing postoperative rehabilitation protocols.","Hence, this systematic review focuses on evaluating existing rehabilitation protocols after surgery.","Because of this, we will focus on rating different rehab strategies that are in published papers."
1689,"summarize: Of the 11,013 studies identified within the last five years, 70 met the inclusion and exclusion criteria.","Of the 11,013 studies identified within the last five years, 70 met the inclusion and exclusion criteria.","Out of more than 11,000 from our search, 70 met our criteria for including them."
1690,"summarize: However, early rehabilitation, telerehabilitation, outpatient therapy, high intensity, and high velocity exercise may be successful forms of rehabilitation.","However, early rehabilitation, telerehab, outpatient therapy, high intensity, and high velocity exercise may be successful forms of rehabilitation.","However, early rehab, tele-rehab, where providers interact with patients remotely using the internet, and outpatient therapy may be successful types of rehab. Exercise at high intensity and high speeds may also be successful types of rehab."
1691,"summarize: Posthospitalization physical therapy is thought to be beneficial, particularly for those patients most at risk of poor outcome, the subgroup with persistent function-limiting pain, despite an apparently successful surgery.","Posthospitalization physical therapy is thought to be beneficial, especially for those patients most at risk of poor outcome, the subgroup with persistent function-limiting pain, despite an apparently successful surgery.","PT after leaving the hospital is thought to be helpful, especially for patients with high risk of bad outcomes. These are patients with persistent pain that impairs function, even though the surgery seemed to go well."
1692,"summarize: In all cases, usual care required a lower dosage of physical therapy compared with the enhanced interventions.","In all cases, usual care required a lower dose of physical therapy compared with the enhanced treatments.","In all cases, usual care required a lower amount of physical therapy compared with the enhanced interventions."
1693,summarize: SARS-CoV-2 infection is characterized by a protean clinical picture that can range from asymptomatic patients to life-threatening conditions.,SARS-CoV-2 infection is characterized by a protean clinical picture that can range from non-symptomatic patients to life-threatening conditions.,SARS-CoV-2 infection (a viral lung infection) can cause effects ranging from patients with no symptoms to life-threatening conditions.
1694,"summarize: Severe COVID-19 patients often display a severe pulmonary involvement and develop neutrophilia, lymphopenia, and strikingly elevated levels of IL-6.","Severe COVID-19 patients often have a severe involvement in the lung and develop neutrophilia, lymphopenia, and strikingly elevated levels of IL-6.",Severe COVID-19 patients often display a severe lung effect and develop altered levels of immune cells and strikingly increased levels of IL-6 (an immune signaling molecule called a cytokine).
1695,"summarize: Background and aims: Iron is an essential trace element to almost all organism, and the delicate balance between host defend system and viral proliferation plays an important role in infective conditions.","Background and aims: Iron is an essential trace element to almost all organisms, and the delicate balance between host defense system and viral proliferation plays an important role in infective conditions.",The background of this study is that iron is a necessary element to almost all living beings. The delicate balance between host immune system and viral growth plays an important role in infections.
1696,"summarize: Methods: In this retrospective cohort study, we included 158 confirmed COVID-19 patients in Tongji Hospital, Wuhan, China (27 January to 5 April, 2020).","158 confirmed COVID-19 patients in Tongji Hospital, Wuhan, China (27 January to 5 April, 2020).","In this clinical study, we included 158 confirmed COVID-19 patients in Tongji Hospital, Wuhan, China (27 January to 5 April, 2020)."
1697,summarize: Multivariable Poisson regression was used to estimate the association of iron parameter levels with the severity and risks of adverse outcomes in COVID-19 patients.,Multivariable Poisson regression was used to estimate the association of iron parameter levels with the severity and risks of adverse outcomes in COVID-19 patients.,A specific mathematical test was used to estimate the links between iron levels with the severity and risks of side effects in COVID-19 patients.
1698,"summarize: The COVID-19 pandemic has boosted an amount of clinical and translational research over the possible influences of nutrients on SARS-CoV-2 infection, in terms of either susceptibility or clinical course.","The pandemic of COVID-19 has boosted an amount of clinical and translational research over the possible influences of nutrients on SARS-CoV-2 infection, in terms of either susceptibility or disease progression.","The COVID-19 pandemic (caused by a virus causing a lung infection) has boosted clinical and medical research over the possible influences of nutrients on SARS-CoV-2 infection, in terms of either contracting or aiding the infection."
1699,"summarize: Here we review the intersections between iron metabolism and COVID-19, belonging to the wider domain of the so-called ""nutritional immunity"".","The authors review the intersections between iron metabolism and COVID-19, belonging to the wider domain of the so-called ""nutritional immunity"".","Here we review the links between iron metabolism and COVID-19, belonging to the wider field of study of the so-called ""nutritional immunity""."
1700,"summarize: While it took decades to arrive to a conclusion that ferritin is more than an indicator of iron storage level, it took a short period of time through the COVID-19 pandemic to wonder what the reason behind high levels of ferritin in patients with severe COVID-19 might be.","While it took decades to come to a conclusion that ferritin is more than an indicator of iron storage level, it took a short period of time through the COVID-19 pandemic to wonder what the reason behind high levels of ferritin in patients with severe COVID-19 might be.","While it took decades to learn that ferritin (an iron-containing protein) is more than a marker of iron storage level, it took some time during the COVID-19 pandemic (a pandemic caused by a virus that causes lung infections) to wonder why there are high levels of ferritin in patients with severe COVID-19."
1701,"summarize: Unsurprisingly, acute phase reactant was not a satisfactory explanation.","Unsurprisingly, acute phase reactant was not a satisfactory explanation.","Unsurprisingly, inflammation markers were not a satisfactory explanation."
1702,"summarize: Doubtlessly, improving our understanding of those aspects of ferritin would enormously contribute to better coping with severe diseases in terms of treatment and prevention of complications.","Doubtlessly, improving our understanding of these aspects of ferritin would greatly contribute to better coping with severe diseases in terms of treatment and prevention of complications.","Without doubt, improving our understanding of those aspects of ferritin would enormously contribute to better treatment and side effect management with severe diseases."
1703,summarize: Serum iron is the simplest laboratory test to be implemented as a predictor of disease progression in COVID-19-positive patients.,Serum iron is the simplest laboratory test to predict disease progression in COVID-19-positive patients.,Blood iron is the simplest lab test to be used as a predictor of disease progression in COVID-19 patients.
1704,"summarize: Finally, an increase in ferritin levels in the inflammatory response to COVID-19 is linked to an increase in inflammatory markers including CRP, WBC, and LDH, which may assist in the diagnosis of COVID-19 infection.","Lastly, an increase in ferritin levels in the inflammatory response to COVID-19 is linked to an increase in inflammatory markers including CRP, WBC, and LDH, which may assist in the diagnosis of COVID-19 infection.","Finally, an increase in ferritin levels in the inflammatory response to COVID-19 is linked to an increase in inflammatory markers including CRP, WBC, and LDH. This understanding may assist in the identification of COVID-19 infection."
1705,summarize: Results: The imbalance of important trace elements can accelerate SARS-CoV-2 neurovirulence and increase the neurotoxicity since many neurological processes can be associated with the homeostasis of metal and metalloproteins.,The imbalance of important trace elements can accelerate SARS-CoV-2 neurovirulence and increase the neurotoxicity since many neurological processes can be linked with the homeostasis of metal and metalloproteins.,The imbalance of important elements can increase SARS-CoV-2 effects in the brain and increase the damage to the brain since many brain processes can be linked with the balance of metal and metal-carrying proteins.
1706,"summarize: Considering the combined evidence, some mechanisms have been suggested to understand the relationship between neurological disorders and imbalance of trace elements in the brain after viral infection.","Considering the combined evidence, some mechanisms have been suggested to understand the relationship between neurological disorders and imbalance of certain elements in the brain after viral infection.","Considering all the evidence, some mechanisms have been suggested to understand the link between brain disorders and imbalance of specific elements in the brain after viral infection."
1707,summarize: In the past year there have been five new studies of antenatal screening for postnatal depression.,In the past year there have been five new studies of antenatal screening for postnatal depression.,In the past year there have been five new studies of antenatal (during pregnancy) screening for postnatal depression.
1708,"summarize: Seven new primary prevention/early intervention trials add evidence on a wide range of interventions ranging from practical support to individual interpersonal therapy, but without identifying significant differences in depression as an outcome.","7 new primary prevention/early intervention trials add evidence on a wide range of treatments from practical support to individual interpersonal therapy, but without identifying significant differences in depression as an outcome.",Seven new prevention and early intervention studies add evidence on a wide range of treatments ranging from practical support to individual interpersonal therapy. These studies have not found significant differences in the outcome of depression.
1709,"summarize: Two new trials of secondary prevention, one involving interpersonal therapy and the other including partners in a series of psychoeducational visits, show promise but neither is large enough to form a basis for practice change.","two new trials of secondary prevention, one involving interpersonal therapy and the other including partners in a series of psychoeducational visits, show promise but neither is large enough to form a basis for practice change.",Two new studies on the prevention of the recurrence of depression show promise of success. One invention study involves interpersonal therapy and the other includes partners in psychoeducational visits. Neither study is large enough to form a basis for practice change.
1710,summarize: The first six months after delivery may represent a high-risk time for depression.,the first six months after delivery may represent a high-risk time for depression.,The first six months after delivery may represent a high-risk time for depression.
1711,summarize: Reviews converge on recommendations for particular antidepressant medications for use while breastfeeding.,Reviews converge on recommendations for particular antidepressant medications for use while breastfeeding.,Reviews meet up on recommendations for particular antidepressant medications for use while breastfeeding.
1712,summarize: Objectives: Both antidepressant medications and psychological therapy are common treatments for depression in postpartum women.,Both antidepressant medications and psychological therapy are common treatments for depression in postpartum women.,Both antidepressant medications and psychological therapy are common treatments for depression in women after childbirth (postpartum depression-PPD).
1713,summarize: In the treatment of depressive disorders there is some evidence that combination therapies (pharmacological plus psychological treatment) may be more efficacious than either form of mono-therapy in isolation.,In the treatment of depressive disorders there is some evidence that combination therapies (pharmacological plus psychological treatment) may be more effective than either form of single therapy in isolation.,"In treating of depression, there is some evidence that combining both therapies (medications plus psychological treatment) may be more successful than either treatment alone."
1714,"summarize: Method: Forty five postpartum women with a DSM-IV diagnosis of depression were randomised to receive either: 1) cognitive behavioural therapy (CBT); 2) sertraline, or 3) a combination of both treatment modalities.","45 postpartum women with depression diagnosed by the DSM-IV diagnosis were randomly placed in groups to receive either cognitive behavioural therapy (CBT), sertraline, or a combination of both treatments.","Researchers did a study in 45 postpartum women with depression. The treatments were assigned randomly. They received either cognitive behavioural therapy (CBT), sertraline (an antidepressant drug), or a combination of both."
1715,summarize: Results: Symptoms of depression and anxiety were reduced to a significant degree following all three treatments.,Symptoms of depression and anxiety were reduced to a significant degree following all three treatments.,Symptoms of depression and anxiety were reduced to a significant degree following all three treatments.
1716,summarize: Postpartum depression is one of the most prevalent psychopathologies.,Postpartum depression is one of the most common psychopathologies.,Postpartum depression (depression after childbirth) is one of the most common mental disorders.
1717,summarize: The goal of the current study was to examine the effectiveness of Practical Resources for Effective Postpartum Parenting (PREPP).,"The goal of the current study is to examine the effectiveness of Practical Resources for Effective Postpartum Parenting (PREPP), a parenting program that provides practical resources for effective postpartum parenting.",This study examines the success of the PREPP (Practical Resources for Effective Postpartum Parenting) intervention.
1718,"summarize: Findings: This trial was done between Dec 15, 2015 (first enrolment), and May 19, 2016 (final visit of the last enrolled patient).","the last enrolled patient was seen between Dec 15, 2015 (first enrollment), and May 19, 2016.","This trial was done between Dec 15, 2015 (first enrolment), and May 19, 2016 (final visit of the last enrolled patient)."
1719,summarize: Four of ten patients in the brexanolone group had adverse events compared with eight of 11 in the placebo group.,four out of ten patients in the brexanolone group had side effects compared with eight out of 11 in the placebo group.,Four of ten patients in the brexanolone group had adverse events compared with eight of 11 in the placebo group.
1720,summarize: Objective: Postpartum mood disorders represent a serious problem affecting 10-20% of women and support groups offer a promising intervention modality.,Postpartum mood disorders are a serious problem affecting 10-20% of women and support groups offer a promising treatment method.,Postpartum (after giving birth) mood disorders represent a serious problem affecting 10-20% of women. Support groups offer a promising treatment.
1721,summarize: Participants: Intake program data were provided by the sponsoring organisation (n = 73) and follow-up data were collected via an online survey from program attendees (n = 45).,73 participants took part in the program and 45 participated in the follow-up.,Facts (data) about the participants at the beginning of the program were provided by the organisation backing the support group. The follow-up data was given by the participants through an online questionnaire.
1722,"summarize: Thus, there is a need for interventions to prevent PPD in adolescent mothers.","Hence, there is a need for interventions to prevent PPD in adolescent mothers.",There is a need for treatments to prevent PPD in adolescent mothers.
1723,"summarize: However, recent systematic reviews have been focused on effective interventions to prevent PPD in adult mothers.",Recent studies have focused on effective treatments to prevent PPD in adult mothers.,Recent thorough reviews of studies on preventing PPD have been focused on successful treatments in adult mothers.
1724,"summarize: The evidence from this systematic review suggests that 6 of 13 studies from both psychological and psychosocial interventions including (1) home-visiting intervention, (2) prenatal antenatal and postnatal educational program, (3) CBT psycho-educational, (4) the REACH program based on interpersonal therapy, and (5) infant massage training is successful in reducing rates of PPD symptoms in adolescent mothers in the intervention group than those mothers in the control group.",the evidence from this systematic review suggests that 6 of 13 studies from both psychological and psychosocial interventions are successful in reducing PPD symptoms in adolescent mothers in the intervention group than those mothers in the control group.,"Six out of 13 studies suggests interventions are successful in lowering rates of PPD symptoms in adolescent mothers (compared to the group that did not receive interventions). The research was from the psychological and social intervention studies. The interventions included: home visits; education (before, during, and after pregnancy and childbirth); psychological therapy; interpersonal therapy, and infant massage training."
1725,"summarize: Postpartum depression (PPD) is common, disabling, and treatable.","Postpartum depression (PPD) is common, disabling, and treatable.","Postpartum depression (PPD) is depression that occurs after childbirth. It is common disorder that is disabling, but it is treatable."
1726,"summarize: The strongest risk factor is a history of mood or anxiety disorder, especially having active symptoms during pregnancy.","the strongest risk factor is a history of mood or anxiety disorder, especially having active symptoms during pregnancy.","The strongest risk factor for PPD is a history of mood or anxiety disorders, especially if women have active symptoms during pregnancy."
1727,summarize: Animal and human studies suggest that vitamin B6 deficiency affects both humoral and cell-mediated immune responses.,Animal and human studies suggest that vitamin B6 deficiency affects both humoral and cell-mediated immune responses.,Animal and human research studies suggest that vitamin B6 deficiency (not enough vitamin B6) affects the immune system.
1728,"summarize: Deficiency of the vitamin has been associated with immunological changes observed in the elderly, persons infected with human immunodeficiency virus (HIV), and those with uremia or rheumatoid arthritis.","Deficiency of the vitamin has been associated with changes in the immune system seen in the elderly, people with human immunodeficiency virus (HIV), and those with high blood pressure or rheumatoid arthritis.","Vitamin B6 deficiency (not enough vitamin B6 in the body) has been associated with immune system changes in the elderly.Vitamin B6 deficiency also affects people with HIV infections, kidney disease, and rheumatoid arthritis."
1729,"summarize: Because of these functions, interest in recent years has been growing particularly in the area of aging and the possibility that certain diseases that afflict the aging population, loss of cognitive function, Alzheimer's disease, cardiovascular disease, cancer and others, may be in part explained by inadequate intake or inadequate status of these vitamins.","Because of these functions, interest in recent years has been growing especially in the area of aging and the possibility that certain diseases that affect the aging population, loss of cognitive function, Alzheimer's disease, cardiovascular disease, cancer and others, may be explained by inadequate intake or inadequate status of these vitamins.","Because of these functions, interest in recent years has been growing particularly in the area of aging. The possibility that certain diseases associated with aging such as the loss of thinking, Alzheimer's disease, cardiovascular disease, cancer and others, may be in part explained by inadequate intake or inadequate amounts in the body of these vitamins."
1730,"summarize: Hypomethylation is also thought to exacerbate depressive tendency in people, and for (colorectal) cancer DNA hypomethylation is thought to be the link between the observed relationship between inadequate folate status and cancer.","Hypomethylation is also thought to exacerbate depressive tendency in people, and for (colorectal) cancer DNA hypomethylation is thought to be the link between inadequate folate status and cancer.",Problems with methionine metabolism are also thought to increase depressive tendency in people.These problems with methionine and DNA metabolism are also thought to be the link between the relationship seen between low levels of vitamin B folate and colorectal cancer.
1731,"summarize: It is involved in amino acid and homocysteine metabolism, glucose and lipid metabolism, neurotransmitter production and DNA/RNA synthesis.","It is involved in amino acid and homocysteine metabolism, glucose and lipid metabolism, neurotransmitter production and DNA/RNA synthesis.","It is involved in protein and amino acid (building blocks of protein) metabolism, carbohydrate (sugar) and lipid (fat) metabolism. It is also involved in neurotransmitter (chemicals involved in nerve impulses) production and DNA/RNA synthesis."
1732,summarize: Vitamin B6 can also be a modulator of gene expression.,Vitamin B6 can also be a modulator of gene expression.,Vitamin B6 can also be a chemical that regulates gene expression.
1733,summarize: These studies were summarised and compared in different chapters.,These studies were summarised and compared in different chapters.,This research was summarised and compared in different chapters.
1734,"summarize: Some of these problems may be related to the elevated homocysteine concentrations associated to vitamin B6 deficiency, but there is also evidence for other mechanisms independent of homocysteine by which a suboptimal vitamin B6 status could increase the risk for these chronic diseases.","Several of these problems may be related to the elevated homocysteine concentrations associated with vitamin B6 deficiency. However, there is also evidence for other mechanisms independent of homocysteine by which a suboptimal vitamin B6 status could increase the risk for these chronic diseases.",Some of these problems may be related to an increased homocysteine (amino acid) levels that is associated with vitamin B6 deficiency. There is also evidence for other ways suboptimal vitamin B6 levels could increase the risk for these chronic diseases.
1735,summarize: It is therefore not surprising that alterations of vitamin B6 metabolism have been associated with multiple human diseases.,It is therefore not surprising that changes in vitamin B6 metabolism have been linked with multiple human diseases.,Changes in vitamin B6 metabolism have been associated with multiple human diseases.
1736,"summarize: During the past 30 years, an intense wave of clinical investigation has attempted to dissect the putative links between vitamin B6 and cancer.","During the past 30 years, an intense wave of clinical investigation has attempted to dissect the possible links between vitamin B6 and cancer.","During the past 30 years, a lot of research has tried to explain links between vitamin B6 and cancer."
1737,"summarize: Moreover, elevated levels of pyridoxal kinase (PDXK), the enzyme that converts pyridoxine and other vitamin B6 precursors into PLP, have been shown to constitute a good, therapy-independent prognostic marker in patients affected by non-small cell lung carcinoma (NSCLC).","Moreover, elevated levels of pyridoxal kinase (PDXK), the enzyme that converts pyridoxine and other vitamin B6 precursors into PLP, have been shown to be a good, therapy-dependent marker in patients affected by non-small cell lung carcinoma (NSCLC).","Also, increased levels of pyridoxal kinase (PDXK-a protein involved in producing PLP), have been shown to predict good outcomes in patients with non-small cell lung carcinoma (NSCLC)."
1738,"summarize: HK: XA and PAr were both associated with increased CRC risk [OR: 1.48 (95% CI: 1.08, 2.02) and OR: 1.50 (95% CI: 1.10, 2.04), respectively] for the fourth compared with the first quartile.",HK: XA and PAr were both linked with increased CRC risk for the fourth compared with the first quartile.,"The calculated biomarkers, HK: XA and PAr were both associated with an increased risk for getting CRC."
1739,summarize: Conclusions: Vitamin B-6 deficiency as measured by plasma PLP is associated with a clear increase in CRC risk.,Vitamin B-6 deficiency as measured by plasma PLP is associated with a clear increase in CRC risk.,Vitamin B6 deficiency (blood PLP) is associated with a clear increase in CRC risk.
1740,"summarize: The immune system is critical in preventing infection and cancer, and malnutrition can weaken different aspects of the immune system to undermine immunity.","The immune system is critical in preventing infection and cancer, and malnutrition can weaken different parts of the immune system to undermine immunity.","The immune system is critical in preventing infection and cancer, and malnutrition can weaken different aspects of the immune system to decrease immunity."
1741,"summarize: Water-soluble vitamin B6 is widely present in many foods, including meat, fish, nuts, beans, grains, fruits, and vegetables.","Vitamin B6 is widely present in many foods, including meat, fish, nuts, beans, grains, fruits, and vegetables.","Vitamin B6 dissolves in water. It is widely present in many foods, including meat, fish, nuts, beans, grains, fruits, and vegetables."
1742,summarize: There are several active compounds or vitamers which fall under the generic B6.,There are several active compounds or vitamers which fall under the generic B6.,There are several active chemicals (vitamers) which fall under the types of vitamin B6.
1743,summarize: The major esters are the active coenzyme form and are pyridoxal 5'phosphate (PLP) and pyridoxamine 5'phosphate (PMP).,pyridoxal 5'phosphate (PLP) and pyridoxamine 5'phosphate (PMP) are the major esters.,Other vitamin B6 vitamers include pyridoxal 5'phosphate (PLP) and pyridoxamine 5'phosphate (PMP).
1744,"summarize: It plays a significant role in transamination, decarboxylation, initial steps of porphyrin synthesis.","It plays a significant role in transamination, decarboxylation, and initial steps of porphyrin synthesis.",It plays a significant role in many important chemical reactions in the body.
1745,"summarize: Vitamin B6 recommendations are made in accordance with age and life stage with pregnancy and breastfeeding, involving the highest recommended daily allowance.","Vitamin B6 recommendations are made in accordance with age and life stage with pregnancy and breastfeeding, involving the highest recommended daily allowance.",The amount of vitamin B6 doctors recommend is made according to age and life stage. The highest recommended daily allowance is during pregnancy and breastfeeding.
1746,summarize: Background: a large number of studies have linked vitamin B6 to inflammation and cardiovascular disease in the general population.,a large number of studies have linked vitamin B6 to inflammation and heart disease in the general population.,A large number of studies have linked vitamin B6 to inflammation and cardiovascular disease in the general population.
1747,"summarize: However, it remains uncertain whether vitamin B6 is associated with cardiovascular outcome independent of inflammation.","Nevertheless, it remains uncertain whether vitamin B6 is associated with cardiovascular outcome independent of inflammation.",It is not known if vitamin B6 is linked to future cardiovascular disease without inflammation.
1748,summarize: There is little evidence regarding the association between serum vitamin B6 concentration and subsequent mortality.,There is little evidence regarding the link between serum vitamin B6 concentration and subsequent death.,There is little evidence about the connection beween blood levels of vitamin B6 and later mortality (death rate).
1749,"summarize: Vitamin B6 status was defined as deficient (PLP  20 nmol/L), insufficient (PLP â° 20.0 and 30.0 nmol/L), and sufficient (PLP â° 30.0 nmol/L).","Vitamin B6 status was defined as deficient, insufficient, and sufficient.","Vitamin B6 blood levels were defined as deficient (not enough), insufficient (low), and sufficient (enough) depending on the level of PLP in the blood.."
1750,"summarize: During follow-up, a total of 1244 deaths were recorded, including 294 cancer deaths and 235 CVD deaths.","During follow-up, a total of 1244 deaths were recorded, including 294 cancer deaths and 235 CVD deaths.","During follow-up, a total of 1244 deaths were recorded, including 294 cancer deaths and 235 cardiovascular disease deaths."
1751,"summarize: After multivariate adjustment in Cox regression, participants with higher serum vitamin B6 had a 15% (HR = 0.85, 95% CI = 0.77, 0.93) reduced risk of all-cause mortality and a 19% (HR = 0.81, 95%CI = 0.68, 0.98) reduced risk for CVD mortality for each unit increment in natural log-transformed PLP.",participants with higher serum vitamin B6 had a 15% reduced risk of all-cause death and a 19% reduced risk for CVD death for each unit increment in natural log-transformed PLP.,Participants with higher blood vitamin B6 had a 15% lower risk of all-cause mortality and a 19% lower risk of cardiovascular disease mortality for each unit level of PLP (using the Cox model).
1752,summarize: Participants with higher levels of vitamin B6 had a lower risk for all-cause mortality.,participants with higher levels of vitamin B6 had a lower risk for all-cause death.,Participants with higher levels of vitamin B6 had a lower risk for all-cause mortality.
1753,"summarize: The major clinical outcome of Achondroplasia is attenuated growth, rhizomelic shortening of the long bones and craniofacial abnormalities.","Achondroplasia is attenuated growth, shortening of the long bones and facial abnormalities.","The major health impact of Achondroplasia is reduced growth, shortening of the long bones and abnormalitiesin the bones of the head and face."
1754,summarize: As of today there is no pharmacological treatment for Achondroplasia.,Achondroplasia is not treated with drugs.,As of today there is no drug treatment for Achondroplasia.
1755,summarize: Some improvement in the patients well being and daily function can be achieved by a surgical limb lengthening procedure.,Some improvement in the patients well being and daily function can be achieved by a surgical leg lengthening procedure.,Some improvement in the patients well being and daily function can be achieved by a surgical limb lengthening procedure.
1756,summarize: Substantial information is available concerning the natural history of this dwarfing disorder.,Substantial information is available regarding the natural history of this dwarfing disorder.,A lot of information is available about how achondroplasia progresses over time.
1757,"summarize: Children commonly have recurrent ear infections, delayed motor milestones, and eventually develop bowed legs and lumbar lordosis.","Children often have recurrent ear infections, delayed motor milestones, and eventually develop bowed legs and lumbar lordosis.","Children commonly have ear infections, delayed walking, and eventually develop bowed legs and a curve in the back."
1758,"summarize: To explore the molecular mechanisms that result in the different phenotypes, we investigated the kinetics of mutated versions of FGFR3.","To explore the molecular mechanisms that result in the different phenotypes, we investigated the kinetics of mutated versions of FGFR3.","To explore the molecular mechanisms that result in the different bone growth impairments and with varying severity, the authors investigated the properties of mutated versions of FGFR3."
1759,"summarize: First, we assayed the phosphorylation states of the mutated FGFR3s and found that the level of phosphorylation in TDI-FGFR3 was lower than in ACH-FGFR3, although the other mutants were phosphorylated according to phenotypic severity.","FGFR3s were altered. The level of phosphorylation in TDI-FGFR3 was lower than in ACH-FGFR3, although the other mutants were phosphorylated according to severity.","First, the authors checked for addition of a phosphate group to FGFR3. Attachement of phosphate groups can change the properites of the receptor and where it is located in the cell. They found that different parts of the receptor had phosphate groups depending on the type of mutation."
1760,"summarize: Second, we analyzed the duration of the phosphorylation.","Second, we analyzed the duration of the phosphorylation.","Second, the authors looked for how long the phosphate groups were present in the mutated FGFR3 receptor."
1761,summarize: The other mutant proteins showed sustained phosphorylation independent of ligand presence.,the other mutant proteins showed sustained phosphorylation independent of ligand presence.,"Generally, the mutated proteins showed longer presence of the phosphate group on FGFR3."
1762,"summarize: Both PLCgamma and STAT1 were activated by FGFR3 signaling, but a dominant-negative form of PLCgamma (DN-PLCgamma) remarkably reduced STAT1 phosphorylation.","Both PLCgamma and STAT1 were activated by FGFR3 signaling, but a dominant-negative form of PLCgamma (DN-PLCgamma) significantly reduced STAT1 phosphorylation.",_
1763,"summarize: DN-PLCgamma reduced the apoptosis of ATDC5 cells expressing TDII-FGFR3, but over-expression of both DN-PLCgamma and STAT1-C induced apoptosis.","DN-PLCgamma reduced the apoptosis of ATDC5 cells expressing TDII-FGFR3, but over-expression of both DN-PLCgamma and STAT1-C induced apoptosis.",_
1764,"summarize: The disease is related to a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene encoding one member of the FGFR subfamily of tyrosine kinase receptors, which results in constitutive activation of the receptor.","fibroblast growth factor receptor-3 (FGFR3) gene is related to a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene. This gene encodes one member of the FGFR subfamily of tyrosine kinase receptors, which results in activation of the receptor.",The diseases is related to a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene and results in a continuously active receptor.
1765,summarize: The most common rheumatological complications of achondroplasia are medullar and radicular compressions due to spinal stenosis and deformities of the lower limbs.,the most common rheumatological complications of achondroplasia are medullar and radicular compressions due to spinal stenosis and deformities of the lower limbs.,The most common bone-related complications of achondroplasia are shortening of the spine and deformities of the lower limbs.
1766,"summarize: Its incidence is between one in 10,000 and one in 30,000.","Its frequency is between one in 10,000 and one in 30,000.","Achondroplasia affects between one in 10,000 and 30,000 people."
1767,"summarize: This autosomal-dominant disorder is caused by a gain-of-function mutation in the gene encoding the type 3 receptor for fibroblast growth factor (FGFR3); in more than 95% of cases, the mutation is G380R.","fibroblast growth factor (FGFR3) is caused by a gain-of-function mutation in the type 3 receptor for fibroblast growth factor (FGFR3). In more than 95% of cases, the gene is G380R.",A mutation in a gene called type 3 receptor for fibroblast growth factor (FGFR3) causes achondroplasia.
1768,"summarize: Anticipatory and management care by a multidisciplinary team will prevent and treat complications, including cervical cord compression, conductive hearing loss and thoracolumbar gibbosity.","Anticipatory and management care by a multidisciplinary team will prevent and treat complications, including cervical cord compression, conductive hearing loss and thoracolumbar gibbosity.","A person with achondroplasia is cared for by a multidisciplinary team that will prevent and treat complications, including spinal cord squeezing, hearing loss and development of a hump in the back."
1769,summarize: Fibroblast growth factors (FGFs) and their receptors (FGFRs) play significant roles in vertebrate organogenesis and morphogenesis.,Fibroblast growth factors (FGFs) and their receptors (FGFRs) play important roles in vertebrate organogenesis and morphogenesis.,Fibroblast growth factors (FGFs) and their receptors (FGFRs) play significant roles in vertebrate organ development.
1770,"summarize: FGFR3 is a negative regulator of chondrogenesis and multiple mutations with constitutive activity of FGFR3 result in achondroplasia, one of the most common dwarfisms in humans, but the molecular mechanism remains elusive.","FGFR3 is a negative regulator of chondrogenesis. Multiple mutations with FGFR3 result in achondroplasia, one of the most common dwarfisms in humans. However, the molecular mechanism remains unknown.","FGFR3 prevents cartilage formation and some mutations with continuously active FGFR3 result in achondroplasia, a common dwarfism in humans, but the molecular mechanisms remain elusive."
1771,"summarize: Some of them have serious health consequences related to fluid build up in the brain, head and neck region shortening, or blockage in the upper breathing passage..","some of them have serious health consequences related to fluid build up in the brain, head and neck region shortening, or blockage in the upper breathing passage.","Some of them have serious health consequences related to hydrocephalus, craniocervical junction compression, or upper-airway obstruction."
1772,"summarize: Autosomal dominant mutations in fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia (Ach), the most common form of dwarfism in humans, and related chondrodysplasia syndromes that include hypochondroplasia (Hch), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), and thanatophoric dysplasia (TD).","achondroplasia (Ach), the most common form of dwarfism in humans, and related chondrodysplasia syndromes include hypochondroplasia (Hch), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), and thanatophoric dysplasia (TD).","Mutations in fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia (Ach), the most common form of dwarfism in humans and related chondrodysplasia syndromes that include hypochondroplasia (Hch), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), and thanatophoric dysplasia (TD). The mutations are passed on nonsex chromosomes and causes the child that inherits the mutation from an affected parent to have a 50% chance to be affected."
1773,summarize: FGFR3 is expressed in chondrocytes and mature osteoblasts where it functions to regulate bone growth.,FGFR3 is expressed in chondrocytes and mature osteoblasts where it functions to regulate bone growth.,FGFR3 is expressed in cartilage cells and mature bone-forming cells where it functions to regulate bone growth.
1774,"summarize: In this review, we discuss the molecular mechanisms that regulate growth plate chondrocytes, the pathogenesis of Ach, and therapeutic approaches that are being evaluated to improve endochondral bone growth in people with Ach and related conditions.","In this review, we discuss the molecular mechanisms that regulate growth plate chondrocytes, the pathogenesis of Ach, and treatments that are being evaluated to improve endochondral bone growth in people with Ach and related conditions.","In this review, authors discuss the molecular mechanisms that regulate growth region cartilage cells, development of Achondroplasia (Ach), and therapeutic approaches that are being evaluated to improve bone growth in people with Ach and related conditions."
1775,"summarize: Fibroblast growth factor receptor 3 (FGFR3) mutations cause dwarfisms, including achondroplasia (ACH) and thanatophoric dysplasia (TD).","Fibroblast growth factor receptor 3 (FGFR3) mutations cause dwarfisms, including achondroplasia (ACH) and thanatophoric dysplasia (TD).","Fibroblast growth factor receptor 3 (FGFR3) gain-of-function mutations cause dwarfisms, including achondroplasia (ACH) and thanatophoric dysplasia (TD)."
1776,summarize: The constitutive activation of FGFR3 disrupts the normal process of skeletal growth.,FGFR3 activation disrupts the normal process of skeletal growth.,The continuously active state of FGFR3 disrupts normal process of bone growth.
1777,"summarize: We also studied the impact of rapamycin, an inhibitor of mammalian target of rapamycin (mTOR) pathway.","Moreover, we also studied the impact of rapamycin, an inhibitor of mammalian target of rapamycin (mTOR) pathway.",The authors also studied the impact of a drug inhibitor of a signaling pathway.
1778,summarize: OBJECTIVES. To establish a database of literature and other evidence on neonatal screening programmes and technologies for inborn errors of metabolism.,OBJECTIVES. To establish a database of literature and other evidence on neonatal screening programmes and technologies for inborn errors of metabolism.,Our first goal in this article was to establish a database of literature and other evidence on newborn screening programmes and technology for genetic disorders related to metabolism.
1779,"summarize: A systematic review of the literature on inborn errors of metabolism, neonatal screening programmes, new technologies for screening and economic factors.","A systematic review of the literature on inborn errors of metabolism, neonatal screening programmes, new technologies for screening and economic factors.","We rigorously reviewed research papers on genetic disorders related to metabolism, newborn screening programs, new technologies for screening, and economic factors."
1780,"summarize: Ethical, safe, simple and robust screening test.","Ethical, safe, simple and robust screening test.","There is an ethical, safe, simple and robust screening test for the disorder."
1781,summarize: Cost-effectiveness of screening.,Cost-effectiveness of screening.,Screening for the disorder is cost-effective.
1782,summarize: Therapeutic advances for GA1 offer prevention of neurological damage but further investigation is required into the costs and benefits of screening for this disorder.,"GA1 is a brain disorder that affects the nervous system. However, further studies are needed to understand the costs and benefits of screening for this disorder.",Advancements in therapy for GA1 can prevent damage to the brain and nerves but more research into the costs and benefits of screening for this disorder is needed.
1783,"summarize: MCAD deficiency is simply and cheaply treatable, preventing possible early death and neurological handicap.","MCAD deficiency is simply and cheaply treatable, preventing possible early death and neurological handicap.","MCAD deficiency can be treated simply and cheaply, preventing possible early death and brain handicap."
1784,"summarize: Neonatal screening for congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (incidence 1:17,000) has been shown to be beneficial in other countries and similar benefits should accrue in the UK.",Neonatal screening for congenital adrenal hyperplasia (CAH) due to lack of a specific protein has been shown to be beneficial in other countries and similar benefits should occur in the UK.,"Newborn screening for congenital adrenal hyperplasia (CAH) has worked well in other countries and the UK should see similar benefits. This disease occurs in one in 17,000 people."
1785,"summarize: There are numerous challenges in clinical follow-up, including diagnosis and appropriate understanding of the consequences of the disorders.","There are many challenges in clinical follow-up, including diagnosis and understanding of the consequences of the disorders.","There are many challenges for following up with patients, including diagnosis and appropriate understanding of the consequences of the disorders."
1786,"summarize: The aim of newborn screening is to detect newborns with serious, treatable disorders so as to facilitate appropriate interventions to avoid or ameliorate adverse outcomes.","The aim of newborn screening is to detect newborns with serious, treatable disorders so as to facilitate appropriate treatments to avoid or improve adverse outcomes.","The goal of newborn screening is to detect newborns with serious, treatable disorders. This allows appropriate action to be taken to prevent or lessen bad outcomes."
1787,"summarize: Dried blood spot calibrators and controls, prepared on the same lot number of filter paper, are needed.","Dried blood spot calibrators and controls, prepared on the same lot number of filter paper, are needed.",Extra dried blood spots need to be prepared on the same filter paper to calibrate the tests.
1788,summarize: Phenylketonuria was the prototype disorder for newborn screening (NBS) and early dietary treatment has resulted in vastly improved outcomes for this disorder.,Phenylketonuria was the first disorder for newborn screening (NBS) and early dietary treatment has resulted in greatly improved outcomes for this disorder.,Phenylketonuria is an inherited disorder that can cause many issues with the brain. This disorder was the original example of how newborn screening can result in big improvements for health outcomes.
1789,"summarize: The simultaneous introduction of many disorders has caused some re-evaluation of the traditional guidelines for NBS, because very rare disorders or disorders without good treatments can be included with minimal effort.","The simultaneous introduction of many disorders has caused some re-evaluation of the traditional guidelines for newborn screening, because very rare disorders or disorders without good treatments can be included with minimal effort.",The addition of many disorders all at once has led to some reconsideration of the way newborn screening is usually done. This is because it is easy to include tests for disorders that are very rare or donât have good treatments.
1790,"summarize: Newborn screening (NBS) of inborn errors of metabolism (IEM) is a coordinated comprehensive system consisting of education, screening, follow-up of abnormal test results, confirmatory testing, diagnosis, treatment, and evaluation of periodic outcome and efficiency.","Newborn screening (NBS) of inborn errors of metabolism (IEM) is a coordinated comprehensive system consisting of education, screening, follow-up of abnormal test results, confirmation testing, diagnosis, treatment, and evaluation of periodic outcome and efficiency.","Inborn Errors of Metabolism (IEM) are hereditary diseases that affect how the body processes nutrients. Newborn screening of IEM is a coordinated, comprehensive system. It is made up of education, screening, follow-up of abnormal test results, confirmatory testing, diagnosis, treatment, and evaluation of outcome and efficiency."
1791,summarize: The ultimate goal of NBS and follow-up programs is to reduce morbidity and mortality from the disorders.,The ultimate goal of NBS and follow-up programs is to reduce illness and death from the disorders.,The ultimate goal of newborn screening and follow-up programs is to reduce poor health and death from the disorders.
1792,"summarize: It has replaced classic screening techniques of one-analysis, one-metabolite, one-disease with one analysis, many-metabolites, and many-diseases.","It has replaced traditional screening methods of one-analysis, one-metabolite, one-disease with one analysis, many-metabolites, and many-diseases.","It has replaced classic screening techniques, which screen for one disease per lab test, with lab tests that screen for many diseases at once."
1793,"summarize: To date, more than 1000 different IEM have been identified.",more than 1000 different IEMs have been identified.,"To date, more than 1000 different IEM have been identified."
1794,"summarize: Some IEM are amenable to treatment, with promising outcomes.","Some IEM are able to be treated, with promising outcomes.","Some IEM can be treated, with promising outcomes."
1795,"summarize: The technology allows inexpensive simultaneous detection of more than 30 different metabolic disorders in one single blood spot specimen at a cost of about USD 10 per baby, with commendable analytical accuracy and precision.","the technology allows inexpensive simultaneous detection of more than 30 different metabolic disorders in one single blood spot at a cost of about USD 10 per baby, with commendable accuracy and precision.","This technology allows more than 30 different metabolic disorders to be detected at low cost in one single blood spot specimen. The cost is about 10 dollars per baby, and the tests are highly accurate."
1796,"summarize: With ongoing advancements in nanotechnology and molecular genomics, the field of biochemical genetics is still expanding rapidly.","With ongoing advances in nanotechnology and molecular genomics, the field of biochemical genetics is still expanding rapidly.",This knowledge is growing because of advancements in nanotechnology (working with things at the microscopic level) and molecular genomics (the study of how changes DNA drive hereditary outcomes).
1797,summarize: NBS represents the highest volume of genetic testing.,NBS represents the highest volume of genetic testing.,Newborn screening represents the highest volume of genetic testing.
1798,"summarize: It is more than a test and it warrants systematic healthcare service delivery across the pre-analytical, analytical, and post-analytical phases.","It is more than a test and it warrants systematic healthcare service delivery across the pre-analysis, analytical, and post-analysis phases.","It is more than a test and it calls for providing organized healthcare before, during, and after the test."
1799,"summarize: State programs encompass screening, as well as the diagnosis and coordination of care for newborns with positive findings.","State programs include screening, as well as the diagnosis and coordination of care for newborns with positive results.","State programs include screening, as well as the diagnosis and coordination of care for newborns with positive test results."
1800,"summarize: For infants with positive screening results leading to diagnosis, long-term follow-up involves ongoing parental education, regular medical examinations, management at a metabolic treatment center, and developmental and neuropsychological testing to detect associated disorders in time for early intervention.","For infants with positive screening results leading to diagnosis, long-term follow-up involves ongoing parental education, regular medical examinations, treatment at a metabolic treatment center, and developmental and neuropsychological testing to detect associated disorders in time for early intervention.","For infants with positive screening results that lead to a diagnosis, long-term follow-up involves ongoing parental education, regular exams, and management at a metabolic treatment center. Long-term follow-up also involves tests of brain development to detect relevant disorders in time for early action."
1801,"summarize: This comprehensive system includes; testing, education, follow up, diagnosis, treatment, management, and evaluation.","This comprehensive system includes; testing, education, follow up, diagnosis, treatment, management, and evaluation.","This comprehensive system includes; testing, education, follow up, diagnosis, treatment, management, and evaluation."
1802,"summarize: With a single dried filter paper blood spot, MS/MS can identify more than 30 inherited metabolic disorders in around two to three minutes.","Using a single dried filter paper blood spot, MS/MS can identify more than 30 metabolic disorders in around two to three minutes.","With a single dried filter paper blood spot, MS/MS can identify more than 30 inherited metabolic disorders in around two to three minutes."
1803,"summarize: Outcomes collected were post-operative pain at rest and during activity after 24 and 48 hours, opioid requirement, mobilisation, hospital stay and complications.","Outcomes collected were post-operation pain at rest and during activity after 24 and 48 hours, opioid need, mobilization, hospital stay and complications.","The information we gathered from the studies was: pain after surgery, both at rest and during activity after 24 and 48 hours, whether opioids were needed, when and how much patients walked, hospital stay, and additional problems cause by the surgery."
1804,"summarize: When feasible, we estimated pooled treatment effects using random effects meta-analyses.","When possible, we estimated the treatment effects using statistical analyses.",nan
1805,summarize: Studies should assess whether local anaesthetic infiltration can prevent long-term pain.,Studies should assess whether local anaesthetic infiltration can prevent long-term pain.,"Second, studies should assess whether local anaesthesia can prevent long-term pain."
1806,summarize: Enhanced pain control with additional analgesia through a catheter should be weighed against a possible infection risk.,Enhanced pain control with additional analgesia through a catheter should be weighed against a possible infection risk.,"Finally, enhanced pain control with additional medicine through a catheter should be weighed against a possible infection risk."
1807,"summarize: Multimodal pain management uses oral medicines, peripheral nerve blocks, intra-articular injections, and other tools to reduce the need for opioids.","Multi-modal pain management uses oral medicines, nerve blocks, injections in the articular area, and other tools to reduce the need for opioids.","Multimodal pain management uses drugs taken by mouth, injections into nerves, injections into joints, and other tools to reduce the need for opioids."
1808,summarize: Pain management has to take these findings into account in the future to further increase patients' satisfaction in the postoperative course after total hip arthroplasty and to adapt pain management programs.,Pain management has to take these findings into account in the future to further increase patients' satisfaction in the post-operation course after hip replacement and to adapt pain management programs.,"When managing pain, doctors need to account for these results in the future. This is needed to further increase patients' satisfaction following hip replacement and to adapt pain management programs."
1809,"summarize: Numeric Rating Scale (NRS) for pain at rest registered in the clinical sheet was retrieved for all patients and analyzed with respect to the spinal anaesthesia given for the surgery, local analgesia, analgesia protocol adopted during the postoperative days in the Orthopaedic Unit, the antalgic treatment given during the stay within the Rehabilitation Unit, the postoperative consumption of rescue pain medication, and any collateral effect due to the analgesic therapy.","Numeric Rating Scale (NRS) for pain at rest registered in the clinical sheet was retrieved for all patients and analyzed with respect to the spinal anaesthesia given for the surgery, local analgesia, analgesia protocol adopted during the post-operation days in the Orthopaedic Unit, the antalgic treatment given during the stay within the Rehabilitation Unit, the use of rescue pain medication after surgery, and any side effects due to the analgesic therapy.","From the medical records, we looked at the Numeric Rating Scale (NRS) for pain for all patients. We analyzed this pain measurement with respect to the spinal anaesthesia given for the surgery, local anaesthesia, and the regimen of pain medicine used in the Orthopaedic Unit after the surgery. We also analyzed the pain ratings with respect to pain medicine given while in the Rehabilitation Unit, additional pain medication given as needed because of more intense pain, and any side effects of the pain treatment."
1810,summarize: A very good control of pain with the perioperative anesthetic protocol and pain treatment protocol in use was obtained.,A very good control of pain with the perioperative anesthetic protocol and pain treatment protocol in use was obtained.,Pain was controlled very well with the protocols for anesthesia at the time of surgery and pain treatment.
1811,"summarize: With regard to intraoperative anesthetic choice and pain control, spinal anesthesia appears to have fewer systemic risks than general anesthesia, and periarticular injections of local anesthetic agents, regardless of technique, and with or without the addition of sympathetic modulators, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, have been shown to improve pain scores postoperatively and to overall carry a low risk profile.","Anesthesia in the spine appears to have fewer risks than general anesthesia. In addition, injections of local anesthetic drugs, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, have been shown to improve pain scores after surgery and overall carry a low risk profile.","Regarding the choice of anesthetic during surgery and pain control, anesthesia applied directly to the spine seems to have fewer general risks to the body than general anesthesia. In addition, injections of local anesthetics around the joint, regardless of technique, have been shown to improve pain scores following surgery and to have low risk overall. This is true whether the injections are used with or without adding other drugs, including those that control the bodyâs fight-or-flight response, opioids, NSAIDs or corticosteroids."
1812,"summarize: In recent years, the transition from opioids to a multimodal pain management approach after total knee and total hip arthroplasty has increasingly become an alternative.","In recent years, the transition from opioids to a multi-modal pain management approach after knee and hip replacement has increasingly become an alternative.","In recent years, changing from opioids after knee and hip replacement to using multiple pain medicines at once has increasingly become an alternative."
1813,"summarize: The literature chosen was extracted through the electronic databases PubMed, CINAHL, and Embase.","The literature chosen was extracted through the electronic databases PubMed, CINAHL, and Embase.",The scientific papers we chose were taken from several electronic databases.
1814,"summarize: However, further quality research trials are necessary for more conclusive evidence-based information.","Nevertheless, further quality research studies are needed for more conclusive evidence-based information.","However, further quality research trials are needed to be more sure."
1815,summarize: Background: We implemented local infiltration analgesia (LIA) as a technique of providing post-operative pain management and early mobilization after arthroplasty surgery and have progressively found patients able to go home earlier.,Background: We implemented local infiltration analgesia (LIA) as a technique of providing post-operative pain management and early mobilization after arthroplasty surgery. We have found patients able to go home earlier.,Local Infiltration Analgesia (LIA) a method for managing pain and encouraging walking early after joint surgery. It involves injecting several painkillers directly into the surgical wound during and after the procedure. We applied LIA and have found more and more that patients are able to go home earlier.
1816,summarize: We developed a standardized opioid-prescribing schedule (SOPS) after total hip arthroplasty (THA) and total knee arthroplasty (TKA) and evaluated opioid usage alongside Patient-Reported Outcomes Measurement Information System (PROMIS) pain interference scores.,the authors developed a standard opioid-prescribing schedule (SOPS) after hip replacement and knee replacement. We also evaluated opioid use along with patient-reported pain interference scores.,We created a standard for prescribing opioids to treat pain after hip and knee replacement. We also studied opioid usage alongside a system of measuring pain as reported by patients.
1817,summarize: SOPSs were implemented during the study.,SOPSs were implemented during the study.,Standards for prescribing opioids were used during the study.
1818,"summarize: Before the SOPS, the mean opioid prescription was 81.2  15.3 tablets for THA and 82.9  10.6 for TKA.","Before the SOPS, the average opioid prescription was 81.2  15.3 tablets for THA and 82.9  10.6 for TKA.","Before the standards were followed, the average opioid prescription was about 81 tablets for hip replacement and about 83 tablets for knee replacement."
1819,"summarize: The mean usage was 35.1  29.4 tablets and 35.4  33.4, respectively.","the average use was 35.1  29.4 tablets and 35.4  33.4, respectively.",The average number of tablets used for both hip replacement and knee replacement was 35.
1820,"summarize: After the SOPS, the mean usage decreased to 19.4  16.8 (P =.04) and 31.6  20.9 (P =.52), respectively.","after the survey, the average use decreased to 19.4  16.8 and 31.6  20.9, respectively.","After the standards were followed, the average number of tables taken dropped to about 19 for hip replacement and about 32 for knee replacement."
1821,summarize: Perioperative management and rehabilitation patterns are of great importance for the success of the procedure.,Perioperative management and rehabilitation patterns are of great importance for the success of the procedure.,How the patient is cared for and rehabilitated around the time of surgery are very important for the success of the procedure.
1822,summarize: The widespread Harris Hip Score (HHS) was used to compare results pre- and 4 weeks postoperatively.,The widespread Harris Hip Score (HHS) was used to compare results before and 4 weeks after surgery.,We used the widely used Harris Hip Score (HHS) to compare results before surgery and 4 weeks after surgery.
1823,"summarize: Conclusions: In addition to CVA, PNDs and GER, eosinophilic bronchitis is also an important cause of chronic cough.","Conclusions: In addition to CVA, PNDs and GER, eosinophilic bronchitis is also an important cause of chronic cough.","Besides CVA, PNDs, and GER, eosinophilic bronchitis (EB) is also an important cause of chronic cough."
1824,"summarize: Chronic cough is often attributed to reflux, postnasal drip, or asthma.","Chronic cough is often attributed to reflux, postnasal drip, or asthma.","Chronic cough is often due to reflux, postnasal drip, or asthma."
1825,"summarize: After a negative workup for reflux, asthma, or postnasal drip, these patients were treated with gabapentin at 100 to 900 mg/d.","after a negative workup for reflux, asthma, or postnasal drip, these patients were treated with gabapentin at 100 to 900 mg/d.","The patients were treated with the drug, gabapentin (a drug used to treat seizures), if the workup did not show reflux, asthma, or postnasal drip."
1826,"summarize: The final diagnosis was made based on clinical manifestation, examination findings and a positive response to therapy.","the final diagnosis was made based on symptoms, examination findings and a positive response to therapy.",The final diagnosis of the cause of chronic cough was made based on all of these tests plus how patients responded to treatment.
1827,summarize: Seventy-two patients with these symptoms who had previously been advised to use the regime were contacted with a postal questionnaire.,772 patients with these symptoms who had previously been advised to use the regime were contacted with a questionnaire.,A questionnaire was mailed to 72 patients that had been told to use this plan.
1828,summarize: The most severely and most frequently affected patients had the greatest benefit.,the most severely and most frequently affected patients had the greatest benefit.,The greatest improvement was seen in patients who had the worse symptoms and who had them most often.
1829,"summarize: The incidence of nocturnal cough in CVA was 26.0% (13/44), significantly higher than in EB (9.1% (5/55), chi2 = 5.272, P0.05), UACS (2.2% (1/45), chi2 = 10.657, P0.01) and GERC (0% (0/46), chi2 = 13.833, P0.01).","the frequency of nighttime cough in CVA was 26.0% (13/44), significantly higher than in EB, UACS and GERC.","Nighttime cough (nocturnal cough) occurred much more often in CVA than in EB, UACS, and GERC."
1830,"summarize: The diagnostic protocol included history inquiring and physical examination, pulmonary function tests, induced sputum cell differentials, 24 h esophageal pH monitoring, CT of the paranasal sinuses or chest, fiberoptic rhinoscopy or bronchoscopy.","Symptoms included history and physical examination, pulmonary function tests, sputum cell differentials, 24 hour esophagus pH monitoring, CT of the sinuses or chest, fiberoptic rhinoscopy or bronchoscopy.","The diagnostic tests included: medical history, physical exam, lung function tests, sputum cell counts, esophagus acid test, CAT scan of sinuses or chest, and looking into the nose or lungs with the endoscope."
1831,"summarize: The most important causes of cough were: cough variant asthma (CVA) (n = 41, 33.3%), rhinitis and/or sinusitis (n = 30, 24.4%), gastroesophageal reflux (GERC) (n = 25, 20.3%), medicine related (n = 7, 5.7%), eosinophilic bronchitis (EB) (n = 6, 4.9%), atopic (n = 4, 3.3%), and idiopathic (n = 6, 4.9%).","the most important causes of cough were: cough variant asthma (CVA), rhinitis and/or sinusitis, gastroesophageal reflux (GERC), medicine related, eosinophilic bronchitis (EB), allergic bronchitis (EB), atopic (BB), and idiopathic (AB).","The most important causes of chronic cough were (most to least): cough variant asthma (CVA), inflammation of the nose (rhinitis) and/or sinuses (sinusitis), gastroesophageal reflux (GERC), medicine related, inflammation of airways (eosinophilic bronchitis -EB), allergies, and unknown cause."
1832,"summarize: Other causes included pulmonary interstitial fibrosis (n = 2, 1.6%), left heart insufficiency (n = 1, 0.8%) and bronchiectasis (n = 1, 0.8%).","Other causes included pulmonary interstitial fibrosis, left heart insufficiency and bronchiectasis.",Other lung and heart diseases caused chronic cough in a small number of patients
1833,"summarize: GERC manifested more day coughs, with 56.0% (14/25) cough associated with taking food and 68.0% (17/25) with reflux symptoms.","GERC manifested more day coughs, with 56.0% (14/25) cough associated with taking food and 68.0% (17/25) with reflux symptoms.","GERC was associated with daytime cough, cough with eating, and with reflux."
1834,"summarize: There was more productive cough in rhinitis and/or sinusitis (73.3% (22/30),chi2 = 24.99, P0.01).",There was more productive cough in rhinitis and/or sinusitis.,Productive cough occurred more in rhinnitis and/or sinusitis.
1835,summarize: The spectrum and clinical features of causes for chronic cough are important in the diagnostic procedure of chronic cough.,The causes of chronic cough are important in the diagnosis of chronic cough.,The range of signs and symptoms of chronic cough are important in order to find out the causes.
1836,summarize: The patients were followed for symptomatic improvement after initiation of treatment with a neuromodulator.,the patients were followed for symptoms improvement after starting treatment with a neuromodulator.,The patients were followed to see if their symptoms improved after starting a neuromodulator (a drug that has an effect on nerves).
1837,summarize: Conclusions: Patients with suspected neuropathy of the recurrent laryngeal nerve frequently respond to neuromodulator therapy.,Conclusions: Patients with suspected neuropathy of the recurrent laryngeal nerve often respond to neuromodulator therapy.,These neuromodulator drugs often help the symptoms if doctors suspect neuropathy of the recurrent laryngeal nerve as the cause.
1838,"summarize: Laryngopharyngeal reflux (LPR) is a complex of symptoms caused by the backflow of gastric contents into the larynx, pharynx, nasopharynx, sinuses and even to the middle ear space.","Laryngopharyngeal reflux (LPR) is a complex of symptoms caused by the backflow of gastric contents into the larynx, pharynx, nasopharynx, sinuses and even to the middle ear space.","A disorder caused by backflow of stomach contents into the back of the throat, nose, sinuses, and even the middle ear space is called laryngopharyngeal reflux (LPR)."
1839,summarize: The appropriate diagnosis and treatment leads the symptoms to subside.,The right diagnosis and treatment leads the symptoms to subside.,The correct diagnosis and treatment results in improvement of the symptoms.
1840,summarize: Interindividual variation in fetal hemoglobin (HbF) expression is a known and potentially heritable modifier of SCD severity.,fetal hemoglobin (HbF) expression is a known and potentially heritable modifier of SCD severity.,The severity of the problems that occur in SCD can vary depending on the amount of fetal hemoglobin (HbF) in the blood.
1841,"summarize: We recently demonstrated an association between a BCL11A SNP and HbF levels in one SCD cohort [Uda M, et al. (2008) Proc Natl Acad Sci USA 105:1620-1625].",the authors recently demonstrated an association between a BCL11A SNP and HbF levels in one SCD cohort.,Research has shown a connection between a single BCL11A gene mutation and HbF levels in some SCD patients.
1842,summarize: We also have shown that HbF-associated SNPs associate with pain crisis rate in SCD patients.,We also have shown that HbF-associated SNPs link with pain crisis rate in SCD patients.,"These mutations, associated with HbF levels, are also associated with the number of pain crises in SCD patients."
1843,"summarize: Increased HbF may result from rare deletions within the Î2-globin gene cluster or from point mutations in the promoters of the fetal Î3-globin genes (hereditary persistence of fetal hemoglobin, HPFH), but additional loci are known to increase HbF levels in adult life.","Increased HbF may result from rare deletions within the Î2-globin gene cluster or from mutations in the promoters of the fetal Î3-globin genes (hereditary persistence of fetal hemoglobin, HPFH), but additional loci are known to increase HbF levels in adult life.",Increased levels of HbF may be due to other mutations in various hemoglobin genes.
1844,"summarize: Female sex, body mass index, Hb/HbF, blood transfusions, leucocytosis and consultation or hospitalisation rates significantly correlated with VOC.","Female sex, body mass index, Hb/HbF, blood transfusions, leucocytosis and consultation or hospitalisation rates were linked with VOC.","Female sex, body mass index, Hb/HbF (hemoglobin/fetal hemoglobin), blood transfusions, higher white blood cell count, and consultations or hospitalisations are significantly linked with blood vessel blockages (vaso-occlusive crises (VOC))."
1845,"summarize: Three pain-related genes variants correlated with VOC (CACNA2D3-rs6777055, P = 0025; DRD2-rs4274224, P = 0037; KCNS1-rs734784, P = 001).",3 pain-related genes were linked to VOC.,Three pain-related gene variants (mutations) are linked to VOC.
1846,summarize: Homozygous HbS patients from the Crteil pediatric cohort with available Î-gene and Î2-haplotype data were included (n = 580; 301 females and 279 males) in this retrospective study.,580 HbS patients from the Crteil pediatric cohort were included in this retrospective study.,This study included boys and girls who inherited the sickle hemoglobin (HbS) from both parents (SS -Creteil pediatric group). Facts about the alpha-gene and beta-globin genetic types were known.
1847,summarize: The other two SNPs were not significant contributors.,The other two SNPs were not significant contributors.,The other two single mutations did not contribute significantly.
1848,summarize: Background: Our objective was to investigate the combined and differential effects of alpha-thalassemia -3.7 kb deletion and HbF-promoting quantitative trait loci (HbF-QTL) in Senegalese hydroxyurea (HU)-free children and young adults with sickle cell anemia (SCA).,the study aimed to investigate the combined and differential effects of alpha-thalassemia -3.7 kb deletion and HbF-promoting genetic trait loci (HbF-QTL) in Senegalese hydroxyurea (HU)-free children and young adults with sickle cell anemia (SCA).,"Researchers analyzed the effects of an alpha-thalassemia (another genetic blood disease) mutation and fetal hemoglobin-promoting quantitative trait loci (HbF-QTL (special section of DNA)) in Senegalese children and young adults with Sickle Cell Anemia (SCA) who have not received the medicine, hydroxyurea."
1849,summarize: Procedure: Steady-state biological parameters and vaso-occlusive crises (VOC) requiring emergency admission were recorded over a 2-year period in 301 children with SCA.,301 children with SCA were recorded over a 2-year period.,Steady biological signs and crises from blood vessel blockages (vaso-occlusive crises-VOC) requiring emergency admission were recorded over a 2-year period in 301 children with Sickle Cell Anemia (SCA).
1850,summarize: The age of the first hospitalized VOC was also recorded.,the age of the first hospitalized VOC was also recorded.,The age of the first hospitalized VOC was also recorded.
1851,summarize: These data were correlated with the alpha-globin and HbF-QTL genotypes.,These data were correlated with the alpha-globin and HbF-QTL genotypes.,These facts were compared to patients who had alpha-globin and HbF-QTL genes.
1852,summarize: Conclusion: Alpha-thalassemia -3.7 kb deletion and HbF-QTL are modulating factors of SCA clinical severity that interact with each other.,Alpha-thalassemia -3.7 kb deletion and HbF-QTL are modulating factors of SCA clinical severity that interact with each other.,The alpha-thalassemia mutation and the HbF-QTL gene mutations react with each other and can change the severity of Sickle Cell Anemia.
1853,summarize: The study included 100 SCD patients and 100 matched controls.,100 SCD patients and 100 matched controls were included in the study.,"The study compared 2 groups, 100 SCD patients and 100 patients without SCD (controls)."
1854,"summarize: Genotyping of BCL11A (rs1886868 C/T), HBS1L-MYB (rs9389268 A/G) and Xmn1 Î3G158 (rs7842144 C/T) SNPs showed no statistically significant difference between SCD patients and controls except for the hetero-mutant genotypes of BCL11A which was significantly higher in SCD patients compared with controls.",SCD patients and controls did not have a statistically significant difference between SCD patients.,"Generally, closer analysis of the BCL11A, HBS1L-MYB, and Xmn1 genes didn't show important differences between the 2 groups. But certain specific genetic mutations in the BCL11A gene were higher in SCD patients."
1855,summarize: Baseline HbF levels were significantly higher in those with co-inheritance of polymorphic genotypes of BCL11A + HSB1L-MYB and BCL11A + Xmn1.,Baseline HbF levels were significantly higher in those with genetic mutations of BCL11A + HSB1L-MYB and BCL11A + Xmn1.,Baseline HbF levels were significantly higher in those who inherited mutations of both BCL11A + HSB1L-MYB and BCL11A+ Xmn1 genes.
1856,summarize: Discovery of the molecular mechanisms controlling HbF production could provide a more effective strategy for HbF induction.,Identifying the molecular mechanisms controlling HbF production could provide a more effective strategy for HbF induction.,If researchers could discover the underlying chemistry of HbF production we might be able to increase it in patients.
1857,summarize: Sickle cell disease (SCD) is a monogenetic disorder due to a single base-pair point mutation in the Î2-globin gene resulting in the substitution of the amino acid valine for glutamic acid in the Î2-globin chain.,Sickle cell disease (SCD) is a single gene disorder due to a single mutation in the Î2-globin gene. This resulted in the substitution of the amino acid valine for glutamic acid in the Î2-globin chain.,Sickle Cell Disease (SCD) is a genetic disorder due to a single mutation in the Beta-globin gene. This mutation causes a change in an amino acid in the Beta-hemoglobin protein that decreases the ability of oxygen to be carried out to the body.
1858,summarize: The aim of our study was to determine if the number of HbF quantitative trait loci (QTL) would also favor a specific sub-phenotype of SCA as it is the case for alpha-thalassemia.,the aim of this study was to determine if the number of HbF gene loci (QTL) would also favor a specific sub-phenotype of SCA as it is the case for alpha-thalassemia.,"The aim of our study was to find out if the number of HbF-QTL, quantitative trait loci (QTL-special sections of DNA) would influence the severity of SCA as seen in alpha-thalassemia."
